文件名,CAS,PubChem CID,Molecular Formula,Synonyms,Molecular Weight,Description,InChI,InChIKey,SMILES,European Community (EC) Number,ChEBI ID,Color / Form,Drug Indication,Drug Classes,Clinical Trials,Therapeutic area,INN/Common name,Melting point,Boiling point,Flash Point,Density,Solubility,Odor,Color3/Form,logP,pKa,Rotatable Bond Count,Hydrogen Bond Acceptor Count,Hydrogen Bond Donor Count,Heavy Atom Count,Topological Polar Surface Area
10034073_Fidaxomicin.json,873857-62-6,,C52H74Cl2O18,Dificid,1058.0,,"InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1",ZVGNESXIJDCBKN-UUEYKCAUSA-N,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,692-555-6,,,Fidaxomicin is indicated for the treatment of _Clostridioides_ (formerly _Clostridium_) _difficile_-associated diarrhea in adult and pediatric patients 6 months of age and older.  Fidaxomicin should only be used in patients with proven or strongly suspected _C. difficile_ infection to reduce the risk of development of drug-resistant bacteria and maximize the therapeutic effectiveness of fidaxomicin and other antimicrobial agents.,"Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Macrocyclic Antibiotics","{'Record': {'RecordType': 'CID', 'RecordNumber': 10034073, 'RecordTitle': 'Fidaxomicin', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since too many atoms'}]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Description': 'HIV/AIDS and Opportunistic Infection Drugs', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of diarrhea caused by entericinfectionwith the bacteriumClostridioides difficile.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}, {'String': 'Certain bacterial enteric infections can be opportunistic infections(OIs) of HIV.'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a novel macrolide antibiotic used in the treatment of diarrhea caused by Clostridioides (formerly Clostridium) difficile in adult and pediatric patients over the age of 6 months. Fidaxomicin is a naturally-occurring 18-member macrocycle derived from fermentation. Because fidaxomicin contains an 18-membered lactone ring in its structure, it is referred to as a macrocyclic lactone antibiotic drug. The antibacterial activity of fidaxomicin is distinct from macrolides and rifamycins, as the bactericidal activity is time-dependent, and not concentration-dependent. Fidaxomicin was the first macrocyclic lactone antibiotic with activity against C. difficile, and it displays a narrow spectrum of activity against gram-positive anaerobes. It mediates its potent bactericidal action on the bacteria by inhibiting the bacterial RNA synthase, thereby disrupting bacterial transcription. The minimum inhibitory concentration (MIC90) for fidaxomicin is four times less than that of [vancomycin], which was the primary drug of choice for C. difficile infection before the approval of fidaxomicin. Unlike vancomycin, however, fidaxomicin has a negligible effect on normal colonic microflora.  The FDA initially approved fidaxomicin in May 2011 for the treatment of C. difficile-associated diarrhea in adult patients over the age of 18. Later that year in December, the drug was also approved by the European Medicine Agency. In June 2012, fidaxomicin was also granted approval by Health Canada. The approved indication of fidaxomicin was expanded by the FDA in January 2020 to include pediatric patients over the age of 6 months in the treatment population.', 'Markup': [{'Start': 88, 'Length': 14, 'Type': 'Italics'}, {'Start': 113, 'Length': 11, 'Type': 'Italics'}, {'Start': 126, 'Length': 9, 'Type': 'Italics'}, {'Start': 660, 'Length': 12, 'Type': 'Italics'}, {'Start': 939, 'Length': 2, 'Type': 'Subscript'}, {'Start': 1046, 'Length': 12, 'Type': 'Italics'}, {'Start': 1272, 'Length': 12, 'Type': 'Italics'}, {'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 194, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 287, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 444, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 581, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 947, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 992, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/vancomycin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14969'}, {'Start': 1092, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1112, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/vancomycin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14969'}, {'Start': 1133, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1227, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1446, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1529, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 22, 'Description': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a Macrolide Antibacterial.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 23, 'Description': 'LiverTox Summary', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 119, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 24, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin has been reported in Actinoplanes deccanensis, Dactylosporangium aurantiacum, and Micromonospora echinospora with data available.', 'Markup': [{'Start': 33, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/113561#section=Natural-Products'}, {'Start': 59, 'Length': 29, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/35754#section=Natural-Products'}, {'Start': 94, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/1877#section=Natural-Products'}, {'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 31, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a narrow-spectrum, 18-membered macrolide antibiotic isolated from the actinomycete Dactylosporangium aurantiacum subsp. hamdenensis with potential antibacterial activity. Although the exact mechanism of action has yet to be fully elucidated, fidaxomicin may bind to and inhibit bacterial DNA-dependent RNA polymerase, thereby inhibiting the initiation of bacterial RNA synthesis. When orally administered, this agent is minimally absorbed into the systemic circulation, acting locally in the gastrointestinal tract. Fidaxomicin appears to be active against pathogenic Gram-positive bacteria, such as clostridia, enterococci, and staphylococci, but does not appear to be active against other beneficial intestinal bacteria.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 257, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 531, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 34, 'Value': {'StringWithMarkup': [{'String': 'FIDAXOMICIN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 4 approved indications.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/FIDAXOMICIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 47, 'Value': {'StringWithMarkup': [{'String': 'A narrow-spectrum macrolide antibacterial agent that is used in the treatment of diarrhea associated with CLOSTRIDIUM DIFFICILE INFECTION.'}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '[(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate', 'Markup': [{'Start': 3, 'Length': 1, 'Type': 'Italics'}, {'Start': 6, 'Length': 1, 'Type': 'Italics'}, {'Start': 9, 'Length': 1, 'Type': 'Italics'}, {'Start': 12, 'Length': 1, 'Type': 'Italics'}, {'Start': 15, 'Length': 1, 'Type': 'Italics'}, {'Start': 24, 'Length': 1, 'Type': 'Italics'}, {'Start': 27, 'Length': 1, 'Type': 'Italics'}, {'Start': 30, 'Length': 1, 'Type': 'Italics'}, {'Start': 33, 'Length': 1, 'Type': 'Italics'}, {'Start': 37, 'Length': 1, 'Type': 'Italics'}, {'Start': 41, 'Length': 1, 'Type': 'Italics'}, {'Start': 45, 'Length': 1, 'Type': 'Italics'}, {'Start': 49, 'Length': 1, 'Type': 'Italics'}, {'Start': 53, 'Length': 1, 'Type': 'Italics'}, {'Start': 62, 'Length': 1, 'Type': 'Italics'}, {'Start': 65, 'Length': 1, 'Type': 'Italics'}, {'Start': 68, 'Length': 1, 'Type': 'Italics'}, {'Start': 71, 'Length': 1, 'Type': 'Italics'}, {'Start': 164, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C52H74Cl2O18/c1-13-30-22-26(6)33(56)18-16-15-17-31(23-66-51-45(65-12)42(61)44(29(9)67-51)69-49(64)35-32(14-2)36(53)39(58)37(54)38(35)57)48(63)68-34(28(8)55)20-19-25(5)21-27(7)43(30)70-50-41(60)40(59)46(52(10,11)72-50)71-47(62)24(3)4/h15-17,19,21-22,24,28-30,33-34,40-46,50-51,55-61H,13-14,18,20,23H2,1-12H3/b16-15+,25-19+,26-22+,27-21+,31-17+/t28-,29-,30+,33+,34+,40-,41+,42+,43+,44-,45+,46+,50-,51-/m1/s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'ZVGNESXIJDCBKN-UUEYKCAUSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\\C)\\C)[C@@H](C)O)\\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\\C'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C52H74Cl2O18'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=873857-62-6', 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}, {'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}, {'ReferenceNumber': 17, 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}, {'ReferenceNumber': 20, 'Value': {'StringWithMarkup': [{'String': '873857-62-6'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '55352-58-4, 56645-60-4, 750595-89-2', 'Markup': [{'Start': 12, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/56645-60-4', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 17, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.220.590', 'Value': {'StringWithMarkup': [{'String': '692-555-6'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 20, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Z5N076G8YQ', 'Value': {'StringWithMarkup': [{'String': 'Z5N076G8YQ'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1255800', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL1255800'}]}}]}, {'TOCHeading': 'DrugBank ID', 'Description': 'Drug identifier used by the DrugBank database', 'URL': 'https://go.drugbank.com/', 'Information': [{'ReferenceNumber': 9, 'URL': 'https://www.drugbank.ca/drugs/DB08874', 'Value': {'StringWithMarkup': [{'String': 'DB08874'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID901016415', 'Value': {'StringWithMarkup': [{'String': 'DTXSID901016415'}]}}]}, {'TOCHeading': 'Metabolomics Workbench ID', 'Description': 'Registration number used by Metabolomics Workbench', 'URL': 'https://www.metabolomicsworkbench.org/', 'Information': [{'ReferenceNumber': 25, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=65104', 'Value': {'StringWithMarkup': [{'String': '65104'}]}}, {'ReferenceNumber': 26, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=104056', 'Value': {'StringWithMarkup': [{'String': '104056'}]}}, {'ReferenceNumber': 27, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=115962', 'Value': {'StringWithMarkup': [{'String': '115962'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 31, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66979', 'Value': {'StringWithMarkup': [{'String': 'C66979'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 32, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1111103', 'Value': {'StringWithMarkup': [{'String': '1111103'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 44, 'URL': 'https://www.wikidata.org/wiki/Q111242331', 'Value': {'StringWithMarkup': [{'String': 'Q111242331'}]}}, {'ReferenceNumber': 45, 'URL': 'https://www.wikidata.org/wiki/Q5446672', 'Value': {'StringWithMarkup': [{'String': 'Q5446672'}]}}]}, {'TOCHeading': 'Wikipedia', 'Description': 'Wikidata entity identifier for this compound.', 'Information': [{'ReferenceNumber': 46, 'URL': 'https://en.wikipedia.org/wiki/Fidaxomicin', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 47, 'Value': {'StringWithMarkup': [{'String': 'Dificid'}, {'String': 'fidaxomicin'}, {'String': 'lipiarmycin'}, {'String': 'lipiarmycin A3'}, {'String': 'lipiarmycin A4'}, {'String': 'lipiarmycin B'}, {'String': 'lipiarmycin B3'}, {'String': 'lipiarmycin B4'}, {'String': 'PAR 101'}, {'String': 'PAR-101'}, {'String': 'PAR101'}, {'String': 'tiacumicin B'}, {'String': 'tiacumicin C'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin'}, {'String': '873857-62-6'}, {'String': 'Dificlir'}, {'String': 'Lipiarmicin'}, {'String': 'Difimicin'}, {'String': 'Clostomicin B1'}, {'String': 'R-Tiacumicin B'}, {'String': 'Lipiarmycin A 3'}, {'String': 'fidaxomicine'}, {'String': 'Fidaxomicina'}, {'String': 'Lipiarrmycin'}, {'String': 'UNII-Z5N076G8YQ'}, {'String': 'PAR 01'}, {'String': 'Z5N076G8YQ'}, {'String': 'BRN 5228707'}, {'String': 'DTXSID901016415'}, {'String': 'CHEBI:68590'}, {'String': 'fidaxomicinum'}, {'String': '56645-60-4'}, {'String': 'A07AA12'}, {'String': 'DTXCID801474599'}, {'String': '(3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-beta-D-mannopyranosyl)oxy)methyl)-12-((6-deoxy-5-C-methyl-4-O-(2-methylpropanoyl)-beta-D-lyxo-hexopyranosyl)oxy)-11-ethyl-8-hydroxy-18-((1R)-1-hydroxyethyl)-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaen-2-one'}, {'String': 'Tiacumicin B'}, {'String': 'Dificid'}, {'String': 'OPT-80'}, {'String': 'PAR-101'}, {'String': 'Lipiarmycin A3'}, {'String': '(2R,3S,4S,5S,6R)-6-{[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-{[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-[(2-methylpropanoyl)oxy]oxan-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy}-4-hydroxy-5-methoxy-2-methyloxan-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate'}, {'String': '[(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate'}, {'String': 'Fidaxomicin [USAN]'}, {'String': 'Fidaxomicin [USAN:INN]'}, {'String': 'Clostomycin B1'}, {'String': 'Fidaxomicin (Dificid)'}, {'String': 'FIDAXOMICIN [MI]'}, {'String': 'FIDAXOMICIN [INN]'}, {'String': 'FIDAXOMICIN [JAN]'}, {'String': 'FIDAXOMICIN [VANDF]'}, {'String': 'FIDAXOMICIN [WHO-DD]'}, {'String': 'CHEMBL1255800'}, {'String': 'SCHEMBL10000818'}, {'String': 'Fidaxomicin, >=98% (HPLC)'}, {'String': 'GTPL10909'}, {'String': 'FIDAXOMICIN [ORANGE BOOK]'}, {'String': 'FI8'}, {'String': 'MSK169310'}, {'String': 'AKOS040758974'}, {'String': 'AF31015'}, {'String': 'DB08874'}, {'String': 'Clostomicin B1;Lipiarmycin;R-Tiacumicin B'}, {'String': '1ST169310'}, {'String': 'F1216'}, {'String': 'OPT-80;PAR-101;Clostomicin B1;Tiacumicin B'}, {'String': 'EN300-21995976'}, {'String': 'Q5446672'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Lipiarmycin'}, {'String': 'lipiarmycin a4'}, {'String': 'Lipiarmycin B'}, {'String': 'Tiacumicin C'}, {'String': 'Lipiarmycin B3'}, {'String': 'Lipiarmycin B4'}, {'String': 'fidaxomicin/Dificid'}, {'String': 'Dificid (TN)'}, {'String': 'D06LNW'}, {'String': 'PAR 101'}, {'String': 'OPT 80'}, {'String': 'OPT80'}, {'String': 'PAR101'}, {'String': 'C52H74Cl2O18'}, {'String': 'C52-H74-Cl2-O18'}, {'String': 'BBF-03418'}, {'String': 'MFCD27976367'}, {'String': '2,4-dihydroxyacetophenone semicarbazone'}, {'String': 'CID10034073'}, {'String': 'CID:10034073'}, {'String': 'SID:406845025'}, {'String': 'C16560'}, {'String': 'S-7827'}, {'String': 'A851944'}, {'String': 'D000077732'}, {'String': '(2R,3S,4S,5S,6R)-6-({(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-{[(2R,3S,4R,5S)-3,4-Dihydroxy-5-(isobutyryloxy)-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15- trimethyl-2-oxooxacyclooctadeca-3,5,9,13,15-pentaen-3-yl}methoxy)-4-hydroxy-5-methoxy-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate'}, {'String': 'Oxacyclooctadeca-3,5,9,13,15-pentaen-2-one, 3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-ss-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-ss-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-, (3E,5E,8S,9E,11S,12R,13E,15E,18S)-; (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-ss-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-ss-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyloxacyclooctadeca-3,5,9,13,15-pentaen-2-one; Clostomicin B1; Dificid; Dificlir; Fidaxomicin; Fidaxomycin; Lipiarmicin; Lipiarmycin; Lipiarmycin A 3; OPT 80; PAR 01; PAR 101; R-Tiacumicin B; Tiacumicin B'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '1058.0'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'XLogP3', 'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/', 'Information': [{'ReferenceNumber': 48, 'Name': 'XLogP3-AA', 'Reference': ['Computed by XLogP3 3.0 (PubChem release 2025.04.14)'], 'Value': {'Number': [6.4]}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [7]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [18]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [15]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '1056.4252209'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '1056.4252209'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [267], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [72]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [1970]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [14]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [5]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 48, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Experimental Properties', 'Description': 'Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Boiling Point', 'Description': 'The temperature at which this compound changes state from liquid to gas at a given atmospheric pressure.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.02%3A_Boiling_Point', 'Information': [{'ReferenceNumber': 9, 'Reference': ['MSDS (Santa Cruz Biotechnology)'], 'ExtendedReference': [{'Citation': 'MSDS (Santa Cruz Biotechnology)', 'Matched': {'PCLID': 906317900, 'Citation': 'MSDS (Santa Cruz Biotechnology)'}}], 'Value': {'Number': [1046.4]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Macrocyclic Antibiotics'}]}}, {'ReferenceNumber': 12, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued; Active ingredient (FIDAXOMICIN)', 'Markup': [{'Start': 47, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/FIDAXOMICIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 18, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Antidiarrheals, intestinal antiinflammatory / antiinfective agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}]}]}, {'TOCHeading': 'Endocrine Disruptors', 'Description': ""Endocrine disruptors are natural or man-made chemicals that may mimic or interfere with the body's hormones, known as the endocrine system."", 'URL': 'https://www.niehs.nih.gov/health/topics/agents/endocrine', 'Information': [{'ReferenceNumber': 33, 'Reference': ['S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198'], 'ExtendedReference': [{'Citation': 'S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198', 'Matched': {'PCLID': 906297454, 'Citation': 'S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198'}}], 'Value': {'StringWithMarkup': [{'String': 'Potential endocrine disrupting compound'}]}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10034073%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10034073%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 48, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [76]}}, {'ReferenceNumber': 48, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 48, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [72]}}, {'ReferenceNumber': 48, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [82]}}, {'ReferenceNumber': 48, 'Name': 'Same Parent, Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_parent_stereo&list_return=redirect', 'Value': {'Number': [7]}}, {'ReferenceNumber': 48, 'Name': 'Same Parent, Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_parent_isotopes&list_return=redirect', 'Value': {'Number': [78]}}, {'ReferenceNumber': 48, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [6]}}, {'ReferenceNumber': 48, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [8]}}, {'ReferenceNumber': 48, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10034073%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 48, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10034073%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 48, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/483927427', 'Value': {'Number': [483927427]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 48, 'Name': 'All Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/sids/JSON?sids_type=all&list_return=redirect', 'Value': {'Number': [91]}}, {'ReferenceNumber': 48, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [83]}}, {'ReferenceNumber': 48, 'Name': 'Mixture Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/sids/JSON?sids_type=component&list_return=redirect', 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 48, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10034073', 'Value': {'Number': [13]}}, {'ReferenceNumber': 48, 'Name': 'Protein Structures Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=10034073', 'Value': {'Number': [2]}}, {'ReferenceNumber': 48, 'Name': 'Taxonomy Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=10034073', 'Value': {'Number': [1]}}, {'ReferenceNumber': 48, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10034073', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'NCBI LinkOut', 'Description': 'NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout/', 'Information': [{'ReferenceNumber': 68, 'Value': {'Boolean': [True]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 48, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is indicated for the treatment of _Clostridioides_ (formerly _Clostridium_) _difficile_-associated diarrhea in adult and pediatric patients 6 months of age and older.  Fidaxomicin should only be used in patients with proven or strongly suspected _C. difficile_ infection to reduce the risk of development of drug-resistant bacteria and maximize the therapeutic effectiveness of fidaxomicin and other antimicrobial agents.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 180, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 390, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 9, 'URL': 'http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB08874.pdf?1368412697', 'Value': {'StringWithMarkup': [{'String': 'FDA Label'}]}}, {'ReferenceNumber': 18, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Dificlir film-coated tablets is indicated for the treatment of Clostridioides difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adult and paediatric patients with a body weight of at least 12. 5 kg. Consideration should be given to official guidelines on the appropriate use of antibacterial agents. DificlirÂ\xa0granules for oral suspension is indicated for the treatment of ClostridioidesÂ\xa0 difficile infections (CDI) also known as C. difficile-associated diarrhoea (CDAD) in adults and paediatric patients from birth to < 18 years of age. Consideration should be given to official guidelines on the appropriate use of antibacterial agents.', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Dificlir', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 100, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/CDI', 'Type': 'PubChem Internal Link', 'Extra': 'CID-68263'}, {'Start': 447, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/CDI', 'Type': 'PubChem Internal Link', 'Extra': 'CID-68263'}]}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of enterocolitis caused by Clostridium difficile'}]}}, {'ReferenceNumber': 34, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'LiverTox Summary', 'Description': 'Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK547852/', 'Information': [{'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 119, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'Drug Classes', 'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Macrocyclic Antibiotics'}]}}, {'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'Antiinfective Agents'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 11, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^FIDAXOMICIN$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 21, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^FIDAXOMICIN$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 28, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^FIDAXOMICIN$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 7, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^FIDAXOMICIN$'""}}, {'ReferenceNumber': 7, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^FIDAXOMICIN$'""}}]}, {'TOCHeading': 'HIV/AIDS and Opportunistic Infection Drugs', 'Description': 'This section contains information and links on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 8, 'Name': 'What is Fidaxomicin', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is an antibacterial prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of diarrhea caused by entericinfectionwith the bacteriumClostridioides difficile.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}, {'String': 'Certain bacterial enteric infections can be opportunistic infections(OIs) of HIV.'}]}}, {'ReferenceNumber': 8, 'Name': 'Drug Class', 'Value': {'StringWithMarkup': [{'String': 'Antibacterial (Macrolide)'}]}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 26}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 15, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 7}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 18, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/dificlir', 'Value': {'StringWithMarkup': [{'String': 'Dificlir'}]}}, {'ReferenceNumber': 18, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs'}]}}, {'ReferenceNumber': 18, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Clostridium Infections'}]}}, {'ReferenceNumber': 18, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'fidaxomicin'}]}}, {'ReferenceNumber': 18, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'fidaxomicin'}]}}, {'ReferenceNumber': 18, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Antidiarrheals, intestinal antiinflammatory / antiinfective agents'}]}}, {'ReferenceNumber': 18, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'This medicine is authorized for use in the European Union'}]}}, {'ReferenceNumber': 18, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'Tillotts Pharma GmbH'}]}}, {'ReferenceNumber': 18, 'Name': 'Market Date', 'Value': {'StringWithMarkup': [{'String': '2011-12-05'}]}}, {'ReferenceNumber': 19, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 19, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000636-pip01-09-m07', 'Value': {'StringWithMarkup': [{'String': 'fidaxomicin'}]}}, {'ReferenceNumber': 19, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Infectious diseases'}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet, Granules for oral suspension'}]}}, {'ReferenceNumber': 19, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2018-03-16'}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'Pharmacodynamics', 'Description': 'Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK507791/', 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin has a narrow-spectrum antibacterial profile, with potent bactericidal activity specifically against C. difficile. The minimum inhibitory concentration for 90% of organisms for fidaxomicin against _C. difficile_ ranged from 0.0078 to 2 μg/mL _in vitro_. The bactericidal activity of fidaxomicin is time-dependent. Other than _C. difficile_, fidaxomicin has moderate inhibitory activity against Gram-positive bacteria (_S. aureus_ and _Enterococcus spp._) and poor activity against normal colonic flora, including anaerobes and enteric Gram-negative bacilli. Isolates of _C. difficile_ that are resistant to rifamycins or other antimicrobial classes (such as cephalosporins, fluoroquinolones, clindamycin) were not shown to be cross-resistant to fidaxomicin.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 188, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 294, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 352, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 703, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/clindamycin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-446598'}, {'Start': 756, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 66, 'Name': 'Anti-Bacterial Agents', 'Value': {'StringWithMarkup': [{'String': 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Markup': [{'Start': 69, 'Length': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68000900'}]}]}}]}, {'TOCHeading': 'FDA Pharmacological Classification', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 22, 'Name': 'FDA UNII', 'Value': {'StringWithMarkup': [{'String': 'Z5N076G8YQ'}]}}, {'ReferenceNumber': 22, 'Name': 'Active Moiety', 'Value': {'StringWithMarkup': [{'String': 'FIDAXOMICIN'}]}}, {'ReferenceNumber': 22, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Chemical Structure [CS] - Macrolides'}]}}, {'ReferenceNumber': 22, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Established Pharmacologic Class [EPC] - Macrolide Antibacterial'}]}}, {'ReferenceNumber': 22, 'Name': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is a Macrolide Antibacterial.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 29, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'FIDAXOMICIN'}]}}, {'ReferenceNumber': 29, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Macrolide Antibacterial [EPC]; Macrolides [CS]'}]}}]}, {'TOCHeading': 'ATC Code', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.whocc.no/atc/structure_and_principles/', 'Information': [{'ReferenceNumber': 18, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'A07AA12'}]}}, {'ReferenceNumber': 43, 'Value': {'StringWithMarkup': [{'String': 'A - Alimentary tract and metabolism', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A'}]}, {'String': 'A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A07'}]}, {'String': 'A07A - Intestinal antiinfectives', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A07A'}]}, {'String': 'A07AA - Antibiotics', 'Markup': [{'Start': 0, 'Length': 5, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A07AA'}]}, {'String': 'A07AA12 - Fidaxomicin', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A07AA12'}]}]}}]}, {'TOCHeading': 'Absorption, Distribution and Excretion', 'Information': [{'ReferenceNumber': 9, 'Name': 'Absorption', 'Value': {'StringWithMarkup': [{'String': 'Following oral administration of a single dose of 200 mg fidaxomicin in healthy adults, the Cmax of fidaxomicin and its main metabolite OP-1118 were 5.20 ± 2.81 ng/mL and 12.0 ± 6.06, respectively. The median Tmax of fidaxomicin was 2 hours. The systemic absorption of fidaxomicin following oral administration is minimal.  In a food-effect study involving healthy adults in either with a high-fat meal versus under fasting conditions, the Cmax of fidaxomicin and OP-1118 were decreased by 21.5% and 33.4%, respectively; however, this effect is deemed to be clinically insignificant as the therapeutic action of fidaxomicin does not depend on drug concentrations in the systemic circulation.', 'Markup': [{'Start': 93, 'Length': 3, 'Type': 'Subscript'}, {'Start': 210, 'Length': 3, 'Type': 'Subscript'}, {'Start': 441, 'Length': 3, 'Type': 'Subscript'}, {'Start': 57, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 100, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 217, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 269, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 448, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 612, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 9, 'Name': 'Route of Elimination', 'Value': {'StringWithMarkup': [{'String': 'Following oral administration, fidaxomicin is mainly excreted in feces. More than 92% of the dose was recovered in the faces as either the unchanged parent drug or metabolites in one study consisting of healthy adults receiving single doses of 200 mg and 300 mg of fidaxomicin. In another study of healthy adults, approximately 0.59% fo the oral dose (200 mg) administered was recovered in the urine as the main metabolite, OP-1118.', 'Markup': [{'Start': 31, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 265, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 9, 'Name': 'Volume of Distribution', 'Value': {'StringWithMarkup': [{'String': 'Fidaxomicin is mainly confined to the gastrointestinal tract when orally administered. There is limited information on the volume of distribution of fidaxomicin.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 149, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}, {'ReferenceNumber': 9, 'Name': 'Clearance', 'Value': {'StringWithMarkup': [{'String': 'There is limited information on the clearance of fidaxomicin.', 'Markup': [{'Start': 49, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'Metabolism/Metabolites', 'Description': 'Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.', 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Following oral administration, fidaxomicin is transformed to its main and pharmacologically active metabolite, OP-1118, via hydrolysis at the isobutyryl ester. As cytochrome enzymes are not involved in the metabolism of fidaxomicin, it is speculated that this biotransformation is mediated by gastric acid or enzymatic activity of intestinal microsomes.', 'Markup': [{'Start': 31, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 220, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'Biological Half-Life', 'Description': 'The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.', 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Following oral administration of a single dose of 200 mg fidaxomicin in healthy adults, the elimination half-life of fidaxomicin was approximately 11.7 ± 4.80 hours.', 'Markup': [{'Start': 57, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 117, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}, {'TOCHeading': 'Mechanism of Action', 'Description': 'In medicine, the term ""mechanism of action"" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug\'s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.', 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': '_Clostridium difficile_ is a Gram-positive bacterium that causes various gastrointestinal complications, such as antibiotic-associated diarrhea. _C. difficile_ infection can be caused by antibiotic therapy, resulting in the disruption of the human gut flora leads to an overgrowth of _C. difficile_. The consequences of _C. difficile_ infection can be mild to severe and sometimes fatal.   Fidaxomicin gets hydrolyzed to its active metabolite, OP-1118, upon oral administration. Both compounds mediate a bactericidal activity against _C. difficile_ by inhibiting bacterial RNA polymerase at the initiation phase of the transcription cycle. The RNA polymerase is an essential bacterial enzyme that regulates gene expression, catalyzes nucleic acid interactions, and promotes several bacterial enzymatic reactions critical for bacterial survival. The core RNA polymerase is composed of a complex of different subunits and contains the active site. To initiate bacterial transcription, the active site of the core RNA polymerase binds to a promoter-specificity σ initiation factor, which locates and binds to a promoter region of the DNA. The DNA-RNA polymerase interaction promotes subsequent steps of transcription, which involves the separation of DNA strands. Fidaxomicin binds to the DNA template-RNA polymerase complex, thereby preventing the initial separation of DNA strands during transcription and inhibiting messenger RNA synthesis. The narrow spectrum of antimicrobial activity of fidaxomicin may be explained by the unique target site of fidaxomicin and differing σ subunits of the core structure of RNA polymerase among bacterial species.', 'Markup': [{'Start': 390, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1261, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1490, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 1548, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Antidiarrheals, intestinal antiinflammatory / antiinfective agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 21, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Warning', 'Markup': [{'Start': 0, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 16, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (97.3%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 36, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P264, P270, P301+P317, P330, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 12, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 23, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 33, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 16, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 37 reports by companies from 2 notifications to the ECHA C&L Inventory.', 'Markup': [{'Start': 0, 'Length': 115, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/226342'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (97.3%)'}]}}]}]}]}, {'TOCHeading': 'Toxicity', 'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.', 'Section': [{'TOCHeading': 'Toxicological Information', 'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.', 'Section': [{'TOCHeading': 'Hepatotoxicity', 'Description': 'This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.', 'Information': [{'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'In large clinical trials, therapy with fidaxomicin for ten days was associated with a low rate of serum aminotransferase elevations [1% to 3.2%], but rates with comparator agents such as vancomycin were similar [up to 2.7%]. There have been no reports of clinically apparent liver injury attributed to fidaxomicin. However, other oral macrolide antibiotics have been linked to many episodes of acute liver injury which can be severe and have resulted in fatalities. The onset of macrolide associated liver injury is typically 1 to 3 weeks after starting the drug and can arise after it is stopped. The injury is typically cholestatic, but can be mixed or hepatocellular. The hepatocellular cases are more likely to be severe and can result in acute liver failure. However, in most instances, recovery occurs within 4 to 8 weeks of withdrawal of the macrolide. No such cases, however, have been linked to use of fidaxomicin, which unlike the other macrolides is not absorbed orally.', 'Markup': [{'Start': 39, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 187, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/vancomycin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14969'}, {'Start': 302, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}, {'Start': 911, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}, {'String': 'Likelihood score: E (unlikely cause of clinically apparent liver injury).'}]}}]}, {'TOCHeading': 'Effects During Pregnancy and Lactation', 'Description': 'Drug effects during pregnancy and lactation.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '◉ Summary of Use during Lactation'}, {'String': 'No information is available on the use of fidaxomicin during breastfeeding. Because it is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants.', 'Markup': [{'Start': 42, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}, {'String': '◉ Effects in Breastfed Infants'}, {'String': 'Relevant published information was not found as of the revision date.'}, {'String': '◉ Effects on Lactation and Breastmilk'}, {'String': 'Relevant published information was not found as of the revision date.'}]}}]}, {'TOCHeading': 'Acute Effects', 'Description': 'The results from acute animal tests and/or acute human studies are presented in this section. Acute animal studies consist of LD50 and LC50 tests, which present the median lethal dose (or concentration) to the animals. Acute human studies usually consist of case reports from accidental poisonings or industrial accidents. These case reports often help to define the levels at which acute toxic effects are seen in humans.', 'Information': [{'ReferenceNumber': 4, 'Value': {'ExternalTableName': 'collection=chemidplus&query_type=sid&query=135262601'}}]}, {'TOCHeading': 'Protein Binding', 'Description': 'In this section, ""protein binding"" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug\'s efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.', 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Since fidaxomicin has minimal systemic absorption following oral administration, there is limited information on the plasma protein binding profile of fidoxamicin.', 'Markup': [{'Start': 6, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 34, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 41, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 48, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 65, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10034073', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 38, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341141870'}}, {'ReferenceNumber': 39, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341355298'}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376619021'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'US8859510', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8859510'}]}, {'String': 'US7906489', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7906489'}]}, {'String': 'US7378508', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7378508'}]}, {'String': 'US7863249', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7863249'}]}, {'String': 'US8586551', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8586551'}]}, {'String': 'US9808530', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9808530'}]}]}}], 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 48, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10034073/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 67, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=ZVGNESXIJDCBKN-UUEYKCAUSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=ZVGNESXIJDCBKN-UUEYKCAUSA-N'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 21, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^FIDAXOMICIN$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 48, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Protein Bound 3D Structures', 'Description': 'Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.', 'Information': [{'ReferenceNumber': 37, 'Value': {'ExternalTableName': 'pdb'}}, {'ReferenceNumber': 48, 'URL': 'https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=10034073', 'Value': {'StringWithMarkup': [{'String': 'View 2 proteins in NCBI Structure'}]}}], 'Section': [{'TOCHeading': 'Ligands from Protein Bound 3D Structures', 'Description': 'Ligands found in experimental protein-ligand co-complexes (e.g., those archived in the Protein Data Bank in Europe (PDBe)).', 'URL': 'https://www.ebi.ac.uk/pdbe/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'MoveToTop': True, 'ShowAtMost': 1}, 'Section': [{'TOCHeading': 'PDBe Ligand Code', 'Description': 'The ligand code for this compound used in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 35, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FI8', 'Value': {'StringWithMarkup': [{'String': 'FI8'}]}}]}, {'TOCHeading': 'PDBe Structure Code', 'Description': ""The structure code for the Protein Data Bank in Europe (PDBe) protein-ligand co-complex from which the ligand's 3-D coordinates were taken."", 'Information': [{'ReferenceNumber': 35, 'URL': 'http://www.ebi.ac.uk/pdbe/entry/pdb/6FBV', 'Value': {'StringWithMarkup': [{'String': '6FBV'}]}}]}, {'TOCHeading': 'PDBe Conformer', 'Description': 'The experimental protein-bound 3D structure of this compound in a protein-ligand co-complex archived in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 35, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FI8', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/8211369_1'], 'MimeType': 'pubchem/compound-gzip-asnb'}}]}]}]}, {'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 9, 'Value': {'ExternalTableName': 'collection=consolidatedcompoundtarget&query_type=name&query=^Fidaxomicin$'}}]}, {'TOCHeading': 'Drug-Drug Interactions', 'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'Information': [{'ReferenceNumber': 9, 'Value': {'ExternalTableName': 'collection=drugbankddi&query_type=name&query=^Fidaxomicin$'}}]}, {'TOCHeading': 'Drug-Food Interactions', 'Description': 'Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'DisplayControls': {'ListType': 'Bulleted'}, 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Take with or without food. High-fat meal decreases the Cmax of fidaxomicin and its metabolite in a clinically insignificant way.', 'Markup': [{'Start': 63, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/fidaxomicin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10034073'}]}]}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 48, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Taxonomy', 'Description': 'Organism-specific information about where this compound originated or is associated', 'Information': [{'ReferenceNumber': 24, 'ExtendedReference': [{'Citation': 'The LOTUS Initiative for Open Natural Products Research: frozen dataset union wikidata (with metadata) | DOI:10.5281/zenodo.5794106', 'DOI': '10.5281/zenodo.5794106', 'Matched': {'PCLID': 423383293, 'Citation': 'The LOTUS Initiative for Open Natural Products Research: frozen dataset union wikidata (with metadata) | DOI:10.5281/zenodo.5794106', 'DOI': '10.5281/zenodo.5794106'}}], 'Value': {'ExternalTableName': 'consolidatedcompoundtaxonomy'}}, {'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'consolidatedcompoundtaxonomy'}}, {'ReferenceNumber': 40, 'Value': {'ExternalTableName': 'consolidatedcompoundtaxonomy'}}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 49, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 60, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'WHO ATC Classification System', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.who.int/tools/atc-ddd-toolkit/atc-classification', 'Information': [{'ReferenceNumber': 52, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79', 'Value': {'Number': [79]}}]}, {'TOCHeading': 'FDA Pharm Classes', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'Information': [{'ReferenceNumber': 51, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78', 'Value': {'Number': [78]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 54, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 55, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 53, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 56, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 57, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'The Natural Products Atlas Classification', 'Description': 'The Natural Products Atlas provides information on microbially-derived natural products, published in the peer-reviewed primary scientific literature.  The Natural Products Atlas Classification provides information on the source organism for a natural product.', 'URL': 'https://www.npatlas.org/', 'Information': [{'ReferenceNumber': 58, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=108', 'Value': {'Number': [108]}}]}, {'TOCHeading': 'LOTUS Tree', 'Description': 'Biological and chemical tree provided by the naturaL prOducTs occUrrence databaSe (LOTUS)', 'URL': 'https://lotus.naturalproducts.net/', 'Information': [{'ReferenceNumber': 61, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=115', 'Value': {'Number': [115]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 62, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 63, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 64, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '873857-62-6', 'Name': 'Fidaxomicin', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=873857-62-6', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12724121}, {'ReferenceNumber': 3, 'SourceName': 'ChemIDplus', 'SourceID': '0873857626', 'Name': 'Fidaxomicin [USAN:INN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0873857626', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1140502}, {'ReferenceNumber': 9, 'SourceName': 'DrugBank', 'SourceID': 'DB08874', 'Name': 'Fidaxomicin', 'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.', 'URL': 'https://www.drugbank.ca/drugs/DB08874', 'LicenseNote': ""Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)"", 'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use', 'ANID': 3624629}, {'ReferenceNumber': 14, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID901016415', 'Name': 'Fidaxomicin', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID901016415', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 17763533}, {'ReferenceNumber': 17, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '692-555-6', 'Name': '(3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.220.590', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15159915}, {'ReferenceNumber': 20, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'Z5N076G8YQ', 'Name': 'FIDAXOMICIN', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Z5N076G8YQ', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5811661}, {'ReferenceNumber': 2, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL1255800', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1255800', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32484216}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': 'r_135262601', 'Description': 'The toxicity data was from the legacy RTECS data set in ChemIDplus.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0873857626', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 19569830}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10034073', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5190390}, {'ReferenceNumber': 6, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'D000077732::Compound', 'Name': 'Fidaxomicin', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=D000077732', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 45677323}, {'ReferenceNumber': 7, 'SourceName': 'DailyMed', 'SourceID': '52f42f81dd45749dd4996acb37c2779f', 'Name': 'FIDAXOMICIN', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=FIDAXOMICIN', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30966713}, {'ReferenceNumber': 8, 'SourceName': 'Drug Database, Clinicalinfo.hiv.gov', 'SourceID': '810286089', 'Name': 'Fidaxomicin', 'Description': 'The Drug database at the clinicalinfo.hiv.gov contains information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.', 'URL': 'https://clinicalinfo.hiv.gov/en/drugs/fidaxomicin/patient', 'LicenseNote': 'Unless otherwise noted, material presented on the HIV.gov website is considered Federal government information and is in the public domain. That means this information may be freely copied and distributed. We request that you use appropriate attribution to HIV.gov.', 'LicenseURL': 'https://www.hiv.gov/about-us/mission-and-team', 'ANID': 39760837}, {'ReferenceNumber': 22, 'SourceName': 'FDA Pharm Classes', 'SourceID': 'Z5N076G8YQ', 'Name': 'FIDAXOMICIN', 'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 6489649}, {'ReferenceNumber': 23, 'SourceName': 'LiverTox', 'SourceID': 'Fidaxomicin', 'Name': 'Fidaxomicin', 'Description': 'LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/livertox/Fidaxomicin/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 2261978}, {'ReferenceNumber': 24, 'SourceName': 'LOTUS - the natural products occurrence database', 'SourceID': 'Q111242331', 'Name': 'Fidaxomicin', 'Description': 'LOTUS is one of the biggest and best annotated resources for natural products occurrences available free of charge and without any restriction.', 'URL': 'https://www.wikidata.org/wiki/Q111242331', 'LicenseNote': 'The code for LOTUS is released under the GNU General Public License v3.0.', 'LicenseURL': 'https://lotus.nprod.net/', 'ANID': 19915830}, {'ReferenceNumber': 31, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C66979::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66979', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 14397253}, {'ReferenceNumber': 34, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL1255800', 'Name': 'FIDAXOMICIN', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL1255800', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45235612}, {'ReferenceNumber': 18, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'c2dd89446732dbaed433a7151deb7deb', 'Name': 'Dificlir (EMEA/H/C/002087)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/dificlir', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37128412}, {'ReferenceNumber': 19, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '4509ae78dbae4c08ed5a2b0eff3643cd', 'Name': 'fidaxomicin (P/0062/2018)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000636-pip01-09-m07', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37131085}, {'ReferenceNumber': 10, 'SourceName': 'Drugs and Lactation Database (LactMed)', 'SourceID': 'LM874', 'Name': 'Fidaxomicin', 'Description': 'The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM874/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 24797432}, {'ReferenceNumber': 12, 'SourceName': 'Drugs@FDA', 'SourceID': 'fceece2086fed9b8a493597619d55808', 'Name': 'FIDAXOMICIN', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38976196}, {'ReferenceNumber': 13, 'SourceName': 'Drugs@FDA', 'SourceID': 'b6c909b94b772a5b393dd7063d8e585f', 'Name': 'DIFICID', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38977564}, {'ReferenceNumber': 11, 'SourceName': 'Drugs@FDA', 'SourceID': '52f42f81dd45749dd4996acb37c2779f', 'Name': 'FIDAXOMICIN', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38964312}, {'ReferenceNumber': 15, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10034073', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482600}, {'ReferenceNumber': 16, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '226342', 'Name': '(3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxacyclooctadeca-3,5,9,13,15-pentaen-2-one (EC: 692-555-6)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/226342', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1952702}, {'ReferenceNumber': 21, 'SourceName': 'FDA Orange Book', 'SourceID': 'a3f6d95d5146d0380dbbc65fa8f85d73', 'Name': 'FIDAXOMICIN', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35235437}, {'ReferenceNumber': 43, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'A07AA12', 'Name': 'Fidaxomicin', 'Description': 'The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A07AA12', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/', 'ANID': 24385936}, {'ReferenceNumber': 29, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': '40151f4bc9c094b6107c5d9589e1830a', 'Name': 'FIDAXOMICIN', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31087015}, {'ReferenceNumber': 30, 'SourceName': 'Natural Product Activity and Species Source (NPASS)', 'SourceID': 'NPC136411', 'Name': 'Fidaxomicin', 'Description': 'The Natural Product Activity and Species Source Database (NPASS) is developed to provide a freely accessible database integrating detailed information of species sources and biological activities of natural products.', 'URL': 'https://bidd.group/NPASS/compound.php?compoundID=NPC136411', 'ANID': 20336287}, {'ReferenceNumber': 40, 'SourceName': 'The Natural Products Atlas', 'SourceID': 'Compound::NPA003282', 'Name': 'Tiacumicin B', 'Description': 'The Natural Products Atlas is designed to cover all microbially-derived natural products published in the peer-reviewed primary scientific literature. The Natural Products Atlas is created by a consortium of data curators from around the world, and is maintained by researchers in the Linington Research Group in the Department of Chemistry at Simon Fraser University in Vancouver, Canada.', 'URL': 'https://www.npatlas.org/explore/compounds/NPA003282', 'LicenseNote': 'The Natural Products Atlas is licensed under a Creative Commons Attribution 4.0 International License.', 'LicenseURL': 'https://www.npatlas.org/terms', 'ANID': 14558781}, {'ReferenceNumber': 25, 'SourceName': 'Metabolomics Workbench', 'SourceID': '65104', 'Name': 'Fidaxomicin', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=65104', 'ANID': 20219405}, {'ReferenceNumber': 26, 'SourceName': 'Metabolomics Workbench', 'SourceID': '104056', 'Name': 'Lipiarmycin A3', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=104056', 'ANID': 20254031}, {'ReferenceNumber': 27, 'SourceName': 'Metabolomics Workbench', 'SourceID': '115962', 'Name': 'Tiacumicin B', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=115962', 'ANID': 20264793}, {'ReferenceNumber': 28, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'b119fe22724419ce885bea8c95b74fad', 'Name': 'FIDAXOMICIN', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31079938}, {'ReferenceNumber': 32, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '1111103', 'Name': 'fidaxomicin', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1111103', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15097753}, {'ReferenceNumber': 33, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'nrm_10034073', 'Description': 'The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/', 'ANID': 38981311}, {'ReferenceNumber': 41, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D06LNW', 'Name': 'Fidaxomicin', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D06LNW', 'ANID': 19768880}, {'ReferenceNumber': 35, 'SourceName': 'Protein Data Bank in Europe (PDBe)', 'SourceID': 'FI8', 'Description': 'The Protein Data Bank in Europe (PDBe) manages the PDB with its wwPDB partners and provides a high-quality, up-to-date and integrated resource of macromolecular structures to support basic and applied research and education across the sciences.', 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/FI8', 'ANID': 8211369}, {'ReferenceNumber': 37, 'SourceName': 'RCSB Protein Data Bank (RCSB PDB)', 'SourceID': '10034073', 'Description': 'The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.', 'URL': 'https://www.rcsb.org/', 'LicenseNote': 'Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.', 'LicenseURL': 'https://www.rcsb.org/pages/policies', 'ANID': 13131725}, {'ReferenceNumber': 38, 'SourceName': 'Springer Nature', 'SourceID': '341141870', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341141870', 'ANID': 47452016}, {'ReferenceNumber': 39, 'SourceName': 'Springer Nature', 'SourceID': '341355298', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341355298', 'ANID': 47637984}, {'ReferenceNumber': 42, 'SourceName': 'Thieme Chemistry', 'SourceID': '376619021', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376619021', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48319571}, {'ReferenceNumber': 44, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q111242331', 'Name': 'fidaxomicin', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q111242331', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44156730}, {'ReferenceNumber': 45, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q5446672', 'Name': 'fidaxomicin', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q5446672', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44348064}, {'ReferenceNumber': 46, 'SourceName': 'Wikipedia', 'SourceID': 'c_8838', 'Name': 'Fidaxomicin', 'Description': 'Link to the chemical information in Wikipedia.', 'URL': 'https://en.wikipedia.org/wiki/Fidaxomicin', 'ANID': 24330374}, {'ReferenceNumber': 47, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2028126', 'Name': 'Fidaxomicin', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2028126', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 48, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 49, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 51, 'SourceName': 'FDA Pharm Classes', 'SourceID': 'FDA_pharm_tree', 'Name': 'FDA Pharmacological Classification', 'Description': 'FDA pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 52, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'ATCTree', 'Name': 'EPA CPDat Classification', 'Description': 'The WHO ATC (Anatomical Therapeutic Chemical) classification system classify the active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/'}, {'ReferenceNumber': 53, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 54, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 55, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 56, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 57, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 58, 'SourceName': 'The Natural Products Atlas', 'SourceID': 'npatlas_tree', 'Name': 'The Natural Products Atlas Classification', 'Description': 'The Natural Products Atlas Classification provides the taxonomy information based on the natural products source.', 'URL': 'https://www.npatlas.org/', 'LicenseNote': 'The Natural Products Atlas is licensed under a Creative Commons Attribution 4.0 International License.', 'LicenseURL': 'https://www.npatlas.org/terms'}, {'ReferenceNumber': 60, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 61, 'SourceName': 'LOTUS - the natural products occurrence database', 'SourceID': 'biochem', 'Name': 'LOTUS Tree', 'Description': 'Biological and chemical tree provided by the LOTUS (naturaL products occurrence database)', 'URL': 'https://lotus.naturalproducts.net/', 'LicenseNote': 'The code for LOTUS is released under the GNU General Public License v3.0.', 'LicenseURL': 'https://lotus.nprod.net/'}, {'ReferenceNumber': 62, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 63, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 64, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 65, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 66, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68000900', 'Name': 'Anti-Bacterial Agents', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68000900', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 67, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 388432561', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/388432561'}, {'ReferenceNumber': 68, 'SourceName': 'NCBI', 'SourceID': 'LinkOut', 'Description': 'LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout'}]}}",Clostridium Infections,fidaxomicin,,[1046.4],,,,,,,,[15],[18],[7],[72],[267]
10039776_Benorterone.json,3570-10-3,,C19H28O2,benorterone,288.4,,"InChI=1S/C19H28O2/c1-17-7-4-13(20)10-12(17)11-14-15(17)5-8-18(2)16(14)6-9-19(18,3)21/h10,14-16,21H,4-9,11H2,1-3H3/t14-,15+,16+,17+,18+,19+/m1/s1",RQETXCPBBLHUIB-UGCZWRCOSA-N,C[C@]12CCC(=O)C=C1C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,,,,,,,,,,,,,,,,,,[0],[2],[1],[21],[37.3]
100427_Palifosfamide.json,31645-39-3,,C4H11Cl2N2O2P,ifosfamide mustard,221.02,,"InChI=1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10)",BKCJZNIZRWYHBN-UHFFFAOYSA-N,C(CCl)NP(=O)(NCCCl)O,,CHEBI:80566,,"Investigated for use/treatment in cancer/tumors (unspecified), lymphoma (unspecified), and sarcoma.",,"{'Record': {'RecordType': 'CID', 'RecordNumber': 100427, 'RecordTitle': 'Palifosfamide', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Description': 'Palifosfamide', 'Value': {'Number': [100427]}}]}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Isophosphamide mustard is a phosphorodiamide.', 'Markup': [{'Start': 0, 'Length': 22, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Isophosphamide%20mustard', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}]}]}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Palifosfamide (ZIO-201) is a proprietary stabilized metabolite of ifosfamide. Ifosfamide has been shown to be effective in high doses in treating testicular cancer, sarcoma and lymphoma.', 'Markup': [{'Start': 0, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Palifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}, {'Start': 15, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ZIO-201', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}, {'Start': 66, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}, {'Start': 78, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}]}]}}, {'ReferenceNumber': 19, 'Value': {'StringWithMarkup': [{'String': 'Palifosfamide is a synthetic mustard compound with potential antineoplastic activity. An active metabolite of ifosfamide covalently linked to the amino acid lysine for stability, palifosfamide irreversibly alkylates and cross-links DNA through GC base pairs, resulting in irreparable 7-atom inter-strand cross-links; inhibition of DNA replication and cell death follow. Unlike ifosfamide, this agent is not metabolized to acrolein or chloroacetaldehyde, metabolites associated with bladder and CNS toxicities. In addition, because palifosfamide does not require activation by aldehyde dehydrogenase, it may overcome the tumor resistance seen with ifosfamide.', 'Markup': [{'Start': 0, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Palifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}, {'Start': 110, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}, {'Start': 157, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/lysine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5962'}, {'Start': 179, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/palifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}, {'Start': 377, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}, {'Start': 422, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/acrolein', 'Type': 'PubChem Internal Link', 'Extra': 'CID-7847'}, {'Start': 434, 'Length': 18, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/chloroacetaldehyde', 'Type': 'PubChem Internal Link', 'Extra': 'CID-33'}, {'Start': 531, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/palifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}, {'Start': 647, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}]}]}}, {'ReferenceNumber': 22, 'Value': {'StringWithMarkup': [{'String': 'PALIFOSFAMIDE is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications.', 'Markup': [{'Start': 0, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/PALIFOSFAMIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'bis(2-chloroethylamino)phosphinic acid'}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10)'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'BKCJZNIZRWYHBN-UHFFFAOYSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C(CCl)NP(=O)(NCCCl)O'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C4H11Cl2N2O2P'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=31645-39-3', 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}, {'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}, {'ReferenceNumber': 9, 'Name': 'CAS', 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}, {'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': '31645-39-3'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '131636-51-6'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 13, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6A4U6NN813', 'Value': {'StringWithMarkup': [{'String': '6A4U6NN813'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:80566', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:80566'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL889', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL889'}]}}]}, {'TOCHeading': 'DrugBank ID', 'Description': 'Drug identifier used by the DrugBank database', 'URL': 'https://go.drugbank.com/', 'Information': [{'ReferenceNumber': 8, 'URL': 'https://www.drugbank.ca/drugs/DB05668', 'Value': {'StringWithMarkup': [{'String': 'DB05668'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 10, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID90865605', 'Value': {'StringWithMarkup': [{'String': 'DTXSID90865605'}]}}]}, {'TOCHeading': 'HMDB ID', 'Description': 'A chemical substance identifier from the HMDB database', 'URL': 'https://hmdb.ca/', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://hmdb.ca/metabolites/HMDB0060691', 'Value': {'StringWithMarkup': [{'String': 'HMDB0060691'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 16, 'URL': 'https://www.kegg.jp/entry/C16559', 'Value': {'StringWithMarkup': [{'String': 'C16559'}]}}, {'ReferenceNumber': 17, 'URL': 'https://www.kegg.jp/entry/D09364', 'Value': {'StringWithMarkup': [{'String': 'D09364'}]}}]}, {'TOCHeading': 'Metabolomics Workbench ID', 'Description': 'Registration number used by Metabolomics Workbench', 'URL': 'https://www.metabolomicsworkbench.org/', 'Information': [{'ReferenceNumber': 18, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=149541', 'Value': {'StringWithMarkup': [{'String': '149541'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 19, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66990', 'Value': {'StringWithMarkup': [{'String': 'C66990'}]}}]}, {'TOCHeading': 'Nikkaji Number', 'Description': 'Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).', 'URL': 'https://jglobal.jst.go.jp/en/', 'Information': [{'ReferenceNumber': 15, 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J426.682J', 'Value': {'StringWithMarkup': [{'String': 'J426.682J'}]}}]}, {'TOCHeading': 'NSC Number', 'Description': 'The National Service Center (NSC) number is a numeric identifier for substances submitted to the National Cancer Institute (NCI) for testing and evaluation. It is a registration number for the Developmental Therapeutics Program (DTP) repository.', 'URL': 'https://dtp.cancer.gov/organization/dscb/compoundSubmission/faqs.htm', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 9, 'Name': 'NSC Number', 'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=297900', 'Value': {'StringWithMarkup': [{'String': '297900'}]}}]}, {'TOCHeading': 'PharmGKB ID', 'Description': 'PharmGKB chemical identifier', 'URL': 'https://www.pharmgkb.org/', 'Information': [{'ReferenceNumber': 23, 'URL': 'https://www.pharmgkb.org/chemical/PA166131259', 'Value': {'StringWithMarkup': [{'String': 'PA166131259'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 29, 'URL': 'https://www.wikidata.org/wiki/Q27149611', 'Value': {'StringWithMarkup': [{'String': 'Q27149611'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 31, 'Value': {'StringWithMarkup': [{'String': 'ifosfamide mustard'}, {'String': 'ifosforamide mustard'}, {'String': 'IPAM'}, {'String': 'iphosphoramide mustard'}, {'String': 'isophosphamide mustard'}, {'String': 'isophosphoramide mustard'}, {'String': ""N,N'-di-(2-chloroethyl)phosphorodiamidic acid""}, {'String': 'palifosfamide'}, {'String': 'palifosfamide-tris'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Palifosfamide'}, {'String': '31645-39-3'}, {'String': 'Ifosfamide mustard'}, {'String': 'Isophosphamide mustard'}, {'String': 'Isophosphoramide mustard'}, {'String': 'Ifosforamide mustard'}, {'String': ""Phosphorodiamidic acid, N,N'-bis(2-chloroethyl)-""}, {'String': 'ZIO-201'}, {'String': 'Palifosfamide [USAN]'}, {'String': 'Palifosfamida'}, {'String': 'Palifosfamide [USAN:INN]'}, {'String': 'NSC 297900'}, {'String': 'NSC-297900'}, {'String': '6A4U6NN813'}, {'String': ""N,N'-Bis(2-chloroethyl)phosphorodiamidic acid""}, {'String': ""N,N'-Di-(2-chloroethyl)phosphorodiamidic acid""}, {'String': 'PALIFOSFAMIDE [INN]'}, {'String': 'PALIFOSFAMIDE [MART.]'}, {'String': 'PALIFOSFAMIDE [WHO-DD]'}, {'String': 'DTXSID90865605'}, {'String': 'N1,N2-Bis(2-chloroethyl)phosphoric acid diamide'}, {'String': 'NSC297900'}, {'String': ""N,N'-BIS-(2-CHLOROETHYL)PHOSPHORIC ACID""}, {'String': 'PALIFOSFAMIDE (MART.)'}, {'String': 'bis((2-chloroethyl)amino)phosphinic acid'}, {'String': 'bis[(2-chloroethyl)amino]phosphinic acid'}, {'String': 'iphosphoramide mustard'}, {'String': 'palifosfamidum'}, {'String': 'IPM-Lysine'}, {'String': 'Isophosphoramide Mustard-Lysine'}, {'String': 'DTXCID80208648'}, {'String': 'IPAM'}, {'String': 'bis(2-chloroethylamino)phosphinic acid'}, {'String': 'CHEBI:80566'}, {'String': 'Isophosphoramide mustard;IPM;ZIO-201'}, {'String': 'Palifosfamide?'}, {'String': 'UNII-6A4U6NN813'}, {'String': 'ZIO 201'}, {'String': 'CHEMBL889'}, {'String': 'Palifosfamide (USAN/INN)'}, {'String': 'SCHEMBL1818045'}, {'String': 'BKCJZNIZRWYHBN-UHFFFAOYSA-N'}, {'String': 'GLXC-10761'}, {'String': 'BCP23687'}, {'String': 's5840'}, {'String': 'AKOS025401661'}, {'String': 'CS-1324'}, {'String': 'DB05668'}, {'String': 'FP65121'}, {'String': 'AC-24201'}, {'String': 'DA-66456'}, {'String': 'HY-14798'}, {'String': 'Isophosphoramide mustard; IPM; ZIO-201'}, {'String': 'NCI60_002493'}, {'String': 'NS00068760'}, {'String': 'D09364'}, {'String': 'N16915'}, {'String': ""Phosphorodiamidic acid,N'-bis(2-chloroethyl)-""}, {'String': ""N,N'-Bis(2-chloroethyl)phosphorodiamidic acid #""}, {'String': 'BRD-K12047401-001-01-5'}, {'String': 'Q27149611'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Palifosfamide-Tris'}, {'String': 'D04FDN'}, {'String': 'AC1L2OQ7'}, {'String': 'CTK4B7420'}, {'String': 'ZINC1869573'}, {'String': 'C4-H11-Cl2-N2-O2-P'}, {'String': 'CID100427'}, {'String': 'CID:100427'}, {'String': 'SID:135653364'}, {'String': 'LS-107954'}, {'String': 'A3696'}, {'String': 'n,n-bis(2-chloroethyl)-phosphorodiamidic acid'}, {'String': 'A12691'}, {'String': 'C16559'}, {'String': 'W-5266'}, {'String': '645P393'}, {'String': 'A919626'}, {'String': 'C027061'}, {'String': '3-(2-(Bromomethyl)phenyl)-1-methoxy-1-methylurea'}, {'String': 'amino-[bis(2-methylsulfonyloxyethyl)amino]phosphinic acid'}, {'String': 'B0084-090037'}, {'String': '131636-51-6'}, {'String': 'IPM'}, {'String': '1070409-31-2'}, {'String': '31645-40-6'}, {'String': 'Isophosphoramide mustard; IPM; ZIO-201; ZIO-201; ZIO 201; IPAM; NSC 297900; NSC-297900; NSC297900'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Value': {'DateISO8601': ['2005-03-26']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '221.02'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'XLogP3', 'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/', 'Information': [{'ReferenceNumber': 30, 'Name': 'XLogP3-AA', 'Reference': ['Computed by XLogP3 3.0 (PubChem release 2025.04.14)'], 'Value': {'Number': [-0.4]}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [3]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [4]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [6]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '219.9935200'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '219.9935200'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [61.4], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [11]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 30, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Information': [{'ReferenceNumber': 21, 'Reference': ['S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'], 'ExtendedReference': [{'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749', 'Matched': {'PCLID': 900163354, 'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'}}], 'Value': {'StringWithMarkup': [{'String': 'Pharmaceuticals -> Listed in ZINC15'}]}}], 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 12, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Rare disease (orphan) drug'}]}}]}]}]}]}, {'TOCHeading': 'Spectral Information', 'Description': 'Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.', 'Section': [{'TOCHeading': '1D NMR Spectra', 'Description': 'One-dimensional (1D) nuclear magnetic resonance (NMR) spectra.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Section': [{'TOCHeading': '1H NMR Spectra', 'Description': 'Hydrogen-1 nuclear magnetic resonance (NMR) spectroscopy (also known as H1 NMR or proton NMR) is a version of NMR spectroscopy used to elucidate the structure of hydrogen-containing compounds.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 26, 'Name': 'Instrument Name', 'Value': {'StringWithMarkup': [{'String': 'Bruker WM-250'}]}}, {'ReferenceNumber': 26, 'Name': 'Copyright', 'Value': {'StringWithMarkup': [{'String': 'Copyright © 2002-2025 Wiley-VCH GmbH. All Rights Reserved.'}]}}, {'ReferenceNumber': 26, 'Name': 'Thumbnail', 'URL': 'https://spectrabase.com/spectrum/BLIYqcybxao', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10387812_1'], 'MimeType': 'image/png'}}]}, {'TOCHeading': '13C NMR Spectra', 'Description': 'Carbon-13 nuclear magnetic resonance (NMR) spectroscopy (also known as 13C NMR) is a version of NMR spectroscopy used to elucidate the structure of carbon-containing compounds.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 24, 'Name': 'Copyright', 'Value': {'StringWithMarkup': [{'String': 'Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved.'}]}}, {'ReferenceNumber': 24, 'Name': 'Thumbnail', 'URL': 'https://spectrabase.com/spectrum/Gx3R5cyon3v', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/4909631_1'], 'MimeType': 'image/png'}}]}]}, {'TOCHeading': 'Mass Spectrometry', 'Description': 'Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Section': [{'TOCHeading': 'GC-MS', 'Description': 'Data from gas chromatography-mass spectrometry (GC-MS) experiments.', 'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 20, 'Name': 'NIST Number', 'Value': {'Number': [141566]}}, {'ReferenceNumber': 20, 'Name': 'Library', 'Value': {'StringWithMarkup': [{'String': 'Main library'}]}}, {'ReferenceNumber': 20, 'Name': 'Total Peaks', 'Value': {'Number': [32]}}, {'ReferenceNumber': 20, 'Name': 'm/z Top Peak', 'Value': {'Number': [185]}}, {'ReferenceNumber': 20, 'Name': 'm/z 2nd Highest', 'Value': {'Number': [120]}}, {'ReferenceNumber': 20, 'Name': 'm/z 3rd Highest', 'Value': {'Number': [187]}}, {'ReferenceNumber': 20, 'Name': 'Thumbnail', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/177635_1'], 'MimeType': 'image/png'}}, {'ReferenceNumber': 25, 'Name': 'Source of Spectrum', 'Value': {'StringWithMarkup': [{'String': 'Chemical Concepts, A Wiley Division, Weinheim, Germany'}]}}, {'ReferenceNumber': 25, 'Name': 'Copyright', 'Value': {'StringWithMarkup': [{'String': 'Copyright © 2002-2025 Wiley-VCH GmbH. All Rights Reserved.'}]}}, {'ReferenceNumber': 25, 'Name': 'Thumbnail', 'URL': 'https://spectrabase.com/spectrum/IH7s3DoB1wE', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/10387811_1'], 'MimeType': 'image/png'}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID100427%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID100427%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 30, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [5]}}, {'ReferenceNumber': 30, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [11]}}, {'ReferenceNumber': 30, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [7]}}, {'ReferenceNumber': 30, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [25]}}, {'ReferenceNumber': 30, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID100427%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 30, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID100427%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 30, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/505854223', 'Value': {'Number': [505854223]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 30, 'Name': 'All Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/sids/JSON?sids_type=all&list_return=redirect', 'Value': {'Number': [156]}}, {'ReferenceNumber': 30, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [108]}}, {'ReferenceNumber': 30, 'Name': 'Mixture Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/sids/JSON?sids_type=component&list_return=redirect', 'Value': {'Number': [48]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 30, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=100427', 'Value': {'Number': [1]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 30, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Investigated for use/treatment in cancer/tumors (unspecified), lymphoma (unspecified), and sarcoma.'}]}}, {'ReferenceNumber': 22, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 4}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 11, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 2}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 12, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Rare disease (orphan) designations'}]}}, {'ReferenceNumber': 12, 'Name': 'Disease/Condition', 'Value': {'StringWithMarkup': [{'String': 'Treatment of soft tissue sarcoma'}]}}, {'ReferenceNumber': 12, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'Palifosfamide'}]}}, {'ReferenceNumber': 12, 'Name': 'Status of Orphan Designation', 'Value': {'StringWithMarkup': [{'String': 'Withdrawn'}]}}, {'ReferenceNumber': 12, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2008-12-03'}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 44, 'Name': 'Antineoplastic Agents, Alkylating', 'Value': {'StringWithMarkup': [{'String': 'A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)', 'Markup': [{'Start': 563, 'Length': 61, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68018906'}]}]}}]}, {'TOCHeading': 'Mechanism of Action', 'Description': 'In medicine, the term ""mechanism of action"" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug\'s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'After metabolic activation, palifosfamide alkylates or binds with many intracellular molecular structures, including nucleic acids. The cytotoxic action is primarily due to cross-linking of strands of DNA and RNA, as well as inhibition of protein synthesis.', 'Markup': [{'Start': 28, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/palifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-100427'}]}]}}]}, {'TOCHeading': 'Human Metabolite Information', 'Description': 'Information on metabolites generated from this compound in the human body.  The data in this section is from the Human Metabolome Database.', 'URL': 'https://hmdb.ca/', 'Section': [{'TOCHeading': 'Tissue Locations', 'Description': 'Tissue locations of this compound or its metabolites (e.g., bone marrow, kidney, liver, placenta, pancreas, skeletal muscle, intestine, etc.)', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 14, 'Name': 'Tissue Locations', 'Value': {'StringWithMarkup': [{'String': 'Kidney'}, {'String': 'Liver'}]}}]}, {'TOCHeading': 'Metabolite Pathways', 'Description': 'Metabolic pathways related to this chemical.  A metabolic pathway is a series of chemical reactions in a cell that build and breakdown molecules for cellular processes.', 'URL': 'https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/Book%3A_General_Biology_(Boundless)/06%3A_Metabolism/6.03%3A__Energy_and_Metabolism_-_Metabolic_Pathways', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 14, 'Name': 'Metabolite Pathways', 'Value': {'StringWithMarkup': [{'String': 'Ifosfamide Action Pathway', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'http://smpdb.ca/view/SMP00448'}]}, {'String': 'Ifosfamide Metabolism Pathway', 'Markup': [{'Start': 0, 'Length': 29, 'URL': 'http://smpdb.ca/view/SMP00605'}, {'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Ifosfamide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3690'}]}]}}]}]}, {'TOCHeading': 'Biochemical Reactions', 'Description': 'Biochemical reactions in which this compound participates.', 'Information': [{'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'pathwayreaction'}}]}, {'TOCHeading': 'Transformations', 'Description': 'Transformations indicate that a compound (predecessor) is transformed into another compound (successor) through a particular process (such as metabolism or fermentation) or medium (such as an animal or plant). The specificity of a transformation may vary depending on the available scientific evidence. A transformation may involve a series or cascade of changes between the predecessor (reactant) and successor (product). The presence of a successor in a sample may imply the predecessor. Predecessor: chemical being transformed. Transformation: process or medium. Successor: transformation product of predecessor. Evidence: the publication providing evidence for this transformation. Dataset: the integrated content containing the transformation information. Source: the entity or group that compiled the dataset containing the transformation information.', 'Information': [{'ReferenceNumber': 21, 'Value': {'ExternalTableName': 'transformations'}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 12, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Rare disease (orphan)'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 22, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 43, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=100427', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 27, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341173016'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/100427/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 45, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=BKCJZNIZRWYHBN-UHFFFAOYSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=BKCJZNIZRWYHBN-UHFFFAOYSA-N'}]}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 30, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'collection=consolidatedcompoundtarget&query_type=name&query=^Palifosfamide$'}}, {'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]}, {'TOCHeading': 'Drug-Drug Interactions', 'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'Information': [{'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'collection=drugbankddi&query_type=name&query=^Palifosfamide$'}}]}, {'TOCHeading': 'Pathways', 'Description': 'Biological pathways in which this compound is involved.', 'Information': [{'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'collection=pathway&core=1'}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 30, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 32, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 41, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 33, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 37, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 35, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 36, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 38, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 39, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 42, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '31645-39-3', 'Name': 'N,N′-Bis(2-chloroethyl)phosphorodiamidic acid', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=31645-39-3', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12913281}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': '0031645393', 'Name': 'Palifosfamide [USAN:INN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0031645393', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 882820}, {'ReferenceNumber': 8, 'SourceName': 'DrugBank', 'SourceID': 'DB05668', 'Name': 'Palifosfamide', 'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.', 'URL': 'https://www.drugbank.ca/drugs/DB05668', 'LicenseNote': ""Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)"", 'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use', 'ANID': 3619644}, {'ReferenceNumber': 9, 'SourceName': 'DTP/NCI', 'SourceID': 'NSC 297900', 'Name': 'Isophosphoramide mustard', 'Description': 'The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.', 'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=297900', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 6799411}, {'ReferenceNumber': 10, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID90865605', 'Name': ""N,N'-Bis(2-chloroethyl)phosphorodiamidic acid"", 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID90865605', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 17766445}, {'ReferenceNumber': 13, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': '6A4U6NN813', 'Name': 'PALIFOSFAMIDE', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6A4U6NN813', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5826904}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:100427', 'Name': 'Isophosphamide mustard', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:80566', 'ANID': 2463306}, {'ReferenceNumber': 19, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C66990::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66990', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 14394727}, {'ReferenceNumber': 22, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL889', 'Name': 'PALIFOSFAMIDE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL889', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45242579}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL889', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL889', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 31237444}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid100427', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5190671}, {'ReferenceNumber': 6, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'C027061::Compound', 'Name': 'isophosphamide mustard', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=C027061', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 9015069}, {'ReferenceNumber': 28, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D04FDN', 'Name': 'Palifosfamide', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D04FDN', 'ANID': 19766545}, {'ReferenceNumber': 7, 'SourceName': 'Drug Gene Interaction database (DGIdb)', 'SourceID': 'ncit:C66990', 'Name': 'PALIFOSFAMIDE', 'Description': 'The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.', 'URL': 'https://www.dgidb.org/drugs/ncit:C66990', 'LicenseNote': 'The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.', 'LicenseURL': 'http://www.dgidb.org/downloads', 'ANID': 37464494}, {'ReferenceNumber': 11, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid100427', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6480470}, {'ReferenceNumber': 12, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '7c7273acd1107b4dd76e1c8138f786f1', 'Name': 'Palifosfamide (EU/3/08/584)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu308584', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 49295344}, {'ReferenceNumber': 14, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0060691', 'Name': 'Isophosphamide mustard', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'http://www.hmdb.ca/metabolites/HMDB0060691', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 2183011}, {'ReferenceNumber': 15, 'SourceName': 'Japan Chemical Substance Dictionary (Nikkaji)', 'SourceID': 'J426.682J', 'Description': 'The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.', 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J426.682J', 'ANID': 21893976}, {'ReferenceNumber': 16, 'SourceName': 'KEGG', 'SourceID': 'C16559', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/C16559', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31110067}, {'ReferenceNumber': 17, 'SourceName': 'KEGG', 'SourceID': 'D09364', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09364', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31113335}, {'ReferenceNumber': 18, 'SourceName': 'Metabolomics Workbench', 'SourceID': '149541', 'Name': 'Palifosfamide', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=149541', 'ANID': 20292898}, {'ReferenceNumber': 20, 'SourceName': 'NIST Mass Spectrometry Data Center', 'SourceID': 'GC-MS #1 for BKCJZNIZRWYHBN-UHFFFAOYSA-N', 'Name': ""Phosphorodiamidic acid, N,N'-bis(2-chloroethyl)-"", 'Description': 'The NIST Mass Spectrometry Data Center, a Group in the Biomolecular Measurement Division (BMD), develops evaluated mass spectral libraries and provides related software tools. These products are intended to assist compound identification by providing reference mass spectra for GC/MS (by electron ionization) and LC-MS/MS (by tandem mass spectrometry) as well as gas phase retention indices for GC.', 'URL': 'http://www.nist.gov/srd/nist1a.cfm', 'LicenseNote': 'Data covered by the Standard Reference Data Act of 1968 as amended.', 'LicenseURL': 'https://www.nist.gov/srd/public-law', 'ANID': 177635}, {'ReferenceNumber': 25, 'SourceName': 'SpectraBase', 'SourceID': 'IH7s3DoB1wE', 'Name': 'ISOPHOSPHORAMIDE MUSTARD', 'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.', 'URL': 'https://spectrabase.com/spectrum/IH7s3DoB1wE', 'ANID': 10387811}, {'ReferenceNumber': 21, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'nrm_100427', 'Name': 'Palifosfamide', 'Description': 'The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/', 'ANID': 30409283}, {'ReferenceNumber': 23, 'SourceName': 'PharmGKB', 'SourceID': 'Compound::PA166131259', 'Name': 'isophosphoramide mustard', 'Description': 'The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships', 'URL': 'https://www.pharmgkb.org/chemical/PA166131259', 'LicenseNote': 'PharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).', 'LicenseURL': 'https://www.pharmgkb.org/page/policies', 'ANID': 39965834}, {'ReferenceNumber': 24, 'SourceName': 'SpectraBase', 'SourceID': 'Gx3R5cyon3v', 'Name': 'IPM;ISOPHOPHORAMIDE_MUSTARD', 'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.', 'URL': 'https://spectrabase.com/spectrum/Gx3R5cyon3v', 'ANID': 4909631}, {'ReferenceNumber': 26, 'SourceName': 'SpectraBase', 'SourceID': 'BLIYqcybxao', 'Name': ""N,N'-Di-2-chloroethyl-phosphordiamide"", 'Description': 'Wiley Science Solutions (https://sciencesolutions.wiley.com) is a leading publisher of spectral databases and KnowItAll spectroscopy software. SpectraBase provides fast text access to hundreds of thousands of NMR, IR, Raman, UV-Vis, and mass spectra.', 'URL': 'https://spectrabase.com/spectrum/BLIYqcybxao', 'ANID': 10387812}, {'ReferenceNumber': 27, 'SourceName': 'Springer Nature', 'SourceID': '341173016', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341173016', 'ANID': 47764321}, {'ReferenceNumber': 29, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27149611', 'Name': 'palifosfamide', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27149611', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44242952}, {'ReferenceNumber': 30, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 31, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67027061', 'Name': 'isophosphamide mustard', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67027061', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 32, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 33, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 35, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 36, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 37, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 38, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 39, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 41, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 42, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 43, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 44, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68018906', 'Name': 'Antineoplastic Agents, Alkylating', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68018906', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 45, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 389044642', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/389044642'}]}}",,,,,,,,,,,,[6],[4],[3],[11],[61.4]
10056071_Aldoxorubicin_Hydrochloride.json,1361563-03-2,,C37H43ClN4O13,ALDOXORUBICIN HYDROCHLORIDE,787.2,,"InChI=1S/C37H42N4O13.ClH/c1-17-32(46)20(38)13-27(53-17)54-22-15-37(51,23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49;/h6-8,10-11,17,20,22,27,32,42,46,48,50-51H,3-5,9,12-16,38H2,1-2H3,(H,40,43);1H/b39-23+;/t17-,20-,22-,27-,32+,37-;/m0./s1",NGKHWQPYPXRQTM-UKFSEGPMSA-N,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(/C(=N/NC(=O)CCCCCN6C(=O)C=CC6=O)/CO)O)N)O.Cl,,,,"{'Record': {'RecordType': 'CID', 'RecordNumber': 10056071, 'RecordTitle': 'Aldoxorubicin Hydrochloride', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since too many atoms, mixture or salt'}]}}]}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 6, 'Value': {'StringWithMarkup': [{'String': 'ALDOXORUBICIN HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications.', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALDOXORUBICIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10056071'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'N-[(E)-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide;hydrochloride', 'Markup': [{'Start': 0, 'Length': 1, 'Type': 'Italics'}, {'Start': 4, 'Length': 1, 'Type': 'Italics'}, {'Start': 13, 'Length': 1, 'Type': 'Italics'}, {'Start': 16, 'Length': 1, 'Type': 'Italics'}, {'Start': 24, 'Length': 1, 'Type': 'Italics'}, {'Start': 27, 'Length': 1, 'Type': 'Italics'}, {'Start': 30, 'Length': 1, 'Type': 'Italics'}, {'Start': 33, 'Length': 1, 'Type': 'Italics'}, {'Start': 128, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C37H42N4O13.ClH/c1-17-32(46)20(38)13-27(53-17)54-22-15-37(51,23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49;/h6-8,10-11,17,20,22,27,32,42,46,48,50-51H,3-5,9,12-16,38H2,1-2H3,(H,40,43);1H/b39-23+;/t17-,20-,22-,27-,32+,37-;/m0./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'NGKHWQPYPXRQTM-UKFSEGPMSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(/C(=N/NC(=O)CCCCCN6C(=O)C=CC6=O)/CO)O)N)O.Cl'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C37H43ClN4O13'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '1361563-03-2'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '480998-12-7'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S098K6HGD9', 'Value': {'StringWithMarkup': [{'String': 'S098K6HGD9'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2107827', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL2107827'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 4, 'URL': 'https://www.kegg.jp/entry/D10384', 'Value': {'StringWithMarkup': [{'String': 'D10384'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 5, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C142909', 'Value': {'StringWithMarkup': [{'String': 'C142909'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 7, 'URL': 'https://www.wikidata.org/wiki/Q27288392', 'Value': {'StringWithMarkup': [{'String': 'Q27288392'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'ALDOXORUBICIN HYDROCHLORIDE'}, {'String': 'INNO-206 hydrochloride'}, {'String': '1361563-03-2'}, {'String': 'Aldoxorubicin Hydrochloride [USAN]'}, {'String': 'S098K6HGD9'}, {'String': 'Aldoxorubicin Hydrochloride (USAN)'}, {'String': 'ALDOXORUBICIN HYDROCHLORIDE [WHO-DD]'}, {'String': 'UNII-S098K6HGD9'}, {'String': '480998-12-7'}, {'String': 'Aldoxorubicin (hydrochloride)'}, {'String': 'N-[(E)-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide;hydrochloride'}, {'String': 'MC-DOXHZN hydrochloride'}, {'String': '[(2S,3S,4S,6R)-6-[[(1S,3S)-3-[(E)-N-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-C-(hydroxymethyl)carbonimidoyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]azanium;chloride'}, {'String': 'Aldoxorubicin?HCl'}, {'String': 'Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%)'}, {'String': 'INNO206HCl'}, {'String': 'INNO206 HCl'}, {'String': 'CHEMBL2107827'}, {'String': 'SCHEMBL16766912'}, {'String': 'HY-16261C'}, {'String': 'AC-36645'}, {'String': 'DA-50314'}, {'String': 'DA-65289'}, {'String': 'CS-0133344'}, {'String': 'D10384'}, {'String': 'Q27288392'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Aldoxorubicin HCl'}, {'String': 'INNO-206 HCl'}, {'String': 'INNO-206 monohydrochloride'}, {'String': 'BADC-00363'}, {'String': 'CID10056071'}, {'String': 'CID 10056071'}, {'String': 'A871956'}, {'String': 'A1248334'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '787.2'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [15]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [12]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '786.2515151'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '786.2515151'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [268], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [55]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [1510]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [6]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Parent Compound', 'Description': 'A parent compound is conceptually the ""important"" part of the molecule when the molecule has more than one covalent component. Specifically, a parent component must have at least one carbon and contain at least 70% of the heavy (non-hydrogen) atoms of all the unique covalent units (ignoring stoichiometry). Note that this is a very empirical definition and is subject to change.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'CID 9810709 (Aldoxorubicin)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9810709', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9810709'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'CID 9810709 (Aldoxorubicin)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9810709', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9810709'}]}, {'String': 'CID 313 (Hydrochloric Acid)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=313', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/313'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [11]}}, {'ReferenceNumber': 8, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [38]}}, {'ReferenceNumber': 8, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [3]}}, {'ReferenceNumber': 8, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 8, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 8, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/500754068', 'Value': {'Number': [500754068]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [49]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10056071', 'Value': {'Number': [2]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 8, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 2, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 3}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=NGKHWQPYPXRQTM-UKFSEGPMSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=NGKHWQPYPXRQTM-UKFSEGPMSA-N'}]}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 13, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 9, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 11, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 14, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL2107827', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2107827', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32450087}, {'ReferenceNumber': 2, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10056071', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5194326}, {'ReferenceNumber': 3, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'S098K6HGD9', 'Name': 'ALDOXORUBICIN HYDROCHLORIDE', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S098K6HGD9', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5861164}, {'ReferenceNumber': 4, 'SourceName': 'KEGG', 'SourceID': 'D10384', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D10384', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31111611}, {'ReferenceNumber': 5, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C142909::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C142909', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19433955}, {'ReferenceNumber': 6, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL2107827', 'Name': 'ALDOXORUBICIN HYDROCHLORIDE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL2107827', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45237734}, {'ReferenceNumber': 7, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27288392', 'Name': 'aldoxorubicin hydrochloride', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27288392', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44319826}, {'ReferenceNumber': 8, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 9, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 11, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 13, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 14, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 15, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 426981530', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/426981530'}]}}",,"{'Record': {'RecordType': 'CID', 'RecordNumber': 10056071, 'RecordTitle': 'Aldoxorubicin Hydrochloride', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since too many atoms, mixture or salt'}]}}]}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 6, 'Value': {'StringWithMarkup': [{'String': 'ALDOXORUBICIN HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications.', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ALDOXORUBICIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10056071'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'N-[(E)-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide;hydrochloride', 'Markup': [{'Start': 0, 'Length': 1, 'Type': 'Italics'}, {'Start': 4, 'Length': 1, 'Type': 'Italics'}, {'Start': 13, 'Length': 1, 'Type': 'Italics'}, {'Start': 16, 'Length': 1, 'Type': 'Italics'}, {'Start': 24, 'Length': 1, 'Type': 'Italics'}, {'Start': 27, 'Length': 1, 'Type': 'Italics'}, {'Start': 30, 'Length': 1, 'Type': 'Italics'}, {'Start': 33, 'Length': 1, 'Type': 'Italics'}, {'Start': 128, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C37H42N4O13.ClH/c1-17-32(46)20(38)13-27(53-17)54-22-15-37(51,23(16-42)39-40-24(43)9-4-3-5-12-41-25(44)10-11-26(41)45)14-19-29(22)36(50)31-30(34(19)48)33(47)18-7-6-8-21(52-2)28(18)35(31)49;/h6-8,10-11,17,20,22,27,32,42,46,48,50-51H,3-5,9,12-16,38H2,1-2H3,(H,40,43);1H/b39-23+;/t17-,20-,22-,27-,32+,37-;/m0./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'NGKHWQPYPXRQTM-UKFSEGPMSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(/C(=N/NC(=O)CCCCCN6C(=O)C=CC6=O)/CO)O)N)O.Cl'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C37H43ClN4O13'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '1361563-03-2'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 3, 'Value': {'StringWithMarkup': [{'String': '480998-12-7'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S098K6HGD9', 'Value': {'StringWithMarkup': [{'String': 'S098K6HGD9'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2107827', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL2107827'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 4, 'URL': 'https://www.kegg.jp/entry/D10384', 'Value': {'StringWithMarkup': [{'String': 'D10384'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 5, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C142909', 'Value': {'StringWithMarkup': [{'String': 'C142909'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 7, 'URL': 'https://www.wikidata.org/wiki/Q27288392', 'Value': {'StringWithMarkup': [{'String': 'Q27288392'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'ALDOXORUBICIN HYDROCHLORIDE'}, {'String': 'INNO-206 hydrochloride'}, {'String': '1361563-03-2'}, {'String': 'Aldoxorubicin Hydrochloride [USAN]'}, {'String': 'S098K6HGD9'}, {'String': 'Aldoxorubicin Hydrochloride (USAN)'}, {'String': 'ALDOXORUBICIN HYDROCHLORIDE [WHO-DD]'}, {'String': 'UNII-S098K6HGD9'}, {'String': '480998-12-7'}, {'String': 'Aldoxorubicin (hydrochloride)'}, {'String': 'N-[(E)-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide;hydrochloride'}, {'String': 'MC-DOXHZN hydrochloride'}, {'String': '[(2S,3S,4S,6R)-6-[[(1S,3S)-3-[(E)-N-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]-C-(hydroxymethyl)carbonimidoyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]-3-hydroxy-2-methyloxan-4-yl]azanium;chloride'}, {'String': 'Aldoxorubicin?HCl'}, {'String': 'Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%)'}, {'String': 'INNO206HCl'}, {'String': 'INNO206 HCl'}, {'String': 'CHEMBL2107827'}, {'String': 'SCHEMBL16766912'}, {'String': 'HY-16261C'}, {'String': 'AC-36645'}, {'String': 'DA-50314'}, {'String': 'DA-65289'}, {'String': 'CS-0133344'}, {'String': 'D10384'}, {'String': 'Q27288392'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Aldoxorubicin HCl'}, {'String': 'INNO-206 HCl'}, {'String': 'INNO-206 monohydrochloride'}, {'String': 'BADC-00363'}, {'String': 'CID10056071'}, {'String': 'CID 10056071'}, {'String': 'A871956'}, {'String': 'A1248334'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '787.2'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [15]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [12]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '786.2515151'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '786.2515151'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [268], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [55]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [1510]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [6]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 8, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Parent Compound', 'Description': 'A parent compound is conceptually the ""important"" part of the molecule when the molecule has more than one covalent component. Specifically, a parent component must have at least one carbon and contain at least 70% of the heavy (non-hydrogen) atoms of all the unique covalent units (ignoring stoichiometry). Note that this is a very empirical definition and is subject to change.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'CID 9810709 (Aldoxorubicin)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9810709', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9810709'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'CID 9810709 (Aldoxorubicin)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9810709', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9810709'}]}, {'String': 'CID 313 (Hydrochloric Acid)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=313', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/313'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [11]}}, {'ReferenceNumber': 8, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [38]}}, {'ReferenceNumber': 8, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [3]}}, {'ReferenceNumber': 8, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 8, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 8, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10056071%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/500754068', 'Value': {'Number': [500754068]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [49]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 8, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10056071', 'Value': {'Number': [2]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 8, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 2, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 3}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10056071/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=NGKHWQPYPXRQTM-UKFSEGPMSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=NGKHWQPYPXRQTM-UKFSEGPMSA-N'}]}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 8, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 13, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 9, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 11, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 14, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL2107827', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2107827', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32450087}, {'ReferenceNumber': 2, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10056071', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5194326}, {'ReferenceNumber': 3, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'S098K6HGD9', 'Name': 'ALDOXORUBICIN HYDROCHLORIDE', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/S098K6HGD9', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5861164}, {'ReferenceNumber': 4, 'SourceName': 'KEGG', 'SourceID': 'D10384', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D10384', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31111611}, {'ReferenceNumber': 5, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C142909::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C142909', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19433955}, {'ReferenceNumber': 6, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL2107827', 'Name': 'ALDOXORUBICIN HYDROCHLORIDE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL2107827', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45237734}, {'ReferenceNumber': 7, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27288392', 'Name': 'aldoxorubicin hydrochloride', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27288392', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44319826}, {'ReferenceNumber': 8, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 9, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 11, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 13, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 14, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 15, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 426981530', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/426981530'}]}}",,,,,,,,,,,,[12],[15],[8],[55],[268]
10064061_Betamethadol.json,17199-55-2,,C21H29NO,Betamethadol,311.5,,"InChI=1S/C21H29NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17,20,23H,5,16H2,1-4H3/t17-,20+/m1/s1",QIRAYNIFEOXSPW-XLIONFOSSA-N,CC[C@@H](C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)O,,,,,,,,,,,,,,,,,,[7],[2],[1],[23],[23.5]
10072_Isomethadone.json,466-40-0,,C21H27NO,isomethadone,309.4,,"InChI=1S/C21H27NO/c1-5-20(23)21(17(2)16-22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3",IFKPLJWIEQBPGG-UHFFFAOYSA-N,CCC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,,CHEBI:135321,,,,,,,,,,,,,,,,[7],[2],[0],[23],[20.3]
10074640_Masitinib.json,790299-79-5,,C28H30N6OS,"4-((4-methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide",498.6,,"InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)",WJEOLQLKVOPQFV-UHFFFAOYSA-N,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,,CHEBI:63450,,Treatment of amyotrophic lateral sclerosis.,,"{'Record': {'RecordType': 'CID', 'RecordNumber': 10074640, 'RecordTitle': 'Masitinib', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Description': 'Masitinib', 'Value': {'Number': [10074640]}}]}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Masitinib is a member of the class of benzamides that is the carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)-1,3-thiazol-2-yl]benzene-1,3-diamine. It is a highly selective oral tyrosine kinase inhibitor. It has a role as a tyrosine kinase inhibitor, an antineoplastic agent and an antirheumatic drug. It is a N-alkylpiperazine, a member of 1,3-thiazoles, a member of pyridines and a member of benzamides.', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Masitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10074640'}, {'Start': 136, 'Length': 46, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/4-%5B%284-methylpiperazin-1-yl%29methyl%5Dbenzoic%20acid', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4769782'}, {'Start': 315, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 361, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}]}]}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in dogs. It has been available in Europe since 2009, under the brand name Masivet. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Masitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10074640'}, {'Start': 15, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 157, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Masivet', 'Type': 'PubChem Internal Link', 'Extra': 'CID-25024769'}, {'Start': 210, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Kinavet', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}]}]}}, {'ReferenceNumber': 26, 'Value': {'StringWithMarkup': [{'String': 'Masitinib is a multi-targeted protein tyrosine kinase inhibitor, with potential antineoplastic activity. Upon administration, masitinib selectively binds to and inhibits both the wild-type and mutated forms of the stem cell factor receptor (c-Kit; SCFR); platelet-derived growth factor receptor (PDGFR); fibroblast growth factor receptor 3 (FGFR3); and, to a lesser extent, focal adhesion kinase (FAK). As a consequence, tumor cell proliferation may be inhibited in cancer cell types that overexpress these receptor tyrosine kinases (RTKs).', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Masitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10074640'}, {'Start': 38, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 126, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/masitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10074640'}, {'Start': 516, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}]}]}}, {'ReferenceNumber': 28, 'Value': {'StringWithMarkup': [{'String': 'MASITINIB is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for neoplasm and has 16 investigational indications.', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MASITINIB', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10074640'}]}]}}, {'ReferenceNumber': 39, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Masitinib Mesylate (annotation moved to).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 18, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/25024769'}, {'Start': 10, 'Length': 18, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=25024769', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide', 'Markup': [{'Start': 35, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'WJEOLQLKVOPQFV-UHFFFAOYSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C28H30N6OS'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=790299-79-5', 'Value': {'StringWithMarkup': [{'String': '790299-79-5'}]}}, {'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '790299-79-5'}]}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': '790299-79-5'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': '790299-79-5'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': '790299-79-5'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M59NC4E26P', 'Value': {'StringWithMarkup': [{'String': 'M59NC4E26P'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63450', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:63450'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1908391', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL1908391'}]}}]}, {'TOCHeading': 'DrugBank ID', 'Description': 'Drug identifier used by the DrugBank database', 'URL': 'https://go.drugbank.com/', 'Information': [{'ReferenceNumber': 8, 'URL': 'https://www.drugbank.ca/drugs/DB11526', 'Value': {'StringWithMarkup': [{'String': 'DB11526'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 9, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID001000207', 'Value': {'StringWithMarkup': [{'String': 'DTXSID001000207'}]}}]}, {'TOCHeading': 'HMDB ID', 'Description': 'A chemical substance identifier from the HMDB database', 'URL': 'https://hmdb.ca/', 'Information': [{'ReferenceNumber': 16, 'URL': 'https://hmdb.ca/metabolites/HMDB0254344', 'Value': {'StringWithMarkup': [{'String': 'HMDB0254344'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 22, 'URL': 'https://www.kegg.jp/entry/D10229', 'Value': {'StringWithMarkup': [{'String': 'D10229'}]}}]}, {'TOCHeading': 'Metabolomics Workbench ID', 'Description': 'Registration number used by Metabolomics Workbench', 'URL': 'https://www.metabolomicsworkbench.org/', 'Information': [{'ReferenceNumber': 25, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=62788', 'Value': {'StringWithMarkup': [{'String': '62788'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 26, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C79910', 'Value': {'StringWithMarkup': [{'String': 'C79910'}]}}]}, {'TOCHeading': 'Nikkaji Number', 'Description': 'Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).', 'URL': 'https://jglobal.jst.go.jp/en/', 'Information': [{'ReferenceNumber': 21, 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.920.360A', 'Value': {'StringWithMarkup': [{'String': 'J2.920.360A'}]}}]}, {'TOCHeading': 'PharmGKB ID', 'Description': 'PharmGKB chemical identifier', 'URL': 'https://www.pharmgkb.org/', 'Information': [{'ReferenceNumber': 29, 'URL': 'https://www.pharmgkb.org/chemical/PA166185383', 'Value': {'StringWithMarkup': [{'String': 'PA166185383'}]}}]}, {'TOCHeading': 'Pharos Ligand ID', 'Description': 'Ligand identifier used by Pharos', 'URL': 'https://pharos.nih.gov/', 'Information': [{'ReferenceNumber': 30, 'URL': 'https://pharos.nih.gov/ligands/LRRGQ4BC2VP3', 'Value': {'StringWithMarkup': [{'String': 'LRRGQ4BC2VP3'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 37, 'URL': 'https://www.wikidata.org/wiki/Q1907109', 'Value': {'StringWithMarkup': [{'String': 'Q1907109'}]}}]}, {'TOCHeading': 'Wikipedia', 'Description': 'Wikidata entity identifier for this compound.', 'Information': [{'ReferenceNumber': 38, 'URL': 'https://en.wikipedia.org/wiki/Masitinib', 'Value': {'StringWithMarkup': [{'String': 'Masitinib'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 40, 'Value': {'StringWithMarkup': [{'String': '4-((4-methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide'}, {'String': 'AB 1010'}, {'String': 'AB-1010'}, {'String': 'AB1010'}, {'String': 'Kinavet'}, {'String': 'kinavet CA-1'}, {'String': 'masatinib'}, {'String': 'Masican'}, {'String': 'masitinib'}, {'String': 'masitinib mesilate'}, {'String': 'masitinib mesylate'}, {'String': 'masitinib methanesulfonate'}, {'String': 'masivet'}, {'String': 'Masiviera'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Masitinib'}, {'String': '790299-79-5'}, {'String': 'AB1010'}, {'String': 'Masatinib'}, {'String': 'Masitinib (AB1010)'}, {'String': 'AB-1010'}, {'String': 'Masitinib [INN]'}, {'String': '4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide'}, {'String': 'Kinavet'}, {'String': 'N-(4-Methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide'}, {'String': 'MFCD09954132'}, {'String': 'M59NC4E26P'}, {'String': 'N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide'}, {'String': 'CHEMBL1908391'}, {'String': 'CHEBI:63450'}, {'String': 'Masitinib (INN)'}, {'String': '4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide'}, {'String': '4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide'}, {'String': '4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide'}, {'String': 'Kinavet CA-1'}, {'String': 'UNII-M59NC4E26P'}, {'String': 'Mastinib'}, {'String': 'Masitinib?'}, {'String': '4-((4-METHYLPIPERAZIN-1-YL)METHYL)-N-(4-METHYL-3-((4-PYRIDIN-3-YL-1,3-THIAZOL-2-YL)AMINO)PHENYL)BENZAMIDE'}, {'String': 'G65'}, {'String': 'Masitinib (Standard)'}, {'String': 'N-(4-methyl-3-(4-(pyridin-3-yl)thiazol-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide'}, {'String': 'MASITINIB [MI]'}, {'String': 'MASITINIB [MART.]'}, {'String': 'MASITINIB [WHO-DD]'}, {'String': 'MLS006010167'}, {'String': 'Masican (proposed trade name)'}, {'String': 'SCHEMBL717239'}, {'String': 'GTPL5656'}, {'String': 'EX-A080'}, {'String': 'WJEOLQLKVOPQFV-UHFFFAOYSA-N'}, {'String': 'DTXSID001000207'}, {'String': 'HMS3244J04'}, {'String': 'HMS3244J08'}, {'String': 'HMS3244J12'}, {'String': 'HMS3295G03'}, {'String': 'HMS3654I13'}, {'String': 'HMS3884E03'}, {'String': 'HMS5079A09'}, {'String': 'BCP01820'}, {'String': 'BDBM50355495'}, {'String': 'HY-10209R'}, {'String': 'NSC755400'}, {'String': 'NSC800789'}, {'String': 's1064'}, {'String': 'AKOS005146325'}, {'String': 'AC-1908'}, {'String': 'BCP9000897'}, {'String': 'CCG-269680'}, {'String': 'CS-0134'}, {'String': 'DB11526'}, {'String': 'FM65073'}, {'String': 'GS-6164'}, {'String': 'NSC-755400'}, {'String': 'NSC-800789'}, {'String': 'SB14844'}, {'String': 'SDCCGSBI-0654333.P001'}, {'String': 'NCGC00241103-01'}, {'String': 'NCGC00241103-03'}, {'String': 'NCGC00241103-04'}, {'String': 'NCGC00241103-06'}, {'String': 'NCGC00241103-09'}, {'String': '4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)thiazol-2-yl]amino]phenyl]benzamide'}, {'String': 'AC-30632'}, {'String': 'HY-10209'}, {'String': 'SMR004701275'}, {'String': 'SY259010'}, {'String': 'NS00072058'}, {'String': 'SW219247-1'}, {'String': 'D10229'}, {'String': 'AB01274735-01'}, {'String': 'AB01274735_02'}, {'String': 'Q1907109'}, {'String': 'BRD-K71035033-001-01-4'}, {'String': 'BRD-K71035033-001-07-1'}, {'String': 'BRD-K71035033-001-08-9'}, {'String': '4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino) -phenyl]-benzamide'}, {'String': '4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-thiazol-2-ylamino)-phenyl]-benzamide'}, {'String': '4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2(3H)-ylidene]amino}phenyl)benzamide'}, {'String': 'Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-; 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide; Masitinib; Masivet'}, {'String': 'N-[4-Methyl-3-[[4-(3-Pyridyl)-2-thiazolyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Masivet'}, {'String': 'masican'}, {'String': 'Masiviera'}, {'String': 'Masitinib mesilate'}, {'String': 'Masitinib mesylate'}, {'String': 'Masitinib/AB1010'}, {'String': 'masitinib methanesulfonate'}, {'String': 'AB 1010'}, {'String': 'D0MW0N'}, {'String': 'AB1010,Masivet,Masitinib'}, {'String': 'cc-179'}, {'String': 'C28H30N6OS'}, {'String': 'CTK8E8465'}, {'String': 'SYN1053'}, {'String': 'AMY14908'}, {'String': 'ABP000249'}, {'String': 'RS0047'}, {'String': 'ZINC34177219'}, {'String': 'AN-5305'}, {'String': 'CID10074640'}, {'String': 'KS-000001C9'}, {'String': '4CA-0798'}, {'String': 'AJ-87321'}, {'String': 'BC686818'}, {'String': 'CID 10074640'}, {'String': 'CID:10074640'}, {'String': 'SC-23334'}, {'String': 'SID:441325528'}, {'String': 'AB0008058'}, {'String': 'RT-013665'}, {'String': 'A2942'}, {'String': 'FT-0652399'}, {'String': 'EC-000.2316'}, {'String': 'A10558'}, {'String': 'W-5430'}, {'String': '299M795'}, {'String': 'A839556'}, {'String': 'C526575'}, {'String': 'I14-1978'}, {'String': 'B0084-077384'}, {'String': 'n-(3-(4-(pyridin-3-yl)thiazol-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '498.6'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'XLogP3', 'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/', 'Information': [{'ReferenceNumber': 39, 'Name': 'XLogP3-AA', 'Reference': ['Computed by XLogP3 3.0 (PubChem release 2025.04.14)'], 'Value': {'Number': [4.3]}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [7]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [7]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '498.22018078'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '498.22018078'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [102], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [36]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [696]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 39, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Information': [{'ReferenceNumber': 27, 'Reference': ['S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'], 'ExtendedReference': [{'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749', 'Matched': {'PCLID': 900163354, 'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'}}], 'Value': {'StringWithMarkup': [{'String': 'Pharmaceuticals -> Listed in ZINC15'}]}}], 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 11, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 12, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 13, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Protein kinase inhibitors -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 14, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Protein kinase inhibitors -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}]}]}]}]}, {'TOCHeading': 'Spectral Information', 'Description': 'Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.', 'Section': [{'TOCHeading': 'Mass Spectrometry', 'Description': 'Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Section': [{'TOCHeading': 'MS-MS', 'Description': 'Data from tandem mass spectrometry (MS-MS) experiments.', 'URL': 'https://goldbook.iupac.org/terms/view/T06250', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 17, 'Name': 'Spectra ID', 'URL': 'https://hmdb.ca/spectra/ms_ms/374201', 'Value': {'StringWithMarkup': [{'String': '374201'}]}}, {'ReferenceNumber': 17, 'Name': 'Instrument Type', 'Value': {'StringWithMarkup': [{'String': 'LC-ESI-qTof'}]}}, {'ReferenceNumber': 17, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'Positive'}]}}, {'ReferenceNumber': 17, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-0002-0236920000-165320b13f69ca2a3a29%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0002-0236920000-165320b13f69ca2a3a29'}]}}, {'ReferenceNumber': 17, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '499.227417 52880'}, {'String': '399.12735 32412'}, {'String': '500.229248 18656'}, {'String': '400.130035 10644'}, {'String': '224.105667 5364'}]}}, {'ReferenceNumber': 17, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:52880,399.12735:32412,500.229248:18656,400.130035:10644,224.105667:5364', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:52880,399.12735:32412,500.229248:18656,400.130035:10644,224.105667:5364'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 17, 'Name': 'Notes', 'Value': {'StringWithMarkup': [{'String': 'From GNPS Library'}]}}, {'ReferenceNumber': 18, 'Name': 'Spectra ID', 'URL': 'https://hmdb.ca/spectra/ms_ms/450580', 'Value': {'StringWithMarkup': [{'String': '450580'}]}}, {'ReferenceNumber': 18, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 18, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-0udi-1291000000-f2e2f823b1870c00bb6d%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0udi-1291000000-f2e2f823b1870c00bb6d'}]}}, {'ReferenceNumber': 18, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '250.118973 100'}, {'String': '250.61972 69.65'}, {'String': '247.636887 40.36'}, {'String': '119.049728 28.41'}, {'String': '251.11824 25.31'}]}}, {'ReferenceNumber': 18, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=250.118973:100,250.61972:69.65,247.636887:40.36,119.049728:28.41,251.11824:25.31', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=250.118973:100,250.61972:69.65,247.636887:40.36,119.049728:28.41,251.11824:25.31'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 18, 'Name': 'Notes', 'Value': {'StringWithMarkup': [{'String': 'instrument=qTof'}]}}, {'ReferenceNumber': 19, 'Name': 'Spectra ID', 'URL': 'https://hmdb.ca/spectra/ms_ms/450581', 'Value': {'StringWithMarkup': [{'String': '450581'}]}}, {'ReferenceNumber': 19, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 19, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query==exists(splash.splash:%27splash10-0002-0236920000-165320b13f69ca2a3a29%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0002-0236920000-165320b13f69ca2a3a29'}]}}, {'ReferenceNumber': 19, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '499.227417 100'}, {'String': '399.12735 61.29'}, {'String': '500.229248 35.28'}, {'String': '400.130035 20.13'}, {'String': '224.105667 10.14'}]}}, {'ReferenceNumber': 19, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:100,399.12735:61.29,500.229248:35.28,400.130035:20.13,224.105667:10.14', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:100,399.12735:61.29,500.229248:35.28,400.130035:20.13,224.105667:10.14'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 19, 'Name': 'Notes', 'Value': {'StringWithMarkup': [{'String': 'instrument=qTof'}]}}]}, {'TOCHeading': 'LC-MS', 'Description': 'Data from liquid chromatography-mass spectrometry (LC-MS) experiments.', 'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 23, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078013', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078013'}]}}, {'ReferenceNumber': 23, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 23, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 23, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 23, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+2H]+'}]}}, {'ReferenceNumber': 23, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '250.118'}]}}, {'ReferenceNumber': 23, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 23, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 23, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '250.118973 100'}, {'String': '250.619720 69.65'}, {'String': '247.636887 40.36'}, {'String': '119.049728 28.41'}, {'String': '251.118240 25.31'}]}}, {'ReferenceNumber': 23, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-0udi-1291000000-f2e2f823b1870c00bb6d%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0udi-1291000000-f2e2f823b1870c00bb6d'}]}}, {'ReferenceNumber': 23, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=250.118973:100,250.619720:69.65,247.636887:40.36,119.049728:28.41,251.118240:25.31', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=250.118973:100,250.619720:69.65,247.636887:40.36,119.049728:28.41,251.118240:25.31'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 24, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078014', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078014'}]}}, {'ReferenceNumber': 24, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 24, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 24, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 24, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}}, {'ReferenceNumber': 24, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '499.227'}]}}, {'ReferenceNumber': 24, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 24, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 24, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '499.227417 100'}, {'String': '399.127350 61.29'}, {'String': '500.229248 35.28'}, {'String': '400.130035 20.13'}, {'String': '224.105667 10.14'}]}}, {'ReferenceNumber': 24, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-0002-0236920000-165320b13f69ca2a3a29%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0002-0236920000-165320b13f69ca2a3a29'}]}}, {'ReferenceNumber': 24, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:100,399.127350:61.29,500.229248:35.28,400.130035:20.13,224.105667:10.14', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=499.227417:100,399.127350:61.29,500.229248:35.28,400.130035:20.13,224.105667:10.14'], 'MimeType': 'image/svg'}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10074640%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10074640%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 39, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [7]}}, {'ReferenceNumber': 39, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [18]}}, {'ReferenceNumber': 39, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10074640%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 39, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10074640%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 39, 'Name': 'All Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/sids/JSON?sids_type=all&list_return=redirect', 'Value': {'Number': [289]}}, {'ReferenceNumber': 39, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [191]}}, {'ReferenceNumber': 39, 'Name': 'Mixture Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/sids/JSON?sids_type=component&list_return=redirect', 'Value': {'Number': [98]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Masitinib Mesylate (annotation moved to)', 'Markup': [{'Start': 0, 'Length': 18, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/25024769'}, {'Start': 0, 'Length': 18, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=25024769', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 39, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10074640', 'Value': {'Number': [58]}}, {'ReferenceNumber': 39, 'Name': 'Protein Structures Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=10074640', 'Value': {'Number': [3]}}, {'ReferenceNumber': 39, 'Name': 'Taxonomy Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=10074640', 'Value': {'Number': [3]}}, {'ReferenceNumber': 39, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10074640', 'Value': {'Number': [159]}}]}, {'TOCHeading': 'NCBI LinkOut', 'Description': 'NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout/', 'Information': [{'ReferenceNumber': 59, 'Value': {'Boolean': [True]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 39, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 11, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of amyotrophic lateral sclerosis.'}]}}, {'ReferenceNumber': 12, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of mastocytosis'}]}}, {'ReferenceNumber': 13, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of non resectable locally advanced or metastatic pancreatic cancer'}]}}, {'ReferenceNumber': 14, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (GIST)'}]}}, {'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 35}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 10, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 37}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 11, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/alsitek', 'Value': {'StringWithMarkup': [{'String': 'Alsitek'}]}}, {'ReferenceNumber': 11, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan'}]}}, {'ReferenceNumber': 11, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Amyotrophic Lateral Sclerosis'}]}}, {'ReferenceNumber': 11, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'Masitinib mesilate'}]}}, {'ReferenceNumber': 11, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 11, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Antineoplastic agents'}]}}, {'ReferenceNumber': 11, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'Refused'}]}}, {'ReferenceNumber': 11, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'AB Science'}]}}, {'ReferenceNumber': 12, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masipro', 'Value': {'StringWithMarkup': [{'String': 'Masipro'}]}}, {'ReferenceNumber': 12, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan'}]}}, {'ReferenceNumber': 12, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Mastocytosis'}]}}, {'ReferenceNumber': 12, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'Masitinib mesilate'}]}}, {'ReferenceNumber': 12, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 12, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Antineoplastic agents'}]}}, {'ReferenceNumber': 12, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'Refused'}]}}, {'ReferenceNumber': 12, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'AB Science'}]}}, {'ReferenceNumber': 13, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masiviera', 'Value': {'StringWithMarkup': [{'String': 'Masiviera'}]}}, {'ReferenceNumber': 13, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan'}]}}, {'ReferenceNumber': 13, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Pancreatic Neoplasms'}]}}, {'ReferenceNumber': 13, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 13, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 13, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Protein kinase inhibitors'}]}}, {'ReferenceNumber': 13, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'Refused'}]}}, {'ReferenceNumber': 13, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'AB Science'}]}}, {'ReferenceNumber': 14, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masican', 'Value': {'StringWithMarkup': [{'String': 'Masican'}]}}, {'ReferenceNumber': 14, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan'}]}}, {'ReferenceNumber': 14, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Gastrointestinal Stromal Tumors'}]}}, {'ReferenceNumber': 14, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 14, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'masitinib'}]}}, {'ReferenceNumber': 14, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Protein kinase inhibitors'}]}}, {'ReferenceNumber': 14, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'Refused'}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'ATC Code', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.whocc.no/atc/structure_and_principles/', 'Information': [{'ReferenceNumber': 11, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'L01XE22'}]}}, {'ReferenceNumber': 12, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'L01XE22'}]}}, {'ReferenceNumber': 13, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'L01XE'}]}}, {'ReferenceNumber': 14, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'L01XE'}]}}, {'ReferenceNumber': 36, 'Value': {'StringWithMarkup': [{'String': 'L - Antineoplastic and immunomodulating agents', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L'}]}, {'String': 'L01 - Antineoplastic agents', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01'}]}, {'String': 'L01E - Protein kinase inhibitors', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01E'}]}, {'String': 'L01EX - Other protein kinase inhibitors', 'Markup': [{'Start': 0, 'Length': 5, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EX'}]}, {'String': 'L01EX06 - Masitinib', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EX06'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 11, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 12, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 13, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Protein kinase inhibitors -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 14, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Protein kinase inhibitors -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 35, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 39, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 57, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10074640', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 34, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341168176'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 39, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 39, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10074640/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 58, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=WJEOLQLKVOPQFV-UHFFFAOYSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=WJEOLQLKVOPQFV-UHFFFAOYSA-N'}]}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 39, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Protein Bound 3D Structures', 'Description': 'Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.', 'Information': [{'ReferenceNumber': 33, 'Value': {'ExternalTableName': 'pdb'}}, {'ReferenceNumber': 39, 'URL': 'https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=10074640', 'Value': {'StringWithMarkup': [{'String': 'View 3 proteins in NCBI Structure'}]}}], 'Section': [{'TOCHeading': 'Ligands from Protein Bound 3D Structures', 'Description': 'Ligands found in experimental protein-ligand co-complexes (e.g., those archived in the Protein Data Bank in Europe (PDBe)).', 'URL': 'https://www.ebi.ac.uk/pdbe/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'MoveToTop': True, 'ShowAtMost': 1}, 'Section': [{'TOCHeading': 'PDBe Ligand Code', 'Description': 'The ligand code for this compound used in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 31, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G65', 'Value': {'StringWithMarkup': [{'String': 'G65'}]}}]}, {'TOCHeading': 'PDBe Structure Code', 'Description': ""The structure code for the Protein Data Bank in Europe (PDBe) protein-ligand co-complex from which the ligand's 3-D coordinates were taken."", 'Information': [{'ReferenceNumber': 31, 'URL': 'http://www.ebi.ac.uk/pdbe/entry/pdb/5MQL', 'Value': {'StringWithMarkup': [{'String': '5MQL'}]}}]}, {'TOCHeading': 'PDBe Conformer', 'Description': 'The experimental protein-bound 3D structure of this compound in a protein-ligand co-complex archived in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 31, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G65', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/8211793_1'], 'MimeType': 'pubchem/compound-gzip-asnb'}}]}]}]}, {'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 3, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 6, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'collection=consolidatedcompoundtarget&query_type=name&query=^Masitinib$'}}, {'ReferenceNumber': 20, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 35, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]}, {'TOCHeading': 'Drug-Drug Interactions', 'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'Information': [{'ReferenceNumber': 8, 'Value': {'ExternalTableName': 'collection=drugbankddi&query_type=name&query=^Masitinib$'}}]}, {'TOCHeading': 'Pathways', 'Description': 'Biological pathways in which this compound is involved.', 'Information': [{'ReferenceNumber': 39, 'Value': {'ExternalTableName': 'collection=pathway&core=1'}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 39, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 41, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 54, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 42, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 43, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 44, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 50, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'WHO ATC Classification System', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.who.int/tools/atc-ddd-toolkit/atc-classification', 'Information': [{'ReferenceNumber': 46, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79', 'Value': {'Number': [79]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 47, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'IUPHAR/BPS Guide to PHARMACOLOGY Target Classification', 'Description': 'Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.', 'URL': 'https://www.guidetopharmacology.org/', 'Information': [{'ReferenceNumber': 49, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92', 'Value': {'Number': [92]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 48, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 51, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 52, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 55, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 56, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '790299-79-5', 'Name': 'Masitinib', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=790299-79-5', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12771477}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': '0790299795', 'Name': 'Masitinib [INN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0790299795', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1139284}, {'ReferenceNumber': 8, 'SourceName': 'DrugBank', 'SourceID': 'DB11526', 'Name': 'Masitinib', 'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.', 'URL': 'https://www.drugbank.ca/drugs/DB11526', 'LicenseNote': ""Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)"", 'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use', 'ANID': 3627787}, {'ReferenceNumber': 9, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID001000207', 'Name': '4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2(3H)-ylidene]amino}phenyl)benzamide', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID001000207', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 17611597}, {'ReferenceNumber': 15, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'M59NC4E26P', 'Name': 'MASITINIB', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/M59NC4E26P', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5868823}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10074640', 'Name': 'Masitinib', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63450', 'ANID': 2454707}, {'ReferenceNumber': 26, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C79910::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C79910', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19447385}, {'ReferenceNumber': 28, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL1908391', 'Name': 'MASITINIB', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL1908391', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45236794}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL1908391', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1908391', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 31390944}, {'ReferenceNumber': 6, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'C526575::Compound', 'Name': 'masitinib', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=C526575', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 13202040}, {'ReferenceNumber': 7, 'SourceName': 'Drug Gene Interaction database (DGIdb)', 'SourceID': 'ncit:C79910', 'Name': 'MASITINIB', 'Description': 'The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.', 'URL': 'https://www.dgidb.org/drugs/ncit:C79910', 'LicenseNote': 'The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.', 'LicenseURL': 'http://www.dgidb.org/downloads', 'ANID': 37459146}, {'ReferenceNumber': 20, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': '5656::Compound', 'Name': 'masitinib', 'Description': 'The IUPHAR database contains quantitative information on drug targets and the prescription medicines and experimental drugs that act on them.\nAll entries in BioAssay data are marked as active as our curation SOP means we only extract data from the literature for relatively potent compounds.', 'URL': 'https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5656', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license', 'ANID': 19630058}, {'ReferenceNumber': 35, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D0MW0N', 'Name': 'Masitinib', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D0MW0N', 'ANID': 19779457}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10074640', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5186798}, {'ReferenceNumber': 10, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10074640', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482606}, {'ReferenceNumber': 11, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'ca2d6a4418cc0eef080cf230a4a87160', 'Name': 'Alsitek (EMEA/H/C/004398)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/alsitek', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37129141}, {'ReferenceNumber': 12, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'd0dea4784960a7cc73ba56e56d08e499', 'Name': 'Masipro (EMEA/H/C/004159)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masipro', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37129157}, {'ReferenceNumber': 13, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '45b8070fec744c73d7a26d53c42057d9', 'Name': 'Masiviera (EMEA/H/C/002659)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masiviera', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37129240}, {'ReferenceNumber': 14, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '19a97142734f0d62fc27c17f01e3374d', 'Name': 'Masican (EMEA/H/C/002670)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/masican', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37129268}, {'ReferenceNumber': 36, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'L01EX06', 'Name': 'Masitinib', 'Description': 'The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EX06', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/', 'ANID': 24382064}, {'ReferenceNumber': 16, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0254344', 'Name': 'Masitinib', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'http://www.hmdb.ca/metabolites/HMDB0254344', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 14485752}, {'ReferenceNumber': 17, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0254344_msms_374201', 'Name': 'HMDB0254344_msms_374201', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'https://hmdb.ca/metabolites/HMDB0254344#spectra', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 19285521}, {'ReferenceNumber': 18, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0254344_msms_450580', 'Name': 'HMDB0254344_msms_450580', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'https://hmdb.ca/metabolites/HMDB0254344#spectra', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 19285522}, {'ReferenceNumber': 19, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0254344_msms_450581', 'Name': 'HMDB0254344_msms_450581', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'https://hmdb.ca/metabolites/HMDB0254344#spectra', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 19285523}, {'ReferenceNumber': 21, 'SourceName': 'Japan Chemical Substance Dictionary (Nikkaji)', 'SourceID': 'J2.920.360A', 'Description': 'The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.', 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.920.360A', 'ANID': 23646704}, {'ReferenceNumber': 22, 'SourceName': 'KEGG', 'SourceID': 'D10229', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D10229', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31113346}, {'ReferenceNumber': 23, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078013', 'Name': 'Masitinib (AB1010)', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27WJEOLQLKVOPQFV-UHFFFAOYSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429036}, {'ReferenceNumber': 24, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078014', 'Name': 'Masitinib (AB1010)', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27WJEOLQLKVOPQFV-UHFFFAOYSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429037}, {'ReferenceNumber': 25, 'SourceName': 'Metabolomics Workbench', 'SourceID': '62788', 'Name': 'Masitinib', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=62788', 'ANID': 20217594}, {'ReferenceNumber': 27, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'nrm_10074640', 'Name': 'Masitinib', 'Description': 'The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/', 'ANID': 45689677}, {'ReferenceNumber': 29, 'SourceName': 'PharmGKB', 'SourceID': 'Compound::PA166185383', 'Name': 'masitinib', 'Description': 'The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships', 'URL': 'https://www.pharmgkb.org/chemical/PA166185383', 'LicenseNote': 'PharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).', 'LicenseURL': 'https://www.pharmgkb.org/page/policies', 'ANID': 39966035}, {'ReferenceNumber': 30, 'SourceName': 'Pharos', 'SourceID': 'Compound::LRRGQ4BC2VP3', 'Name': 'masitinib', 'Description': 'Pharos gives access to a comprehensive, integrated knowledge-base for the Druggable Genome (DG) to illuminate the uncharacterized and/or poorly annotated portion of the DG, focusing on three of the most commonly drug-targeted protein families: G-protein-coupled receptors (GPCRs), Ion channels (ICs) and Kinases. It is the user interface to the Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) program.', 'URL': 'https://pharos.nih.gov/ligands/LRRGQ4BC2VP3', 'LicenseNote': 'Data accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.', 'LicenseURL': 'https://pharos.nih.gov/about', 'ANID': 24597809}, {'ReferenceNumber': 31, 'SourceName': 'Protein Data Bank in Europe (PDBe)', 'SourceID': 'G65', 'Description': 'The Protein Data Bank in Europe (PDBe) manages the PDB with its wwPDB partners and provides a high-quality, up-to-date and integrated resource of macromolecular structures to support basic and applied research and education across the sciences.', 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/G65', 'ANID': 8211793}, {'ReferenceNumber': 33, 'SourceName': 'RCSB Protein Data Bank (RCSB PDB)', 'SourceID': '10074640', 'Description': 'The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.', 'URL': 'https://www.rcsb.org/', 'LicenseNote': 'Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.', 'LicenseURL': 'https://www.rcsb.org/pages/policies', 'ANID': 13131781}, {'ReferenceNumber': 34, 'SourceName': 'Springer Nature', 'SourceID': '341168176', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341168176', 'ANID': 48007909}, {'ReferenceNumber': 37, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q1907109', 'Name': 'masitinib', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q1907109', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44205268}, {'ReferenceNumber': 38, 'SourceName': 'Wikipedia', 'SourceID': 'c_11189', 'Name': 'Masitinib', 'Description': 'Link to the chemical information in Wikipedia.', 'URL': 'https://en.wikipedia.org/wiki/Masitinib', 'ANID': 24332725}, {'ReferenceNumber': 39, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 40, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67526575', 'Name': 'masitinib', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67526575', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 41, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 42, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 43, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 44, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 46, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'ATCTree', 'Name': 'EPA CPDat Classification', 'Description': 'The WHO ATC (Anatomical Therapeutic Chemical) classification system classify the active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/'}, {'ReferenceNumber': 47, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 48, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 49, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': 'Target Classification', 'Name': 'Guide to Pharmacology Target Classification', 'Description': 'An expert-driven guide to pharmacological targets and the substances that act on them', 'URL': 'https://www.guidetopharmacology.org/targets.jsp', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license'}, {'ReferenceNumber': 50, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 51, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 52, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 54, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 55, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 56, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 57, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 58, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 390132664', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/390132664'}, {'ReferenceNumber': 59, 'SourceName': 'NCBI', 'SourceID': 'LinkOut', 'Description': 'LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout'}]}}",Amyotrophic Lateral Sclerosis,masitinib,,,,,,,,,,[7],[7],[2],[36],[102]
10089_Phenadoxone.json,467-84-5,,C23H29NO2,Phenadoxone,351.5,,"InChI=1S/C23H29NO2/c1-3-22(25)23(20-10-6-4-7-11-20,21-12-8-5-9-13-21)18-19(2)24-14-16-26-17-15-24/h4-13,19H,3,14-18H2,1-2H3",LOXCOAXRHYDLOW-UHFFFAOYSA-N,CCC(=O)C(CC(C)N1CCOCC1)(C2=CC=CC=C2)C3=CC=CC=C3,207-400-6,CHEBI:135484,,,,,,,,,,,,,,,,[7],[3],[0],[26],[29.5]
10095659_Givinostat_hydrochloride.json,199657-29-9,,C24H28ClN3O4,givinostat hydrochloride,457.9,,"InChI=1S/C24H27N3O4.ClH/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30;/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28);1H",QKSGNWJOQMSBEP-UHFFFAOYSA-N,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO.Cl,979-490-1,CHEBI:231333,,,"Breast Feeding; Lactation; Milk, Human; Histone Deacetylase Inhibitors","{'Record': {'RecordType': 'CID', 'RecordNumber': 10095659, 'RecordTitle': 'Givinostat hydrochloride', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Name': '3D Conformer of Parent', 'Description': 'Givinostat', 'Value': {'Number': [9804992]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 1, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Givinostat hydrochloride is the hydrochloride salt of givinostat. It has a role as an angiogenesis inhibitor, an anti-inflammatory agent, an antineoplastic agent, an apoptosis inducer and an EC 3.5.1.98 (histone deacetylase) inhibitor. It contains a givinostat(1+).', 'Markup': [{'Start': 0, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Givinostat%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10095659'}, {'Start': 54, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/givinostat', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9804992'}, {'Start': 250, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/givinostat', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9804992'}]}]}}, {'ReferenceNumber': 12, 'Value': {'StringWithMarkup': [{'String': 'Histone Deacetylase Inhibitor is any substance that inhibits histone deacetylase, an enzyme that catalyzes the removal of acetyl groups from core histones. Inhibition of histone deacetylase can result in hyperacetylation of histones, with an effect on gene expression and cell differentiation.'}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrochloride', 'Markup': [{'Start': 46, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C24H27N3O4.ClH/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30;/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28);1H'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'QKSGNWJOQMSBEP-UHFFFAOYSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO.Cl'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C24H28ClN3O4'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 2, 'Value': {'StringWithMarkup': [{'String': '199657-29-9'}]}}, {'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': '199657-29-9'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '199657-29-9'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 2, 'Value': {'StringWithMarkup': [{'String': '383198-22-9'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 8, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.409.460', 'Value': {'StringWithMarkup': [{'String': '979-490-1'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 10, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Z02132R2QQ', 'Value': {'StringWithMarkup': [{'String': 'Z02132R2QQ'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:231333', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:231333'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 12, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1946', 'Value': {'StringWithMarkup': [{'String': 'C1946'}]}}, {'ReferenceNumber': 13, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C204143', 'Value': {'StringWithMarkup': [{'String': 'C204143'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://www.wikidata.org/wiki/Q27294820', 'Value': {'StringWithMarkup': [{'String': 'Q27294820'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 17, 'Value': {'StringWithMarkup': [{'String': 'givinostat hydrochloride'}, {'String': 'ITF 2357'}, {'String': 'ITF2357'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Givinostat hydrochloride'}, {'String': '199657-29-9'}, {'String': 'ITF 2357'}, {'String': 'Z02132R2QQ'}, {'String': 'UNII-Z02132R2QQ'}, {'String': 'Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester, hydrochloride (1:1)'}, {'String': 'ITF-2357'}, {'String': 'Carbamic acid, N-(4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl ester, hydrochloride (1:1)'}, {'String': 'Givinostat HCl'}, {'String': 'Givinostat (hydrochloride)'}, {'String': 'ITF2357 Hydrochloride'}, {'String': 'ITF-2357 Hydrochloride'}, {'String': 'Histone deacetylase inhibitor'}, {'String': '[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrochloride'}, {'String': '(6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate hydrochloride'}, {'String': 'MFCD28502062'}, {'String': '{6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate hydrochloride'}, {'String': 'ITF 2357 hydrochloride'}, {'String': 'givinostat monohydrochloride'}, {'String': 'SCHEMBL1554636'}, {'String': 'Givinostat hydrochloride anhydrous'}, {'String': 'CHEBI:231333'}, {'String': 'EX-A8024'}, {'String': 'ZHA65729'}, {'String': 'HY-14842A'}, {'String': 'AKOS030526700'}, {'String': 'CS-4728'}, {'String': 'SB16937'}, {'String': 'AS-52365'}, {'String': 'EN300-257964'}, {'String': 'P14959'}, {'String': 'Q27294820'}, {'String': 'Z2327390266'}, {'String': '(6-((Diethylamino)methyl)naphthalen-2-yl)methyl 4-(hydroxycarbamoyl)phenylcarbamate hydrochloride'}, {'String': '[6-[(Diethylamino)methyl]-2-naphthalenyl]methyl N-[4-[(hydroxyamino)carbonyl]phenyl]carbamate hydrochloride (1:1)'}, {'String': '{6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate--hydrogen chloride'}, {'String': '{6-[(diethylamino)methyl]naphthalen-2-yl}methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate hydrochloride'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Givinostat'}, {'String': 'ITF2357'}, {'String': 'C24H27N3O4.ClH'}, {'String': '2652AH'}, {'String': 'CID10095659'}, {'String': 'CID 10095659'}, {'String': 'KS-00000644'}, {'String': '[6-[(Diethylamino)methyl]-2-naphthalenyl]methyl-N-[4-[(hydroxyamino)carbonyl]phenyl]carbamate hydrochloride'}, {'String': '732302-99-7'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '457.9'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [4]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [5]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [9]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '457.1768341'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '457.1768341'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [90.9], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [32]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [575]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 16, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Histone Deacetylase Inhibitors'}]}}, {'ReferenceNumber': 6, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Active ingredient (GIVINOSTAT HYDROCHLORIDE)', 'Markup': [{'Start': 33, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/GIVINOSTAT%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10095659'}]}]}}]}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10095659%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10095659%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Parent Compound', 'Description': 'A parent compound is conceptually the ""important"" part of the molecule when the molecule has more than one covalent component. Specifically, a parent component must have at least one carbon and contain at least 70% of the heavy (non-hydrogen) atoms of all the unique covalent units (ignoring stoichiometry). Note that this is a very empirical definition and is subject to change.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'CID 9804992 (Givinostat)', 'Markup': [{'Start': 0, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9804992', 'Type': 'Icon'}, {'Start': 0, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9804992'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'CID 313 (Hydrochloric Acid)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=313', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/313'}]}, {'String': 'CID 9804992 (Givinostat)', 'Markup': [{'Start': 0, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9804992', 'Type': 'Icon'}, {'Start': 0, 'Length': 24, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9804992'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10095659/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [10]}}, {'ReferenceNumber': 16, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10095659/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 16, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10095659%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 16, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10095659%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/500786678', 'Value': {'Number': [500786678]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10095659/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [55]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 16, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Classes', 'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404', 'Information': [{'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Histone Deacetylase Inhibitors'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 5, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^GIVINOSTAT HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 11, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^GIVINOSTAT HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 3, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 2}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 7, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 1}}]}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 26, 'Name': 'Histone Deacetylase Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains. (See all compounds classified as Histone Deacetylase Inhibitors.)', 'Markup': [{'Start': 178, 'Length': 58, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68056572'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 9, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}, {'ReferenceNumber': 9, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Warning', 'Markup': [{'Start': 0, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 9, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 35, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]', 'Markup': [{'Start': 37, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]', 'Markup': [{'Start': 44, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]', 'Markup': [{'Start': 47, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 9, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P261'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 12, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264+P265'}, {'Start': 23, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 29, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P271'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 41, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 52, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P302+P352'}, {'Start': 63, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P304+P340'}, {'Start': 74, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P305+P351+P338'}, {'Start': 90, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P319'}, {'Start': 96, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P321'}, {'Start': 102, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 108, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P332+P317'}, {'Start': 119, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P337+P317'}, {'Start': 130, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P362+P364'}, {'Start': 141, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P403+P233'}, {'Start': 152, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 162, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 9, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.', 'Markup': [{'Start': 0, 'Length': 92, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (100%)'}, {'String': 'Skin Irrit. 2 (100%)'}, {'String': 'Eye Irrit. 2A (100%)'}, {'String': 'STOT SE 3 (100%)'}]}}]}]}]}, {'TOCHeading': 'Toxicity', 'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.', 'Section': [{'TOCHeading': 'Toxicological Information', 'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.', 'Section': [{'TOCHeading': 'Effects During Pregnancy and Lactation', 'Description': 'Drug effects during pregnancy and lactation.', 'Information': [{'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '◉ Summary of Use during Lactation'}, {'String': 'No information is available on the use of givinostat during breastfeeding. Because it is 96% bound to human plasma proteins, amounts in milk are likely to be very low. If a mother requires givinostat, it is not a reason to discontinue breastfeeding. Until more data become available, givinostat should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. Monitor the breastfed infant for diarrhea, vomiting, bruising, excessive bleeding from cuts, and blood in the stool.', 'Markup': [{'Start': 42, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/givinostat', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9804992'}, {'Start': 189, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/givinostat', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9804992'}, {'Start': 284, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/givinostat', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9804992'}]}, {'String': '◉ Effects in Breastfed Infants'}, {'String': 'Relevant published information was not found as of the revision date.'}, {'String': '◉ Effects on Lactation and Breastmilk'}, {'String': 'Relevant published information was not found as of the revision date.'}]}}]}]}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 16, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 25, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10095659', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 14, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=495941939'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 16, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10095659/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 11, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^GIVINOSTAT HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 16, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 18, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 19, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 22, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 21, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 24, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10095659', 'Name': 'Givinostat hydrochloride', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:231333', 'ANID': 39415201}, {'ReferenceNumber': 12, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C1946::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C1946', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19440293}, {'ReferenceNumber': 2, 'SourceName': 'ChemIDplus', 'SourceID': '0199657299', 'Name': 'Givinostat hydrochloride', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0199657299', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1131137}, {'ReferenceNumber': 8, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '979-490-1', 'Name': '{6-[(diethylamino)methyl]naphthalen-2-yl}methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate hydrochloride', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.409.460', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 39324977}, {'ReferenceNumber': 10, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'Z02132R2QQ', 'Name': 'Givinostat hydrochloride anhydrous', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/Z02132R2QQ', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5826124}, {'ReferenceNumber': 3, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10095659', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5189243}, {'ReferenceNumber': 4, 'SourceName': 'Drugs and Lactation Database (LactMed)', 'SourceID': 'givinostat', 'Name': 'Givinostat', 'Description': 'The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/lactmed/givinostat/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 49128769}, {'ReferenceNumber': 6, 'SourceName': 'Drugs@FDA', 'SourceID': '6cfd460f9b534b504710da8bbb4257c0', 'Name': 'GIVINOSTAT HYDROCHLORIDE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38976241}, {'ReferenceNumber': 5, 'SourceName': 'Drugs@FDA', 'SourceID': 'ed8da8e16bf523e08901b7dfde90798a', 'Name': 'GIVINOSTAT HYDROCHLORIDE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38964362}, {'ReferenceNumber': 7, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10095659', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482615}, {'ReferenceNumber': 9, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '368079', 'Name': '{6-[(diethylamino)methyl]naphthalen-2-yl}methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate hydrochloride (EC: 979-490-1)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/368079', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 39329228}, {'ReferenceNumber': 11, 'SourceName': 'FDA Orange Book', 'SourceID': '3c63eabcd2c4568b8bd5477324cc5233', 'Name': 'GIVINOSTAT HYDROCHLORIDE', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38981291}, {'ReferenceNumber': 13, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C204143::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C204143', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 39287302}, {'ReferenceNumber': 14, 'SourceName': 'Springer Nature', 'SourceID': '495941939', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/495941939', 'ANID': 47612636}, {'ReferenceNumber': 15, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27294820', 'Name': 'givinostat hydrochloride', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27294820', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44324777}, {'ReferenceNumber': 16, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 17, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67502418', 'Name': 'givinostat hydrochloride', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67502418', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 18, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 19, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 21, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 22, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 24, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 25, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 26, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68056572', 'Name': 'Histone Deacetylase Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68056572', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}]}}",,,,,,,,,,,,[9],[5],[4],[32],[90.9]
10096344_Linagliptin.json,668270-12-0,,C25H28N8O2,"(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione",472.5,,"InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1",LTXREWYXXSTFRX-QGZVFWFLSA-N,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,620-351-9,CHEBI:68610,,"Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise. It should not be used to treat type I diabetes or in diabetic ketoacidosis. An extended-release combination product containing empagliflozin, linagliptin, and metformin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.",Breast Feeding; Lactation; Hypoglycemic Agents; Incretins; Dipeptidyl-Peptidase IV Inhibitors; DPP-4 Inhibitors;,"{'Record': {'RecordType': 'CID', 'RecordNumber': 10096344, 'RecordTitle': 'Linagliptin', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Description': 'Linagliptin', 'Value': {'Number': [10096344]}}]}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 3, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. It has a role as an EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor and a hypoglycemic agent. It is a member of quinazolines and an aminopiperidine. It is functionally related to a 7H-xanthine.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 17, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/xanthine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-1188'}, {'Start': 34, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/7H-xanthine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-1188'}, {'Start': 87, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/methyl', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3034819'}, {'Start': 380, 'Length': 15, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/aminopiperidine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16658'}, {'Start': 429, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/7H-xanthine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-1188'}]}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a DPP-4 inhibitor developed by Boehringer Ingelheim for the treatment of type II diabetes. Linagliptin differs from other DPP-4 inhibitors in that it has a non-linear pharmacokinetic profile, is not primarily eliminated by the renal system, and obeys concentration dependant protein binding. Linagliptin was approved by the FDA on May 2, 2011.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 106, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 307, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 25, 'Description': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a Dipeptidyl Peptidase 4 Inhibitor. The mechanism of action of linagliptin is as a Dipeptidyl Peptidase 4 Inhibitor.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 78, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 30, 'Description': 'LiverTox Summary', 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Linagliptin has been linked to rare instances of clinically apparent liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 213, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 38, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. The inhibition of DPP-4 by linagliptin appears to be longer lasting than that by some other DPP-4 inhibitors tested.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 170, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 42, 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 8 investigational indications.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/LINAGLIPTIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 58, 'Value': {'StringWithMarkup': [{'String': 'A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS.'}]}}, {'ReferenceNumber': 59, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Empagliflozin; Linagliptin (component of); Linagliptin; METformin Hydrochloride (component of) ... View More ...', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/85364159'}, {'Start': 10, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=85364159', 'Type': 'Icon'}, {'Start': 53, 'Length': 36, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/46861711'}, {'Start': 53, 'Length': 36, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=46861711', 'Type': 'Icon'}, {'Start': 109, 'Length': 9, 'URL': '#section=Other-Relationships'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione', 'Markup': [{'Start': 5, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'LTXREWYXXSTFRX-QGZVFWFLSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C25H28N8O2'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=668270-12-0', 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 5, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 17, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 20, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}, {'ReferenceNumber': 26, 'Value': {'StringWithMarkup': [{'String': '668270-12-0'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 17, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.149.135', 'Value': {'StringWithMarkup': [{'String': '620-351-9'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 20, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3X29ZEJ4R2', 'Value': {'StringWithMarkup': [{'String': '3X29ZEJ4R2'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:68610', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:68610'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 4, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL237500', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL237500'}]}}]}, {'TOCHeading': 'DrugBank ID', 'Description': 'Drug identifier used by the DrugBank database', 'URL': 'https://go.drugbank.com/', 'Information': [{'ReferenceNumber': 10, 'URL': 'https://www.drugbank.ca/drugs/DB08882', 'Value': {'StringWithMarkup': [{'String': 'DB08882'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID201021653', 'Value': {'StringWithMarkup': [{'String': 'DTXSID201021653'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 29, 'URL': 'https://www.kegg.jp/entry/D09566', 'Value': {'StringWithMarkup': [{'String': 'D09566'}]}}]}, {'TOCHeading': 'Metabolomics Workbench ID', 'Description': 'Registration number used by Metabolomics Workbench', 'URL': 'https://www.metabolomicsworkbench.org/', 'Information': [{'ReferenceNumber': 34, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=65122', 'Value': {'StringWithMarkup': [{'String': '65122'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 38, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C83887', 'Value': {'StringWithMarkup': [{'String': 'C83887'}]}}]}, {'TOCHeading': 'Nikkaji Number', 'Description': 'Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).', 'URL': 'https://jglobal.jst.go.jp/en/', 'Information': [{'ReferenceNumber': 28, 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.712.937D', 'Value': {'StringWithMarkup': [{'String': 'J2.712.937D'}]}}]}, {'TOCHeading': 'PharmGKB ID', 'Description': 'PharmGKB chemical identifier', 'URL': 'https://www.pharmgkb.org/', 'Information': [{'ReferenceNumber': 43, 'URL': 'https://www.pharmgkb.org/chemical/PA166368161', 'Value': {'StringWithMarkup': [{'String': 'PA166368161'}]}}]}, {'TOCHeading': 'Pharos Ligand ID', 'Description': 'Ligand identifier used by Pharos', 'URL': 'https://pharos.nih.gov/', 'Information': [{'ReferenceNumber': 44, 'URL': 'https://pharos.nih.gov/ligands/VM52B1CFQDAQ', 'Value': {'StringWithMarkup': [{'String': 'VM52B1CFQDAQ'}]}}, {'ReferenceNumber': 45, 'URL': 'https://pharos.nih.gov/ligands/VMG5TXYCPR3B', 'Value': {'StringWithMarkup': [{'String': 'VMG5TXYCPR3B'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 40, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1100699', 'Value': {'StringWithMarkup': [{'String': '1100699'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 55, 'URL': 'https://www.wikidata.org/wiki/Q909745', 'Value': {'StringWithMarkup': [{'String': 'Q909745'}]}}]}, {'TOCHeading': 'Wikipedia', 'Description': 'Wikidata entity identifier for this compound.', 'Information': [{'ReferenceNumber': 56, 'URL': 'https://en.wikipedia.org/wiki/Linagliptin', 'Value': {'StringWithMarkup': [{'String': 'Linagliptin'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 58, 'Value': {'StringWithMarkup': [{'String': '(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione'}, {'String': '1356, BI'}, {'String': '1H-purine-2,6-dione, 8-((3r)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-'}, {'String': 'BI 1356'}, {'String': 'BI-1356'}, {'String': 'BI1356'}, {'String': 'Linagliptin'}, {'String': 'Tradjenta'}, {'String': 'Trajenta'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin'}, {'String': '668270-12-0'}, {'String': 'Ondero'}, {'String': 'Trajenta'}, {'String': 'Trazenta'}, {'String': 'BI-1356-BS'}, {'String': 'linagliptine'}, {'String': 'Linagliptina'}, {'String': 'BS 1356 BS'}, {'String': 'UNII-3X29ZEJ4R2'}, {'String': '3X29ZEJ4R2'}, {'String': '(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione'}, {'String': 'CHEBI:68610'}, {'String': 'BI-1356BS'}, {'String': 'HSDB 8204'}, {'String': 'BI 1356 BS'}, {'String': 'BS-1356-BS'}, {'String': 'GLYXAMBI COMPONENT LINAGLIPTIN'}, {'String': '(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione'}, {'String': '1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-'}, {'String': 'TRIJARDY XR COMPONENT LINAGLIPTIN'}, {'String': 'LINAGLIPTIN (MART.)'}, {'String': 'LINAGLIPTIN [MART.]'}, {'String': '8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione'}, {'String': 'linagliptinum'}, {'String': '8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE'}, {'String': 'A10BH05'}, {'String': 'LINAGLIPTIN COMPONENT OF GLYXAMBI'}, {'String': 'JENTADUETO COMPONENT OF LINAGLIPTIN'}, {'String': 'LINAGLIPTIN COMPONENT OF JENTADUETO'}, {'String': 'LINAGLIPTIN COMPONENT OF TRIJARDY XR'}, {'String': 'Tradjenta'}, {'String': 'BI-1356'}, {'String': 'BI 1356'}, {'String': 'Linagliptin (BI-1356)'}, {'String': 'ione'}, {'String': 'CHEMBL237500'}, {'String': '(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione'}, {'String': '(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione'}, {'String': '1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-'}, {'String': '8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione'}, {'String': '8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione'}, {'String': '8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione'}, {'String': 'Linaglitpin'}, {'String': 'Linagliptin [USAN:INN:JAN]'}, {'String': 'Tradjenta (TN)'}, {'String': '8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione'}, {'String': 'BI1356'}, {'String': 'MFCD14635356'}, {'String': 'Linagliptin (Standard)'}, {'String': 'LINAGLIPTIN [MI]'}, {'String': 'LINAGLIPTIN [INN]'}, {'String': 'LINAGLIPTIN [JAN]'}, {'String': 'LINAGLIPTIN [USAN]'}, {'String': 'LINAGLIPTIN [VANDF]'}, {'String': 'LINAGLIPTIN [WHO-DD]'}, {'String': 'Linagliptin (BI-1356)?'}, {'String': 'MLS006010217'}, {'String': 'SCHEMBL160188'}, {'String': 'Linagliptin (JAN/USAN/INN)'}, {'String': 'GTPL6318'}, {'String': 'Linagliptin - Bio-X trade mark'}, {'String': 'EX-A076'}, {'String': 'LINAGLIPTIN [ORANGE BOOK]'}, {'String': 'LTXREWYXXSTFRX-QGZVFWFLSA-N'}, {'String': 'BCPP000185'}, {'String': 'DTXSID201021653'}, {'String': 'GLXC-10521'}, {'String': 'BCP02462'}, {'String': 'MSK15589'}, {'String': 'BDBM50228403'}, {'String': 'HY-10284R'}, {'String': 's3031'}, {'String': 'AKOS015951179'}, {'String': 'AKOS015995251'}, {'String': 'AC-8761'}, {'String': 'BCP9000854'}, {'String': 'CCG-269463'}, {'String': 'CS-0637'}, {'String': 'DB08882'}, {'String': 'FL24893'}, {'String': 'NCGC00346655-01'}, {'String': 'NCGC00346655-02'}, {'String': 'NCGC00346655-08'}, {'String': '1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-'}, {'String': 'AS-35080'}, {'String': 'BL164627'}, {'String': 'DA-54932'}, {'String': 'HY-10284'}, {'String': 'SMR004701306'}, {'String': 'NS00098773'}, {'String': 'SW219813-1'}, {'String': 'D09566'}, {'String': 'AB01563307_01'}, {'String': 'AB01563307_03'}, {'String': 'EN300-6481354'}, {'String': 'Q909745'}, {'String': 'BRD-K96550715-001-02-6'}, {'String': 'BRD-K96550715-001-03-4'}, {'String': 'BRD-K96550715-001-04-2'}, {'String': 'BRD-K96550715-003-01-4'}, {'String': 'Z2235801970'}, {'String': '1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine'}, {'String': '1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine'}, {'String': '1-[(4-methyl-quinazolin-2yl) methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R) amino-piperidin-1-yl]-xanthine'}, {'String': '1-[(4-Methylquinazolin-2-yl)-methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine'}, {'String': '1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine'}, {'String': '1233245-11-8'}, {'String': '8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R) -3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione'}, {'String': '8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione'}, {'String': '8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Ondero (TN)'}, {'String': 'Linagliptin S-Isomer'}, {'String': 'Linagliptin [USAN:INN]'}, {'String': 'D02EYG'}, {'String': 'C25H28N8O2'}, {'String': 'cc-405'}, {'String': 'BI 1356BS'}, {'String': 'AMY8953'}, {'String': 'ZINC3820029'}, {'String': 'NP2669'}, {'String': '1-(1H-Indol-3-ylmethyl)-propylamine'}, {'String': 'ACN-028592'}, {'String': 'AN-2539'}, {'String': 'CS-O-30970'}, {'String': 'RL04547'}, {'String': 'CID10096344'}, {'String': '1356, BI'}, {'String': 'AJ-45731'}, {'String': 'CID 10096344'}, {'String': 'CID:10096344'}, {'String': 'SC-66358'}, {'String': 'SC-83230'}, {'String': 'SID:283537495'}, {'String': 'AB0008009'}, {'String': 'AB1008521'}, {'String': 'A4034'}, {'String': 'FT-0670793'}, {'String': 'X1062'}, {'String': 'KS-00000765'}, {'String': 'A26901'}, {'String': 'Q-4491'}, {'String': '270L120'}, {'String': 'C568794'}, {'String': 'D000069476'}, {'String': '8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione'}, {'String': '8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione'}, {'String': '1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-; 1H-Purine-2,6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- (9CI); (R)-8-[3-Aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine; BI 1356; BI 1356BS; Linagliptin; ONDERO; Tradjenta; Trazenta'}, {'String': '668270-11-9'}, {'String': '8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione'}, {'String': '8-[3(R)-aminopiperidin-1-yl]-7-(2-butynyl)-3-methyl-1-(4-methylquinazolin-2-ylmethyl)xanthine'}, {'String': 'Linagliptin; (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '472.5'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'XLogP3', 'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/', 'Information': [{'ReferenceNumber': 59, 'Name': 'XLogP3-AA', 'Reference': ['Computed by XLogP3 3.0 (PubChem release 2025.04.14)'], 'Value': {'Number': [1.9]}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [7]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [4]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '472.23352217'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '472.23352217'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [113], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [35]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [885]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 59, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Experimental Properties', 'Description': 'Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Color/Form', 'Description': 'Color is the aspect of any object that may be described in terms of hue, lightness, and saturation.', 'URL': 'https://www.britannica.com/science/color', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""], 'ExtendedReference': [{'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022"", 'Matched': {'PCLID': 900151761, 'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""}}], 'Value': {'StringWithMarkup': [{'String': 'White to yellow solid; also reported as a crystalline solid'}]}}]}, {'TOCHeading': 'Melting Point', 'Description': 'This section provides the melting point and/or freezing point. The melting point is the temperature at which a substance changes state from solid to liquid at atmospheric pressure. When considered as the temperature of the reverse change (from liquid to solid), it is referred to as the freezing point.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Organic_Chemistry_Lab_Techniques_(Nichols)/06%3A_Miscellaneous_Techniques/6.01%3A_Melting_Point', 'Information': [{'ReferenceNumber': 10, 'Reference': ['http://www.chemspider.com/Chemical-Structure.8271879.html?rid=e059df1a-34ab-48c0-9c24-9d6c4d699c47&page_num=0'], 'ExtendedReference': [{'Citation': 'http://www.chemspider.com/Chemical-Structure.8271879.html?rid=e059df1a-34ab-48c0-9c24-9d6c4d699c47&page_num=0', 'Matched': {'PCLID': 900289067, 'Citation': 'http://www.chemspider.com/Chemical-Structure.8271879.html?rid=e059df1a-34ab-48c0-9c24-9d6c4d699c47&page_num=0'}}], 'Value': {'StringWithMarkup': [{'String': '190-196'}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""], 'ExtendedReference': [{'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022"", 'Matched': {'PCLID': 900151761, 'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""}}], 'Value': {'StringWithMarkup': [{'String': '202 °C'}]}}]}, {'TOCHeading': 'Solubility', 'Description': 'The solubility of a substance is the amount of that substance that will dissolve in a given amount of solvent. The default solvent is water, if not indicated.', 'URL': 'https://chem.libretexts.org/Courses/Purdue/Purdue%3A_Chem_26505%3A_Organic_Chemistry_I_(Lipton)/Chapter_4._Intermolecular_Forces_and_Physical_Properties/4.4_Solubility', 'Information': [{'ReferenceNumber': 10, 'Reference': ['MSDS'], 'ExtendedReference': [{'Citation': 'MSDS', 'Matched': {'PCLID': 900289440, 'Citation': 'MSDS'}}], 'Value': {'StringWithMarkup': [{'String': '<1 mg/mL'}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""], 'ExtendedReference': [{'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022"", 'Matched': {'PCLID': 900151761, 'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""}}], 'Value': {'StringWithMarkup': [{'String': 'Soluble in methanol; sparingly soluble in ethanol; very slightly soluble in isopropanol, alcohol', 'Markup': [{'Start': 11, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/methanol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-887'}, {'Start': 42, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-702'}, {'Start': 76, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/isopropanol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3776'}]}]}}]}, {'TOCHeading': 'Stability/Shelf Life', 'Description': 'Tendency of a material to resist change or decomposition due to internal reaction, or due to the action of air, heat, light, pressure, etc. See also the Stability and Reactivity subsection under the Safety and Hazards section on this page (when available).', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Stable if stored as directed; avoid strong oxidizing agents'}]}}]}, {'TOCHeading': 'Decomposition', 'Description': 'Information on the decomposition of this compound, including the decomposition conditions and products.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Thermal decomposition may produce toxic gases such as carbon monoxide, carbon dioxide, and nitrogen oxides.', 'Markup': [{'Start': 54, 'Length': 15, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20monoxide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-281'}, {'Start': 71, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20dioxide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-280'}]}]}}]}, {'TOCHeading': 'Dissociation Constants', 'Description': 'A specific type of equilibrium constant that measures the propensity of a larger object to separate (dissociate) reversibly into smaller components, as when a complex falls apart into its component molecules, or when a salt splits up into its component ions. This includes pKa (the negative logarithm of the acid dissociation constant) and pKb (the negative logarithm of the base dissociation constant).', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""], 'ExtendedReference': [{'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022"", 'Matched': {'PCLID': 900151761, 'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""}}], 'Value': {'StringWithMarkup': [{'String': 'pKa1 = 1.9; pKa2 = 8.6'}]}}]}, {'TOCHeading': 'Other Experimental Properties', 'Description': 'Other experimental properties of this chemical.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""], 'ExtendedReference': [{'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022"", 'Matched': {'PCLID': 900151761, 'Citation': ""O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. Cambridge, UK:  Royal Society of Chemistry, 2013., p. 1022""}}], 'Value': {'StringWithMarkup': [{'String': 'Slightly hygroscopic'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Information': [{'ReferenceNumber': 41, 'Reference': ['S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'], 'ExtendedReference': [{'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749', 'Matched': {'PCLID': 900163354, 'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'}}], 'Value': {'StringWithMarkup': [{'String': 'Pharmaceuticals -> Listed in ZINC15'}]}}], 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Hypoglycemic Agents; Incretins; Dipeptidyl-Peptidase IV Inhibitors; DPP-4 Inhibitors;'}]}}, {'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription; None (Tentative Approval); Discontinued; Active ingredient (LINAGLIPTIN)', 'Markup': [{'Start': 88, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/LINAGLIPTIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 18, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Drugs used in diabetes -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}]}]}]}]}, {'TOCHeading': 'Spectral Information', 'Description': 'Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.', 'Section': [{'TOCHeading': 'Mass Spectrometry', 'Description': 'Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Section': [{'TOCHeading': 'LC-MS', 'Description': 'Data from liquid chromatography-mass spectrometry (LC-MS) experiments.', 'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 31, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078544', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078544'}]}}, {'ReferenceNumber': 31, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 31, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 31, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 31, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}}, {'ReferenceNumber': 31, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '473.241'}]}}, {'ReferenceNumber': 31, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 31, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 31, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '473.242706 100'}, {'String': '474.244263 32.53'}, {'String': '364.152191 16.55'}, {'String': '420.202209 13.17'}, {'String': '403.175690 9.29'}]}}, {'ReferenceNumber': 31, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-00di-0113900000-1cf1f79967a4761f3983%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-00di-0113900000-1cf1f79967a4761f3983'}]}}, {'ReferenceNumber': 31, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=473.242706:100,474.244263:32.53,364.152191:16.55,420.202209:13.17,403.175690:9.29', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=473.242706:100,474.244263:32.53,364.152191:16.55,420.202209:13.17,403.175690:9.29'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 32, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078545', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078545'}]}}, {'ReferenceNumber': 32, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 32, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 32, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 32, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+2H]+'}]}}, {'ReferenceNumber': 32, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '237.125'}]}}, {'ReferenceNumber': 32, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 32, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 32, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '228.612778 100'}, {'String': '404.184052 55.36'}, {'String': '202.595474 54.99'}, {'String': '229.113129 51.16'}, {'String': '202.090942 20.22'}]}}, {'ReferenceNumber': 32, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-0ufr-0391100000-8df1ebbcbdc456f86470%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0ufr-0391100000-8df1ebbcbdc456f86470'}]}}, {'ReferenceNumber': 32, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=228.612778:100,404.184052:55.36,202.595474:54.99,229.113129:51.16,202.090942:20.22', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=228.612778:100,404.184052:55.36,202.595474:54.99,229.113129:51.16,202.090942:20.22'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 33, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078546', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078546'}]}}, {'ReferenceNumber': 33, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 33, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 33, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 33, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}}, {'ReferenceNumber': 33, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '473.241'}]}}, {'ReferenceNumber': 33, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 33, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 33, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '473.241730 100'}, {'String': '474.243164 27.53'}, {'String': '364.151520 17.77'}, {'String': '420.201538 13.64'}, {'String': '351.142151 10.94'}]}}, {'ReferenceNumber': 33, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-00di-0114900000-928cf1c76b7fa52190f2%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-00di-0114900000-928cf1c76b7fa52190f2'}]}}, {'ReferenceNumber': 33, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=473.241730:100,474.243164:27.53,364.151520:17.77,420.201538:13.64,351.142151:10.94', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=473.241730:100,474.243164:27.53,364.151520:17.77,420.201538:13.64,351.142151:10.94'], 'MimeType': 'image/svg'}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10096344%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10096344%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 59, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [10]}}, {'ReferenceNumber': 59, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [6]}}, {'ReferenceNumber': 59, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [3]}}, {'ReferenceNumber': 59, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [83]}}, {'ReferenceNumber': 59, 'Name': 'Same Parent, Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_parent_stereo&list_return=redirect', 'Value': {'Number': [75]}}, {'ReferenceNumber': 59, 'Name': 'Same Parent, Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_parent_isotopes&list_return=redirect', 'Value': {'Number': [76]}}, {'ReferenceNumber': 59, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [70]}}, {'ReferenceNumber': 59, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [119]}}, {'ReferenceNumber': 59, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10096344%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 59, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10096344%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 59, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/481107288', 'Value': {'Number': [481107288]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 59, 'Name': 'All Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/sids/JSON?sids_type=all&list_return=redirect', 'Value': {'Number': [386]}}, {'ReferenceNumber': 59, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [185]}}, {'ReferenceNumber': 59, 'Name': 'Mixture Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/sids/JSON?sids_type=component&list_return=redirect', 'Value': {'Number': [201]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Empagliflozin; Linagliptin (component of)', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/85364159'}, {'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=85364159', 'Type': 'Icon'}]}, {'String': 'Linagliptin; METformin Hydrochloride (component of)', 'Markup': [{'Start': 0, 'Length': 36, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/46861711'}, {'Start': 0, 'Length': 36, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=46861711', 'Type': 'Icon'}]}, {'String': 'Empagliflozin; Linagliptin; METformin Hydrochloride (component of)', 'Markup': [{'Start': 0, 'Length': 51, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Empagliflozin%3B%20Linagliptin%3B%20METformin%20Hydrochloride'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 59, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Number': [145]}}, {'ReferenceNumber': 59, 'Name': 'Protein Structures Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Number': [2]}}, {'ReferenceNumber': 59, 'Name': 'Taxonomy Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Number': [2]}}, {'ReferenceNumber': 59, 'Name': 'OMIM Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Number': [3]}}, {'ReferenceNumber': 59, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Number': [40]}}]}, {'TOCHeading': 'NCBI LinkOut', 'Description': 'NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout/', 'Information': [{'ReferenceNumber': 86, 'Value': {'Boolean': [True]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 59, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise. It should not be used to treat type I diabetes or in diabetic ketoacidosis. An extended-release combination product containing empagliflozin, linagliptin, and metformin was approved by the FDA in January 2020 for the improvement of glycemic control in adults with type 2 diabetes mellitus when used adjunctively with diet and exercise.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 224, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/empagliflozin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-11949646'}, {'Start': 239, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 256, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}]}]}}, {'ReferenceNumber': 10, 'URL': 'http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB08882.pdf?1369177888', 'Value': {'StringWithMarkup': [{'String': 'FDA Label'}]}}, {'ReferenceNumber': 18, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Trajenta is indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control in adults: as monotherapyin patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to intolerance, or contraindicated due to renal impairment. as combination therapyin combination with metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. in combination with a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. in combination with insulin with or without metformin, when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Trajenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 197, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}, {'Start': 330, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}, {'Start': 368, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}, {'Start': 467, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}, {'Start': 635, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}]}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of type II diabetes mellitus'}]}}, {'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'LiverTox Summary', 'Description': 'Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK547852/', 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other oral hypoglycemic agents. Linagliptin has been linked to rare instances of clinically apparent liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 213, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Drug Classes', 'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Hypoglycemic Agents; Incretins; Dipeptidyl-Peptidase IV Inhibitors; DPP-4 Inhibitors;'}]}}, {'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'Antidiabetic Agents'}]}}]}, {'TOCHeading': 'FDA Medication Guides', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.', 'URL': 'https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 5, 'ColumnsFromNamedLists': {'Name': ['Drug', 'Active Ingredient', 'Form;Route', 'Company', 'Date'], 'UseNamesAsColumnHeadings': True}}, 'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 21, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'JENTADUETO', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201281s035lbl.pdf#page=21'}]}]}}, {'ReferenceNumber': 21, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN; METFORMIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/LINAGLIPTIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 13, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/METFORMIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}]}]}}, {'ReferenceNumber': 21, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 21, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'BOEHRINGER INGELHEIM'}]}}, {'ReferenceNumber': 21, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '06/20/2023'}]}}, {'ReferenceNumber': 22, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'JENTADUETO XR', 'Markup': [{'Start': 0, 'Length': 13, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/208026s024lbl.pdf#page=22'}]}]}}, {'ReferenceNumber': 22, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN; METFORMIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/LINAGLIPTIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 13, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/METFORMIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}]}]}}, {'ReferenceNumber': 22, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET, EXTENDED RELEASE;ORAL'}]}}, {'ReferenceNumber': 22, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'BOEHRINGER INGELHEIM'}]}}, {'ReferenceNumber': 22, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '06/20/2023'}]}}, {'ReferenceNumber': 23, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'TRADJENTA', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/201280s027lbl.pdf#page=16'}]}]}}, {'ReferenceNumber': 23, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN'}]}}, {'ReferenceNumber': 23, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 23, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'BOEHRINGER INGELHEIM'}]}}, {'ReferenceNumber': 23, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '06/20/2023'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 12, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^LINAGLIPTIN$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 24, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^LINAGLIPTIN$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 35, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^LINAGLIPTIN$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 8, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^LINAGLIPTIN$'""}}, {'ReferenceNumber': 8, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^LINAGLIPTIN$'""}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 6, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 147}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 16, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 53}}]}, {'TOCHeading': 'NIPH Clinical Trials Search of Japan', 'Description': 'Brief clinical trials summary from the NIPH Clinical Trials Search of Japan, which allows one to cross-search four national clinical research information registries in Japan: the Japan Registry of Clinical Trials (JRCT), the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials (JMACCT).', 'URL': 'https://rctportal.niph.go.jp/en/', 'Information': [{'ReferenceNumber': 39, 'Name': 'NIPH Clinical Trials Search of Japan', 'Value': {'ExternalTableName': 'clinicaltrials_jp', 'ExternalTableNumRows': 31}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 18, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/trajenta', 'Value': {'StringWithMarkup': [{'String': 'Trajenta'}]}}, {'ReferenceNumber': 18, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs'}]}}, {'ReferenceNumber': 18, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Diabetes Mellitus, Type 2'}]}}, {'ReferenceNumber': 18, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'linagliptin'}]}}, {'ReferenceNumber': 18, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'linagliptin'}]}}, {'ReferenceNumber': 18, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Drugs used in diabetes'}]}}, {'ReferenceNumber': 18, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'This medicine is authorized for use in the European Union'}]}}, {'ReferenceNumber': 18, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'Boehringer Ingelheim International GmbH'}]}}, {'ReferenceNumber': 18, 'Name': 'Market Date', 'Value': {'StringWithMarkup': [{'String': '2011-08-23'}]}}, {'ReferenceNumber': 19, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 19, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000498-pip01-08-m10', 'Value': {'StringWithMarkup': [{'String': 'linagliptin'}]}}, {'ReferenceNumber': 19, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Endocrinology-Gynaecology-Fertility-Metabolism'}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet'}]}}, {'ReferenceNumber': 19, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2021-10-29'}]}}]}, {'TOCHeading': 'Therapeutic Uses', 'Description': 'Therapeutic uses information for this compound, provided by the Hazardous Substances Data Bank (HSDB).', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html""], 'ExtendedReference': [{'Citation': ""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html"", 'Matched': {'PCLID': 900072243, 'Citation': ""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html""}}], 'Value': {'StringWithMarkup': [{'String': 'Hypoglycemic Agents'}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900125149, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Tradjenta tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. /Included in US product label/', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Drug Warnings', 'Description': 'Drug warnings information collected by the Hazardous Substances Data Bank (HSDB) from various sources, including US Pharmacopeia (USP), physicians desk references, MSDS, etc.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933', 'Information': [{'ReferenceNumber': 26, 'Description': 'QC REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597', 'Matched': {'PCLID': 900080223, 'Citation': 'NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597'}}], 'Value': {'StringWithMarkup': [{'String': '/BOXED WARNING/ WARNING: RISK OF LACTIC ACIDOSIS. Lactic acidosis is a rare, but serious, complication that can occur due to metformin accumulation. The risk increases with conditions such as renal impairment, sepsis, dehydration, excess alcohol intake, hepatic impairment, and acute congestive heart failure. The onset is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, increasing somnolence, and nonspecific abdominal distress. Laboratory abnormalities include low pH, increased anion gap, and elevated blood lactate. If acidosis is suspected, Jentadueto should be discontinued and the patient hospitalized immediately. /Linagliptin and metformin hydrochloride combination product/', 'Markup': [{'Start': 125, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4091'}, {'Start': 567, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/lactate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-91435'}, {'Start': 602, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Jentadueto', 'Type': 'PubChem Internal Link', 'Extra': 'CID-46861711'}, {'Start': 679, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 695, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['US FDA; Safety Alerts for Human Medicial Products: Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas (Posted March 14, 1013). Available from, as of August 1, 2014: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm343805.htm'], 'ExtendedReference': [{'Citation': 'US FDA; Safety Alerts for Human Medicial Products: Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas (Posted March 14, 1013). Available from, as of August 1, 2014: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm343805.htm', 'Matched': {'PCLID': 900125932, 'Citation': 'US FDA; Safety Alerts for Human Medicial Products: Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas (Posted March 14, 1013). Available from, as of August 1, 2014: https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm343805.htm'}}], 'Value': {'StringWithMarkup': [{'String': 'FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics. These findings were based on examination of a small number of pancreatic tissue specimens taken from patients after they died from unspecified causes. FDA has asked the researchers to provide the methodology used to collect and study these specimens and to provide the tissue samples so the Agency can further investigate potential pancreatic toxicity associated with the incretin mimetics. Drugs in the incretin mimetic class include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal. They are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. FDA has not reached any new conclusions about safety risks with incretin mimetic drugs. This early communication is intended only to inform the public and health care professionals that the Agency intends to obtain and evaluate this new information. ... FDA will communicate its final conclusions and recommendations when its review is complete or when the Agency has additional information to report. The Warnings and Precautions section of drug labels and patient Medication Guides for incretin mimetics contain warnings about the risk of acute pancreatitis. FDA has not previously communicated about the potential risk of pre-cancerous findings  of the pancreas with incretin mimetics. FDA has not concluded these drugs may cause or contribute to the development of pancreatic cancer.  At this time, patients should continue to take their medicine as directed until they talk to their health care professional, and health care professionals should continue to follow the prescribing recommendations in the drug labels. ...', 'Markup': [{'Start': 718, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/exenatide', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}, {'Start': 729, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Byetta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-53396299'}, {'Start': 737, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Bydureon', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}, {'Start': 748, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/liraglutide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16134956'}, {'Start': 761, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Victoza', 'Type': 'PubChem Internal Link', 'Extra': 'CID-131709229'}, {'Start': 771, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/sitagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-4369359'}, {'Start': 784, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Januvia', 'Type': 'PubChem Internal Link', 'Extra': 'CID-11591741'}, {'Start': 793, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Janumet', 'Type': 'PubChem Internal Link', 'Extra': 'CID-74331896'}, {'Start': 802, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Janumet%20XR', 'Type': 'PubChem Internal Link', 'Extra': 'CID-24848107'}, {'Start': 825, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/saxagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-11243969'}, {'Start': 838, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Onglyza', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}, {'Start': 847, 'Length': 13, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Kombiglyze%20XR', 'Type': 'PubChem Internal Link', 'Extra': 'CID-56842229'}, {'Start': 863, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/alogliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-11450633'}, {'Start': 875, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Nesina', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16088021'}, {'Start': 883, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Kazano', 'Type': 'PubChem Internal Link', 'Extra': 'CID-71300638'}, {'Start': 891, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Oseni', 'Type': 'PubChem Internal Link', 'Extra': 'CID-24764414'}, {'Start': 903, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 916, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 927, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Jentadueto', 'Type': 'PubChem Internal Link', 'Extra': 'CID-46861711'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'There have been postmarketing reports of acute pancreatitis, including fatal pancreatitis, in patients taking Tradjenta. Take careful notice of potential signs and symptoms of pancreatitis. If pancreatitis is suspected, promptly discontinue Tradjenta and initiate appropriate management. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Tradjenta.', 'Markup': [{'Start': 110, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 241, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 420, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Tradjenta. These reactions include anaphylaxis, angioedema, and exfoliative skin conditions. Onset of these reactions occurred within the first 3 months after initiation of treatment with Tradjenta, with some reports occurring after the first dose. If a serious hypersensitivity reaction is suspected, discontinue Tradjenta, assess for other potential causes for the event, and institute alternative treatment for diabetes.  Angioedema has also been reported with other dipeptidyl peptidase-4 (DPP-4) inhibitors. Use caution in a patient with a history of angioedema to another DPP-4 inhibitor because it is unknown whether such patients will be predisposed to angioedema with Tradjenta.', 'Markup': [{'Start': 101, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 289, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 415, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 778, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'For more Drug Warnings (Complete) data for Linagliptin (20 total), please visit the HSDB record page.', 'Markup': [{'Start': 84, 'Length': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204#section=Drug-Warnings-(Complete)'}, {'Start': 43, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'Pharmacodynamics', 'Description': 'Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK507791/', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'A 5mg oral dose of linagliptin results in >80% inhibition of dipeptidyl peptidase 4 (DPP-4) for ≥24 hours. Inhibition of DPP-4 increases the concentration of glucagon-like peptide 1 (GLP-1), leading to decreased glycosylated hemoglobin and fasting plasma glucose.', 'Markup': [{'Start': 19, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 158, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucagon', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16132283'}, {'Start': 255, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}]}]}}]}, {'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 82, 'Name': 'Dipeptidyl-Peptidase IV Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Compounds that suppress the degradation of INCRETINS by blocking the action of DIPEPTIDYL-PEPTIDASE IV. This helps to correct the defective INSULIN and GLUCAGON secretion characteristic of TYPE 2 DIABETES MELLITUS by stimulating insulin secretion and suppressing glucagon release. (See all compounds classified as Dipeptidyl-Peptidase IV Inhibitors.)', 'Markup': [{'Start': 286, 'Length': 62, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68054873'}]}]}}, {'ReferenceNumber': 83, 'Name': 'Hypoglycemic Agents', 'Value': {'StringWithMarkup': [{'String': 'Substances which lower blood glucose levels. (See all compounds classified as Hypoglycemic Agents.)', 'Markup': [{'Start': 50, 'Length': 47, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68007004'}]}]}}, {'ReferenceNumber': 84, 'Name': 'Incretins', 'Value': {'StringWithMarkup': [{'String': 'Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially. (See all compounds classified as Incretins.)', 'Markup': [{'Start': 131, 'Length': 37, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68054795'}]}]}}]}, {'TOCHeading': 'FDA Pharmacological Classification', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 25, 'Name': 'FDA UNII', 'Value': {'StringWithMarkup': [{'String': '3X29ZEJ4R2'}]}}, {'ReferenceNumber': 25, 'Name': 'Active Moiety', 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN'}]}}, {'ReferenceNumber': 25, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Mechanisms of Action [MoA] - Dipeptidyl Peptidase 4 Inhibitors'}]}}, {'ReferenceNumber': 25, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Established Pharmacologic Class [EPC] - Dipeptidyl Peptidase 4 Inhibitor'}]}}, {'ReferenceNumber': 25, 'Name': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a Dipeptidyl Peptidase 4 Inhibitor. The mechanism of action of linagliptin is as a Dipeptidyl Peptidase 4 Inhibitor.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 78, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 36, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'LINAGLIPTIN'}]}}, {'ReferenceNumber': 36, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Dipeptidyl Peptidase 4 Inhibitors [MoA]; Dipeptidyl Peptidase 4 Inhibitor [EPC]'}]}}]}, {'TOCHeading': 'ATC Code', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.whocc.no/atc/structure_and_principles/', 'Information': [{'ReferenceNumber': 18, 'Name': 'ATC Code', 'Value': {'StringWithMarkup': [{'String': 'A10BH05'}]}}, {'ReferenceNumber': 54, 'Value': {'StringWithMarkup': [{'String': 'A - Alimentary tract and metabolism', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A'}]}, {'String': 'A10 - Drugs used in diabetes', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A10'}]}, {'String': 'A10B - Blood glucose lowering drugs, excl. insulins', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A10B'}, {'Start': 13, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}]}, {'String': 'A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors', 'Markup': [{'Start': 0, 'Length': 5, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A10BH'}]}, {'String': 'A10BH05 - Linagliptin', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A10BH05'}]}]}}]}, {'TOCHeading': 'Absorption, Distribution and Excretion', 'Information': [{'ReferenceNumber': 10, 'Name': 'Absorption', 'Value': {'StringWithMarkup': [{'String': 'Oral bioavailability of linagliptin is 30%.', 'Markup': [{'Start': 24, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 10, 'Name': 'Route of Elimination', 'Value': {'StringWithMarkup': [{'String': '84.7% of linagliptin is eliminated in the feces and 5.4% is eliminated in the urine.', 'Markup': [{'Start': 9, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 10, 'Name': 'Volume of Distribution', 'Value': {'StringWithMarkup': [{'String': 'A single intravenous dose of 5mg results in a volume of distribution of 1110L. However an intravenous infusion of 0.5-10mg results in a volume of distribution of 380-1540L.'}]}}, {'ReferenceNumber': 10, 'Name': 'Clearance', 'Value': {'StringWithMarkup': [{'String': 'Total clearance of linagliptin is 374mL/min.', 'Markup': [{'Start': 19, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Available animal data have shown excretion of linagliptin in milk at a milk-to-plasma ratio of 4:1.', 'Markup': [{'Start': 46, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'After oral administration of a single 5-mg dose to healthy subjects, peak plasma concentrations of linagliptin occurred at approximately 1.5 hours post dose (Tmax); the mean plasma area under the curve (AUC) was 139 nmol*h/L and maximum concentration (Cmax) was 8.9 nmol/L.', 'Markup': [{'Start': 99, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'The absolute bioavailability of linagliptin is approximately 30%. High-fat meal reduced Cmax by 15% and increased AUC by 4%; this effect is not clinically relevant. Tradjenta may be administered with or without food.', 'Markup': [{'Start': 32, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 165, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Following administration of an oral (14C)-linagliptin dose to healthy subjects, approximately 85% of the administered radioactivity was eliminated via the enterohepatic system (80%) or urine (5%) within 4 days of dosing. Renal clearance at steady state was approximately 70 mL/min.', 'Markup': [{'Start': 42, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'For more Absorption, Distribution and Excretion (Complete) data for Linagliptin (6 total), please visit the HSDB record page.', 'Markup': [{'Start': 108, 'Length': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204#section=Absorption-Distribution-and-Excretion-(Complete)'}, {'Start': 68, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Metabolism/Metabolites', 'Description': 'Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'An oral dose of linagliptin is excreted primarily in the feces. 90% of an oral dose is excreted unchanged in the urine and feces. The predominant metabolite in the plasma is CD1790 and the predominant metabolite recovered after excretion was M489(1). Other metabolites are produced through oxidation, oxidative degradation, N-acetylation, glucuronidation, and cysteine adduct formation. Other metabolites have been identified through mass spectrometry though no structures were determined. Metabolism of linagliptin is mediated by cytochrome P450 3A4, aldo-keto reductases, and carbonyl reductases.', 'Markup': [{'Start': 16, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 360, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cysteine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5862'}, {'Start': 504, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Following oral administration, the majority (about 90%) of linagliptin is excreted unchanged, indicating that metabolism represents a minor elimination pathway. A small fraction of absorbed linagliptin is metabolized to a pharmacologically inactive metabolite, which shows a steady-state exposure of 13.3% relative to linagliptin.', 'Markup': [{'Start': 59, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 190, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 318, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Biological Half-Life', 'Description': 'The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'The terminal half life of linagliptin is 155 hours.', 'Markup': [{'Start': 26, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'The effective half-life for accumulation of linagliptin, as determined from oral administration of multiple doses of linagliptin 5 mg, is approximately 12 hours.', 'Markup': [{'Start': 44, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 117, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Plasma concentrations of linagliptin decline in at least a biphasic manner with a long terminal half-life (>100 hours), related to the saturable binding of linagliptin to DPP-4.', 'Markup': [{'Start': 25, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 156, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Mechanism of Action', 'Description': 'In medicine, the term ""mechanism of action"" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug\'s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a competitive, reversible DPP-4 inhibitor. Inhibition of this enzyme slows the breakdown of GLP-1 and glucose-dependant insulinotropic polypeptide (GIP). GLP-1 and GIP stimulate the release of insulin from beta cells in the pancreas while inhibiting release of glucagon from pancreatic beta cells. These effects together reduce the breakdown of glycogen in the liver and increase insulin release in response to glucose.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 117, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 276, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucagon', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16132283'}, {'Start': 360, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glycogen', 'Type': 'PubChem Internal Link', 'Extra': 'CID-439177'}, {'Start': 426, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900103592, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Thus, linagliptin increases the concentrations of active incretin hormones, stimulating the release of insulin in a glucose-dependent manner and decreasing the levels of glucagon in the circulation. Both incretin hormones are involved in the physiological regulation of glucose homeostasis. Incretin hormones are secreted at a low basal level throughout the day and levels rise immediately after meal intake. GLP-1 and GIP increase insulin biosynthesis and secretion from pancreatic beta-cells in the presence of normal and elevated blood glucose levels. Furthermore, GLP-1 also reduces glucagon secretion from pancreatic alpha-cells, resulting in a reduction in hepatic glucose output.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 84, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucagon', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16132283'}, {'Start': 120, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 178, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 288, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 342, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucagon', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16132283'}, {'Start': 442, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 711, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 759, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucagon', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16132283'}, {'Start': 843, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'MEDICATION'}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html""], 'ExtendedReference': [{'Citation': ""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html"", 'Matched': {'PCLID': 900072243, 'Citation': ""National Library of Medicine's Medical Subject Headings. Linagliptin. Online file (MeSH, 2014). Available from, as of July 18, 2014: https://www.nlm.nih.gov/mesh/2014/mesh_browser/MBrowser.html""}}], 'Value': {'StringWithMarkup': [{'String': 'Hypoglycemic Agents'}]}}], 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Drugs used in diabetes -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 24, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}, {'TOCHeading': 'Formulations/Preparations', 'Description': 'Information on Formulations/Preparations of this chemical, collected by the Hazardous Substances Data Bank (HSDB) from various sources.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597', 'Matched': {'PCLID': 900080223, 'Citation': 'NIH; DailyMed. Current Medication Information for Jentadueto (Linagliptin and Metformin Hydrochloride) Tablets (Revised: May 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6dd9b86-0d18-95d4-2bc7-05591bfdd597'}}], 'Value': {'StringWithMarkup': [{'String': 'Jentadueto is a combination of linagliptin and metformin hydrochloride. Jentadueto tablets are available in the following dosage forms and strengths: 2.5 mg linagliptin/500 mg metformin hydrochloride; 2.5 mg linagliptin/850 mg metformin hydrochloride tablets; 2.5 mg linagliptin/1000 mg metformin hydrochloride tablets.', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Jentadueto', 'Type': 'PubChem Internal Link', 'Extra': 'CID-46861711'}, {'Start': 31, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 47, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}, {'Start': 72, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Jentadueto', 'Type': 'PubChem Internal Link', 'Extra': 'CID-46861711'}, {'Start': 157, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 176, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}, {'Start': 208, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 227, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}, {'Start': 267, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 287, 'Length': 23, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/metformin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-14219'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3207'], 'ExtendedReference': [{'Citation': 'American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3207', 'Matched': {'PCLID': 900105254, 'Citation': 'American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3207'}}], 'Value': {'StringWithMarkup': [{'String': 'Oral: Tablet, film coated: 5 mg, Tradjenta (Boehringer Ingelheim, comarketed by Lilly)', 'Markup': [{'Start': 33, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}]}, {'TOCHeading': 'Identification', 'Description': 'This section contains laboratory methods used to identify this chemical.', 'Section': [{'TOCHeading': 'Analytic Laboratory Methods', 'Description': 'Analytic laboratory methods for analyzing this compound in a sample. The information in this section is collected by the Hazardous Substances Data Bank (HSDB) from various sources.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['PMID:23675275', 'Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615276', 'El-Bagary RI et al; Int J Biomed Sci 8 (3): 209-14 (2012)'], 'ExtendedReference': [{'Citation': 'PMID:23675275', 'Matched': {'PCLID': 24240376, 'Citation': 'El-Bagary RI et al; Int J Biomed Sci 8 (3): 209-14 (2012)', 'PMID': 23675275, 'PMCID': 'PMC3615276', 'DOI': '10.59566/ijbs.2012.8209'}}, {'Citation': 'Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615276', 'Matched': {'PCLID': 906272365, 'Citation': 'Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615276'}}, {'Citation': 'El-Bagary RI et al; Int J Biomed Sci 8 (3): 209-14 (2012)', 'Matched': {'PCLID': 24240376, 'Citation': 'El-Bagary RI et al; Int J Biomed Sci 8 (3): 209-14 (2012)', 'PMID': 23675275, 'PMCID': 'PMC3615276', 'DOI': '10.59566/ijbs.2012.8209'}}], 'Value': {'StringWithMarkup': [{'String': 'In this work, two reversed-phase liquid chromatographic (RP-LC) methods have been developed for the determination of linagliptin (LNG) based on isocratic elution using a mobile phase consisting of potassium dihydrogen phosphate buffer pH (4.6)-acetonitrile(20:80, v/v) at a flow rate of 1 mL min(-1). Two detection techniques have been applied either UV detection at 299 nm in the first method or fluorometric detection at 239 nm for excitation and 355 nm for emission in the second method. Chromatographic separation in the two methods was achieved on a Symmetry cyanide column (150 mm x 4.6 mm, 5 um). Linearity, accuracy and precision were found to be acceptable over the concentration ranges of 2.5-80 ug mL(-1) for LNG in bulk and 2.5-15 ug mL(-1) for LNG in plasma with the first method and 5-160 ug mL(-1) for LNG in bulk with the second method. The optimized methods were validated and proved to be specific, robust and accurate for the quality control of the cited drug in its pharmaceutical preparation.', 'Markup': [{'Start': 117, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 197, 'Length': 30, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/potassium%20dihydrogen%20phosphate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-516951'}, {'Start': 244, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/acetonitrile', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6342'}, {'Start': 564, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/cyanide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-13847878'}]}]}}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Fire Fighting', 'Description': 'This section provides fire fighting information, including fire fighting procedures and hazards.', 'Section': [{'TOCHeading': 'Fire Fighting Procedures', 'Description': 'This section provides information on the actions to be taken in the event of a fire emergency involving this chemical, to prevent the spread of and extinguish fires.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Suitable extinguishing agents: water spray, carbon dioxide, dry chemical powder or foam. Protective equipment: wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes.', 'Markup': [{'Start': 31, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 44, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20dioxide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-280'}]}]}}]}]}, {'TOCHeading': 'Accidental Release Measures', 'Description': 'This section provides recommendations on the appropriate response to spills, leaks, or releases, including containment and cleanup practices to prevent or minimize exposure to people, properties, or the environment. It may also include recommendations distinguishing between responses for large and small spills where the spill volume has a significant impact on the hazard.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'Cleanup Methods', 'Description': 'Procedures for cleanup of chemical spill or hazardous waste', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Accidental release measures: After Inhalation: cordon off area of spill; wear self-contained breathing apparatus, protective clothing and heavy rubber gloves Measures for cleaning/collecting absorb solutions with finely-powdered liquid-binding material (diatomite, universal binders); decontaminate surfaces and equipment by scrubbing with alcohol; dispose of contaminated material /in accordance with prevailing country, fedreal, state and local regulations/.'}]}}]}, {'TOCHeading': 'Disposal Methods', 'Description': 'Disposal methods or procedures for this chemical or hazardous waste containing it.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'SRP: Expired or waste pharmaceuticals shall carefully take into consideration applicable DEA, EPA, and FDA regulations. It is not appropriate to dispose by flushing the pharmaceutical down the toilet or discarding to trash. If possible return the pharmaceutical to the manufacturer for proper disposal being careful to properly label and securely package the material. Alternatively, the waste pharmaceutical shall be labeled, securely packaged and transported by a state licensed medical waste contractor to dispose by burial in a licensed hazardous or toxic waste landfill or incinerator.'}]}}]}, {'TOCHeading': 'Preventive Measures', 'Description': 'Preventive measures to take to avoid suffering negative health effects from this chemical.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Handling should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients.'}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Information for safe handling: avoid inhalation and contact with skin, eyes and clothing ... .'}]}}]}]}, {'TOCHeading': 'Exposure Control and Personal Protection', 'Description': 'This section provides information on the exposure limits, engineering controls, and personal protective measures that can be used to minimize worker exposure.  The information in this section includes OSHA Permissible Exposure Limits (PELs), American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Values (TLVs), and any other exposure limit used or recommended by the chemical manufacturer, importer, or employer preparing the safety data sheet, where available. In addition, this section contains information on appropriate engineering controls (e.g., use local exhaust ventilation, or use only in an enclosed system) as well as recommendations for personal protective measures to prevent illness or injury from exposure to chemicals, such as personal protective equipment (PPE) (e.g., appropriate types of eye, face, skin or respiratory protection needed based on hazards and potential exposure).', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'Personal Protective Equipment (PPE)', 'Description': 'Personal protective equipment (PPE) to use when handling this chemical.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Personal protective equipment as follows: Breathing equipment: NIOSH/MSHA-approved respirator. Protection of hands: chemical-resistant rubber gloves. Eye protection: chemical safety goggles.'}]}}]}]}, {'TOCHeading': 'Regulatory Information', 'Description': 'This section lists the regulations related to the safety, health, and environment of the chemical and its associated products. The regulatory information, which may encompass national and/or regional regulations pertaining to the chemical or mixtures, is presented solely for informational purposes. For additional details, please consult the links to the information sources provided under each data entry.', 'Section': [{'TOCHeading': 'FDA Requirements', 'Description': 'FDA requirements regarding this chemical and products containing it.  FDA Requirements means any requirements of the Federal Food, Drug and Cosmetic Act (FDCA), as amended, and any rules or regulations promulgated thereunder which are or may be applicable to the manufacture, sale, labeling or distribution of the products regulated by FDA (e.g., drugs, biologics, dietary supplements, foods, cosmetics, tobacco products, etc.).', 'URL': 'https://www.fda.gov/regulatory-information/laws-enforced-fda/federal-food-drug-and-cosmetic-act-fdc-act', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of July 18, 2014: https://www.fda.gov/cder/ob/'], 'ExtendedReference': [{'Citation': 'DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of July 18, 2014: https://www.fda.gov/cder/ob/', 'Matched': {'PCLID': 900105389, 'Citation': 'DHHS/FDA; Electronic Orange Book-Approved Drug Products with Therapeutic Equivalence Evaluations. Available from, as of July 18, 2014: https://www.fda.gov/cder/ob/'}}], 'Value': {'StringWithMarkup': [{'String': 'The Approved Drug Products with Therapeutic Equivalence Evaluations identifies currently marketed prescription drug products, including linagliptin, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act.', 'Markup': [{'Start': 136, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}]}, {'TOCHeading': 'Other Safety Information', 'Description': 'Miscellaneous safety information for this chemical that is not shown in other sections, such as history, incidents, special reports, and so on.', 'Section': [{'TOCHeading': 'Toxic Combustion Products', 'Description': 'Toxic products (e.g., gases and vapors) produced from the combustion of this chemical.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'], 'ExtendedReference': [{'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html', 'Matched': {'PCLID': 906275368, 'Citation': 'Selleck Chemicals; Material Safety Data Sheet: Linagliptin, Cat. Number S3031, RN 668270-12-0 (Revision Date: 10/1/2012). Available from, as of June 11, 2014: https://www.selleckchem.com/msds/linagliptin-bi-1356-MSDS.html'}}], 'Value': {'StringWithMarkup': [{'String': 'Emits toxic fumes such as carbon monoxide, etc.', 'Markup': [{'Start': 26, 'Length': 15, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/carbon%20monoxide', 'Type': 'PubChem Internal Link', 'Extra': 'CID-281'}]}]}}]}]}]}, {'TOCHeading': 'Toxicity', 'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.', 'Section': [{'TOCHeading': 'Toxicological Information', 'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.', 'Section': [{'TOCHeading': 'Toxicity Summary', 'Description': 'Summary of the toxicity of this compound, provided by the Hazardous Substances Data Bank (HSDB) and other sources.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'IDENTIFICATION AND USE: Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, but should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. HUMAN EXPOSURE AND TOXICITY: In a pooled dataset of 14 placebo-controlled clinical trials, adverse reactions that occurred in > or = 2% of patients receiving Tradjenta (Linagliptin) (n = 3625) were nasopharyngitis (7.0%), diarrhea  (3.3%), and cough (2.1%). Other adverse reactions reported in clinical studies with treatment of Tradjenta (Linagliptin) were hypersensitivity (e.g., urticaria, angioedema, localized skin exfoliation, or bronchial hyperreactivity), and myalgia. Additional adverse reactions have been identified during postapproval use of Tradjenta (Linagliptin); acute pancreatitis, including fatal pancreatitis, hypersensitivity reactions including anaphylaxis, angioedema, exfoliative skin conditions, and rash. ANIMAL STUDIES: Linagliptin did not increase the incidence of tumors in male and female rats in a 2-year study at doses of 6, 18, and 60 mg/kg. Linagliptin did not increase the incidence of tumors in mice in a 2-year study at doses up to 80 mg/kg (males) and 25 mg/kg (females). Higher doses of Linagliptin in female mice (80 mg/kg) increased the incidence of lymphoma. In fertility studies in rats, Linagliptin had no adverse effects on early embryonic development, mating, fertility, or bearing live young up to the highest dose of 240 mg/kg.  Linagliptin crossed the placenta into the fetus following oral dosing in pregnant rats and rabbits and available animal data have shown excretion of linagliptin in milk at a milk-to-plasma ratio of 4:1. Linagliptin was not mutagenic or clastogenic with or without metabolic activation in the Ames bacterial mutagenicity assay, a chromosomal aberration test in human lymphocytes, and an in vivo micronucleus assay.', 'Markup': [{'Start': 24, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 457, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 468, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 628, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 639, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 853, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 864, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1045, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1173, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1324, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1429, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1575, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1724, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1778, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Hepatotoxicity', 'Description': 'This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.', 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'In large clinical trials, rates of serum enzyme elevations were similar with linagliptin therapy (', 'Markup': [{'Start': 77, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}, {'String': 'Likelihood score: D (possible rare cause of clinically apparent acute liver injury).'}]}}]}, {'TOCHeading': 'Effects During Pregnancy and Lactation', 'Description': 'Drug effects during pregnancy and lactation.', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': '◉ Summary of Use during Lactation'}, {'String': ""No information is available on the clinical use of linagliptin during breastfeeding. Linagliptin's plasma protein binding ranges from 80% to over 99%, so it is unlikely to pass into breastmilk in clinically important amounts and might be a better choice among drugs in this class for nursing mothers. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with linagliptin.[1]"", 'Markup': [{'Start': 51, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 85, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 615, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}, {'Start': 665, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}, {'String': '◉ Effects in Breastfed Infants'}, {'String': 'Relevant published information was not found as of the revision date.'}, {'String': '◉ Effects on Lactation and Breastmilk'}, {'String': 'Relevant published information was not found as of the revision date.'}]}}]}, {'TOCHeading': 'Interactions', 'Description': 'Interactions of this compound with other chemicals, according to the Hazardous Substances Data Bank (HSDB).', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'], 'ExtendedReference': [{'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng', 'Matched': {'PCLID': 900159014, 'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'}}], 'Value': {'StringWithMarkup': [{'String': 'Trajenta is not indicated in combination with insulin due to an increase in cardiovascular risk, which cannot be excluded.', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Trajenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Insulin secretagogues and insulin are known to cause hypoglycemia. The use of Tradjenta in combination with an insulin secretagogue (e.g., sulfonylurea) was associated with a higher rate of hypoglycemia compared with placebo in a clinical trial. The use of Tradjenta in combination with insulin in subjects with severe renal impairment was associated with a higher rate of hypoglycemia. Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with Tradjenta.', 'Markup': [{'Start': 78, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 139, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/sulfonylurea', 'Type': 'PubChem Internal Link', 'Extra': 'CID-140987867'}, {'Start': 257, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 531, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Rifampin decreased linagliptin exposure, suggesting that the efficacy of Tradjenta may be reduced when administered in combination with a strong P-gp or CYP3A4 inducer. Therefore, use of alternative treatments is strongly recommended when linagliptin is to be administered with a strong P-gp or CYP3A4 inducer.', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Rifampin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-135398735'}, {'Start': 19, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 73, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 239, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Sulfonylureas and insulin are known to cause hypoglycemia. Therefore, caution is advised when linagliptin is used in combination with a sulfonylurea and/or insulin. A dose reduction of the sulfonylurea or insulin, may be considered.', 'Markup': [{'Start': 94, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 136, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/sulfonylurea', 'Type': 'PubChem Internal Link', 'Extra': 'CID-140987867'}, {'Start': 189, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/sulfonylurea', 'Type': 'PubChem Internal Link', 'Extra': 'CID-140987867'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3206'], 'ExtendedReference': [{'Citation': 'American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3206', 'Matched': {'PCLID': 906282558, 'Citation': 'American Society of Health-System Pharmacists 2014; Drug Information 2014. Bethesda, MD. 2014, p. 3206'}}], 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is a weak to moderate inhibitor of cytochrome P-450 (CYP) isoenzyme 3A4; however, it does not inhibit or induce CYP isoenzymes 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, or 4A11 in vitro. In vivo studies indicate that drug interactions are unlikely with substrates of CYP isoenzymes 3A4, 2C9, or 2C8.  No adjustment of linagliptin dosage is recommended based on results of pharmacokinetic studies.  Inducers of CYP3A4 (e.g., rifampin) decrease exposure to linagliptin, resulting in subtherapeutic and likely ineffective concentrations. The manufacturer states that alternatives to linagliptin are strongly recommended in patients who require therapy with potent CYP3A4 inducers.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 329, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 435, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/rifampin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-135398735'}, {'Start': 466, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 591, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Antidote and Emergency Treatment', 'Description': 'Information on antidote and emergency treatment when exposed to this chemical.  The information here is from the Hazardous Substances Data Bank (HSDB).', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/11933', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160'], 'ExtendedReference': [{'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160', 'Matched': {'PCLID': 900012526, 'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160'}}], 'Value': {'StringWithMarkup': [{'String': '/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/', 'Markup': [{'Start': 324, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160'], 'ExtendedReference': [{'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160', 'Matched': {'PCLID': 900012526, 'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160'}}], 'Value': {'StringWithMarkup': [{'String': '/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/', 'Markup': [{'Start': 216, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Oxygen', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Oxygen'}, {'Start': 468, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 637, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160-1'], 'ExtendedReference': [{'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160-1', 'Matched': {'PCLID': 900112227, 'Citation': 'Currance, P.L. Clements, B., Bronstein, A.C. (Eds).; Emergency Care For Hazardous Materials Exposure. 3rd revised edition, Elsevier Mosby, St. Louis, MO 2007, p. 160-1'}}], 'Value': {'StringWithMarkup': [{'String': '/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Consider administering a beta agonist such as albuterol for severe bronchospasm ... . Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start IV administration of D5W TKO /SRP: ""To keep open"", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer\'s (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... .  /Poisons A and B/', 'Markup': [{'Start': 378, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/albuterol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-2083'}, {'Start': 775, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/diazepam', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3016'}, {'Start': 787, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/lorazepam', 'Type': 'PubChem Internal Link', 'Extra': 'CID-3958'}, {'Start': 807, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/proparacaine%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-517321'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['OLSON, K.R. (Ed). Poisoning and Drug Overdose, Sixth Edition. McGraw-Hill, New York, NY 2012, p. 103'], 'ExtendedReference': [{'Citation': 'OLSON, K.R. (Ed). Poisoning and Drug Overdose, Sixth Edition. McGraw-Hill, New York, NY 2012, p. 103', 'Matched': {'PCLID': 900018134, 'Citation': 'OLSON, K.R. (Ed). Poisoning and Drug Overdose, Sixth Edition. McGraw-Hill, New York, NY 2012, p. 103'}}], 'Value': {'StringWithMarkup': [{'String': 'Emergency and supportive measures. 1. Maintain an open airway and assist ventilation if necessary. 2. Treat coma and seizures if the occur. 3. Obtain finger stick blood glucose levels every 1-2 hours until stabilized. /Antidiabetic agents/', 'Markup': [{'Start': 169, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/glucose', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5793'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'For more Antidote and Emergency Treatment (Complete) data for Linagliptin (6 total), please visit the HSDB record page.', 'Markup': [{'Start': 102, 'Length': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204#section=Antidote-and-Emergency-Treatment-(Complete)'}, {'Start': 62, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Human Toxicity Excerpts', 'Description': 'Excerpts about human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/HUMAN EXPOSURE STUDIES/ An open-label pharmacokinetic study evaluated the pharmacokinetics of linagliptin 5 mg in male and female patients with varying degrees of chronic renal impairment. The study included 6 healthy subjects with normal renal function (creatinine clearance [CrCl] =80 mL/min), 6 patients with mild renal impairment (CrCl 50 to <80 mL/min), 6 patients with moderate renal impairment (CrCl 30 to <50 mL/min), 10 patients with type 2 diabetes mellitus and severe renal impairment (CrCl <30 mL/min), and 11 patients with type 2 diabetes mellitus and normal renal function. Creatinine clearance was measured by 24-hour urinary creatinine clearance measurements or estimated from serum creatinine based on the Cockcroft-Gault formula.  Under steady-state conditions, linagliptin exposure in patients with mild renal impairment was comparable to healthy subjects.  In patients with moderate renal impairment under steady-state conditions, mean exposure of linagliptin increased (AUCt,ss by 71% and Cmax by 46%) compared with healthy subjects. This increase was not associated with a prolonged accumulation half-life, terminal half-life, or an increased accumulation factor. Renal excretion of linagliptin was below 5% of the administered dose and was not affected by decreased renal function.  Patients with type 2 diabetes mellitus and severe renal impairment showed steady-state exposure approximately 40% higher than that of patients with type 2 diabetes mellitus and normal renal function (increase in AUCt,ss by 42% and Cmax by 35%). For both type 2 diabetes mellitus groups, renal excretion was below 7% of the administered dose.', 'Markup': [{'Start': 95, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 256, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/creatinine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-588'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900103592, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 31, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/HUMAN EXPOSURE STUDIES/ In a randomized, placebo-controlled, active-comparator, 4-way crossover study, 36 healthy subjects were administered a single oral dose of linagliptin 5 mg, linagliptin 100 mg (20 times the recommended dose), moxifloxacin, and placebo. No increase in QTc was observed with either the recommended dose of 5 mg or the 100-mg dose. At the 100-mg dose, peak linagliptin plasma concentrations were approximately 38-fold higher than the peak concentrations following a 5-mg dose.', 'Markup': [{'Start': 164, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 182, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 234, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}, {'Start': 379, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of September 10, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of September 10, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900022898, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of September 10, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/SIGNS AND SYMPTOMS/ In a pooled dataset of 14 placebo-controlled clinical trials, adverse reactions that occurred in > or = 2% of patients receiving Tradjenta (Linagliptin) (n = 3625) were nasopharyngitis (7.0%), diarrhea  (3.3%), and cough (2.1%). ... Other adverse reactions reported in clinical studies with treatment of Tradjenta (Linagliptin) were hypersensitivity (e.g., urticaria, angioedema, localized skin exfoliation, or bronchial hyperreactivity), and myalgia.', 'Markup': [{'Start': 150, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 161, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 325, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 336, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/SIGNS AND SYMPTOMS/ Adverse reactions have been identified during postapproval use of Tradjenta: acute pancreatitis, including fatal pancreatitis; hypersensitivity reactions including anaphylaxis, angioedema, and exfoliative skin conditions; and rash.', 'Markup': [{'Start': 87, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'For more Human Toxicity Excerpts (Complete) data for Linagliptin (11 total), please visit the HSDB record page.', 'Markup': [{'Start': 94, 'Length': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204#section=Human-Toxicity-Excerpts-(Complete)'}, {'Start': 53, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Non-Human Toxicity Excerpts', 'Description': 'Excerpts about non-human toxicity of this compound, extracted from authoritative documents, such as journal articles, government reports, and reference books.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ Linagliptin did not increase the incidence of tumors in male and female rats in a 2-year study at doses of 6, 18, and 60 mg/kg. The highest dose of 60 mg/kg is approximately 418 times the clinical dose of 5 mg/day based on AUC exposure. Linagliptin did not increase the incidence of tumors in mice in a 2-year study at doses up to 80 mg/kg (males) and 25 mg/kg (females), or approximately 35- and 270-times the clinical dose based on AUC exposure. Higher doses of linagliptin in female mice (80 mg/kg) increased the incidence of lymphoma at approximately 215-times the clinical dose based on AUC exposure', 'Markup': [{'Start': 58, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 295, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 522, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.34 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'], 'ExtendedReference': [{'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.34 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng', 'Matched': {'PCLID': 900038753, 'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.34 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'}}], 'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Chronic Exposure or Carcinogenicity/ A two-year carcinogenicity study was conducted in male and female rats given oral doses of linagliptin of 6, 18, and 60 mg/kg/day. There was no increase in the incidence of tumors in any organ up to 60 mg/kg/day. This dose results in exposures approximately 400 times the human exposure at the maximum recommended daily adult human dose (MRHD) of 5 mg/day based on AUC comparisons. A two-year carcinogenicity study was conducted in male and female mice given oral doses of 8, 25 and 80 mg/kg/day. There was no evidence of a carcinogenic potential up to 80 mg/kg/day, approximately 240 times human clinical exposure.', 'Markup': [{'Start': 149, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ Linagliptin administered during the period of organogenesis was not teratogenic at doses up to 30 mg/kg in the rat and 150 mg/kg in the rabbit, or approximately 49 and 1943 times the clinical dose based on AUC exposure. Doses of linagliptin causing maternal toxicity in the rat and the rabbit also caused developmental delays in skeletal ossification and slightly increased embryofetal loss in the rat (1000 times the clinical dose) and increased fetal resorptions and visceral and skeletal variations in the rabbit (1943 times the clinical dose).', 'Markup': [{'Start': 61, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 290, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': '/LABORATORY ANIMALS: Developmental or Reproductive Toxicity/ In fertility studies in rats, linagliptin had no adverse effects on early embryonic development, mating, fertility, or bearing live young up to the highest dose of 240 mg/kg (approximately 943-times the clinical dose based on AUC exposure).', 'Markup': [{'Start': 91, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'For more Non-Human Toxicity Excerpts (Complete) data for Linagliptin (11 total), please visit the HSDB record page.', 'Markup': [{'Start': 98, 'Length': 16, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204#section=Non-Human-Toxicity-Excerpts-(Complete)'}, {'Start': 57, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Populations at Special Risk', 'Description': 'People within the general population vary greatly in their sensitivity to chemical agents on an individual or mixture basis.  Some segments of the general population may be at greatest risk for adverse outcomes.  Well-known groups at special risk include children, women of childbearing age, the elderly and are also defined by nutritional status, occupations, contamination of local food supplies, gender and genetic inheritance.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'], 'ExtendedReference': [{'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng', 'Matched': {'PCLID': 900159014, 'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'}}], 'Value': {'StringWithMarkup': [{'String': 'Trajenta is not recommended for use in pregnancy.', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Trajenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'], 'ExtendedReference': [{'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng', 'Matched': {'PCLID': 900159014, 'Citation': 'Health Canada; Product Monograph for Trajenta (linagliptin), Drug Identification Number (DIN): 02370921 p.4 (Preparation date: February 19, 2014). Available from, as of August 1, 2014: https://webprod5.hc-sc.gc.ca/dpd-bdpp/start-debuter.do?lang=eng'}}], 'Value': {'StringWithMarkup': [{'String': 'A limited number of patients with history of congestive heart failure participated in clinical studies with Trajenta. In clinical trials, patients with a clinically significant history of cardiac disease or presence of active cardiac disease within 6 months were excluded. Use in this population is not recommended.', 'Markup': [{'Start': 108, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Trajenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900125149, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (Linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of July 18, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Tradjenta should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Protein Binding', 'Description': 'In this section, ""protein binding"" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug\'s efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is 99% protein bound at a concentration of 1nmol/L and 75-89% protein bound at a concentration of >30nmol/L.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}]}, {'TOCHeading': 'Ecological Information', 'Description': 'This section provides information to evaluate the environmental impact of the chemical if it were released to the environment. The information may include data from toxicity tests performed on aquatic and/or terrestrial organisms, where available (e.g., acute or chronic aquatic toxicity data for fish, algae, and crustaceans; toxicity data on birds, bees, and plants).  This section also includes information on whether there is a potential for the chemical to persist or degrade in the environment either through biodegradation or other processes (such as oxidation or hydrolysis) as well as the concentration or amount of the chemical found in the environment (e.g., in plants, animals as well as in the atmosphere or water).', 'Section': [{'TOCHeading': 'Environmental Fate/Exposure Summary', 'Description': 'This section summarizes the environmental fate/exposure of this chemical, including the natural and artificial sources of the chemical as a pollutant, its environmental fate, biodegradation, abiotic degradation, bioconcentration, etc.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': ""Linalipton's production and use as an antidiabetic drug may result in its release to the environment through various waste streams. If released to air, an estimated vapor pressure of 5.6X10-17 mm Hg at 25 °C indicates linagliptin will exist solely in the particulate phase in the atmosphere. Particulate-phase linagliptin will be removed from the atmosphere by wet and dry deposition. Linagliptin contains chromophores that absorb at wavelengths >290 nm and, therefore, may be susceptible to direct photolysis by sunlight. If released to soil, linagliptin is expected to have slight mobility based upon an estimated Koc of 3,100. The pKa of linagliptin is 8.6, indicating that this compound will exist almost entirely in the cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts. Volatilization of linagliptin from moist soil surfaces is not expected to be an important fate process because linagliptin exists as a cation and cations do not volatilize. Linagliptin is not expected to volatilize from dry soil surfaces based upon its vapor pressure. Biodegradation data in soil or water were not available. If released into water, linagliptin is expected to adsorb to suspended solids and sediment based upon the estimated Koc. The pKa indicates linagliptin will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, volatilization from water surfaces and bioconcentration are not expected to be important fate processes. Hydrolysis is not expected to be an important environmental fate process since this compound lacks functional groups that hydrolyze under environmental conditions (pH 5 to 9). Occupational exposure to linagliptin may occur through inhalation and dermal contact with this compound at workplaces where linagliptin is produced or used. Exposure to linagliptin among the general population may be among those administered the drug, anantidiabetic. (SRC)"", 'Markup': [{'Start': 218, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 310, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 385, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 544, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 641, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 827, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Carbon', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Carbon'}, {'Start': 894, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 987, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1049, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1176, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 1219, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 1226, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1341, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1458, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 1744, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1843, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 1888, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Artificial Pollution Sources', 'Description': 'Pollutants are emitted from a range of natural and man-made (artificial) sources.  This section provides information on the artificial sources of the compound as a pollutant.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['PMID:22483984', ""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)"", '(2) Martin J et al; J Chromatogr B Analyt Technol Biomed Life Sci 2012 May 1;895-896:94-101. doi: 10.1016/j.jchromb.2012.03.023. Epub 2012 Mar 28.'], 'ExtendedReference': [{'Citation': 'PMID:22483984', 'Matched': {'PCLID': 25603952, 'Citation': '2012; 895-896 94-101', 'PMID': 22483984, 'DOI': '10.1016/j.jchromb.2012.03.023'}}, {'Citation': ""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}, {'Citation': '(2) Martin J et al; J Chromatogr B Analyt Technol Biomed Life Sci 2012 May 1;895-896:94-101. doi: 10.1016/j.jchromb.2012.03.023. Epub 2012 Mar 28.'}], 'Value': {'StringWithMarkup': [{'String': ""Linagliptin's production and use as an antidiabetic drug(1) may result in its release to the environment through various waste streams(SRC). Antidiabetic compounds are among the most prescribed pharmaceuticals(2)."", 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Environmental Fate', 'Description': 'Environmental fate describes where this chemical goes when it gets out into the environment and how it might be chemically transformed in that process.  This section may provide information on multiple types of environmental fates of the chemical (e.g., aquatic fate, terrestrial fate, and atmospheric fate).   ', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) Swann RL et al; Res Rev 85: 17-28 (1983)', '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm', ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)"", '(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)'], 'ExtendedReference': [{'Citation': '(1) Swann RL et al; Res Rev 85: 17-28 (1983)'}, {'Citation': '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'}, {'Citation': ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}, {'Citation': '(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)'}], 'Value': {'StringWithMarkup': [{'String': 'TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3,100(SRC), determined from a structure estimation method(2), indicates that linagliptin is expected to have slight mobility in soil(SRC). The pKa of linagliptin is 8.6(3), indicating that this compound will exist almost entirely in the cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of linagliptin from moist soil surfaces is not expected to be an important fate process because linagliptin exists as a cation and cations do not volatilize(SRC). Linagliptin is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 5.6X10-17 mm Hg at 25 °C(SRC), determined from a fragment constant method(2). Biodegradation data in soil were not available(SRC, 2014).', 'Markup': [{'Start': 158, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 231, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 420, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Carbon', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Carbon'}, {'Start': 490, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 583, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 650, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) Swann RL et al; Res Rev 85: 17-28 (1983)', '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm', ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""], 'ExtendedReference': [{'Citation': '(1) Swann RL et al; Res Rev 85: 17-28 (1983)'}, {'Citation': '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'}, {'Citation': ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}], 'Value': {'StringWithMarkup': [{'String': 'AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3,100(SRC), determined from a structure estimation method(2), indicates that linagliptin is expected to adsorb to suspended solids and sediment(SRC). A pKa of 8.6(3) indicates linagliptin will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, volatilization from water surfaces and bioconcentration are not expected to be important fate processes. Biodegradation data in water were not available(SRC, 2014).', 'Markup': [{'Start': 154, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 253, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 370, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 478, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}]}]}}, {'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) Bidleman TF; Environ Sci Technol 22: 361-367 (1988)', '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm', '(3) Meylan WM, Howard PH; Chemosphere 26: 2293-99 (1993)', '(4) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 8-12 (1990)'], 'ExtendedReference': [{'Citation': '(1) Bidleman TF; Environ Sci Technol 22: 361-367 (1988)'}, {'Citation': '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'}, {'Citation': '(3) Meylan WM, Howard PH; Chemosphere 26: 2293-99 (1993)'}, {'Citation': '(4) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 8-12 (1990)'}], 'Value': {'StringWithMarkup': [{'String': 'ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), linagliptin, which has an estimated vapor pressure of 5.6X10-17 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase linagliptin may be removed from the air by wet and dry deposition(SRC). Linagliptin contains chromophores that absorb at wavelengths >290 nm(4) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).', 'Markup': [{'Start': 124, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 354, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 426, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Environmental Abiotic Degradation', 'Description': 'Abiotic degradation is a process by which a chemical substance is broken down into smaller molecules by non-biotic means (e.g., hydrolysis, photolysis, and oxidation).', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5, 8-12 (1990)'], 'ExtendedReference': [{'Citation': '(1) Lyman WJ et al; Handbook of Chemical Property Estimation Methods. Washington, DC: Amer Chem Soc pp. 7-4, 7-5, 8-12 (1990)'}], 'Value': {'StringWithMarkup': [{'String': 'Linagliptin is not expected to undergo hydrolysis in the environment due to the lack of functional groups that hydrolyze under environmental conditions(1). Linagliptin contains chromophores that absorb at wavelengths >290 nm(1) and, therefore, may be susceptible to direct photolysis by sunlight(SRC).', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 156, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Environmental Bioconcentration', 'Description': 'This section provides information on environmental bioconcentration for this compound.  Bioconcentration is the accumulation of a chemical in or on an organism when the source of chemical is solely water. Bioconcentration is a term that was created for use in the field of aquatic toxicology. Bioconcentration can also be defined as the process by which a chemical concentration in an aquatic organism exceeds that in water as a result of exposure to a waterborne chemical.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""], 'ExtendedReference': [{'Citation': ""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}], 'Value': {'StringWithMarkup': [{'String': 'A pKa of 8.6(1) indicates linagliptin will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, bioconcentration is not expected to be an important fate process(SRC).', 'Markup': [{'Start': 26, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Soil Adsorption/Mobility', 'Description': 'Sorption to soils and sediments is an important factor on the transport and fate of organic contaminants in the environment.  The soil/water adsorption coefficient, also known as solid-water distribution coefficient (Kd), measures the amount of chemical substance adsorbed onto soil per amount of water.  Since adsorption occurs predominantly by partition into the soil organic matter, it is more useful to normalize the Kd value to the organic carbon content of a soil and express the distribution coefficient in Koc (organic carbon normalized distribution coefficient).  The greater the Kd (or Koc) value, the less likely a chemical will leach or contribute to runoff.  A very high value means it is strongly adsorbed onto soil and organic matter and does not move throughout the soil.', 'URL': 'https://toxics.usgs.gov/pubs/FS-087-00/fs-087-00.pdf', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm', '(2) Swann RL et al; Res Rev 85: 17-28 (1983)', ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)"", '(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)'], 'ExtendedReference': [{'Citation': '(1) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'}, {'Citation': '(2) Swann RL et al; Res Rev 85: 17-28 (1983)'}, {'Citation': ""(3) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}, {'Citation': '(4) Doucette WJ; pp. 141-188 in Handbook of Property Estimation Methods for Chemicals. Boethling RS, Mackay D, eds. Boca Raton, FL: Lewis Publ (2000)'}], 'Value': {'StringWithMarkup': [{'String': 'Using a structure estimation method based on molecular connectivity indices(1), the Koc of linagliptin can be estimated to be 3,100(SRC). According to a classification scheme(2), this estimated Koc value suggests that linagliptin is expected to have slight mobility in soil. The pKa of linagliptin is 8.6(3), indicating that this compound will exist almost entirely  in the cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4).', 'Markup': [{'Start': 91, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 218, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 286, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 476, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Carbon', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Carbon'}]}]}}]}, {'TOCHeading': 'Volatilization from Water/Soil', 'Description': 'Volatilization of chemicals from water/soil is the transfer of the chemical as a gas through the water-air or soil-air interface under environmental conditions', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': [""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)"", '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'], 'ExtendedReference': [{'Citation': ""(1) O'Neil MJ, ed; The Merck Index. 15th ed., Cambridge, UK: Royal Society of Chemistry, p. 1022 (2013)""}, {'Citation': '(2) US EPA; Estimation Program Interface (EPI) Suite. Ver. 4.1. Nov, 2012. Available from, as of Jun 18, 2014: https://www.epa.gov/oppt/exposure/pubs/episuitedl.htm'}], 'Value': {'StringWithMarkup': [{'String': 'A pKa of 8.6(1) indicates linagliptin will exist almost entirely in the cation form at pH values of 5 to 9 and, therefore, volatilization from water surfaces is not expected to be an important fate process. Linagliptin is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 5.6X10-12 mm Hg(SRC), determined from a fragment constant method(2).', 'Markup': [{'Start': 26, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 143, 'Length': 5, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/water', 'Type': 'PubChem Internal Link', 'Extra': 'CID-962'}, {'Start': 207, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Environmental Water Concentrations', 'Description': 'Concentrations of this chemical in water in various stages of hydrologic cycle (e.g., drinking water, ground water, surface water, and rain/snow).', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['(1) Heberer T; Tox Lett 131: 5-17 (2002)', '(2) Koplin DW et al; Environ Sci Toxicol 36: 1202-211 (2002)'], 'ExtendedReference': [{'Citation': '(1) Heberer T; Tox Lett 131: 5-17 (2002)'}, {'Citation': '(2) Koplin DW et al; Environ Sci Toxicol 36: 1202-211 (2002)'}], 'Value': {'StringWithMarkup': [{'String': 'While data specific to linagliptin were not located(SRC, 2014), the literature suggests that some pharmaceutically active compounds originating from human and veterinary therapy are not eliminated completely in municipal sewage treatment plants and are, therefore, discharged into receiving waters(1). Wastewater treatment processes often were not designed to remove them from the effluent(2). Selected organic waste compounds may be degrading to new and more persistent compounds that may be released instead of or in addition to the parent compound(2).', 'Markup': [{'Start': 23, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Milk Concentrations', 'Description': 'Concentrations of this compound in milk.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Reference': ['NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'], 'ExtendedReference': [{'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f', 'Matched': {'PCLID': 900083724, 'Citation': 'NIH; DailyMed. Current Medication Information for Tradjenta (linagliptin) Tablet, Film-coated (Revised: June 2014). Available from, as of August 1, 2014: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c797ea5c-cab7-494b-9044-27eba0cfe40f'}}], 'Value': {'StringWithMarkup': [{'String': 'Available animal data /in rats and rabbits/ have shown excretion of linagliptin in milk at a milk-to-plasma ratio of 4:1.', 'Markup': [{'Start': 68, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}, {'TOCHeading': 'Probable Routes of Human Exposure', 'Description': 'Potential way(s) in which people may come into contact with a hazardous chemical.  Examples of common exposure routes are inhalation, ingestion, skin/eye contact.', 'Information': [{'ReferenceNumber': 26, 'Description': 'PEER REVIEWED', 'Value': {'StringWithMarkup': [{'String': 'Occupational exposure to linagliptin may occur through inhalation and dermal contact with this compound at workplaces where linagliptin is produced or used. Exposure to linagliptin among the general population may be among those administered the drugs Jentadueto or Tradjenta, antidiabetics. (SRC)', 'Markup': [{'Start': 25, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 124, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 169, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/linagliptin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}, {'Start': 252, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Jentadueto', 'Type': 'PubChem Internal Link', 'Extra': 'CID-46861711'}, {'Start': 266, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tradjenta', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10096344'}]}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 51, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 52, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 59, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 81, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10096344', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341551602'}}, {'ReferenceNumber': 50, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341142651'}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 53, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376821150'}}]}, {'TOCHeading': 'Wiley References', 'Description': 'Literature references related to scientific contents from Wiley journals and books.', 'Information': [{'ReferenceNumber': 57, 'Value': {'ExternalTableName': 'collection=wiley&query_type=sid&query=386267596'}}]}, {'TOCHeading': 'Nature Journal References', 'Description': 'Literature references provided by Nature journals including Nature Chemistry, Nature Synthesis, Nature Chemical Biology, Nature Communications, Nature Catalysis, etc.', 'Information': [{'ReferenceNumber': 37, 'URL': 'https://www.nature.com/articles/s41589-023-01357-8', 'Value': {'StringWithMarkup': [{'String': 'Keller et al. Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicron. Nature Chemical Biology, DOI: 10.1038/s41589-023-01357-8, published online 22 June 2023'}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'CA2435730'}, {'String': 'CA2496249'}, {'String': 'US7407955', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7407955'}]}, {'String': 'US6340475', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US6340475'}]}, {'String': 'US6635280', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US6635280'}]}, {'String': 'US6488962', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US6488962'}]}, {'String': 'US6303661', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US6303661'}]}, {'String': 'US6890898', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US6890898'}]}, {'String': 'US7078381', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7078381'}]}, {'String': 'US7459428', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7459428'}]}, {'String': 'US8119648', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8119648'}]}, {'String': 'US8178541', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8178541'}]}, {'String': 'US8846695', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8846695'}]}, {'String': 'US9173859', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9173859'}]}, {'String': 'US8853156', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8853156'}]}, {'String': 'US8673927', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8673927'}]}, {'String': 'US8883805', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8883805'}]}, {'String': 'US9155705', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9155705'}]}, {'String': 'US8551957', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8551957'}]}, {'String': 'US7713938', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7713938'}]}, {'String': 'US7579449', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7579449'}]}, {'String': 'US9486526', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9486526'}]}, {'String': 'US9415016', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9415016'}]}, {'String': 'US9555001', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9555001'}]}, {'String': 'US9949998', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9949998'}]}, {'String': 'US10034877', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10034877'}]}, {'String': 'US10022379', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10022379'}]}, {'String': 'US10258637', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10258637'}]}, {'String': 'US10406172', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10406172'}]}, {'String': 'US10596120', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10596120'}]}, {'String': 'US10973827', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US10973827'}]}, {'String': 'US11090323', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11090323'}]}, {'String': 'US11033552', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11033552'}]}, {'String': 'US11564886', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11564886'}]}, {'String': 'US11833166', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11833166'}]}, {'String': 'US11911388', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11911388'}]}]}}], 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 59, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 59, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10096344/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 85, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=LTXREWYXXSTFRX-QGZVFWFLSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=LTXREWYXXSTFRX-QGZVFWFLSA-N'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 24, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^LINAGLIPTIN$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 59, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Protein Bound 3D Structures', 'Description': 'Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.', 'Information': [{'ReferenceNumber': 48, 'Value': {'ExternalTableName': 'pdb'}}, {'ReferenceNumber': 59, 'URL': 'https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=10096344', 'Value': {'StringWithMarkup': [{'String': 'View 2 proteins in NCBI Structure'}]}}], 'Section': [{'TOCHeading': 'Ligands from Protein Bound 3D Structures', 'Description': 'Ligands found in experimental protein-ligand co-complexes (e.g., those archived in the Protein Data Bank in Europe (PDBe)).', 'URL': 'https://www.ebi.ac.uk/pdbe/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'MoveToTop': True, 'ShowAtMost': 1}, 'Section': [{'TOCHeading': 'PDBe Ligand Code', 'Description': 'The ligand code for this compound used in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 46, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/356', 'Value': {'StringWithMarkup': [{'String': '356'}]}}]}, {'TOCHeading': 'PDBe Structure Code', 'Description': ""The structure code for the Protein Data Bank in Europe (PDBe) protein-ligand co-complex from which the ligand's 3-D coordinates were taken."", 'Information': [{'ReferenceNumber': 46, 'URL': 'http://www.ebi.ac.uk/pdbe/entry/pdb/2RGU', 'Value': {'StringWithMarkup': [{'String': '2RGU'}]}}]}, {'TOCHeading': 'PDBe Conformer', 'Description': 'The experimental protein-bound 3D structure of this compound in a protein-ligand co-complex archived in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 46, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/356', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/8189571_1'], 'MimeType': 'pubchem/compound-gzip-asnb'}}]}]}]}, {'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 1, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 4, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 9, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 10, 'Value': {'ExternalTableName': 'collection=consolidatedcompoundtarget&query_type=name&query=^Linagliptin$'}}, {'ReferenceNumber': 27, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 51, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]}, {'TOCHeading': 'Drug-Drug Interactions', 'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'Information': [{'ReferenceNumber': 10, 'Value': {'ExternalTableName': 'collection=drugbankddi&query_type=name&query=^Linagliptin$'}}]}, {'TOCHeading': 'Drug-Food Interactions', 'Description': 'Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'DisplayControls': {'ListType': 'Bulleted'}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Avoid excessive or chronic alcohol consumption. Chronic or binge drinking can increase the risk of serious side effects.'}, {'String': 'Take with or without food. High fat meals reduce the maximum concentration and increase the AUC, but not to a clinically significant extent.'}]}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 59, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 60, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 76, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 61, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug', 'Description': 'Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08301', 'Information': [{'ReferenceNumber': 62, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14', 'Value': {'Number': [14]}}]}, {'TOCHeading': 'KEGG: USP', 'Description': 'US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08302', 'Information': [{'ReferenceNumber': 63, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15', 'Value': {'Number': [15]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 64, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 65, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 72, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'KEGG: Drug Classes', 'Description': 'Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08332', 'Information': [{'ReferenceNumber': 78, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118', 'Value': {'Number': [118]}}]}, {'TOCHeading': 'WHO ATC Classification System', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.who.int/tools/atc-ddd-toolkit/atc-classification', 'Information': [{'ReferenceNumber': 68, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79', 'Value': {'Number': [79]}}]}, {'TOCHeading': 'FDA Pharm Classes', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'Information': [{'ReferenceNumber': 67, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78', 'Value': {'Number': [78]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 69, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'IUPHAR/BPS Guide to PHARMACOLOGY Target Classification', 'Description': 'Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.', 'URL': 'https://www.guidetopharmacology.org/', 'Information': [{'ReferenceNumber': 71, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92', 'Value': {'Number': [92]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 70, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 73, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 74, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 77, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 79, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 80, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'BindingDB', 'SourceID': 'Compound::50228403', 'Name': '(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione', 'Description': 'The Binding Database projects aims to make experimental data on the noncovalent association of molecules in solution searchable via the WWW.  The initial focus is on biomolecular systems, but data on host-guest and supramolecular systems are also important and being included over time.', 'URL': 'https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50228403', 'LicenseNote': 'All data curated by BindingDB staff are provided under the Creative Commons Attribution 3.0 License (https://creativecommons.org/licenses/by/3.0/us/).', 'LicenseURL': 'https://www.bindingdb.org/rwd/bind/info.jsp', 'ANID': 19611385}, {'ReferenceNumber': 4, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL237500', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL237500', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 31511824}, {'ReferenceNumber': 7, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'D000069476::Compound', 'Name': 'Linagliptin', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=D000069476', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 9022969}, {'ReferenceNumber': 9, 'SourceName': 'Drug Gene Interaction database (DGIdb)', 'SourceID': 'rxcui:1100699', 'Name': 'LINAGLIPTIN', 'Description': 'The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.', 'URL': 'https://www.dgidb.org/drugs/rxcui:1100699', 'LicenseNote': 'The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.', 'LicenseURL': 'http://www.dgidb.org/downloads', 'ANID': 37461056}, {'ReferenceNumber': 10, 'SourceName': 'DrugBank', 'SourceID': 'DB08882', 'Name': 'Linagliptin', 'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.', 'URL': 'https://www.drugbank.ca/drugs/DB08882', 'LicenseNote': ""Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)"", 'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use', 'ANID': 3624663}, {'ReferenceNumber': 27, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': '6318::Compound', 'Name': 'linagliptin', 'Description': 'The IUPHAR database contains quantitative information on drug targets and the prescription medicines and experimental drugs that act on them.\nAll entries in BioAssay data are marked as active as our curation SOP means we only extract data from the literature for relatively potent compounds.', 'URL': 'https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6318', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license', 'ANID': 19630724}, {'ReferenceNumber': 51, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D02EYG', 'Name': 'Linagliptin', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D02EYG', 'ANID': 19764431}, {'ReferenceNumber': 2, 'SourceName': 'CAS Common Chemistry', 'SourceID': '668270-12-0', 'Name': 'Linagliptin', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=668270-12-0', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12917772}, {'ReferenceNumber': 5, 'SourceName': 'ChemIDplus', 'SourceID': '0668270120', 'Name': 'Linagliptin [USAN:INN:JAN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0668270120', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1138353}, {'ReferenceNumber': 15, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID201021653', 'Name': 'Linagliptin', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID201021653', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 17647052}, {'ReferenceNumber': 17, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '620-351-9', 'Name': '8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.149.135', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15104902}, {'ReferenceNumber': 20, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': '3X29ZEJ4R2', 'Name': 'Linagliptin', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3X29ZEJ4R2', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5797168}, {'ReferenceNumber': 26, 'SourceName': 'Hazardous Substances Data Bank (HSDB)', 'SourceID': '8204', 'Name': 'Linagliptin', 'Description': 'The Hazardous Substances Data Bank (HSDB) is a toxicology database that focuses on the toxicology of potentially hazardous chemicals. It provides information on human exposure, industrial hygiene, emergency handling procedures, environmental fate, regulatory requirements, nanomaterials, and related areas. The information in HSDB has been assessed by a Scientific Review Panel.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/hsdb/8204', 'LicenseURL': 'https://www.nlm.nih.gov/web_policies.html', 'IsToxnet': True, 'ANID': 5717}, {'ReferenceNumber': 3, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10096344', 'Name': 'Linagliptin', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:68610', 'ANID': 2501925}, {'ReferenceNumber': 25, 'SourceName': 'FDA Pharm Classes', 'SourceID': '3X29ZEJ4R2', 'Name': 'LINAGLIPTIN', 'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 6489484}, {'ReferenceNumber': 30, 'SourceName': 'LiverTox', 'SourceID': 'Linagliptin', 'Name': 'Linagliptin', 'Description': 'LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/livertox/Linagliptin/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 2262113}, {'ReferenceNumber': 38, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C83887::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C83887', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 14398324}, {'ReferenceNumber': 42, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL237500', 'Name': 'LINAGLIPTIN', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL237500', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45238153}, {'ReferenceNumber': 6, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10096344', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5186849}, {'ReferenceNumber': 52, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D05JAC', 'Name': 'Linagliptin', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D05JAC', 'ANID': 37398258}, {'ReferenceNumber': 8, 'SourceName': 'DailyMed', 'SourceID': 'a54271be5ee2e869d8518bfd4d292d4d', 'Name': 'LINAGLIPTIN', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=LINAGLIPTIN', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30964103}, {'ReferenceNumber': 18, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '53e7dd627f351b0c9b6a68df5836d997', 'Name': 'Trajenta (EMEA/H/C/002110)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/trajenta', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37128154}, {'ReferenceNumber': 19, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '69064fb798b4fd121c0281b3478766bf', 'Name': 'linagliptin (P/0446/2021)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000498-pip01-08-m10', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37129731}, {'ReferenceNumber': 11, 'SourceName': 'Drugs and Lactation Database (LactMed)', 'SourceID': 'LM878', 'Name': 'Linagliptin', 'Description': 'The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM878/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 24797436}, {'ReferenceNumber': 13, 'SourceName': 'Drugs@FDA', 'SourceID': 'df836dec3de72b586f22730d6076295f', 'Name': 'TRADJENTA', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38976617}, {'ReferenceNumber': 14, 'SourceName': 'Drugs@FDA', 'SourceID': '34026449062958adf99bebcc5b3f7797', 'Name': 'LINAGLIPTIN', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38977866}, {'ReferenceNumber': 12, 'SourceName': 'Drugs@FDA', 'SourceID': 'a54271be5ee2e869d8518bfd4d292d4d', 'Name': 'LINAGLIPTIN', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38969444}, {'ReferenceNumber': 16, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10096344', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482617}, {'ReferenceNumber': 24, 'SourceName': 'FDA Orange Book', 'SourceID': 'e0f3c654e8c302f260f749cf33476bc5', 'Name': 'LINAGLIPTIN', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35236236}, {'ReferenceNumber': 54, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'A10BH05', 'Name': 'Linagliptin', 'Description': 'The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/?code=A10BH05', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/', 'ANID': 24386497}, {'ReferenceNumber': 21, 'SourceName': 'FDA Medication Guides', 'SourceID': 'JENTADUETO', 'Name': 'JENTADUETO', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228468}, {'ReferenceNumber': 22, 'SourceName': 'FDA Medication Guides', 'SourceID': 'JENTADUETO XR', 'Name': 'JENTADUETO XR', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228469}, {'ReferenceNumber': 23, 'SourceName': 'FDA Medication Guides', 'SourceID': 'TRADJENTA', 'Name': 'TRADJENTA', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228811}, {'ReferenceNumber': 36, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'b521c10816886172a49946e24ac0f2f8', 'Name': 'LINAGLIPTIN', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31087994}, {'ReferenceNumber': 28, 'SourceName': 'Japan Chemical Substance Dictionary (Nikkaji)', 'SourceID': 'J2.712.937D', 'Description': 'The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.', 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.712.937D', 'ANID': 23631827}, {'ReferenceNumber': 29, 'SourceName': 'KEGG', 'SourceID': 'D09566', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09566', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31097153}, {'ReferenceNumber': 31, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078544', 'Name': 'Linagliptin (BI-1356)', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27LTXREWYXXSTFRX-QGZVFWFLSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429536}, {'ReferenceNumber': 32, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078545', 'Name': 'Linagliptin (BI-1356)', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27LTXREWYXXSTFRX-QGZVFWFLSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429537}, {'ReferenceNumber': 33, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078546', 'Name': 'Linagliptin (BI-1356)', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27LTXREWYXXSTFRX-QGZVFWFLSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429538}, {'ReferenceNumber': 34, 'SourceName': 'Metabolomics Workbench', 'SourceID': '65122', 'Name': 'Linagliptin', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=65122', 'ANID': 20219411}, {'ReferenceNumber': 35, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': '5d34af8ae21567d154ae2ff2f4870dc0', 'Name': 'LINAGLIPTIN', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31077102}, {'ReferenceNumber': 37, 'SourceName': 'Nature Chemical Biology', 'SourceID': 'NCHEMB-A220815234B-complinagliptin', 'Description': 'Nature Chemical Biology is an international monthly journal that provides a high-visibility forum for the publication of top-tier original research and commentary for the chemical biology community. Chemical biology combines the scientific ideas and approaches of chemistry, biology and allied disciplines to understand and manipulate biological systems with molecular precision.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/482095969', 'ANID': 30409514}, {'ReferenceNumber': 39, 'SourceName': 'NIPH Clinical Trials Search of Japan', 'SourceID': 'cid10096344', 'Description': 'NIPH Clinical Trials Search of Japan allows one to search clinical research (trials) from the registries of three institutions; the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials.', 'URL': 'https://rctportal.niph.go.jp/en/', 'ANID': 6488380}, {'ReferenceNumber': 40, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '1100699', 'Name': 'linagliptin', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1100699', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15097747}, {'ReferenceNumber': 41, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'nrm_10096344', 'Name': 'linagliptin', 'Description': 'The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/', 'ANID': 45689694}, {'ReferenceNumber': 43, 'SourceName': 'PharmGKB', 'SourceID': 'Compound::PA166368161', 'Name': 'linagliptin', 'Description': 'The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships', 'URL': 'https://www.pharmgkb.org/chemical/PA166368161', 'LicenseNote': 'PharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).', 'LicenseURL': 'https://www.pharmgkb.org/page/policies', 'ANID': 49421194}, {'ReferenceNumber': 44, 'SourceName': 'Pharos', 'SourceID': 'Compound::VM52B1CFQDAQ', 'Name': 'Linagliptin', 'Description': 'Pharos gives access to a comprehensive, integrated knowledge-base for the Druggable Genome (DG) to illuminate the uncharacterized and/or poorly annotated portion of the DG, focusing on three of the most commonly drug-targeted protein families: G-protein-coupled receptors (GPCRs), Ion channels (ICs) and Kinases. It is the user interface to the Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) program.', 'URL': 'https://pharos.nih.gov/ligands/VM52B1CFQDAQ', 'LicenseNote': 'Data accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.', 'LicenseURL': 'https://pharos.nih.gov/about', 'ANID': 24695926}, {'ReferenceNumber': 45, 'SourceName': 'Pharos', 'SourceID': 'Compound::VMG5TXYCPR3B', 'Name': 'linagliptin', 'Description': 'Pharos gives access to a comprehensive, integrated knowledge-base for the Druggable Genome (DG) to illuminate the uncharacterized and/or poorly annotated portion of the DG, focusing on three of the most commonly drug-targeted protein families: G-protein-coupled receptors (GPCRs), Ion channels (ICs) and Kinases. It is the user interface to the Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) program.', 'URL': 'https://pharos.nih.gov/ligands/VMG5TXYCPR3B', 'LicenseNote': 'Data accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.', 'LicenseURL': 'https://pharos.nih.gov/about', 'ANID': 24696029}, {'ReferenceNumber': 46, 'SourceName': 'Protein Data Bank in Europe (PDBe)', 'SourceID': '356', 'Description': 'The Protein Data Bank in Europe (PDBe) manages the PDB with its wwPDB partners and provides a high-quality, up-to-date and integrated resource of macromolecular structures to support basic and applied research and education across the sciences.', 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/356', 'ANID': 8189571}, {'ReferenceNumber': 48, 'SourceName': 'RCSB Protein Data Bank (RCSB PDB)', 'SourceID': '10096344', 'Description': 'The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.', 'URL': 'https://www.rcsb.org/', 'LicenseNote': 'Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.', 'LicenseURL': 'https://www.rcsb.org/pages/policies', 'ANID': 13131800}, {'ReferenceNumber': 49, 'SourceName': 'Springer Nature', 'SourceID': '341551602', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341551602', 'ANID': 47615254}, {'ReferenceNumber': 50, 'SourceName': 'Springer Nature', 'SourceID': '341142651', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341142651', 'ANID': 47943881}, {'ReferenceNumber': 53, 'SourceName': 'Thieme Chemistry', 'SourceID': '376821150', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376821150', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48173580}, {'ReferenceNumber': 55, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q909745', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q909745', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 45193636}, {'ReferenceNumber': 56, 'SourceName': 'Wikipedia', 'SourceID': 'c_6742', 'Name': 'Linagliptin', 'Description': 'Link to the chemical information in Wikipedia.', 'URL': 'https://en.wikipedia.org/wiki/Linagliptin', 'ANID': 24328278}, {'ReferenceNumber': 57, 'SourceName': 'Wiley', 'SourceID': '386267596', 'Description': 'Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/386267596', 'ANID': 49078138}, {'ReferenceNumber': 58, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2010013', 'Name': 'Linagliptin', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2010013', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 59, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 60, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 61, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 62, 'SourceName': 'KEGG', 'SourceID': 'br08301', 'Name': 'Therapeutic category of drugs in Japan', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08301.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 63, 'SourceName': 'KEGG', 'SourceID': 'br08302', 'Name': 'USP drug classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08302.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 64, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 65, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 67, 'SourceName': 'FDA Pharm Classes', 'SourceID': 'FDA_pharm_tree', 'Name': 'FDA Pharmacological Classification', 'Description': 'FDA pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 68, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'ATCTree', 'Name': 'EPA CPDat Classification', 'Description': 'The WHO ATC (Anatomical Therapeutic Chemical) classification system classify the active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/'}, {'ReferenceNumber': 69, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 70, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 71, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': 'Target Classification', 'Name': 'Guide to Pharmacology Target Classification', 'Description': 'An expert-driven guide to pharmacological targets and the substances that act on them', 'URL': 'https://www.guidetopharmacology.org/targets.jsp', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license'}, {'ReferenceNumber': 72, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 73, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 74, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 76, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 77, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 78, 'SourceName': 'KEGG', 'SourceID': 'br08332', 'Name': 'Drug Classes', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08332.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 79, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 80, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 81, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 82, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68054873', 'Name': 'Dipeptidyl-Peptidase IV Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68054873', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 83, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68007004', 'Name': 'Hypoglycemic Agents', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68007004', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 84, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68054795', 'Name': 'Incretins', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68054795', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 85, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 403166046', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/403166046'}, {'ReferenceNumber': 86, 'SourceName': 'NCBI', 'SourceID': 'LinkOut', 'Description': 'LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout'}]}}","Diabetes Mellitus, Type 2",linagliptin,190-196,,,,<1 mg/mL,,,,,[4],[7],[1],[35],[113]
10100_Propoxyphene.json,469-62-5,,C22H29NO2,D Propoxyphene,339.5,,"InChI=1S/C22H29NO2/c1-5-21(24)25-22(18(2)17-23(3)4,20-14-10-7-11-15-20)16-19-12-8-6-9-13-19/h6-15,18H,5,16-17H2,1-4H3/t18-,22+/m1/s1",XLMALTXPSGQGBX-GCJKJVERSA-N,CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C,207-420-5,CHEBI:51173,,For the relief of mild to moderate pain.,"Breast Feeding; Lactation; Milk, Human; Analgesics, Opioid; Narcotics",,,,[75.5],,,,[3.32],,,[4.18],,[9],[3],[0],[25],[29.5]
10101_Ketobemidone.json,469-79-4,,C15H21NO2,1-(4-(m-hydroxyphenyl)-1-methyl-4-piperidyl)-1-propanone,247.33,,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",ALFGKMXHOUSVAD-UHFFFAOYSA-N,CCC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O,207-421-0,CHEBI:6125,,"For the treatment of all types of severe pain, such as postoperative, cancer, kidney stones and fractures.",,,,,156.5 °C,,,,,,,,,[3],[3],[1],[18],[40.5]
10127622_Selumetinib.json,606143-52-6,,C17H15BrClFN4O3,ARRY 142886,457.7,,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)",CYOHGALHFOKKQC-UHFFFAOYSA-N,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,641-434-6,CHEBI:90227,,"Selumetinib is indicated for the treatment of neurofibromatosis type 1 (NF1) in patients two years and older who have symptomatic, inoperable plexiform neurofibromas (PN).","Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors","{'Record': {'RecordType': 'CID', 'RecordNumber': 10127622, 'RecordTitle': 'Selumetinib', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Description': 'Selumetinib', 'Value': {'Number': [10127622]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS05.svg', 'Type': 'Icon', 'Extra': 'Corrosive'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 2, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}, {'Start': 3, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS09.svg', 'Type': 'Icon', 'Extra': 'Environmental Hazard'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is a member of the class of benzimidazoles that is 1-methyl-1H-benzimidazole which is substituted at positions 4, 5, and 6 by fluorine, (4-bromo-2-chlorophenyl)amino, and N-(2-hydroxyethoxy)aminocarbonyl groups, respectively. It is a MEK1 and MEK2 inhibitor. It has a role as an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor, an antineoplastic agent and an anticoronaviral agent. It is a member of benzimidazoles, a hydroxamic acid ester, a member of monochlorobenzenes, a member of bromobenzenes, an organofluorine compound and a secondary amino compound.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 63, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/1-methyl-1H-benzimidazole', 'Type': 'PubChem Internal Link', 'Extra': 'CID-95890'}, {'Start': 138, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Fluorine', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Fluorine'}]}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Activation of the Raf-MEK-ERK signalling pathway is known to be implemented in several types of malignancies; thus, mitogen-activated protein kinase kinase (MEK) inhibitors such as selumetinib are important tools that can target the problematic overactivity of this pathway. Results from clinical trials investigating earlier developed MEK inhibitors were underwhelming. However, selumetinib demonstrated impressive efficacy and tolerability in Phase I trials, leading to its continued investigation for the treatment of various types of tumours in Phase II trials.  Currently, the novel MEK 1 / 2 inhibitor, selumetinib, is approved solely for the treatment of Neurofibromatosis type 1 (NF-1) in a limited age group. NF-1 is considered rare, with an estimated incidence of 1/3000 individuals. It is a genetic, autosomal dominant condition resulting from mutations of the NF1 gene, which can lead to various complications, including the development of multiple tumours in the nervous system. Some patients with this disorder develop plexiform neurofibromas (PN); however, this is considered relatively uncommon compared to other variants of NF-1. Luckily, the use of selumetinib in patients with NF-1 have shown efficacy in shrinking associated tumours and is linked to other positive clinical outcomes. Selumetinib was approved by the FDA on April 10, 2020. It was later approved by Health Canada on August 23, 2022.', 'Markup': [{'Start': 22, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 157, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 181, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 336, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 380, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 588, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 609, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 1167, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 1304, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 22, 'Description': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is a Kinase Inhibitor. The mechanism of action of selumetinib is as a Mitogen-Activated Protein Kinase Kinase 1 Inhibitor, and Mitogen-Activated Protein Kinase Kinase 2 Inhibitor.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 62, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 27, 'Description': 'LiverTox Summary', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is an oral, small molecule inhibitor of the mitogen activated protein kinase 1 and 2 (MEK1/2) that is used to treat symptomatic, refractory fibromas in neurofibromatosis type 1. Selumetinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy, but has not been linked to cases of clinically apparent acute liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 190, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 32, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is an orally active, small molecule with potential antineoplastic activity. Selumetinib is an ATP-independent inhibitor of mitogen-activated protein kinase kinase (MEK or MAPK/ERK kinase) 1 and 2. MEK 1 and 2 are dual specificity kinases that are essential mediators in the activation of the RAS/RAF/MEK/ERK pathway, are often upregulated in various cancer cells, and are drivers of diverse cellular responses, including proliferation. Inhibition of both MEK1 and 2 by selumetinib prevents the activation of MEK1/2 dependent effector proteins and transcription factors, thereby leading to an inhibition of cellular proliferation in various cancers.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 88, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 106, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ATP', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5957'}, {'Start': 176, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 209, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 312, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 481, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 36, 'Value': {'StringWithMarkup': [{'String': 'SELUMETINIB is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 approved and 48 investigational indications.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/SELUMETINIB', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 49, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Selumetinib Sulfate (has salt form).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/16214875'}, {'Start': 10, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=16214875', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide', 'Markup': [{'Start': 37, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CYOHGALHFOKKQC-UHFFFAOYSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C17H15BrClFN4O3'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=606143-52-6', 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}, {'ReferenceNumber': 5, 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}, {'ReferenceNumber': 17, 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}, {'ReferenceNumber': 21, 'Value': {'StringWithMarkup': [{'String': '606143-52-6'}]}}]}, {'TOCHeading': 'Deprecated CAS', 'Description': 'The Chemical Abstract Service (CAS) registry numbers that are no longer used.  These numbers are old, deprecated, and/or deleted, but users may still encounter them in some (old) references.', 'Information': [{'ReferenceNumber': 5, 'Value': {'StringWithMarkup': [{'String': '865610-79-3'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 17, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.169.311', 'Value': {'StringWithMarkup': [{'String': '641-434-6'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 21, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6UH91I579U', 'Value': {'StringWithMarkup': [{'String': '6UH91I579U'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:90227', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:90227'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1614701', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL1614701'}]}}]}, {'TOCHeading': 'DrugBank ID', 'Description': 'Drug identifier used by the DrugBank database', 'URL': 'https://go.drugbank.com/', 'Information': [{'ReferenceNumber': 10, 'URL': 'https://www.drugbank.ca/drugs/DB11689', 'Value': {'StringWithMarkup': [{'String': 'DB11689'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID3048944', 'Value': {'StringWithMarkup': [{'String': 'DTXSID3048944'}]}}]}, {'TOCHeading': 'HMDB ID', 'Description': 'A chemical substance identifier from the HMDB database', 'URL': 'https://hmdb.ca/', 'Information': [{'ReferenceNumber': 23, 'URL': 'https://hmdb.ca/metabolites/HMDB0304858', 'Value': {'StringWithMarkup': [{'String': 'HMDB0304858'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 26, 'URL': 'https://www.kegg.jp/entry/D09666', 'Value': {'StringWithMarkup': [{'String': 'D09666'}]}}]}, {'TOCHeading': 'Metabolomics Workbench ID', 'Description': 'Registration number used by Metabolomics Workbench', 'URL': 'https://www.metabolomicsworkbench.org/', 'Information': [{'ReferenceNumber': 28, 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=152804', 'Value': {'StringWithMarkup': [{'String': '152804'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 32, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66939', 'Value': {'StringWithMarkup': [{'String': 'C66939'}]}}]}, {'TOCHeading': 'Nikkaji Number', 'Description': 'Substance identifier used in the Japan Chemical Substance Dictionary (Nikkaji).', 'URL': 'https://jglobal.jst.go.jp/en/', 'Information': [{'ReferenceNumber': 25, 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.516.155F', 'Value': {'StringWithMarkup': [{'String': 'J2.516.155F'}]}}]}, {'TOCHeading': 'NSC Number', 'Description': 'The National Service Center (NSC) number is a numeric identifier for substances submitted to the National Cancer Institute (NCI) for testing and evaluation. It is a registration number for the Developmental Therapeutics Program (DTP) repository.', 'URL': 'https://dtp.cancer.gov/organization/dscb/compoundSubmission/faqs.htm', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 13, 'Name': 'NSC Number', 'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=741078', 'Value': {'StringWithMarkup': [{'String': '741078'}]}}]}, {'TOCHeading': 'PharmGKB ID', 'Description': 'PharmGKB chemical identifier', 'URL': 'https://www.pharmgkb.org/', 'Information': [{'ReferenceNumber': 37, 'URL': 'https://www.pharmgkb.org/chemical/PA166129529', 'Value': {'StringWithMarkup': [{'String': 'PA166129529'}]}}]}, {'TOCHeading': 'Pharos Ligand ID', 'Description': 'Ligand identifier used by Pharos', 'URL': 'https://pharos.nih.gov/', 'Information': [{'ReferenceNumber': 38, 'URL': 'https://pharos.nih.gov/ligands/T5L9Y2W2CV11', 'Value': {'StringWithMarkup': [{'String': 'T5L9Y2W2CV11'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 34, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/2289380', 'Value': {'StringWithMarkup': [{'String': '2289380'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 47, 'URL': 'https://www.wikidata.org/wiki/Q7448840', 'Value': {'StringWithMarkup': [{'String': 'Q7448840'}]}}]}, {'TOCHeading': 'Wikipedia', 'Description': 'Wikidata entity identifier for this compound.', 'Information': [{'ReferenceNumber': 48, 'URL': 'https://en.wikipedia.org/wiki/Selumetinib', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 50, 'Value': {'StringWithMarkup': [{'String': 'ARRY 142886'}, {'String': 'ARRY-142886'}, {'String': 'ARRY142886'}, {'String': 'AZD 6244'}, {'String': 'AZD-6244'}, {'String': 'AZD6244'}, {'String': 'selumetinib'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib'}, {'String': '606143-52-6'}, {'String': 'ARRY-142886'}, {'String': '5-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE'}, {'String': 'ARRY 142886'}, {'String': 'ARRY-886'}, {'String': 'selumetinibum'}, {'String': 'UNII-6UH91I579U'}, {'String': '6UH91I579U'}, {'String': 'ARRY142886'}, {'String': 'DTXSID3048944'}, {'String': 'CHEBI:90227'}, {'String': 'DTXCID0028870'}, {'String': 'NSC 741O78'}, {'String': '1H-Benzimidazole-6-carboxamide, 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-'}, {'String': '5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE'}, {'String': 'MEK inhibitor AZD6244'}, {'String': 'AZD6244'}, {'String': 'AZD 6244'}, {'String': 'AZD-6244'}, {'String': 'Selumetinib (AZD6244)'}, {'String': '5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide'}, {'String': 'Selumetinib [USAN:INN]'}, {'String': 'Koselugo'}, {'String': 'CHEMBL1614701'}, {'String': 'NSC741078'}, {'String': 'NCGC00189073-01'}, {'String': 'NCGC00189073-02'}, {'String': '6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide'}, {'String': 'AZD6244 (Selumetinib)'}, {'String': '5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide'}, {'String': '6-[(4-bromo-2-chlorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide'}, {'String': 'AZD 6244;5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide;6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide'}, {'String': 'CAS-606143-52-6'}, {'String': 'C17H15BrClFN4O3'}, {'String': '5-(4-broMo-2-chlorophenylaMino)-4-fluoro-N-(2-hydroxyethoxy)-1-Methyl-1H-benzo[d]iMidazole-6-carboxaMide'}, {'String': '3EW'}, {'String': 'MFCD11977472'}, {'String': 'SELUMETINIB [MI]'}, {'String': 'SELUMETINIB [INN]'}, {'String': 'Selumetinib (USAN/INN)'}, {'String': 'SELUMETINIB [USAN]'}, {'String': 'SELUMETINIB [WHO-DD]'}, {'String': 'SCHEMBL155456'}, {'String': 'GTPL5665'}, {'String': 'EX-A020'}, {'String': 'CYOHGALHFOKKQC-UHFFFAOYSA-N'}, {'String': 'BCPP000367'}, {'String': 'HMS3244G03'}, {'String': 'HMS3244G04'}, {'String': 'HMS3244H03'}, {'String': 'HMS3265K01'}, {'String': 'HMS3265K02'}, {'String': 'HMS3265L01'}, {'String': 'HMS3265L02'}, {'String': 'HMS3654O03'}, {'String': 'HMS5079E03'}, {'String': 'BCP01739'}, {'String': 'Tox21_113362'}, {'String': 'BDBM50355497'}, {'String': 'NSC800882'}, {'String': 's1008'}, {'String': 'AKOS015904255'}, {'String': 'Tox21_113362_1'}, {'String': 'BCP9000354'}, {'String': 'CCG-264774'}, {'String': 'CS-0059'}, {'String': 'DB11689'}, {'String': 'EX-8621'}, {'String': 'FS27812'}, {'String': 'NSC-741078'}, {'String': 'NSC-800882'}, {'String': 'SB14707'}, {'String': 'SDCCGSBI-0654324.P001'}, {'String': 'NCGC00189073-07'}, {'String': '6-(4-bromo-2-chloro-anilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamide'}, {'String': 'AC-25059'}, {'String': 'AZD6244,Selumetinib, ARRY-142886'}, {'String': 'HY-50706'}, {'String': 'Selumetinib (ARRY142886/AZD6244)'}, {'String': 'AZD6244 (Selumetinib,ARRY-142886)?'}, {'String': 'NS00071922'}, {'String': 'SW202561-3'}, {'String': 'D09666'}, {'String': 'EN300-18166787'}, {'String': 'Q7448840'}, {'String': 'BRD-K57080016-001-01-9'}, {'String': 'BRD-K57080016-001-15-9'}, {'String': 'BRD-K57080016-001-19-1'}, {'String': '1H-BENZIMIDAZOLE-6-CARBOXAMIDE, 5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-N-(2- HYDROXYETHOXY)-1-METHYL-'}, {'String': '6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy -ethoxy)-amide'}, {'String': '6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide'}, {'String': '6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxy-ethoxy)-amide'}, {'String': '6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide'}, {'String': '6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxyethoxy)-amide'}, {'String': '6-(4-bromo-2chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'MEK inhibitors'}, {'String': 'Selumetinib sulfate'}, {'String': 'AZD6244(Selumetinib)'}, {'String': 'AZD 6244 Selumetinib'}, {'String': 'AZD-6244(Selumetinib)'}, {'String': 'AZD6244 - Selumetinib'}, {'String': 'D0T5DP'}, {'String': 'D0TH0Z'}, {'String': 'AZD 6244 (Selumetinib)'}, {'String': 'JSPY-st000254'}, {'String': 'QCR-91'}, {'String': 'Selumetinib, ARRY-142886'}, {'String': 'CTK8B4577'}, {'String': 'SYN1016'}, {'String': 'CC-49'}, {'String': 'AOB87732'}, {'String': 'API01002'}, {'String': 'ABP000918'}, {'String': 'ANW-45526'}, {'String': 'RS0061'}, {'String': 'ZINC31773258'}, {'String': 'ACN-031539'}, {'String': 'AN-4474'}, {'String': 'CID10127622'}, {'String': 'KS-0000003K'}, {'String': '4CA-0236'}, {'String': 'AJ-84328'}, {'String': 'AK-40782'}, {'String': 'AM808016'}, {'String': 'BC004624'}, {'String': 'BC660025'}, {'String': 'CID:10127622'}, {'String': 'CJ-17817'}, {'String': 'SC-85661'}, {'String': 'SID:53837732'}, {'String': 'AZD6244 (Selumetinib, ARRY142886)'}, {'String': 'AB0007973'}, {'String': 'TX-013341'}, {'String': 'A8207'}, {'String': 'A8446'}, {'String': 'FT-0674552'}, {'String': 'ST24031611'}, {'String': 'X2640'}, {'String': 'A10257'}, {'String': 'S-7764'}, {'String': '143A526'}, {'String': 'C517975'}, {'String': 'I14-17010'}, {'String': 'B0084-095434'}, {'String': 'Selumetinib, 99%, a highly selective MEK1 inhibitor - 1G 1g'}, {'String': 'ARRY-142886, Selumetinib, AZD-6244, ARRY142886, AZD6244'}, {'String': '1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-'}, {'String': '1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-'}, {'String': '5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxami'}, {'String': '6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '457.7'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'XLogP3', 'Description': 'XLogP3 is a predicted octanol-water partition coefficient, computed using the algorithm described in J. Chem. Inf. Model. 2007, 47, 6, 2140-2148. It is used as a measure of hydrophilicity or hydrophobicity of a molecule.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/17985865/', 'Information': [{'ReferenceNumber': 49, 'Name': 'XLogP3-AA', 'Reference': ['Computed by XLogP3 3.0 (PubChem release 2025.04.14)'], 'Value': {'Number': [3.6]}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [3]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [6]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [6]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '456.00001'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '456.00001'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [88.4], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [27]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [523]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [1]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Information': [{'ReferenceNumber': 35, 'Reference': ['S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'], 'ExtendedReference': [{'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749', 'Matched': {'PCLID': 900163354, 'Citation': 'S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749'}}], 'Value': {'StringWithMarkup': [{'String': 'Pharmaceuticals -> Listed in ZINC15'}]}}], 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors', 'Markup': [{'Start': 109, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}]}]}}, {'ReferenceNumber': 12, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 18, 'Name': 'Human Drugs', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}, {'ReferenceNumber': 20, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Rare disease (orphan) drug'}]}}]}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10127622%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10127622%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [11]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [17]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [7]}}, {'ReferenceNumber': 49, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [29]}}, {'ReferenceNumber': 49, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10127622%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 49, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10127622%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/483928800', 'Value': {'Number': [483928800]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'All Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/sids/JSON?sids_type=all&list_return=redirect', 'Value': {'Number': [318]}}, {'ReferenceNumber': 49, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [226]}}, {'ReferenceNumber': 49, 'Name': 'Mixture Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/sids/JSON?sids_type=component&list_return=redirect', 'Value': {'Number': [92]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib Sulfate (has salt form)', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/16214875'}, {'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=16214875', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Number': [20]}}, {'ReferenceNumber': 49, 'Name': 'Protein Structures Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_structure&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Number': [4]}}, {'ReferenceNumber': 49, 'Name': 'Taxonomy Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Number': [2]}}, {'ReferenceNumber': 49, 'Name': 'OMIM Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Number': [7]}}, {'ReferenceNumber': 49, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Number': [38]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 49, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is indicated for the treatment of neurofibromatosis type 1 (NF1) in patients two years and older who have symptomatic, inoperable plexiform neurofibromas (PN).', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 18, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Koselugo as monotherapy is indicated for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in paediatric patients with neurofibromatosis type 1 (NF1) aged 3 years and above', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Koselugo', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}]}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Treatment of melanoma, Treatment of neurofibromatosis type 1, Treatment of thyroid cancer'}]}}, {'ReferenceNumber': 36, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'LiverTox Summary', 'Description': 'Summary of liver toxicity for this compound, provided by LiverTox.  This section provides an overview of drug induced liver injury, diagnostic criteria, assessment of causality and severity, descriptions of different clinical patterns (phenotypes), information on management and treatment, and standardized nomenclature.  The role of liver biopsy and major histological patterns of drug induced liver disease are also given.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK547852/', 'Information': [{'ReferenceNumber': 27, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is an oral, small molecule inhibitor of the mitogen activated protein kinase 1 and 2 (MEK1/2) that is used to treat symptomatic, refractory fibromas in neurofibromatosis type 1. Selumetinib is associated with transient and usually mild elevations in serum aminotransferase levels during therapy, but has not been linked to cases of clinically apparent acute liver injury.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 190, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}, {'TOCHeading': 'Drug Classes', 'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Tyrosine Kinase Inhibitors', 'Markup': [{'Start': 109, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}]}]}}, {'ReferenceNumber': 27, 'Value': {'StringWithMarkup': [{'String': 'Genetic Disorder Agents, Antineoplastic Agents'}]}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^SELUMETINIB$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 8, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^SELUMETINIB$'""}}, {'ReferenceNumber': 8, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^SELUMETINIB$'""}}]}, {'TOCHeading': 'Cancer Drugs', 'Description': 'This section contains a list of cancer drugs information from the National Cancer Institute.', 'URL': 'https://www.cancer.gov/about-cancer/treatment/drugs', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 31, 'Name': 'Drug Name', 'Value': {'StringWithMarkup': [{'String': 'Koselugo (Selumetinib Sulfate)', 'Markup': [{'Start': 0, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Koselugo', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}, {'Start': 10, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib%20Sulfate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16214875'}]}]}}, {'ReferenceNumber': 31, 'Name': 'Brand Name(s)', 'Value': {'StringWithMarkup': [{'String': 'Koselugo'}]}}, {'ReferenceNumber': 31, 'Name': 'FDA Approved', 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}, {'ReferenceNumber': 31, 'Name': 'Drug Use', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib sulfate is approved to treat:', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib%20sulfate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16214875'}]}, {'String': '• Neurofibromatosis type 1 (NF1) in children aged 2 years and older who have plexiform neurofibromas that are causing symptoms and cannot be removed by surgery.'}, {'String': 'Selumetinib sulfate is also being studied in the treatment of other types of cancer.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib%20sulfate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-16214875'}]}]}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 6, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 112}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 15, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 28}}]}, {'TOCHeading': 'NIPH Clinical Trials Search of Japan', 'Description': 'Brief clinical trials summary from the NIPH Clinical Trials Search of Japan, which allows one to cross-search four national clinical research information registries in Japan: the Japan Registry of Clinical Trials (JRCT), the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials (JMACCT).', 'URL': 'https://rctportal.niph.go.jp/en/', 'Information': [{'ReferenceNumber': 33, 'Name': 'NIPH Clinical Trials Search of Japan', 'Value': {'ExternalTableName': 'clinicaltrials_jp', 'ExternalTableNumRows': 4}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 18, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/koselugo', 'Value': {'StringWithMarkup': [{'String': 'Koselugo'}]}}, {'ReferenceNumber': 18, 'Name': 'Category', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan'}]}}, {'ReferenceNumber': 18, 'Name': 'Therapeutic area', 'Value': {'StringWithMarkup': [{'String': 'Neurofibromatosis 1'}]}}, {'ReferenceNumber': 18, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib sulfate'}]}}, {'ReferenceNumber': 18, 'Name': 'INN/Common name', 'Value': {'StringWithMarkup': [{'String': 'selumetinib'}]}}, {'ReferenceNumber': 18, 'Name': 'Pharmacotherapeutic Classes', 'Value': {'StringWithMarkup': [{'String': 'Antineoplastic agents'}]}}, {'ReferenceNumber': 18, 'Name': 'Status', 'Value': {'StringWithMarkup': [{'String': 'This medicine is authorized for use in the European Union'}]}}, {'ReferenceNumber': 18, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'AstraZeneca AB'}]}}, {'ReferenceNumber': 18, 'Name': 'Market Date', 'Value': {'StringWithMarkup': [{'String': '2021-06-17'}]}}, {'ReferenceNumber': 19, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 19, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001585-pip01-13-m05', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib'}]}}, {'ReferenceNumber': 19, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Oncology'}]}}, {'ReferenceNumber': 19, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Age-appropriate oral dosage form, Capsule, hard'}]}}, {'ReferenceNumber': 19, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 19, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2021-08-12'}]}}, {'ReferenceNumber': 20, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Rare disease (orphan) designations'}]}}, {'ReferenceNumber': 20, 'Name': 'Medicine', 'URL': 'https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2050', 'Value': {'StringWithMarkup': [{'String': 'Koselugo'}]}}, {'ReferenceNumber': 20, 'Name': 'Disease/Condition', 'Value': {'StringWithMarkup': [{'String': 'Treatment of neurofibromatosis type 1'}]}}, {'ReferenceNumber': 20, 'Name': 'Active Substance', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib'}]}}, {'ReferenceNumber': 20, 'Name': 'Status of Orphan Designation', 'Value': {'StringWithMarkup': [{'String': 'Positive'}]}}, {'ReferenceNumber': 20, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2018-07-31'}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'Pharmacodynamics', 'Description': 'Pharmacodynamic information for this compound as a drug (i.e., what does this drug do to the body).  Pharmacodynamics is the study of the biochemical, physiologic, and molecular effects of drugs on the body.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/NBK507791/', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is a non-ATP-competitive mitogen-activated protein kinase kinase 1 and 2 (MEK1 and MEK2) inhibitor. By selectively targeting MEK1 and MEK2, selumetinib is able to inhibit oncogenic downstream effects of the Raf-MEK-ERK signaling pathway, which is often overactive in certain types of cancer. Indeed, a study investigating the effects of selumetinib in children with NF-1 found that treatment with the anti-neoplastic resulted in reduced tumor size. Decreases in tumor-associated pain and improvements in overall function were also subjectively reported.  Selumetinib has minimal off-target activity, contributing to its impressive safety profile.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 21, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ATP', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5957'}, {'Start': 152, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 223, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 349, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 567, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}, {'TOCHeading': 'FDA Pharmacological Classification', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 22, 'Name': 'FDA UNII', 'Value': {'StringWithMarkup': [{'String': '6UH91I579U'}]}}, {'ReferenceNumber': 22, 'Name': 'Active Moiety', 'Value': {'StringWithMarkup': [{'String': 'SELUMETINIB'}]}}, {'ReferenceNumber': 22, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Established Pharmacologic Class [EPC] - Kinase Inhibitor'}]}}, {'ReferenceNumber': 22, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Mechanisms of Action [MoA] - Mitogen-Activated Protein Kinase Kinase 1 Inhibitors'}]}}, {'ReferenceNumber': 22, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Mechanisms of Action [MoA] - Mitogen-Activated Protein Kinase Kinase 2 Inhibitors'}]}}, {'ReferenceNumber': 22, 'Name': 'FDA Pharmacology Summary', 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is a Kinase Inhibitor. The mechanism of action of selumetinib is as a Mitogen-Activated Protein Kinase Kinase 1 Inhibitor, and Mitogen-Activated Protein Kinase Kinase 2 Inhibitor.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 62, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 30, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'SELUMETINIB'}]}}, {'ReferenceNumber': 30, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]; Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]; Kinase Inhibitor [EPC]'}]}}]}, {'TOCHeading': 'ATC Code', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.whocc.no/atc/structure_and_principles/', 'Information': [{'ReferenceNumber': 46, 'Value': {'StringWithMarkup': [{'String': 'L - Antineoplastic and immunomodulating agents', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L'}]}, {'String': 'L01 - Antineoplastic agents', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01'}]}, {'String': 'L01E - Protein kinase inhibitors', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01E'}]}, {'String': 'L01EE - Mitogen-activated protein kinase (mek) inhibitors', 'Markup': [{'Start': 0, 'Length': 5, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EE'}]}, {'String': 'L01EE04 - Selumetinib', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EE04'}]}]}}]}, {'TOCHeading': 'Absorption, Distribution and Excretion', 'Information': [{'ReferenceNumber': 10, 'Name': 'Absorption', 'Value': {'StringWithMarkup': [{'String': 'Based on several studies investigating selumetinib at various doses in both pediatric and adult populations, the Tmax generally ranges between 1- 1.5 hours. In healthy adults, the mean absolute oral bioavailability was reported to be 62%. Selumetinib should be administered on an empty stomach since food significantly decreases serum concentrations of the drug.', 'Markup': [{'Start': 39, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 239, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 10, 'Name': 'Route of Elimination', 'Value': {'StringWithMarkup': [{'String': 'Approximately 59% of selumetinib is eliminated in the feces, while 33% is eliminated in the urine.', 'Markup': [{'Start': 21, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 10, 'Name': 'Volume of Distribution', 'Value': {'StringWithMarkup': [{'String': 'The mean apparent volume of distribution of selumetinib at steady state in pediatric patients ranged from 78 L to 171 L.   A study in healthy adult males found a mean apparent volume of distribution of 146 L.   Another study observing the pharmacokinetic effects of various selumetinib doses and regimens in select Japanese patients found that the apparent volume of distribution values at steady-state ranged from 73.2 - 148.1 L.', 'Markup': [{'Start': 44, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 274, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}, {'ReferenceNumber': 10, 'Name': 'Clearance', 'Value': {'StringWithMarkup': [{'String': 'The clearance of selumetinib in pediatric patients is 8.8 L/hr. A study in healthy adult males found a clearance value of 15.7 L/hr. Another study observing the pharmacokinetic effects of various selumetinib doses and regimens in select Japanese patients found clearance values that ranged from 9.2 - 15.9 L/hr.', 'Markup': [{'Start': 17, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 196, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}, {'TOCHeading': 'Metabolism/Metabolites', 'Description': 'Metabolites are substances made or used when the body breaks down food, drugs or chemicals, or its own tissue (for example, fat or muscle tissue). This process is called metabolism and makes energy and the materials needed for growth, reproduction, and maintaining health. Metabolism also helps get rid of toxic substances.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is heavily metabolized in the liver and the proposed metabolic pathway is as follows:  Hydrolysis of selumetinib’s amide functional group produces M15 (AZ13326637), which contains a carboxylic acid.   Elimination of the ethanediol moiety from the parent compound results in the formation of the primary amide M14 (AZ12791138) metabolite. Amide hydrolysis transforms M14 into M15, glucuronidation and further oxidation of M14 leads to M2, M6 and M1, and N-demethylation of M14 produces M12.  The amide glucuronide (M2) is thought to be the major circulating metabolite.  Demethylation of selumetinib produces the pharmacologically active M8 (AZ12442942), and further oxidation of M8 leads to M11. Glucuronidation of M8 produces M3 or M5, and elimination of the ethanediol moiety from M8 results in a primary amide, producing M12.   Although the N-demethylated metabolite (M8) accounts for <10% of the circulating metabolites, it is responsible for approximately 21-35% of any observed pharmacological activity.   Ribose conjugation transforms M12 into M9, while oxidation of M12 leads to M10 and M13 metabolites. Glucuronidation of M10 produces M1.  Direct glucuronidation of selumetinib produces M4 or M7, which can both eventually transform into M3 and M5 metabolites.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 113, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 232, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanediol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-174'}, {'Start': 326, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/AZ12791138', 'Type': 'PubChem Internal Link', 'Extra': 'CID-155804660'}, {'Start': 599, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 653, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/AZ12442942', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10238358'}, {'Start': 772, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/ethanediol', 'Type': 'PubChem Internal Link', 'Extra': 'CID-174'}]}]}}]}, {'TOCHeading': 'Biological Half-Life', 'Description': 'The time required for a biological system (e.g., human body) to eliminate, by natural processes, half of the amount of a chemical (e.g., alcohol, medication, or radioactive material) that has entered it.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Selumetinib is characterized by a short half-life. The elimination half-life associated with a dose of 25 mg/m<sup>2</sup> in pediatric patients is 6.2 hours.  In a study observing the pharmacokinetic effects of various selumetinib regimens in select Japanese patients, the half-life ranged from 9.2- 10.6 hours.    In other studies where selumetinib 75 mg is administered twice daily, the half-life is reported to be approximately 13 hours.', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 220, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 339, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}, {'TOCHeading': 'Mechanism of Action', 'Description': 'In medicine, the term ""mechanism of action"" (also called MOA) is used to describe how a drug or other substance produces an effect in the body. For example, a drug\'s mechanism of action could be how it affects a specific target in a cell, such as an enzyme, or a cell function, such as cell growth. Knowing the mechanism of action of a drug may help provide information about the safety of the drug and how it affects the body. It may also help identify the right dose of a drug and which patients are most likely to respond to treatment.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'The Ras-Raf-MEK-ERK signaling cascade is known to be activated in several types of cancer, and regulates the transcription of proteins involved in apoptosis. In addition, studies have shown that mutations of the Raf component of the pathway can contribute to chemotherapy drug resistance.   Ras as well as several kinases and phosphatases are responsible for regulating the Raf-MEK-ERK pathway. Often in cancers, Ras (a G-protein coupled receptor) is deregulated, allowing downstream signalling to proceed unchecked. Through several complex steps, Raf phosphorylates and activates MEK, which then phosphorylates and activates ERK. ERK is then able to exert its effects on several downstream targets.   As such, therapies inhibiting upstream components of this pathway have become attractive targets for cancer treatment. Selumetinib exerts its effects by selectively inhibiting MEK1 and MEK2 which can effectively blunt the pleiotropic effects of the Ras-Raf-MEK-ERK cascade. By inhibiting this oncogenic pathway, selumetinib reduces cell proliferation, and promotes pro-apoptotic signal transduction.', 'Markup': [{'Start': 12, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 378, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 581, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 821, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 959, 'Length': 3, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MEK', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6569'}, {'Start': 1014, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Orphan -> Antineoplastic agents -> Human pharmacotherapeutic group -> EMA Drug Category'}]}}, {'ReferenceNumber': 19, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 20, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human drugs -> Rare disease (orphan)'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS05.svg', 'Type': 'Icon', 'Extra': 'Corrosive'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 2, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}, {'Start': 3, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS09.svg', 'Type': 'Icon', 'Extra': 'Environmental Hazard'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Danger', 'Markup': [{'Start': 0, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 16, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (40%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 34, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H317 (80%): May cause an allergic skin reaction [Warning Sensitization, Skin]', 'Markup': [{'Start': 49, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H318 (60%): Causes serious eye damage [Danger Serious eye damage/eye irritation]', 'Markup': [{'Start': 39, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}, {'String': 'H361 (80%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]', 'Markup': [{'Start': 65, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H361f (20%): Suspected of damaging fertility [Warning Reproductive toxicity]', 'Markup': [{'Start': 46, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H373 (80%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]', 'Markup': [{'Start': 80, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H411 (60%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]'}, {'String': 'H413 (20%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]'}]}}, {'ReferenceNumber': 16, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P203, P260, P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P354+P338, P317, P318, P319, P321, P330, P333+P317, P362+P364, P391, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P203'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P260'}, {'Start': 12, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P261'}, {'Start': 18, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 24, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264+P265'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 41, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P272'}, {'Start': 47, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P273'}, {'Start': 53, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 59, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 70, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P302+P352'}, {'Start': 81, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P305+P354+P338'}, {'Start': 97, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P317'}, {'Start': 103, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P318'}, {'Start': 109, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P319'}, {'Start': 115, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P321'}, {'Start': 121, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 127, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P333+P317'}, {'Start': 138, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P362+P364'}, {'Start': 149, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P391'}, {'Start': 155, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 165, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 16, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 5 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 175, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/174198'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (40%)'}, {'String': 'Skin Sens. 1 (80%)'}, {'String': 'Eye Dam. 1 (60%)'}, {'String': 'Repr. 2 (80%)'}, {'String': 'Repr. 2 (20%)'}, {'String': 'STOT RE 2 (80%)'}, {'String': 'Aquatic Chronic 2 (60%)'}, {'String': 'Aquatic Chronic 4 (20%)'}]}}]}]}]}, {'TOCHeading': 'Toxicity', 'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.', 'Section': [{'TOCHeading': 'Toxicological Information', 'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.', 'Section': [{'TOCHeading': 'Hepatotoxicity', 'Description': 'This section provides a short description about the hepatotoxicity associated with this compound, the rate of serum enzyme elevations during use, and the frequency and character of the clinically apparent liver injury associated with the compound.', 'Information': [{'ReferenceNumber': 27, 'Value': {'StringWithMarkup': [{'String': 'In the prelicensure clinical trials conducted in children and adults with neurofibromatosis, serum aminotransferase elevations occurred in 35% of treated subject but rose to above 5 times the upper limit of normal (ULN) in only 4%. However, there were no liver related serious adverse events and no patient had a concurrent elevation in serum aminotransferase and bilirubin levels. The ALT elevations were typically mild and transient and usually resolved even without dose adjustment. There were no instances of clinically apparent liver injury attributed to selumetinib. Since approval and more wide scale availability of selumetinib, there have been no published reports of clinically apparent drug induced liver injury associated with its use in neurofibromatosis, although clinical experience with the drug, particularly with long term therapy, has been limited. However, in studies of experimental therapy with somewhat higher doses of selumetinib in patients with advanced, refractory cancers, liver test abnormalities were common and sometimes graded as severe (ALT above 20 times ULN) and requiring drug discontinuation. Thus, in patients with neurofibromatosis and use of recommended doses of selumetinib, clinically apparent liver injury is rare if it occurs at all. At higher doses, however, selumetinib has been associated with a very high rate of serum enzyme elevations, many of which were in the range suggestive of severe injury.', 'Markup': [{'Start': 364, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/bilirubin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5280352'}, {'Start': 560, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 624, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 942, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 1203, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 1304, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}, {'String': 'Likelihood score: E* (suspected but unproven rare cause of clinically apparent liver injury).'}]}}]}, {'TOCHeading': 'Effects During Pregnancy and Lactation', 'Description': 'Drug effects during pregnancy and lactation.', 'Information': [{'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': '◉ Summary of Use during Lactation'}, {'String': 'No information is available on the clinical use of selumetinib during breastfeeding. Because selumetinib is 98% bound to plasma proteins, the amount in milk is likely to be low. However, because of its potential toxicity in the breastfed, the manufacturer recommends that breastfeeding be discontinued during selumetinib therapy and for 1 week after the last dose.', 'Markup': [{'Start': 51, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 93, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 309, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}, {'String': '◉ Effects in Breastfed Infants'}, {'String': 'Relevant published information was not found as of the revision date.'}, {'String': '◉ Effects on Lactation and Breastmilk'}, {'String': 'Relevant published information was not found as of the revision date.'}]}}]}, {'TOCHeading': 'Protein Binding', 'Description': 'In this section, ""protein binding"" refers to the degree to which medications attach to plasma proteins (i.e., proteins within the blood, such as human serum albumin, lipoprotein, glycoprotein and globulins). A drug\'s efficiency may be affected by the degree to which it binds to plasma proteins. The less bound a drug is, the more efficiently it can traverse cell membranes or diffuse.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Separate studies investigating selumetinib protein binding found that 96% of selumetinib was bound to serum albumin, while <35% was bound to ɑ-1 acid glycoprotein. Overall, approximately 98.4% of selumetinib is plasma protein bound.', 'Markup': [{'Start': 31, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}, {'Start': 77, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/selumetinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10127622'}]}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 36, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 43, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 44, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 71, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10127622', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341148277'}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 45, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=441666220'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'US8178693', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US8178693'}]}, {'String': 'US9562017', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9562017'}]}, {'String': 'US7425637', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US7425637'}]}, {'String': 'US9156795', 'Markup': [{'Start': 0, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US9156795'}]}, {'String': 'US11813246', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/patent/US11813246'}]}]}}], 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10127622/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 72, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=CYOHGALHFOKKQC-UHFFFAOYSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=CYOHGALHFOKKQC-UHFFFAOYSA-N'}]}]}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Protein Bound 3D Structures', 'Description': 'Experimentally determined 3D structures of the macromolecules (e.g., proteins) that this compounds bind to.  The 3D structures in this section are from multiple sources including the RCSB Protein Data Bank (PDB), PDB in Europe (PDBe), and NCBI Structure database.', 'Information': [{'ReferenceNumber': 41, 'Value': {'ExternalTableName': 'pdb'}}, {'ReferenceNumber': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/structure?cmd=Link&LinkName=pccompound_structure&from_uid=10127622', 'Value': {'StringWithMarkup': [{'String': 'View 4 proteins in NCBI Structure'}]}}], 'Section': [{'TOCHeading': 'Ligands from Protein Bound 3D Structures', 'Description': 'Ligands found in experimental protein-ligand co-complexes (e.g., those archived in the Protein Data Bank in Europe (PDBe)).', 'URL': 'https://www.ebi.ac.uk/pdbe/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'MoveToTop': True, 'ShowAtMost': 1}, 'Section': [{'TOCHeading': 'PDBe Ligand Code', 'Description': 'The ligand code for this compound used in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 39, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3EW', 'Value': {'StringWithMarkup': [{'String': '3EW'}]}}]}, {'TOCHeading': 'PDBe Structure Code', 'Description': ""The structure code for the Protein Data Bank in Europe (PDBe) protein-ligand co-complex from which the ligand's 3-D coordinates were taken."", 'Information': [{'ReferenceNumber': 39, 'URL': 'http://www.ebi.ac.uk/pdbe/entry/pdb/4U7Z', 'Value': {'StringWithMarkup': [{'String': '4U7Z'}]}}]}, {'TOCHeading': 'PDBe Conformer', 'Description': 'The experimental protein-bound 3D structure of this compound in a protein-ligand co-complex archived in the Protein Data Bank in Europe (PDBe).', 'Information': [{'ReferenceNumber': 39, 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3EW', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/key/8201689_1'], 'MimeType': 'pubchem/compound-gzip-asnb'}}]}]}]}, {'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 3, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 4, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 9, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 10, 'Value': {'ExternalTableName': 'collection=consolidatedcompoundtarget&query_type=name&query=^Selumetinib$'}}, {'ReferenceNumber': 24, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}, {'ReferenceNumber': 43, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]}, {'TOCHeading': 'Drug-Drug Interactions', 'Description': 'Drug-drug interactions for this compound.  Drug-drug interactions occur when two or more drugs react with each other. This drug-drug interaction may cause you to experience an unexpected side effect. For example, mixing a drug you take to help you sleep (a sedative) and a drug you take for allergies (an antihistamine) can slow your reactions and make driving a car or operating machinery dangerous.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'Information': [{'ReferenceNumber': 10, 'Value': {'ExternalTableName': 'collection=drugbankddi&query_type=name&query=^Selumetinib$'}}]}, {'TOCHeading': 'Drug-Food Interactions', 'Description': 'Drug-food interactions for this compound. Drug-food/beverage interactions result from drugs reacting with foods or beverages. For example, mixing alcohol with some drugs may cause you to feel tired or slow your reactions.', 'URL': 'https://www.fda.gov/drugs/resources-you-drugs/drug-interactions-what-you-should-know', 'DisplayControls': {'ListType': 'Bulleted'}, 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Take on an empty stomach. Avoid consuming food 2 hours before and 1 hour after each dose.'}]}}]}, {'TOCHeading': 'Pathways', 'Description': 'Biological pathways in which this compound is involved.', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'collection=pathway&core=1'}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 51, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 66, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 52, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 53, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 54, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 62, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'WHO ATC Classification System', 'Description': 'The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of drugs. This pharmaceutical coding system divides drugs into different groups according to the organ or system on which they act and/or their therapeutic and chemical characteristics. Each bottom-level ATC code stands for a pharmaceutically used substance, or a combination of substances, in a single indication (or use). This means that one drug can have more than one code: acetylsalicylic acid (aspirin), for example, has A01AD05 as a drug for local oral treatment, B01AC06 as a platelet inhibitor, and N02BA01 as an analgesic and antipyretic. On the other hand, several different brands share the same code if they have the same active substance and indications.', 'URL': 'https://www.who.int/tools/atc-ddd-toolkit/atc-classification', 'Information': [{'ReferenceNumber': 57, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=79', 'Value': {'Number': [79]}}]}, {'TOCHeading': 'FDA Pharm Classes', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'Information': [{'ReferenceNumber': 56, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=78', 'Value': {'Number': [78]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 59, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'IUPHAR/BPS Guide to PHARMACOLOGY Target Classification', 'Description': 'Classification of this entity in the context of targets, provided by the IUPHAR/BPS Guide to PHARMACOLOGY.', 'URL': 'https://www.guidetopharmacology.org/', 'Information': [{'ReferenceNumber': 61, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=92', 'Value': {'Number': [92]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 60, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 58, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 63, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 64, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 67, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'PFAS and Fluorinated Organic Compounds in PubChem', 'Description': 'A classification tree to browse per- and polyfluoroalkyl substances (PFAS) and other fluorinated organic compounds in PubChem.', 'Information': [{'ReferenceNumber': 68, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=120', 'Value': {'Number': [120]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 69, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 70, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '606143-52-6', 'Name': 'Selumetinib', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=606143-52-6', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12933153}, {'ReferenceNumber': 5, 'SourceName': 'ChemIDplus', 'SourceID': '0606143526', 'Name': 'Selumetinib [USAN:INN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0606143526', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1137937}, {'ReferenceNumber': 10, 'SourceName': 'DrugBank', 'SourceID': 'DB11689', 'Name': 'Selumetinib', 'Description': 'The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.', 'URL': 'https://www.drugbank.ca/drugs/DB11689', 'LicenseNote': ""Creative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)"", 'LicenseURL': 'https://www.drugbank.ca/legal/terms_of_use', 'ANID': 3628306}, {'ReferenceNumber': 14, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID3048944', 'Name': 'Selumetinib', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID3048944', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 1163404}, {'ReferenceNumber': 17, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '641-434-6', 'Name': '5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.169.311', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15123034}, {'ReferenceNumber': 21, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': '6UH91I579U', 'Name': 'SELUMETINIB', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/6UH91I579U', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5791691}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10127622', 'Name': 'Selumetinib', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:90227', 'ANID': 2454413}, {'ReferenceNumber': 22, 'SourceName': 'FDA Pharm Classes', 'SourceID': '6UH91I579U', 'Name': 'SELUMETINIB', 'Description': 'FDA Pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety. Read more at https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 13501442}, {'ReferenceNumber': 27, 'SourceName': 'LiverTox', 'SourceID': 'Selumetinib', 'Name': 'Selumetinib', 'Description': 'LIVERTOX provides up-to-date, accurate, and easily accessed information on the diagnosis, cause, frequency, patterns, and management of liver injury attributable to prescription and nonprescription medications, herbals and dietary supplements.', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/livertox/Selumetinib/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 13162836}, {'ReferenceNumber': 32, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C66939::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C66939', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 14397247}, {'ReferenceNumber': 36, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL1614701', 'Name': 'SELUMETINIB', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL1614701', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45236219}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL1614701', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1614701', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 31257868}, {'ReferenceNumber': 4, 'SourceName': 'Chemical Probes Portal', 'SourceID': 'Compound::Selumetinib', 'Name': 'Selumetinib', 'Description': 'The Chemical Probes Portal is a expert-driven, community resource that guides scientists in the selection, application and sourcing of chemical probes for their research.', 'URL': 'https://www.chemicalprobes.org/selumetinib', 'ANID': 20032184}, {'ReferenceNumber': 7, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'C517975::Compound', 'Name': 'AZD 6244', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=C517975', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 9021630}, {'ReferenceNumber': 9, 'SourceName': 'Drug Gene Interaction database (DGIdb)', 'SourceID': 'rxcui:2289380', 'Name': 'SELUMETINIB', 'Description': 'The Drug Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that consolidates disparate data sources describing drug - gene interactions and gene druggability.', 'URL': 'https://www.dgidb.org/drugs/rxcui:2289380', 'LicenseNote': 'The data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.', 'LicenseURL': 'http://www.dgidb.org/downloads', 'ANID': 37458861}, {'ReferenceNumber': 24, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': '5665::Compound', 'Name': 'selumetinib', 'Description': 'The IUPHAR database contains quantitative information on drug targets and the prescription medicines and experimental drugs that act on them.\nAll entries in BioAssay data are marked as active as our curation SOP means we only extract data from the literature for relatively potent compounds.', 'URL': 'https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5665', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license', 'ANID': 19630068}, {'ReferenceNumber': 43, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D0T5DP', 'Name': 'Selumetinib', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D0T5DP', 'ANID': 19782867}, {'ReferenceNumber': 6, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10127622', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5186167}, {'ReferenceNumber': 44, 'SourceName': 'Therapeutic Target Database (TTD)', 'SourceID': 'D0YN5T', 'Name': 'Selumetinib', 'Description': 'Therapeutic Target Database (TTD) is a database to provide information about the known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these targets.', 'URL': 'https://idrblab.net/ttd/data/drug/details/D0YN5T', 'ANID': 37398695}, {'ReferenceNumber': 8, 'SourceName': 'DailyMed', 'SourceID': 'b81e491953cc5b6ec94391962d4b2ffc', 'Name': 'SELUMETINIB', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=SELUMETINIB', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30956381}, {'ReferenceNumber': 18, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'ca774db56729e7d6aa69dcb83eaa8075', 'Name': 'Koselugo (EMEA/H/C/005244)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/EPAR/koselugo', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37128019}, {'ReferenceNumber': 19, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'db184e23a16ad84389be47d1edd1508a', 'Name': 'Selumetinib (P/0341/2021)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001585-pip01-13-m05', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37130111}, {'ReferenceNumber': 11, 'SourceName': 'Drugs and Lactation Database (LactMed)', 'SourceID': 'selumetinib', 'Name': 'Selumetinib', 'Description': 'The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/lactmed/selumetinib/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 49310070}, {'ReferenceNumber': 12, 'SourceName': 'Drugs@FDA', 'SourceID': '2fd23120d752414af94f15ceb00e4654', 'Name': 'KOSELUGO', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38970100}, {'ReferenceNumber': 20, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '6f77c252fb59e5ace289679de1fdacd8', 'Name': 'Selumetinib (EU/3/18/2050)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-18-2050', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 49296484}, {'ReferenceNumber': 13, 'SourceName': 'DTP/NCI', 'SourceID': 'NSC 741078', 'Name': 'Selumetinib', 'Description': 'The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.', 'URL': 'https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=741078', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 6614118}, {'ReferenceNumber': 15, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10127622', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482623}, {'ReferenceNumber': 16, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '174198', 'Name': '5-[(4-Bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide (EC: 641-434-6)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/174198', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1909954}, {'ReferenceNumber': 30, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'a5f00b6b4e9fcef255e97128591492c9', 'Name': 'SELUMETINIB', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31089587}, {'ReferenceNumber': 23, 'SourceName': 'Human Metabolome Database (HMDB)', 'SourceID': 'HMDB0304858', 'Name': 'Selumetinib', 'Description': 'The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.', 'URL': 'http://www.hmdb.ca/metabolites/HMDB0304858', 'LicenseNote': '\tHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.', 'LicenseURL': 'http://www.hmdb.ca/citing', 'ANID': 38481323}, {'ReferenceNumber': 25, 'SourceName': 'Japan Chemical Substance Dictionary (Nikkaji)', 'SourceID': 'J2.516.155F', 'Description': 'The Japan Chemical Substance Dictionary (Nikkaji) has a search system that helps obtain knowledge from dissimilar fields and discover concepts that cross boundaries of specializations.', 'URL': 'http://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J2.516.155F', 'ANID': 21575255}, {'ReferenceNumber': 26, 'SourceName': 'KEGG', 'SourceID': 'D09666', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09666', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31102049}, {'ReferenceNumber': 28, 'SourceName': 'Metabolomics Workbench', 'SourceID': '152804', 'Name': 'Selumetinib', 'Description': 'The Metabolomics Workbench serves as a national and international repository for metabolomics data and metadata and provides analysis tools and access to metabolite standards, protocols, tutorials, training, and more.', 'URL': 'https://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=152804', 'ANID': 20295227}, {'ReferenceNumber': 29, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': '880106567cc9505a43e81beac2841c52', 'Name': 'SELUMETINIB', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31068933}, {'ReferenceNumber': 31, 'SourceName': 'NCI Cancer Drugs', 'SourceID': 'cddb517211c644c1ecbadf344e4994ac', 'Name': 'Koselugo (Selumetinib Sulfate)', 'Description': 'The collection of NCI Cancer Drugs has over 200 cancer drug information summaries from NCI. The summaries provide consumer-friendly information about cancer drugs and drug combinations.', 'URL': 'https://www.cancer.gov/about-cancer/treatment/drugs/selumetinibsulfate', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 37402922}, {'ReferenceNumber': 33, 'SourceName': 'NIPH Clinical Trials Search of Japan', 'SourceID': 'cid10127622', 'Description': 'NIPH Clinical Trials Search of Japan allows one to search clinical research (trials) from the registries of three institutions; the University Hospital Medical Information Network Center (UMIN-CTR), the Japan Pharmaceutical Information Center (JAPIC), and the Japan Medical Association Center for Clinical Trials.', 'URL': 'https://rctportal.niph.go.jp/en/', 'ANID': 6488383}, {'ReferenceNumber': 34, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '2289380', 'Name': 'selumetinib', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/2289380', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15099469}, {'ReferenceNumber': 35, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'nrm_10127622', 'Name': 'Selumetinib', 'Description': 'The NORMAN network enhances the exchange of information on emerging environmental substances, and encourages the validation and harmonisation of common measurement methods and monitoring tools so that the requirements of risk assessors and risk managers can be better met. The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point to find suspect lists relevant for various environmental monitoring questions, described in DOI:10.1186/s12302-022-00680-6', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/', 'ANID': 45689706}, {'ReferenceNumber': 37, 'SourceName': 'PharmGKB', 'SourceID': 'Compound::PA166129529', 'Name': 'selumetinib', 'Description': 'The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including clinical guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships', 'URL': 'https://www.pharmgkb.org/chemical/PA166129529', 'LicenseNote': 'PharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).', 'LicenseURL': 'https://www.pharmgkb.org/page/policies', 'ANID': 39966900}, {'ReferenceNumber': 38, 'SourceName': 'Pharos', 'SourceID': 'Compound::T5L9Y2W2CV11', 'Name': 'selumetinib', 'Description': 'Pharos gives access to a comprehensive, integrated knowledge-base for the Druggable Genome (DG) to illuminate the uncharacterized and/or poorly annotated portion of the DG, focusing on three of the most commonly drug-targeted protein families: G-protein-coupled receptors (GPCRs), Ion channels (ICs) and Kinases. It is the user interface to the Knowledge Management Center (KMC) for the Illuminating the Druggable Genome (IDG) program.', 'URL': 'https://pharos.nih.gov/ligands/T5L9Y2W2CV11', 'LicenseNote': 'Data accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.', 'LicenseURL': 'https://pharos.nih.gov/about', 'ANID': 24668557}, {'ReferenceNumber': 39, 'SourceName': 'Protein Data Bank in Europe (PDBe)', 'SourceID': '3EW', 'Description': 'The Protein Data Bank in Europe (PDBe) manages the PDB with its wwPDB partners and provides a high-quality, up-to-date and integrated resource of macromolecular structures to support basic and applied research and education across the sciences.', 'URL': 'http://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/3EW', 'ANID': 8201689}, {'ReferenceNumber': 41, 'SourceName': 'RCSB Protein Data Bank (RCSB PDB)', 'SourceID': '10127622', 'Description': 'The RCSB Protein Data Bank (PDB) contains crystallographic data defining 3D shapes of proteins, nucleic acids, and complex assemblies that helps students and researchers understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease.', 'URL': 'https://www.rcsb.org/', 'LicenseNote': 'Data files contained in the PDB archive (ftp://ftp.wwpdb.org) are free of all copyright restrictions and made fully and freely available for both non-commercial and commercial use. Users of the data should attribute the original authors of that structural data.', 'LicenseURL': 'https://www.rcsb.org/pages/policies', 'ANID': 13131837}, {'ReferenceNumber': 42, 'SourceName': 'Springer Nature', 'SourceID': '341148277', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341148277', 'ANID': 47990689}, {'ReferenceNumber': 45, 'SourceName': 'Thieme Chemistry', 'SourceID': '441666220', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/441666220', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48114200}, {'ReferenceNumber': 46, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'L01EE04', 'Name': 'Selumetinib', 'Description': 'The WHO Anatomical Therapeutic Chemical (ATC) Classification System is a classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/?code=L01EE04', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/', 'ANID': 24384475}, {'ReferenceNumber': 47, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q7448840', 'Name': 'selumetinib', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q7448840', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44399824}, {'ReferenceNumber': 48, 'SourceName': 'Wikipedia', 'SourceID': 'c_10438', 'Name': 'Selumetinib', 'Description': 'Link to the chemical information in Wikipedia.', 'URL': 'https://en.wikipedia.org/wiki/Selumetinib', 'ANID': 24331974}, {'ReferenceNumber': 49, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 50, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67517975', 'Name': 'AZD 6244', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67517975', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 51, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 52, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 53, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 54, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 56, 'SourceName': 'FDA Pharm Classes', 'SourceID': 'FDA_pharm_tree', 'Name': 'FDA Pharmacological Classification', 'Description': 'FDA pharmacologic class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of attributes of the active moiety.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 57, 'SourceName': 'WHO Anatomical Therapeutic Chemical (ATC) Classification', 'SourceID': 'ATCTree', 'Name': 'EPA CPDat Classification', 'Description': 'The WHO ATC (Anatomical Therapeutic Chemical) classification system classify the active substances into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.', 'URL': 'https://www.whocc.no/atc_ddd_index/', 'LicenseNote': 'Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.', 'LicenseURL': 'https://www.whocc.no/copyright_disclaimer/'}, {'ReferenceNumber': 58, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 59, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 60, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 61, 'SourceName': 'IUPHAR/BPS Guide to PHARMACOLOGY', 'SourceID': 'Target Classification', 'Name': 'Guide to Pharmacology Target Classification', 'Description': 'An expert-driven guide to pharmacological targets and the substances that act on them', 'URL': 'https://www.guidetopharmacology.org/targets.jsp', 'LicenseNote': 'The Guide to PHARMACOLOGY database is licensed under the Open Data Commons Open Database License (ODbL) https://opendatacommons.org/licenses/odbl/. Its contents are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-sa/4.0/)', 'LicenseURL': 'https://www.guidetopharmacology.org/about.jsp#license'}, {'ReferenceNumber': 62, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 63, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 64, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 66, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 67, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 68, 'SourceName': 'PubChem', 'SourceID': 'pfas5_pubchem_tree', 'Name': 'PFAS and Fluorinated Compounds in PubChem', 'Description': ""The collection of per- and polyfluoroalkyl substances (PFAS) and other fluorinated compounds in PubChem as described in https://doi.org/10.1021/acs.est.3c04855. The 'OECD PFAS definition' (no salts) and 'PFAS breakdowns by chemistry' (with salts/mixtures) nodes contain PubChem content matching the OECD PFAS definition of saturated CF2 (Report ENV/CBC/MONO(2021)25). Other nodes explore 'organofluorine compounds'; 'other diverse fluorinated compounds'; 'PFAS and fluorinated compound collections' (including CompTox; NORMAN-SLE; NIST; OntoChem PFAS lists) and 'regulatory PFAS collections' (including Stockholm Convention/EU regulations for PFOS; PFOA; PFHxS; LC-PFCAs). Expand each node for more detailed content. Read more about this tree here: https://gitlab.com/uniluxembourg/lcsb/eci/pubchem-docs/-/raw/main/pfas-tree/PFAS_Tree.pdf?inline=false"", 'URL': 'https://gitlab.com/uniluxembourg/lcsb/eci/pubchem-docs/-/raw/main/pfas-tree/PFAS_Tree.pdf'}, {'ReferenceNumber': 69, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 70, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 71, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 72, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 404180194', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/404180194'}]}}",Neurofibromatosis 1,selumetinib,,,,,,,,,,[6],[6],[3],[27],[88.4]
10135765_Delmadinone_Acetate.json,13698-49-2,,C23H27ClO4,delmadinone,402.9,,"InChI=1S/C23H27ClO4/c1-13(25)23(28-14(2)26)10-7-18-16-12-20(24)19-11-15(27)5-8-21(19,3)17(16)6-9-22(18,23)4/h5,8,11-12,16-18H,6-7,9-10H2,1-4H3/t16-,17+,18+,21-,22+,23+/m1/s1",CGBCCZZJVKUAMX-DFXBJWIESA-N,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)C=C[C@]34C)Cl)C)OC(=O)C,237-219-8,CHEBI:135645,,,,,,,,,,,,,,,,[3],[4],[0],[28],[60.4]
101526_Moxifloxacin_Hydrochloride.json,186826-86-8,,C21H25ClFN3O4,"1-cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid",437.9,,"InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1",IDIIJJHBXUESQI-DFIJPDEKSA-N,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,641-756-7,CHEBI:7008,,"Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis","Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones","{'Record': {'RecordType': 'CID', 'RecordNumber': 101526, 'RecordTitle': 'Moxifloxacin Hydrochloride', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Conformer', 'Description': 'A three-dimensional (3D) structure representation of the compound.  This 3D structure is not experimentally determined, but computed by PubChem.  This structure may or may not be the same as the inherent structure of the compound you would expect to see in vacuum or in the gas phase, because the underlying computational algorithm aims to generate a protein-bound structure, which would be observed in a protein-ligand complex.  More detailed information on this conformer model can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Name': '3D Conformer of Parent', 'Description': 'Moxifloxacin', 'Value': {'Number': [152946]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 3, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride is a hydrochloride comprising equimolar amounts of moxifloxacin and hydrogen chloride. It has a role as an antibacterial drug. It contains a moxifloxacinium(1+).', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}, {'Start': 78, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}, {'Start': 95, 'Length': 17, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/hydrogen%20chloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-313'}, {'Start': 168, 'Length': 15, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacinium', 'Type': 'PubChem Internal Link', 'Extra': 'CID-56927899'}]}]}}, {'ReferenceNumber': 9, 'Description': 'HIV/AIDS and Opportunistic Infection Drugs', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride is an antibacterial&nbsp;prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, such as community-acquired pneumonia, acute worsening of chronic bronchitis, acute sinus infections, plague, and skin and abdominal infections.', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}, {'String': 'Community-acquired pneumonia, a bacterial respiratory infection, can be an opportunistic infection (OI) of HIV.'}]}}, {'ReferenceNumber': 40, 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin Hydrochloride is the hydrochloride salt of a fluoroquinolone antibacterial antibiotic. Moxifloxacin binds to and inhibits the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell death in sensitive bacterial species.', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20Hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}, {'Start': 100, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}]}]}}, {'ReferenceNumber': 42, 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 5 approved and 8 investigational indications. This drug has a black box warning from the FDA.', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': 'A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.'}]}}, {'ReferenceNumber': 49, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Moxifloxacin (has active moiety).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/152946'}, {'Start': 10, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=152946', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride', 'Markup': [{'Start': 5, 'Length': 1, 'Type': 'Italics'}, {'Start': 6, 'Length': 1, 'Type': 'Italics'}, {'Start': 9, 'Length': 1, 'Type': 'Italics'}, {'Start': 10, 'Length': 1, 'Type': 'Italics'}, {'Start': 22, 'Length': 1, 'Type': 'Italics'}, {'Start': 29, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'IDIIJJHBXUESQI-DFIJPDEKSA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C21H25ClFN3O4'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=186826-86-8', 'Value': {'StringWithMarkup': [{'String': '186826-86-8'}]}}, {'ReferenceNumber': 5, 'Value': {'StringWithMarkup': [{'String': '186826-86-8'}]}}, {'ReferenceNumber': 18, 'Value': {'StringWithMarkup': [{'String': '186826-86-8'}]}}, {'ReferenceNumber': 22, 'Value': {'StringWithMarkup': [{'String': '186826-86-8'}]}}, {'ReferenceNumber': 28, 'Value': {'StringWithMarkup': [{'String': '186826-86-8'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 22, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.169.607', 'Value': {'StringWithMarkup': [{'String': '641-756-7'}]}}, {'ReferenceNumber': 23, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.257.131', 'Value': {'StringWithMarkup': [{'String': '947-143-3'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 28, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/C53598599T', 'Value': {'StringWithMarkup': [{'String': 'C53598599T'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7008', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:7008'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 4, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1200735', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL1200735'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 18, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID4045921', 'Value': {'StringWithMarkup': [{'String': 'DTXSID4045921'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 33, 'URL': 'https://www.kegg.jp/entry/D00874', 'Value': {'StringWithMarkup': [{'String': 'D00874'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 40, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38696', 'Value': {'StringWithMarkup': [{'String': 'C38696'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 41, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/228750', 'Value': {'StringWithMarkup': [{'String': '228750'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 47, 'URL': 'https://www.wikidata.org/wiki/Q27107395', 'Value': {'StringWithMarkup': [{'String': 'Q27107395'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 48, 'Value': {'StringWithMarkup': [{'String': '1-cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid'}, {'String': 'Actira'}, {'String': 'Avalox'}, {'String': 'Avelox'}, {'String': 'BAY 12 8039'}, {'String': 'BAY 12-8039'}, {'String': 'BAY 128039'}, {'String': 'BAY-12-8039'}, {'String': 'BAY-128039'}, {'String': 'BAY128039'}, {'String': 'Izilox'}, {'String': 'moxifloxacin'}, {'String': 'moxifloxacin hydrochloride'}, {'String': 'Octegra'}, {'String': 'Proflox'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride'}, {'String': '186826-86-8'}, {'String': 'Moxifloxacin HCl'}, {'String': 'Vigamox'}, {'String': 'Moxeza'}, {'String': 'CHEBI:7008'}, {'String': 'Moxifloxacin (as hydrochloride)'}, {'String': 'DTXSID4045921'}, {'String': 'UNII-C53598599T'}, {'String': 'AL-15469A'}, {'String': 'BAY12-8039'}, {'String': 'NSC-758875'}, {'String': '(4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride'}, {'String': 'AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER'}, {'String': 'C53598599T'}, {'String': 'DTXCID2025921'}, {'String': 'Moxifloxacin hydrochloride [USAN:USP]'}, {'String': 'NSC 758875'}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride'}, {'String': '3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-, monohydrochloride'}, {'String': 'MFLX'}, {'String': 'Moxifloxacin hydrochloride (USAN:USP)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE (MART.)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [MART.]'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE (USP-RS)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [USP-RS]'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE (EP MONOGRAPH)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [EP MONOGRAPH]'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE (USP MONOGRAPH)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [USP MONOGRAPH]'}, {'String': 'Avelox Abc Pack'}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': 'Moxifloxacin Ophthalmic'}, {'String': 'Moxifloxacin Ophthalmic Solution'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-7-((4as,7as)-octahydropyrrolo(3,4-b)pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride'}, {'String': 'Avelox'}, {'String': 'Avalox'}, {'String': 'BAY 12-8039'}, {'String': 'Moxifloxacin (Hydrochloride)'}, {'String': 'Bay-12-8039'}, {'String': 'Actira'}, {'String': 'Izilox'}, {'String': 'MFCD00949117'}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1)'}, {'String': '7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': 'Moxifloxacine hydrochloride'}, {'String': '1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': '7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid hydrochloride'}, {'String': '186826-86-8 (HCl); 354812-41-2 (free base)'}, {'String': 'Octegra'}, {'String': 'Vigamox (TN)'}, {'String': 'Avelox (TN)'}, {'String': '7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride'}, {'String': 'CAS-186826-86-8'}, {'String': 'Moxifloxacin hydrochloride [USAN]'}, {'String': 'Vegamox'}, {'String': 'Actura'}, {'String': 'BAY12-8039 HCl'}, {'String': 'NCGC00095130-01'}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; d-Moxifloxacin Hydrochloride; (4R,7R)-Moxifloxacin Hydrochloride;'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': '1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': 'CPD000469185'}, {'String': 'SCHEMBL37285'}, {'String': 'MLS001401368'}, {'String': 'CHEMBL1200735'}, {'String': 'MOXIFLOXACIN HCL [VANDF]'}, {'String': 'MSK5732'}, {'String': 'GLXC-04757'}, {'String': '1346603-25-5'}, {'String': 'BCP03623'}, {'String': 'Tox21_111439'}, {'String': 'HY-66011R'}, {'String': 'Moxifloxacin hydrochloride (JAN/USP)'}, {'String': 'AKOS015920132'}, {'String': 'AKOS016015225'}, {'String': 'Tox21_111439_1'}, {'String': 'AC-1275'}, {'String': 'AM10805'}, {'String': 'BCP9000963'}, {'String': 'CCG-100924'}, {'String': 'KS-1181'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [MI]'}, {'String': 'NC00174'}, {'String': 'Moxifloxacin (Hydrochloride) (Standard)'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [JAN]'}, {'String': 'NCGC00271749-02'}, {'String': 'HY-66011'}, {'String': 'SMR000469185'}, {'String': 'BCP0726000173'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [WHO-DD]'}, {'String': 'Moxifloxacin hydrochloride, >=98% (HPLC)'}, {'String': 'M2479'}, {'String': 'S1465'}, {'String': 'SW197554-3'}, {'String': 'D00874'}, {'String': 'MOXIFLOXACIN HYDROCHLORIDE [ORANGE BOOK]'}, {'String': 'EN300-2009156'}, {'String': 'Q27107395'}, {'String': 'Z2235801869'}, {'String': '186826-86-8  151096-09-2(base)'}, {'String': 'Moxifloxacin hydrochloride, VETRANAL(TM), analytical standard'}, {'String': 'Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard'}, {'String': 'Moxifloxacin for peak identification, European Pharmacopoeia (EP) Reference Standard'}, {'String': 'Moxifloxacin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material'}, {'String': 'Moxifloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard'}, {'String': ""(1'S,6',S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid""}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride'}, {'String': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Hydrochloride'}, {'String': '1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid HCl'}, {'String': '1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacidhydrochloride'}, {'String': '1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-((4aS,7aS)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride'}, {'String': '1-Cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydropyrrolo(3,4-b)pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic  acid  monohydrochloride'}, {'String': '7-[[(4As,8aS)-2,3,4,4a,5,6,8,8a-octahydro-1H-1,7-naphthyridin-7-yl]methyl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'moxifloxacin'}, {'String': 'Proflox'}, {'String': 'Moxivig'}, {'String': 'Moxifloxacin HCI'}, {'String': 'Avelox I.V.'}, {'String': 'cc-97'}, {'String': 'AC1L2R0P'}, {'String': 'C21H25ClFN3O4'}, {'String': 'C23H29ClFN3O4'}, {'String': 'C21H24FN3O4.ClH'}, {'String': 'C21H24FN3O4.HCl'}, {'String': 'ent-Moxifloxacin Hydrochloride'}, {'String': 'IDIIJJHBXUESQI-DFIJPDEKSA-N'}, {'String': 'ERK5-3D08'}, {'String': 'ACT02692'}, {'String': 'AMY25227'}, {'String': 'BAY128039'}, {'String': 'BBF-04614'}, {'String': 'CID101526'}, {'String': 'CM0156'}, {'String': 'Moxifloxacin hydrochloride monohydrate'}, {'String': 'C21-H24-F-N3-O4.Cl-H'}, {'String': 'ACN-029245'}, {'String': 'BAY 128039'}, {'String': 'BAY-128039'}, {'String': 'CID:101526'}, {'String': 'CS-1063'}, {'String': 'RL02375'}, {'String': '2,2,4,4-Tetrafluoro-1,3-dithietane'}, {'String': 'BAY 12 8039'}, {'String': 'BAY 12-0839'}, {'String': 'AN-15101'}, {'String': 'AT-15459'}, {'String': 'BC205778'}, {'String': 'BR-72941'}, {'String': 'O381'}, {'String': 'SAM001246654'}, {'String': 'SID:376229688'}, {'String': 'AB0016427'}, {'String': 'LS-173737'}, {'String': 'ST2413518'}, {'String': 'A5323'}, {'String': 'S-3681'}, {'String': '826M868'}, {'String': 'A847989'}, {'String': 'C104727'}, {'String': 'D000077266'}, {'String': '151096-09-2'}, {'String': '1-cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid'}, {'String': '1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4'}, {'String': '192927-63-2'}, {'String': '3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-,monohydrochloride'}, {'String': '7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid hydrochloride'}, {'String': 'Moxifloxacin Hydrochloride; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1); (4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid monohydrochloride; Actira; Avalox; Avelox; BAY 12-8039; Lapinix; Moxifloxacin hydrochloride; Octegra'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'DateISO8601': ['2005-08-08']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '437.9'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [3]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [4]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '437.1517621'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '437.1517621'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [82.1], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [30]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [727]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 49, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Experimental Properties', 'Description': 'Various experimentally determined properties for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Collision Cross Section', 'Description': 'Collision cross section (CCS) represents the effective area for the interaction between an individual ion and the neutral gas through which it is traveling (e.g., in ion mobility spectrometry (IMS) experiments).  It quantifies the probability of a collision taking place between two or more particles.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/28035808/', 'Information': [{'ReferenceNumber': 2, 'Reference': ['https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709'], 'ExtendedReference': [{'Citation': 'https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709', 'Matched': {'PCLID': 900164357, 'Citation': 'https://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b01709'}}], 'Value': {'StringWithMarkup': [{'String': '195 Å² [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]', 'Markup': [{'Start': 12, 'Length': 1, 'Type': 'Superscript'}]}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones'}]}}, {'ReferenceNumber': 12, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription; Discontinued'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued'}]}}, {'ReferenceNumber': 16, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued'}]}}, {'ReferenceNumber': 17, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription; None (Tentative Approval); Discontinued; Active ingredient (MOXIFLOXACIN HYDROCHLORIDE)', 'Markup': [{'Start': 88, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 24, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}, {'ReferenceNumber': 25, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}, {'ReferenceNumber': 26, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}, {'ReferenceNumber': 27, 'Name': '', 'Value': {'StringWithMarkup': [{'String': 'Paediatric drug'}]}}]}]}]}]}, {'TOCHeading': 'Spectral Information', 'Description': 'Spectral data for this compound, including 1-D and 2-D nuclear magnetic resonance (NMR), Infrared (IR), Raman, and Ultraviolet (UV) spectroscopy, mass spectrometry (MS), and chromatography.', 'Section': [{'TOCHeading': 'Mass Spectrometry', 'Description': 'Mass spectrometry (MS or mass spec) is a technique to determine molecular structure through ionization and fragmentation of the parent compound into smaller components.', 'URL': 'https://chem.libretexts.org/Bookshelves/Organic_Chemistry/Supplemental_Modules_(Organic_Chemistry)/Spectroscopy/Mass_Spectrometry', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Section': [{'TOCHeading': 'LC-MS', 'Description': 'Data from liquid chromatography-mass spectrometry (LC-MS) experiments.', 'URL': 'https://chem.libretexts.org/Bookshelves/General_Chemistry/Book%3A_Structure_and_Reactivity_in_Organic_Biological_and_Inorganic_Chemistry_(Schaller)/II%3A_Practical_Aspects_of_Structure_-_Purification_and_Spectroscopy/06%3A_Introductory_Mass_Spectrometry/6.03%3A_GC-MS_and_LC-MS', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 34, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078158', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078158'}]}}, {'ReferenceNumber': 34, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 34, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 34, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 34, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+H]+'}]}}, {'ReferenceNumber': 34, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '402.182'}]}}, {'ReferenceNumber': 34, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 34, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 34, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '402.184753 100'}, {'String': '403.187469 68.52'}, {'String': '384.172974 43.56'}, {'String': '358.193481 15.54'}, {'String': '404.188324 12.66'}]}}, {'ReferenceNumber': 34, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-0udi-1497800000-975830409e5d1220a9fc%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0udi-1497800000-975830409e5d1220a9fc'}]}}, {'ReferenceNumber': 34, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=402.184753:100,403.187469:68.52,384.172974:43.56,358.193481:15.54,404.188324:12.66', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=402.184753:100,403.187469:68.52,384.172974:43.56,358.193481:15.54,404.188324:12.66'], 'MimeType': 'image/svg'}}, {'ReferenceNumber': 35, 'Name': 'MoNA ID', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/display/CCMSLIB00000078159', 'Value': {'StringWithMarkup': [{'String': 'CCMSLIB00000078159'}]}}, {'ReferenceNumber': 35, 'Name': 'MS Category', 'Value': {'StringWithMarkup': [{'String': 'Experimental'}]}}, {'ReferenceNumber': 35, 'Name': 'MS Type', 'Value': {'StringWithMarkup': [{'String': 'LC-MS'}]}}, {'ReferenceNumber': 35, 'Name': 'MS Level', 'Value': {'StringWithMarkup': [{'String': 'MS2'}]}}, {'ReferenceNumber': 35, 'Name': 'Precursor Type', 'Value': {'StringWithMarkup': [{'String': '[M+2H]+'}]}}, {'ReferenceNumber': 35, 'Name': 'Precursor m/z', 'Value': {'StringWithMarkup': [{'String': '201.595'}]}}, {'ReferenceNumber': 35, 'Name': 'Instrument', 'Value': {'StringWithMarkup': [{'String': 'qTof'}]}}, {'ReferenceNumber': 35, 'Name': 'Ionization Mode', 'Value': {'StringWithMarkup': [{'String': 'positive'}]}}, {'ReferenceNumber': 35, 'Name': 'Top 5 Peaks', 'Value': {'StringWithMarkup': [{'String': '201.595703 100'}, {'String': '192.590866 29.01'}, {'String': '344.140594 28.66'}, {'String': '202.096283 21.37'}, {'String': '247.051804 7.65'}]}}, {'ReferenceNumber': 35, 'Name': 'SPLASH', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(splash.splash:%27splash10-0udi-0492000000-9c86052a0b842353cf88%27)', 'Value': {'StringWithMarkup': [{'String': 'splash10-0udi-0492000000-9c86052a0b842353cf88'}]}}, {'ReferenceNumber': 35, 'Name': 'Thumbnail', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=201.595703:100,192.590866:29.01,344.140594:28.66,202.096283:21.37,247.051804:7.65', 'Value': {'ExternalDataURL': ['https://pubchem.ncbi.nlm.nih.gov/image/ms.cgi?peaks=201.595703:100,192.590866:29.01,344.140594:28.66,202.096283:21.37,247.051804:7.65'], 'MimeType': 'image/svg'}}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID101526%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID101526%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Parent Compound', 'Description': 'A parent compound is conceptually the ""important"" part of the molecule when the molecule has more than one covalent component. Specifically, a parent component must have at least one carbon and contain at least 70% of the heavy (non-hydrogen) atoms of all the unique covalent units (ignoring stoichiometry). Note that this is a very empirical definition and is subject to change.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'CID 152946 (Moxifloxacin)', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=152946', 'Type': 'Icon'}, {'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/152946'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'CID 313 (Hydrochloric Acid)', 'Markup': [{'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=313', 'Type': 'Icon'}, {'Start': 0, 'Length': 27, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/313'}]}, {'String': 'CID 152946 (Moxifloxacin)', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=152946', 'Type': 'Icon'}, {'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/152946'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [9]}}, {'ReferenceNumber': 49, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [4]}}, {'ReferenceNumber': 49, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [5]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_parent_connectivity&list_return=redirect', 'Value': {'Number': [121]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_parent_stereo&list_return=redirect', 'Value': {'Number': [79]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_parent_isotopes&list_return=redirect', 'Value': {'Number': [103]}}, {'ReferenceNumber': 49, 'Name': 'Same Parent, Exact Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=same_parent&list_return=redirect', 'Value': {'Number': [71]}}, {'ReferenceNumber': 49, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 49, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID101526%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 49, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID101526%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 49, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/481107996', 'Value': {'Number': [481107996]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [187]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin (has active moiety)', 'Markup': [{'Start': 0, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/152946'}, {'Start': 0, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=152946', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 49, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=101526', 'Value': {'Number': [32]}}, {'ReferenceNumber': 49, 'Name': 'Taxonomy Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_taxonomy&db=pccompound&cmd=Link&from_uid=101526', 'Value': {'Number': [4]}}, {'ReferenceNumber': 49, 'Name': 'OMIM Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_omim&db=pccompound&cmd=Link&from_uid=101526', 'Value': {'Number': [3]}}, {'ReferenceNumber': 49, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=101526', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'NCBI LinkOut', 'Description': 'NCBI LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout/', 'Information': [{'ReferenceNumber': 75, 'Value': {'Boolean': [True]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 49, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 24, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis'}]}}, {'ReferenceNumber': 25, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis'}]}}, {'ReferenceNumber': 26, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis'}]}}, {'ReferenceNumber': 27, 'Name': 'Drug Indication', 'Value': {'StringWithMarkup': [{'String': 'Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis'}]}}, {'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'Drug Classes', 'Description': 'Drug classes of this compound, based on its therapeutic uses and/or structure. The data presented in this section is from LiverTox.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/15404', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Quinolones; Fluoroquinolones'}]}}]}, {'TOCHeading': 'FDA Medication Guides', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.', 'URL': 'https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 5, 'ColumnsFromNamedLists': {'Name': ['Drug', 'Active Ingredient', 'Form;Route', 'Company', 'Date'], 'UseNamesAsColumnHeadings': True}}, 'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'AVELOX', 'Markup': [{'Start': 0, 'Length': 6, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33'}]}]}}, {'ReferenceNumber': 29, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 29, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 29, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'BAYER HLTHCARE'}]}}, {'ReferenceNumber': 29, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '05/06/2020'}]}}, {'ReferenceNumber': 30, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER', 'Markup': [{'Start': 0, 'Length': 51, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021085s066,021277s062lbl.pdf#page=33'}, {'Start': 0, 'Length': 6, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/AVELOX', 'Type': 'PubChem Internal Link', 'Extra': 'multiple-CIDs'}, {'Start': 10, 'Length': 15, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/SODIUM%20CHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-5234'}]}]}}, {'ReferenceNumber': 30, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 30, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'SOLUTION;INTRAVENOUS'}]}}, {'ReferenceNumber': 30, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'BAYER HLTHCARE'}]}}, {'ReferenceNumber': 30, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '05/06/2020'}]}}, {'ReferenceNumber': 31, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205572s007lbl.pdf#page=49'}, {'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 31, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 31, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'SOLUTION;INTRAVENOUS'}]}}, {'ReferenceNumber': 31, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'FRESENIUS KABI USA'}]}}, {'ReferenceNumber': 31, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '07/26/2016'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 11, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 32, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 36, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 8, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}, {'ReferenceNumber': 8, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'HIV/AIDS and Opportunistic Infection Drugs', 'Description': 'This section contains information and links on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 9, 'Name': 'What is Moxifloxacin Hydrochloride', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride is an antibacterial&nbsp;prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain bacterial infections, such as community-acquired pneumonia, acute worsening of chronic bronchitis, acute sinus infections, plague, and skin and abdominal infections.', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}, {'String': 'Community-acquired pneumonia, a bacterial respiratory infection, can be an opportunistic infection (OI) of HIV.'}]}}, {'ReferenceNumber': 9, 'Name': 'Drug Class', 'Value': {'StringWithMarkup': [{'String': 'Antibacterial (Quinolone)'}]}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 6, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 49}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 19, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 40}}]}]}, {'TOCHeading': 'EMA Drug Information', 'Description': 'Drug information from the European Medicines Agency (EMA).', 'URL': 'https://www.ema.europa.eu/en', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 24, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 24, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000288-pip01-08-m02', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 24, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Infectious diseases'}]}}, {'ReferenceNumber': 24, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet, Solution for infusion, Granules and solvent for oral suspension'}]}}, {'ReferenceNumber': 24, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use, Intravenous use'}]}}, {'ReferenceNumber': 24, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 24, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2010-11-24'}]}}, {'ReferenceNumber': 25, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 25, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000491-pip01-08-m01', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 25, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Infectious diseases'}]}}, {'ReferenceNumber': 25, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet, Solution for infusion, Granules and solvent for oral suspension'}]}}, {'ReferenceNumber': 25, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use, Intravenous use'}]}}, {'ReferenceNumber': 25, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 25, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2009-12-23'}]}}, {'ReferenceNumber': 26, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 26, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000492-pip01-08-m01', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 26, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Infectious diseases'}]}}, {'ReferenceNumber': 26, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet, Solution for infusion, Granules and solvent for oral suspension'}]}}, {'ReferenceNumber': 26, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use, Intravenous use'}]}}, {'ReferenceNumber': 26, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 26, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2009-12-23'}]}}, {'ReferenceNumber': 27, 'Name': 'Type', 'Value': {'StringWithMarkup': [{'String': 'Paediatric investigation'}]}}, {'ReferenceNumber': 27, 'Name': 'Active Substance', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000493-pip01-08-m01', 'Value': {'StringWithMarkup': [{'String': 'Moxifloxacin hydrochloride', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Moxifloxacin%20hydrochloride', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 27, 'Name': 'Therapeutic Area', 'Value': {'StringWithMarkup': [{'String': 'Infectious diseases'}]}}, {'ReferenceNumber': 27, 'Name': 'Drug Form', 'Value': {'StringWithMarkup': [{'String': 'Film-coated tablet, Solution for infusion, Granules and solvent for oral suspension'}]}}, {'ReferenceNumber': 27, 'Name': 'Administration Route', 'Value': {'StringWithMarkup': [{'String': 'Oral use, Intravenous use'}]}}, {'ReferenceNumber': 27, 'Name': 'Decision Type', 'Value': {'StringWithMarkup': [{'String': 'PM: decision on the application for modification of an agreed PIP'}]}}, {'ReferenceNumber': 27, 'Name': 'Decision Date', 'Value': {'StringWithMarkup': [{'String': '2009-12-23'}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 72, 'Name': 'Anti-Bacterial Agents', 'Value': {'StringWithMarkup': [{'String': 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Markup': [{'Start': 69, 'Length': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68000900'}]}]}}, {'ReferenceNumber': 73, 'Name': 'Topoisomerase II Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)', 'Markup': [{'Start': 264, 'Length': 55, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=68059005'}]}]}}]}, {'TOCHeading': 'FDA Pharmacological Classification', 'Description': 'Pharmacologic Class is a group of active moieties that share scientifically documented properties and is defined on the basis of any combination of three attributes of the active moiety: mechanism of action (MOA), physiologic effect (PE) and chemical structure (CS).  An FDA ""Established Pharmacologic Class"" (EPC) text phrase is a pharmacologic class associated with an approved indication of an active moiety that the FDA has determined to be scientifically valid and clinically meaningful.', 'URL': 'https://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 37, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN HYDROCHLORIDE', 'Markup': [{'Start': 0, 'Length': 26, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN%20HYDROCHLORIDE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-101526'}]}]}}, {'ReferenceNumber': 37, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Fluoroquinolone Antibacterial [EPC]; Quinolone Antimicrobial [EPC]; Fluoroquinolones [CS]; Quinolones [CS]', 'Markup': [{'Start': 37, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Quinolone', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6038'}]}]}}, {'ReferenceNumber': 38, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN OPHTHALMIC'}]}}, {'ReferenceNumber': 38, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Fluoroquinolones [CS]; Quinolones [CS]; Fluoroquinolone Antibacterial [EPC]; Quinolone Antimicrobial [EPC]', 'Markup': [{'Start': 77, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Quinolone', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6038'}]}]}}, {'ReferenceNumber': 39, 'Name': 'Non-Proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'MOXIFLOXACIN OPHTHALMIC SOLUTION', 'Markup': [{'Start': 0, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/MOXIFLOXACIN', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}]}]}}, {'ReferenceNumber': 39, 'Name': 'Pharmacological Classes', 'Value': {'StringWithMarkup': [{'String': 'Fluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]'}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 24, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 25, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 26, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 27, 'Name': 'Use Classification', 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> EU pediatric investigation plans'}]}}, {'ReferenceNumber': 32, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 20, 'Name': 'Note', 'Value': {'StringWithMarkup': [{'String': 'This chemical does not meet GHS hazard criteria for 1.2% (1  of 84) of reports.', 'Markup': [{'Start': 0, 'Length': 79, 'Type': 'Italics'}]}]}}, {'ReferenceNumber': 20, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}]}]}}, {'ReferenceNumber': 20, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Warning', 'Markup': [{'Start': 0, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 20, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 36, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H319 (95.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]', 'Markup': [{'Start': 45, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H412 (94%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]'}]}}, {'ReferenceNumber': 20, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P264, P264+P265, P270, P273, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 6, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264+P265'}, {'Start': 17, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 23, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P273'}, {'Start': 29, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 35, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 46, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P305+P351+P338'}, {'Start': 62, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 68, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P337+P317'}, {'Start': 83, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 20, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 84 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 176, 'Type': 'Italics'}]}, {'String': 'Reported as not meeting GHS hazard criteria per 1 of 84 reports by companies.', 'Markup': [{'Start': 0, 'Length': 77, 'Type': 'Italics'}]}, {'String': 'There are 5 notifications provided by 83 of 84 reports by companies with hazard statement code(s).', 'Markup': [{'Start': 0, 'Length': 98, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/174495'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}, {'ReferenceNumber': 21, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}, {'ReferenceNumber': 21, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Warning', 'Markup': [{'Start': 0, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 21, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 35, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]', 'Markup': [{'Start': 44, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]', 'Markup': [{'Start': 66, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H373 (100%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]', 'Markup': [{'Start': 81, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}]}}, {'ReferenceNumber': 21, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P203, P260, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P319, P330, P337+P317, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P203'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P260'}, {'Start': 12, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 18, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264+P265'}, {'Start': 29, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 41, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 52, 'Length': 14, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P305+P351+P338'}, {'Start': 68, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P318'}, {'Start': 74, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P319'}, {'Start': 80, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 86, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P337+P317'}, {'Start': 97, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 107, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 21, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 35 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 176, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/265028'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 20, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (97.6%)'}, {'String': 'Eye Irrit. 2 (95.2%)'}, {'String': 'Aquatic Chronic 3 (94%)'}]}}, {'ReferenceNumber': 21, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (100%)'}, {'String': 'Eye Irrit. 2 (100%)'}, {'String': 'Repr. 2 (100%)'}, {'String': 'STOT RE 2 (100%)'}]}}]}]}]}, {'TOCHeading': 'Toxicity', 'Description': 'Toxicity information related to this compound, including routes of exposure, related symptoms, acute and chronic effects, and numerical measures of toxicity.', 'Section': [{'TOCHeading': 'Toxicological Information', 'Description': 'This section provides toxicological and health effects information for the chemical.  It includes the likely routes of exposure (inhalation, ingestion, skin and eye contact), and the delayed, immediate, or chronic effects/symptoms from short- and long-term exposure, and the numerical measures of toxicity [e.g., acute toxicity estimates such as the LD50 (median lethal dose, the estimated amount of a chemical expected to kill 50% of test animals in a single dose)].  This section also includes information on whether the chemical is considered as a potential carcinogen according to authoritative sources such as the National Toxicology Program (NTP) Report on Carcinogens and the International agency for Research on Cancer (IARC) Monographs.', 'Section': [{'TOCHeading': 'Effects During Pregnancy and Lactation', 'Description': 'Drug effects during pregnancy and lactation.', 'Information': [{'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': '◉ Summary of Use during Lactation'}, {'String': ""No information is available on the use of moxifloxacin during breastfeeding. Fluoroquinolones have traditionally not been used in infants because of concern about adverse effects on the infants' developing joints. However, recent studies indicate little risk. The calcium in milk might prevent absorption of the small amounts of fluoroquinolones in milk, but insufficient data exist to prove or disprove this assertion. Use of moxifloxacin is acceptable in nursing mothers with monitoring of the infant for possible effects on the gastrointestinal flora, such as diarrhea or candidiasis (thrush, diaper rash). However, it is preferable to use an alternate drug for which safety information is available."", 'Markup': [{'Start': 42, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}, {'Start': 264, 'Length': 7, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/element/Calcium', 'Type': 'PubChem Internal Link', 'Extra': 'Element-Calcium'}, {'Start': 427, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}]}, {'String': 'Maternal use of an eye drop that contains moxifloxacin presents negligible risk for the nursing infant. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.', 'Markup': [{'Start': 42, 'Length': 12, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/moxifloxacin', 'Type': 'PubChem Internal Link', 'Extra': 'CID-152946'}]}, {'String': '◉ Effects in Breastfed Infants'}, {'String': 'Relevant published information was not found as of the revision date.'}, {'String': '◉ Effects on Lactation and Breastmilk'}, {'String': 'Relevant published information was not found as of the revision date.'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}, {'ReferenceNumber': 42, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 71, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=101526', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Springer Nature References', 'Description': ""Literature references related to scientific contents from Springer Nature journals and books. These references have been ranked automatically by an algorithm which calculates the relevance for each substance in a Springer Nature document. It is based on: (1) the TF-IDF, adapted to chemical structures, (2) location information in the text (e.g. title, abstract, keywords), and (3) the document size.  Springer Nature aims to provide only highly qualitative and relevant content but references of lower relevance aren't withheld as they might contain also very useful information."", 'Information': [{'ReferenceNumber': 44, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341148480'}}, {'ReferenceNumber': 45, 'Value': {'ExternalTableName': 'collection=springernature&query_type=sid&query=341140610'}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 46, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376720374'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 49, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101526/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'WIPO PATENTSCOPE', 'Description': ""Use the provided link to show patents associated with this chemical structure in WIPO's PATENTSCOPE system."", 'URL': 'https://www.wipo.int/patentscope/en/', 'Information': [{'ReferenceNumber': 74, 'Value': {'StringWithMarkup': [{'String': 'Patents are available for this chemical structure:'}, {'String': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=IDIIJJHBXUESQI-DFIJPDEKSA-N', 'Markup': [{'Start': 0, 'Length': 86, 'URL': 'https://patentscope.wipo.int/search/en/result.jsf?inchikey=IDIIJJHBXUESQI-DFIJPDEKSA-N'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 32, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^MOXIFLOXACIN HYDROCHLORIDE$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 49, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Interactions and Pathways', 'Description': 'This section provides information on the biomolecular interactions of this compound with drugs, genes, proteins, etc., as well as the pathways in which this compound is involved.', 'Section': [{'TOCHeading': 'Chemical-Target Interactions', 'Description': 'Interactions between targets and this compound', 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': 'consolidatedcompoundtarget'}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 49, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 50, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 66, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 51, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug', 'Description': 'Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08301', 'Information': [{'ReferenceNumber': 52, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14', 'Value': {'Number': [14]}}]}, {'TOCHeading': 'KEGG: USP', 'Description': 'US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08302', 'Information': [{'ReferenceNumber': 53, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15', 'Value': {'Number': [15]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 54, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 60, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'KEGG : Antimicrobials', 'Description': 'Antiinfectives classification/ontology tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08307', 'Information': [{'ReferenceNumber': 55, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=20', 'Value': {'Number': [20]}}]}, {'TOCHeading': 'KEGG: Drug Classes', 'Description': 'Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08332', 'Information': [{'ReferenceNumber': 68, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118', 'Value': {'Number': [118]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 58, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 59, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 57, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'NORMAN Suspect List Exchange Classification', 'Description': 'A classification from the NORMAN Suspect List Exchange, which serve as a central access point to find lists of chemicals with environmental concerns.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'Information': [{'ReferenceNumber': 61, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=101', 'Value': {'Number': [101]}}]}, {'TOCHeading': 'CCSBase Classification', 'Description': 'CCSbase is an integrated platform that contains collision cross section data for the compound.  The CCSbase classification groups the compounds by the type of adduct ions that can be formed from them (e.g., [M-H]-, [M+H]+, [M+Na]+, [M+K]+).', 'URL': 'https://ccsbase.net/', 'Information': [{'ReferenceNumber': 62, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=104', 'Value': {'Number': [104]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 63, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 67, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 69, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 70, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '186826-86-8', 'Name': 'Moxifloxacin hydrochloride', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=186826-86-8', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12926266}, {'ReferenceNumber': 5, 'SourceName': 'ChemIDplus', 'SourceID': '0186826868', 'Name': 'Moxifloxacin hydrochloride [USAN:USP]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0186826868', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1129636}, {'ReferenceNumber': 18, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID4045921', 'Name': 'Moxifloxacin hydrochloride', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID4045921', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 1160909}, {'ReferenceNumber': 22, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '641-756-7', 'Name': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.169.607', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15123095}, {'ReferenceNumber': 28, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'C53598599T', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/C53598599T', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5864069}, {'ReferenceNumber': 2, 'SourceName': 'CCSbase', 'SourceID': '1145336100', 'Description': 'CCSbase curates experimental collision cross section values measured on various ion mobility platforms as a resource for the research community. CCSbase also builds prediction models for comprehensive prediction of collision cross sections for a given molecule.', 'ANID': 39653228}, {'ReferenceNumber': 3, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:101526', 'Name': 'Moxifloxacin hydrochloride', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:7008', 'ANID': 2437658}, {'ReferenceNumber': 9, 'SourceName': 'Drug Database, Clinicalinfo.hiv.gov', 'SourceID': '3964849513', 'Name': 'Moxifloxacin Hydrochloride', 'Description': 'The Drug database at the clinicalinfo.hiv.gov contains information on FDA-approved HIV/AIDS and opportunistic infection drugs and investigational HIV/AIDS drugs.', 'URL': 'https://clinicalinfo.hiv.gov/en/drugs/moxifloxacin-hydrochloride/patient', 'LicenseNote': 'Unless otherwise noted, material presented on the HIV.gov website is considered Federal government information and is in the public domain. That means this information may be freely copied and distributed. We request that you use appropriate attribution to HIV.gov.', 'LicenseURL': 'https://www.hiv.gov/about-us/mission-and-team', 'ANID': 39760869}, {'ReferenceNumber': 40, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C38696::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C38696', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 14395703}, {'ReferenceNumber': 42, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL1200735', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL1200735', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45234960}, {'ReferenceNumber': 4, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL1200735', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1200735', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 31876551}, {'ReferenceNumber': 6, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid101526', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 5187139}, {'ReferenceNumber': 7, 'SourceName': 'Comparative Toxicogenomics Database (CTD)', 'SourceID': 'D000077266::Compound', 'Name': 'Moxifloxacin', 'Description': 'CTD is a robust, publicly available database that aims to advance understanding about how environmental exposures affect human health.', 'URL': 'https://ctdbase.org/detail.go?type=chem&acc=D000077266', 'LicenseNote': 'It is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.', 'LicenseURL': 'http://ctdbase.org/about/legal.jsp', 'ANID': 9023021}, {'ReferenceNumber': 8, 'SourceName': 'DailyMed', 'SourceID': '69c885cf0969a12e9aa3a11b833b5456', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=MOXIFLOXACIN+HYDROCHLORIDE', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30963056}, {'ReferenceNumber': 10, 'SourceName': 'Drugs and Lactation Database (LactMed)', 'SourceID': 'LM191', 'Name': 'Moxifloxacin', 'Description': 'The LactMed(R) database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. https://www.ncbi.nlm.nih.gov/books/NBK501922/', 'URL': 'https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM191/', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 24796691}, {'ReferenceNumber': 12, 'SourceName': 'Drugs@FDA', 'SourceID': '6aa317e888d221a53f2fad3ce3c40199', 'Name': 'VIGAMOX', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38971254}, {'ReferenceNumber': 13, 'SourceName': 'Drugs@FDA', 'SourceID': '2d8d3848ff3a35483f6d3e556a3b752b', 'Name': 'AVELOX', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38972424}, {'ReferenceNumber': 14, 'SourceName': 'Drugs@FDA', 'SourceID': 'b47c505e4deb957f55904ac59b6a8c63', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38975947}, {'ReferenceNumber': 15, 'SourceName': 'Drugs@FDA', 'SourceID': 'df5526c3898d3f1fb3af060a3fd24cce', 'Name': 'MOXEZA', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38977467}, {'ReferenceNumber': 16, 'SourceName': 'Drugs@FDA', 'SourceID': '619504ef3a5af3423de247b369e7a2c4', 'Name': 'AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38978917}, {'ReferenceNumber': 17, 'SourceName': 'Drugs@FDA', 'SourceID': 'a2870468565b6404afe83f2bb19e9220', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38979240}, {'ReferenceNumber': 24, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '71d74d3c0bc0ae9a7597b3b1185c3ff1', 'Name': 'Moxifloxacin hydrochloride (P/230/2010)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000288-pip01-08-m02', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37131920}, {'ReferenceNumber': 25, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '8e13416a6c54d24675c9427f7328dc2b', 'Name': 'Moxifloxacin hydrochloride (P/263/2009)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000491-pip01-08-m01', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37132012}, {'ReferenceNumber': 26, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': '9032bca743774ccb3b7afbc889364fda', 'Name': 'Moxifloxacin hydrochloride (P/264/2009)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000492-pip01-08-m01', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37132013}, {'ReferenceNumber': 27, 'SourceName': 'European Medicines Agency (EMA)', 'SourceID': 'f21560ba1030916f79d55f568a8c1d7c', 'Name': 'Moxifloxacin hydrochloride (P/265/2009)', 'Description': 'The European Medicines Agency (EMA) presents information on regulatory topics of the medicinal product lifecycle in EU countries.', 'URL': 'https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-000493-pip01-08-m01', 'LicenseNote': ""Information on the European Medicines Agency's (EMA)  website is subject to a disclaimer and copyright and limited reproduction notices."", 'LicenseURL': 'https://www.ema.europa.eu/en/about-us/legal-notice', 'ANID': 37132014}, {'ReferenceNumber': 11, 'SourceName': 'Drugs@FDA', 'SourceID': '69c885cf0969a12e9aa3a11b833b5456', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38968090}, {'ReferenceNumber': 19, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid101526', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6480473}, {'ReferenceNumber': 20, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '174495', 'Name': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (EC: 641-756-7)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/174495', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1910013}, {'ReferenceNumber': 21, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '265028', 'Name': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (EC: 947-143-3)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/265028', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1974635}, {'ReferenceNumber': 23, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '947-143-3', 'Name': '1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.257.131', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15229859}, {'ReferenceNumber': 32, 'SourceName': 'FDA Orange Book', 'SourceID': '48899494fa72b8c985d01815b53cb62e', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35236658}, {'ReferenceNumber': 29, 'SourceName': 'FDA Medication Guides', 'SourceID': 'AVELOX', 'Name': 'AVELOX', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228217}, {'ReferenceNumber': 30, 'SourceName': 'FDA Medication Guides', 'SourceID': 'AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER', 'Name': 'AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228218}, {'ReferenceNumber': 31, 'SourceName': 'FDA Medication Guides', 'SourceID': 'MOXIFLOXACIN HYDROCHLORIDE', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228556}, {'ReferenceNumber': 33, 'SourceName': 'KEGG', 'SourceID': 'D00874', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D00874', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31100585}, {'ReferenceNumber': 34, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078158', 'Name': 'Moxifloxacin hydrochloride', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27IDIIJJHBXUESQI-DFIJPDEKSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429171}, {'ReferenceNumber': 35, 'SourceName': 'MassBank of North America (MoNA)', 'SourceID': 'CCMSLIB00000078159', 'Name': 'Moxifloxacin hydrochloride', 'Description': 'MassBank of North America (MoNA) is a metadata-centric, auto-curating repository designed for efficient storage and querying of mass spectral records.', 'URL': 'https://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27IDIIJJHBXUESQI-DFIJPDEKSA-N%27)', 'LicenseNote': 'The content of the MoNA database is licensed under CC BY 4.0.', 'LicenseURL': 'https://mona.fiehnlab.ucdavis.edu/documentation/license', 'ANID': 3429172}, {'ReferenceNumber': 36, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'e9f2feb834d43542eb9a82447cf201f3', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31075981}, {'ReferenceNumber': 37, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': '9c482bfe38aa47db197312d749c88a95', 'Name': 'MOXIFLOXACIN HYDROCHLORIDE', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31088397}, {'ReferenceNumber': 38, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'eb847d51b34e13f81f17e0357431936d', 'Name': 'MOXIFLOXACIN OPHTHALMIC', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31088399}, {'ReferenceNumber': 39, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': '87ab6b05dc4be6aa4d1dba9ee831b914', 'Name': 'MOXIFLOXACIN OPHTHALMIC SOLUTION', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31088400}, {'ReferenceNumber': 41, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '228750', 'Name': 'moxifloxacin hydrochloride', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/228750', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15097368}, {'ReferenceNumber': 44, 'SourceName': 'Springer Nature', 'SourceID': '341148480', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341148480', 'ANID': 47520415}, {'ReferenceNumber': 45, 'SourceName': 'Springer Nature', 'SourceID': '341140610', 'Description': ""Springer Nature is the world's largest academic book publisher, publisher of the world's most influential journals, and a pioneer in the field of open research. SpringerLink provides electronic access to its book and journal content."", 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/341140610', 'ANID': 47926296}, {'ReferenceNumber': 46, 'SourceName': 'Thieme Chemistry', 'SourceID': '376720374', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376720374', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48916033}, {'ReferenceNumber': 47, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27107395', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27107395', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44221748}, {'ReferenceNumber': 48, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2027958', 'Name': 'Moxifloxacin', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2027958', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 49, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 50, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 51, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 52, 'SourceName': 'KEGG', 'SourceID': 'br08301', 'Name': 'Therapeutic category of drugs in Japan', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08301.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 53, 'SourceName': 'KEGG', 'SourceID': 'br08302', 'Name': 'USP drug classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08302.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 54, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 55, 'SourceName': 'KEGG', 'SourceID': 'br08307', 'Name': 'Antiinfectives', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08307.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 57, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 58, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 59, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 60, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 61, 'SourceName': 'NORMAN Suspect List Exchange', 'SourceID': 'norman_sle_tree', 'Name': 'NORMAN Suspect List Exchange Classification', 'Description': 'The NORMAN Suspect List Exchange (NORMAN-SLE) is a central access point for NORMAN members (and others) to find suspect lists relevant for their environmental monitoring questions.', 'URL': 'https://www.norman-network.com/nds/SLE/', 'LicenseNote': 'Data: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 62, 'SourceName': 'CCSbase', 'SourceID': 'ccsbase_tree', 'Name': 'CCSbase Classification', 'Description': 'CCSbase is an integrated platform consisting of a comprehensive database of Collision Cross Section (CCS) measurements taken from a variety of sources and a high-quality and high-throughput CCS prediction model trained with this database using machine learning.', 'URL': 'https://ccsbase.net/'}, {'ReferenceNumber': 63, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 66, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 67, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 68, 'SourceName': 'KEGG', 'SourceID': 'br08332', 'Name': 'Drug Classes', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08332.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 69, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 70, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 71, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 72, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68000900', 'Name': 'Anti-Bacterial Agents', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68000900', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 73, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '68059005', 'Name': 'Topoisomerase II Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/68059005', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 74, 'SourceName': 'PATENTSCOPE (WIPO)', 'Name': 'SID 389376915', 'Description': 'The PATENTSCOPE database from WIPO includes patent and chemical structure search (with a free account) that gives access to millions of patent documents. The World Intellectual Property Organisation (WIPO) is a specialized United Nations (UN) agency headquartered in Geneva (Switzerland). Our mission is to lead the development of a balanced and effective international Intellectual Property (IP) system that enables innovation and creativity for the benefit of all. We help governments, businesses and society realize the benefits of Intellectual Property and are notably a world reference source for IP information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/389376915'}, {'ReferenceNumber': 75, 'SourceName': 'NCBI', 'SourceID': 'LinkOut', 'Description': 'LinkOut is a service that allows one to link directly from NCBI databases to a wide range of information and services beyond NCBI systems.', 'URL': 'https://www.ncbi.nlm.nih.gov/projects/linkout'}]}}",Infectious diseases,,,,,,,,,,,[4],[8],[3],[30],[82.1]
10174505_Tofacitinib_Citrate.json,540737-29-9,,C22H28N6O8,"CP 690,550",504.5,,"InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1",SYIKUFDOYJFGBQ-YLAFAASESA-N,C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,638-826-4,CHEBI:71197,,"{'Record': {'RecordType': 'CID', 'RecordNumber': 10174505, 'RecordTitle': 'Tofacitinib Citrate', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since mixture or salt'}]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor and an antirheumatic drug. It contains a tofacitinib.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 81, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 97, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/citric%20acid', 'Type': 'PubChem Internal Link', 'Extra': 'CID-311'}, {'Start': 230, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 298, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib Citrate is the citrate salt form of tofacitinib, an orally bioavailable inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon oral administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha (IFN-a) and -beta (IFN-b), and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20Citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 48, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 200, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 25, 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for psoriatic arthritis and rheumatoid arthritis and has 4 investigational indications. This drug has a black box warning from the FDA.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}, {'ReferenceNumber': 29, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Tofacitinib (has active moiety).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile', 'Markup': [{'Start': 47, 'Length': 1, 'Type': 'Italics'}, {'Start': 50, 'Length': 1, 'Type': 'Italics'}, {'Start': 73, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C22H28N6O8'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'Value': {'StringWithMarkup': [{'String': '638-826-4'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'Value': {'StringWithMarkup': [{'String': 'O1FF4DIV0D'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:71197'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL2103743'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 11, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'Value': {'StringWithMarkup': [{'String': 'DTXSID80202404'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 21, 'URL': 'https://www.kegg.jp/entry/D09783', 'Value': {'StringWithMarkup': [{'String': 'D09783'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 23, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'Value': {'StringWithMarkup': [{'String': 'C95801'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 24, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'Value': {'StringWithMarkup': [{'String': '1358492'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 27, 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'Value': {'StringWithMarkup': [{'String': 'Q27139435'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'CP 690,550'}, {'String': 'CP 690550'}, {'String': 'CP-690,550'}, {'String': 'CP-690550'}, {'String': 'CP690550'}, {'String': 'tasocitinib'}, {'String': 'tofacitinib'}, {'String': 'tofacitinib citrate'}, {'String': 'Xeljanz'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}, {'String': '540737-29-9'}, {'String': 'Xeljanz'}, {'String': 'CP-690550 citrate'}, {'String': 'Xeljanz Xr'}, {'String': 'Tasocitinib monocitrate'}, {'String': 'UNII-O1FF4DIV0D'}, {'String': 'O1FF4DIV0D'}, {'String': 'CP-690550-10'}, {'String': 'CHEBI:71197'}, {'String': 'Tofacitinib monocitrate'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'DTXSID80202404'}, {'String': 'CP-690'}, {'String': '3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'XELJANZXR'}, {'String': 'DTXCID40124895'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-beta-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile monocitrate'}, {'String': 'Tasocitinib citrate'}, {'String': 'Tofacitinib (CP-690550) Citrate'}, {'String': 'Tofacitinib (citrate)'}, {'String': 'Tofacitinib citrate [USAN]'}, {'String': 'CP-690,550-10'}, {'String': '540737-29-9 (citrate)'}, {'String': '1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': 'CP 690550 citrate'}, {'String': 'MFCD11616529'}, {'String': '3-{(3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl}-amino]-piperidin-1-yl)-3-oxo-propionitrile citrate salt'}, {'String': 'Xeljanz (TN)'}, {'String': 'Tasocitinib citric acid salt'}, {'String': 'MLS006010058'}, {'String': 'SCHEMBL1374185'}, {'String': 'CHEMBL2103743'}, {'String': 'Tofacitinib citrate (JAN/USAN)'}, {'String': 'EX-A204'}, {'String': 'TOFACITINIB CITRATE [JAN]'}, {'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}, {'String': 'Tofacitinib (citrate) (Standard)'}, {'String': 'HY-40354AR'}, {'String': 'TOFACITINIB MONOCITRATE [MI]'}, {'String': 'HB1427'}, {'String': 'HY-40354A'}, {'String': 's5001'}, {'String': 'TOFACITINIB CITRATE [WHO-DD]'}, {'String': 'AKOS022178222'}, {'String': 'Tofacitinib citrate, >=98% (HPLC)'}, {'String': 'CCG-269730'}, {'String': 'CS-0928'}, {'String': 'TOFACITINIB CITRATE [ORANGE BOOK]'}, {'String': 'AC-25004'}, {'String': 'AS-19392'}, {'String': 'BT163661'}, {'String': 'DA-78526'}, {'String': 'SMR004701220'}, {'String': 'CP 690550 citrate (Tofacitinib citrate)'}, {'String': 'Tofacitinib citrate (CP-690550 citrate)'}, {'String': 'CP 690550-10'}, {'String': 'D09783'}, {'String': 'EN300-7423761'}, {'String': 'Q27139435'}, {'String': 'Z2235801937'}, {'String': '(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 2-hydroxy-1,2,3-propanetricarboxylate'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1)'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile  monocitrate'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile mono citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile Mono Citrate Salt'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib'}, {'String': 'citro; tofacitinib'}, {'String': 'tofacitinib citric acid'}, {'String': 'Tofacitinib citrate (API)'}, {'String': 'CEP-18770(Delanzomib)'}, {'String': 'AMY4175'}, {'String': 'CP-690550'}, {'String': 'Tofacitinib citrate(CP690550)'}, {'String': 'C22H28N6O8'}, {'String': 'AOB87768'}, {'String': 'NP2603'}, {'String': 'CP-690550  - Tofacitinib citrate'}, {'String': 'ACN-037647'}, {'String': 'CID10174505'}, {'String': 'CP-690550 Citrate (Tofacitinib Citrate)'}, {'String': 'BC600313'}, {'String': 'CID 10174505'}, {'String': 'CP690550'}, {'String': 'SC-12808'}, {'String': 'Tofacitinib citrate, 99% - 10MG 10mg'}, {'String': 'AB0033779'}, {'String': 'C16-H20-N6-O.C6-H8-O7'}, {'String': 'CP 690550'}, {'String': 'A4135'}, {'String': 'CP-690,550'}, {'String': 'FT-0665216'}, {'String': 'ST24050181'}, {'String': 'X7518'}, {'String': 'Q-3287'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-?-oxo-1-piperidinepropanenitrile citrate'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3- -BETA-OXO-, -,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE'}, {'String': '1092578-47-6'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.5'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [5]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [12]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [221], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [36]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [716]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued; Active ingredient (TOFACITINIB CITRATE)', 'Markup': [{'Start': 47, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}]}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'CID 9926791 (Tofacitinib)', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}, {'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}]}, {'String': 'CID 311 (Citric Acid)', 'Markup': [{'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=311', 'Type': 'Icon'}, {'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/311'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [8]}}, {'ReferenceNumber': 29, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [4]}}, {'ReferenceNumber': 29, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [5]}}, {'ReferenceNumber': 29, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 29, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 29, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/483926425', 'Value': {'Number': [483926425]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib (has active moiety)', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [1]}}, {'ReferenceNumber': 29, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [4]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'FDA Medication Guides', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.', 'URL': 'https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 5, 'ColumnsFromNamedLists': {'Name': ['Drug', 'Active Ingredient', 'Form;Route', 'Company', 'Date'], 'UseNamesAsColumnHeadings': True}}, 'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}, {'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}, {'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 16, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'SOLUTION;ORAL'}, {'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 16, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}, {'String': 'PF PRISM CV'}]}}, {'ReferenceNumber': 16, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}, {'String': '02/21/2025'}]}}, {'ReferenceNumber': 17, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ XR', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 17, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 17, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET, EXTENDED RELEASE;ORAL'}]}}, {'ReferenceNumber': 17, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}]}}, {'ReferenceNumber': 17, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 22, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 6, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}, {'ReferenceNumber': 6, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 8}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 12, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 56}}]}]}, {'TOCHeading': 'Japan PMDA Drugs', 'Description': 'Drug information from Japan Pharmaceuticals and Medical Devices Agency (PMDA).', 'URL': 'https://www.pmda.go.jp/english/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 19, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 19, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Initial Approval'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'March 2013'}]}}, {'ReferenceNumber': 19, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000153609.pdf'}]}]}}, {'ReferenceNumber': 20, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 20, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Partial Change Approval'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'May 2018'}]}}, {'ReferenceNumber': 20, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000237584.pdf'}]}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 50, 'Name': 'Janus Kinase Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Agents that inhibit JANUS KINASES. (See all compounds classified as Janus Kinase Inhibitors.)', 'Markup': [{'Start': 40, 'Length': 51, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=2023419'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 13, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Danger', 'Markup': [{'Start': 0, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (97%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 34, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H360 (90.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]', 'Markup': [{'Start': 56, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P203'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 12, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 18, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 24, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P318'}, {'Start': 41, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 47, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 57, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 13, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 33 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 176, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (97%)'}, {'String': 'Repr. 1B (90.9%)'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 26, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376755820'}}]}, {'TOCHeading': 'Wiley References', 'Description': 'Literature references related to scientific contents from Wiley journals and books.', 'Information': [{'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'collection=wiley&query_type=sid&query=386269757'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 31, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 44, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 32, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug', 'Description': 'Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08301', 'Information': [{'ReferenceNumber': 33, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14', 'Value': {'Number': [14]}}]}, {'TOCHeading': 'KEGG: USP', 'Description': 'US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08302', 'Information': [{'ReferenceNumber': 34, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15', 'Value': {'Number': [15]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 35, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 36, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 41, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'KEGG: Drug Classes', 'Description': 'Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08332', 'Information': [{'ReferenceNumber': 46, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118', 'Value': {'Number': [118]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 39, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 40, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 38, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 42, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 45, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 47, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 48, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '540737-29-9', 'Name': 'Tofacitinib citrate', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12841017}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': '0540737299', 'Name': 'Tofacitinib citrate [USAN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0540737299', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1137661}, {'ReferenceNumber': 11, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID80202404', 'Name': 'Tofacitinib citrate', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 1256973}, {'ReferenceNumber': 14, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '638-826-4', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15121079}, {'ReferenceNumber': 15, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'O1FF4DIV0D', 'Name': 'Tofacitinib citrate', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5827374}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10174505', 'Name': 'Tofacitinib citrate', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'ANID': 2438742}, {'ReferenceNumber': 23, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C95801::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19450627}, {'ReferenceNumber': 25, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL2103743', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL2103743', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45237079}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL2103743', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32458663}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10174505', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 8469261}, {'ReferenceNumber': 6, 'SourceName': 'DailyMed', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TOFACITINIB+CITRATE', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30969489}, {'ReferenceNumber': 7, 'SourceName': 'Drugs@FDA', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38968356}, {'ReferenceNumber': 8, 'SourceName': 'Drugs@FDA', 'SourceID': '91a4b6f22fd3e0eb99d193e3250db37b', 'Name': 'XELJANZ', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38973752}, {'ReferenceNumber': 9, 'SourceName': 'Drugs@FDA', 'SourceID': '0db3870d4aaa0c78f4bbac3dbfb8ab49', 'Name': 'XELJANZ XR', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38978315}, {'ReferenceNumber': 10, 'SourceName': 'Drugs@FDA', 'SourceID': '17e547e9102d0f62a452eaeb90cfaee7', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38979432}, {'ReferenceNumber': 12, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10174505', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482641}, {'ReferenceNumber': 13, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '171285', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile (EC: 638-826-4)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1908109}, {'ReferenceNumber': 16, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ', 'Name': 'XELJANZ', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228897}, {'ReferenceNumber': 17, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ XR', 'Name': 'XELJANZ XR', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228898}, {'ReferenceNumber': 18, 'SourceName': 'FDA Orange Book', 'SourceID': '0da72ea9c4041d0c7d8fda95597fe4b9', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35238202}, {'ReferenceNumber': 19, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2316230497', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413640}, {'ReferenceNumber': 20, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2672473321', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413641}, {'ReferenceNumber': 21, 'SourceName': 'KEGG', 'SourceID': 'D09783', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09783', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31108837}, {'ReferenceNumber': 22, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'ef6063d1c5af5f9f88d17fd81a91f5e9', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31082893}, {'ReferenceNumber': 24, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '1358492', 'Name': 'tofacitinib citrate', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15098179}, {'ReferenceNumber': 26, 'SourceName': 'Thieme Chemistry', 'SourceID': '376755820', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376755820', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48717829}, {'ReferenceNumber': 27, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27139435', 'Name': 'tofacitinib citrate', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44237777}, {'ReferenceNumber': 28, 'SourceName': 'Wiley', 'SourceID': '386269757', 'Description': 'Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/386269757', 'ANID': 49039699}, {'ReferenceNumber': 29, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 30, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67479163', 'Name': 'tofacitinib', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67479163', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 31, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 32, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 33, 'SourceName': 'KEGG', 'SourceID': 'br08301', 'Name': 'Therapeutic category of drugs in Japan', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08301.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 34, 'SourceName': 'KEGG', 'SourceID': 'br08302', 'Name': 'USP drug classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08302.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 35, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 36, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 38, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 39, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 40, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 41, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 42, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 44, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 45, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 46, 'SourceName': 'KEGG', 'SourceID': 'br08332', 'Name': 'Drug Classes', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08332.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 47, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 48, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 49, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 50, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2023419', 'Name': 'Janus Kinase Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2023419', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}]}}","{'Record': {'RecordType': 'CID', 'RecordNumber': 10174505, 'RecordTitle': 'Tofacitinib Citrate', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since mixture or salt'}]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor and an antirheumatic drug. It contains a tofacitinib.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 81, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 97, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/citric%20acid', 'Type': 'PubChem Internal Link', 'Extra': 'CID-311'}, {'Start': 230, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 298, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib Citrate is the citrate salt form of tofacitinib, an orally bioavailable inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon oral administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha (IFN-a) and -beta (IFN-b), and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20Citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 48, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 200, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 25, 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for psoriatic arthritis and rheumatoid arthritis and has 4 investigational indications. This drug has a black box warning from the FDA.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}, {'ReferenceNumber': 29, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Tofacitinib (has active moiety).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile', 'Markup': [{'Start': 47, 'Length': 1, 'Type': 'Italics'}, {'Start': 50, 'Length': 1, 'Type': 'Italics'}, {'Start': 73, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C22H28N6O8'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'Value': {'StringWithMarkup': [{'String': '638-826-4'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'Value': {'StringWithMarkup': [{'String': 'O1FF4DIV0D'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:71197'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL2103743'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 11, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'Value': {'StringWithMarkup': [{'String': 'DTXSID80202404'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 21, 'URL': 'https://www.kegg.jp/entry/D09783', 'Value': {'StringWithMarkup': [{'String': 'D09783'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 23, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'Value': {'StringWithMarkup': [{'String': 'C95801'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 24, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'Value': {'StringWithMarkup': [{'String': '1358492'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 27, 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'Value': {'StringWithMarkup': [{'String': 'Q27139435'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'CP 690,550'}, {'String': 'CP 690550'}, {'String': 'CP-690,550'}, {'String': 'CP-690550'}, {'String': 'CP690550'}, {'String': 'tasocitinib'}, {'String': 'tofacitinib'}, {'String': 'tofacitinib citrate'}, {'String': 'Xeljanz'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}, {'String': '540737-29-9'}, {'String': 'Xeljanz'}, {'String': 'CP-690550 citrate'}, {'String': 'Xeljanz Xr'}, {'String': 'Tasocitinib monocitrate'}, {'String': 'UNII-O1FF4DIV0D'}, {'String': 'O1FF4DIV0D'}, {'String': 'CP-690550-10'}, {'String': 'CHEBI:71197'}, {'String': 'Tofacitinib monocitrate'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'DTXSID80202404'}, {'String': 'CP-690'}, {'String': '3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'XELJANZXR'}, {'String': 'DTXCID40124895'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-beta-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile monocitrate'}, {'String': 'Tasocitinib citrate'}, {'String': 'Tofacitinib (CP-690550) Citrate'}, {'String': 'Tofacitinib (citrate)'}, {'String': 'Tofacitinib citrate [USAN]'}, {'String': 'CP-690,550-10'}, {'String': '540737-29-9 (citrate)'}, {'String': '1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': 'CP 690550 citrate'}, {'String': 'MFCD11616529'}, {'String': '3-{(3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl}-amino]-piperidin-1-yl)-3-oxo-propionitrile citrate salt'}, {'String': 'Xeljanz (TN)'}, {'String': 'Tasocitinib citric acid salt'}, {'String': 'MLS006010058'}, {'String': 'SCHEMBL1374185'}, {'String': 'CHEMBL2103743'}, {'String': 'Tofacitinib citrate (JAN/USAN)'}, {'String': 'EX-A204'}, {'String': 'TOFACITINIB CITRATE [JAN]'}, {'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}, {'String': 'Tofacitinib (citrate) (Standard)'}, {'String': 'HY-40354AR'}, {'String': 'TOFACITINIB MONOCITRATE [MI]'}, {'String': 'HB1427'}, {'String': 'HY-40354A'}, {'String': 's5001'}, {'String': 'TOFACITINIB CITRATE [WHO-DD]'}, {'String': 'AKOS022178222'}, {'String': 'Tofacitinib citrate, >=98% (HPLC)'}, {'String': 'CCG-269730'}, {'String': 'CS-0928'}, {'String': 'TOFACITINIB CITRATE [ORANGE BOOK]'}, {'String': 'AC-25004'}, {'String': 'AS-19392'}, {'String': 'BT163661'}, {'String': 'DA-78526'}, {'String': 'SMR004701220'}, {'String': 'CP 690550 citrate (Tofacitinib citrate)'}, {'String': 'Tofacitinib citrate (CP-690550 citrate)'}, {'String': 'CP 690550-10'}, {'String': 'D09783'}, {'String': 'EN300-7423761'}, {'String': 'Q27139435'}, {'String': 'Z2235801937'}, {'String': '(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 2-hydroxy-1,2,3-propanetricarboxylate'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1)'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile  monocitrate'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile mono citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile Mono Citrate Salt'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib'}, {'String': 'citro; tofacitinib'}, {'String': 'tofacitinib citric acid'}, {'String': 'Tofacitinib citrate (API)'}, {'String': 'CEP-18770(Delanzomib)'}, {'String': 'AMY4175'}, {'String': 'CP-690550'}, {'String': 'Tofacitinib citrate(CP690550)'}, {'String': 'C22H28N6O8'}, {'String': 'AOB87768'}, {'String': 'NP2603'}, {'String': 'CP-690550  - Tofacitinib citrate'}, {'String': 'ACN-037647'}, {'String': 'CID10174505'}, {'String': 'CP-690550 Citrate (Tofacitinib Citrate)'}, {'String': 'BC600313'}, {'String': 'CID 10174505'}, {'String': 'CP690550'}, {'String': 'SC-12808'}, {'String': 'Tofacitinib citrate, 99% - 10MG 10mg'}, {'String': 'AB0033779'}, {'String': 'C16-H20-N6-O.C6-H8-O7'}, {'String': 'CP 690550'}, {'String': 'A4135'}, {'String': 'CP-690,550'}, {'String': 'FT-0665216'}, {'String': 'ST24050181'}, {'String': 'X7518'}, {'String': 'Q-3287'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-?-oxo-1-piperidinepropanenitrile citrate'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3- -BETA-OXO-, -,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE'}, {'String': '1092578-47-6'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.5'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [5]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [12]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [221], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [36]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [716]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued; Active ingredient (TOFACITINIB CITRATE)', 'Markup': [{'Start': 47, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}]}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'CID 9926791 (Tofacitinib)', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}, {'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}]}, {'String': 'CID 311 (Citric Acid)', 'Markup': [{'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=311', 'Type': 'Icon'}, {'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/311'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [8]}}, {'ReferenceNumber': 29, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [4]}}, {'ReferenceNumber': 29, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [5]}}, {'ReferenceNumber': 29, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 29, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 29, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/483926425', 'Value': {'Number': [483926425]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib (has active moiety)', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [1]}}, {'ReferenceNumber': 29, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [4]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'FDA Medication Guides', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.', 'URL': 'https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 5, 'ColumnsFromNamedLists': {'Name': ['Drug', 'Active Ingredient', 'Form;Route', 'Company', 'Date'], 'UseNamesAsColumnHeadings': True}}, 'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}, {'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}, {'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 16, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'SOLUTION;ORAL'}, {'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 16, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}, {'String': 'PF PRISM CV'}]}}, {'ReferenceNumber': 16, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}, {'String': '02/21/2025'}]}}, {'ReferenceNumber': 17, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ XR', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 17, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 17, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET, EXTENDED RELEASE;ORAL'}]}}, {'ReferenceNumber': 17, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}]}}, {'ReferenceNumber': 17, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 22, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 6, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}, {'ReferenceNumber': 6, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 8}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 12, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 56}}]}]}, {'TOCHeading': 'Japan PMDA Drugs', 'Description': 'Drug information from Japan Pharmaceuticals and Medical Devices Agency (PMDA).', 'URL': 'https://www.pmda.go.jp/english/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 19, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 19, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Initial Approval'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'March 2013'}]}}, {'ReferenceNumber': 19, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000153609.pdf'}]}]}}, {'ReferenceNumber': 20, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 20, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Partial Change Approval'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'May 2018'}]}}, {'ReferenceNumber': 20, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000237584.pdf'}]}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 50, 'Name': 'Janus Kinase Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Agents that inhibit JANUS KINASES. (See all compounds classified as Janus Kinase Inhibitors.)', 'Markup': [{'Start': 40, 'Length': 51, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=2023419'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 13, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Danger', 'Markup': [{'Start': 0, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (97%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 34, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H360 (90.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]', 'Markup': [{'Start': 56, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P203'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 12, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 18, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 24, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P318'}, {'Start': 41, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 47, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 57, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 13, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 33 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 176, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (97%)'}, {'String': 'Repr. 1B (90.9%)'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 26, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376755820'}}]}, {'TOCHeading': 'Wiley References', 'Description': 'Literature references related to scientific contents from Wiley journals and books.', 'Information': [{'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'collection=wiley&query_type=sid&query=386269757'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 31, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 44, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 32, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug', 'Description': 'Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08301', 'Information': [{'ReferenceNumber': 33, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14', 'Value': {'Number': [14]}}]}, {'TOCHeading': 'KEGG: USP', 'Description': 'US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08302', 'Information': [{'ReferenceNumber': 34, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15', 'Value': {'Number': [15]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 35, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 36, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 41, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'KEGG: Drug Classes', 'Description': 'Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08332', 'Information': [{'ReferenceNumber': 46, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118', 'Value': {'Number': [118]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 39, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 40, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 38, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 42, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 45, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 47, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 48, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '540737-29-9', 'Name': 'Tofacitinib citrate', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12841017}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': '0540737299', 'Name': 'Tofacitinib citrate [USAN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0540737299', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1137661}, {'ReferenceNumber': 11, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID80202404', 'Name': 'Tofacitinib citrate', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 1256973}, {'ReferenceNumber': 14, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '638-826-4', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15121079}, {'ReferenceNumber': 15, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'O1FF4DIV0D', 'Name': 'Tofacitinib citrate', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5827374}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10174505', 'Name': 'Tofacitinib citrate', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'ANID': 2438742}, {'ReferenceNumber': 23, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C95801::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19450627}, {'ReferenceNumber': 25, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL2103743', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL2103743', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45237079}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL2103743', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32458663}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10174505', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 8469261}, {'ReferenceNumber': 6, 'SourceName': 'DailyMed', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TOFACITINIB+CITRATE', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30969489}, {'ReferenceNumber': 7, 'SourceName': 'Drugs@FDA', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38968356}, {'ReferenceNumber': 8, 'SourceName': 'Drugs@FDA', 'SourceID': '91a4b6f22fd3e0eb99d193e3250db37b', 'Name': 'XELJANZ', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38973752}, {'ReferenceNumber': 9, 'SourceName': 'Drugs@FDA', 'SourceID': '0db3870d4aaa0c78f4bbac3dbfb8ab49', 'Name': 'XELJANZ XR', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38978315}, {'ReferenceNumber': 10, 'SourceName': 'Drugs@FDA', 'SourceID': '17e547e9102d0f62a452eaeb90cfaee7', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38979432}, {'ReferenceNumber': 12, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10174505', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482641}, {'ReferenceNumber': 13, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '171285', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile (EC: 638-826-4)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1908109}, {'ReferenceNumber': 16, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ', 'Name': 'XELJANZ', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228897}, {'ReferenceNumber': 17, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ XR', 'Name': 'XELJANZ XR', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228898}, {'ReferenceNumber': 18, 'SourceName': 'FDA Orange Book', 'SourceID': '0da72ea9c4041d0c7d8fda95597fe4b9', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35238202}, {'ReferenceNumber': 19, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2316230497', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413640}, {'ReferenceNumber': 20, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2672473321', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413641}, {'ReferenceNumber': 21, 'SourceName': 'KEGG', 'SourceID': 'D09783', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09783', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31108837}, {'ReferenceNumber': 22, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'ef6063d1c5af5f9f88d17fd81a91f5e9', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31082893}, {'ReferenceNumber': 24, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '1358492', 'Name': 'tofacitinib citrate', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15098179}, {'ReferenceNumber': 26, 'SourceName': 'Thieme Chemistry', 'SourceID': '376755820', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376755820', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48717829}, {'ReferenceNumber': 27, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27139435', 'Name': 'tofacitinib citrate', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44237777}, {'ReferenceNumber': 28, 'SourceName': 'Wiley', 'SourceID': '386269757', 'Description': 'Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/386269757', 'ANID': 49039699}, {'ReferenceNumber': 29, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 30, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67479163', 'Name': 'tofacitinib', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67479163', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 31, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 32, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 33, 'SourceName': 'KEGG', 'SourceID': 'br08301', 'Name': 'Therapeutic category of drugs in Japan', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08301.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 34, 'SourceName': 'KEGG', 'SourceID': 'br08302', 'Name': 'USP drug classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08302.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 35, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 36, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 38, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 39, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 40, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 41, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 42, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 44, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 45, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 46, 'SourceName': 'KEGG', 'SourceID': 'br08332', 'Name': 'Drug Classes', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08332.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 47, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 48, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 49, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 50, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2023419', 'Name': 'Janus Kinase Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2023419', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}]}}","{'Record': {'RecordType': 'CID', 'RecordNumber': 10174505, 'RecordTitle': 'Tofacitinib Citrate', 'Section': [{'TOCHeading': 'Structures', 'Description': 'Structure depictions of this compound, including computationally generated two-dimensional (2D) and three-dimensional (3D) structures, as well as experimentally determined 3D single-crystal structures.', 'Section': [{'TOCHeading': '2D Structure', 'Description': 'A two-dimensional (2D) structure representation of the compound.  Because this structure is processed through chemical structure standardization (Hähnke et al., J. Cheminform. 2018, 10, 36), it is not necessarily the same as the structures provided by individual data contributors.  ', 'URL': 'https://doi.org/10.1186/s13321-018-0293-8', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': '3D Status', 'Description': 'The reason why three-dimensional (3D) conformers for this compound cannot be generated.  PubChem generates 3D conformers for each compound that satisfies the following conditions: [1] not too large (with <= 50 non-hydrogen atoms), [2] not too flexible (with <= 15 rotatable bonds), [3] consisting of only supported elements (H, C, N, O, F, Si, P, S, Cl, Br, and I), [4] having only a single covalent unit (i.e., not a salt or a mixture), [5] contains only atom types recognized by the MMFF94s force field used for conformer generation, and [6] has fewer than six undefined atom or bond stereo centers.  Compounds that do not satisfy any of these conditions are not considered for 3-D conformer generation.  In some rare cases, a compound satisfies all conditions but the conformer generation for the compound fails for some reason. More detailed information on 3D conformer generation can be found in Kim et al., J. Cheminform. 2013, 5, 1.', 'URL': 'https://doi.org/10.1186/1758-2946-5-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Conformer generation is disallowed since mixture or salt'}]}}]}]}, {'TOCHeading': 'Primary Hazards', 'Description': 'Link to the Safety and Hazard section of this page and link to the Laboratory Chemical Safety Summary (LCSS) datasheet for this compound.', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}]}, {'TOCHeading': 'Names and Identifiers', 'Description': 'Chemical names, synonyms, identifiers, and descriptors.', 'Section': [{'TOCHeading': 'Record Description', 'Description': 'Summary Information', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 2, 'Name': 'Record Description', 'Description': 'Ontology Summary', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate is a citrate salt obtained by combining equimolar amounts of tofacitinib and citric acid. Used to treat moderately to severely active Rheumatoid Arthritis. It has a role as an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor and an antirheumatic drug. It contains a tofacitinib.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 81, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 97, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/citric%20acid', 'Type': 'PubChem Internal Link', 'Extra': 'CID-311'}, {'Start': 230, 'Length': 8, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tyrosine', 'Type': 'PubChem Internal Link', 'Extra': 'CID-6057'}, {'Start': 298, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 23, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib Citrate is the citrate salt form of tofacitinib, an orally bioavailable inhibitor of Janus kinases (JAK), with immunomodulatory and anti-inflammatory activities. Upon oral administration, tofacitinib binds to JAK and prevents the activation of the JAK-signal transducers and activators of transcription (STAT) signaling pathway. This may decrease the production of pro-inflammatory cytokines, such as interleukin (IL)-6, -7, -15, -21, interferon-alpha (IFN-a) and -beta (IFN-b), and may prevent both an inflammatory response and the inflammation-induced damage caused by certain immunological diseases. JAK kinases are intracellular enzymes involved in signaling pathways affecting hematopoiesis, immunity and inflammation.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/Tofacitinib%20Citrate', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}, {'Start': 48, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}, {'Start': 200, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/tofacitinib', 'Type': 'PubChem Internal Link', 'Extra': 'CID-9926791'}]}]}}, {'ReferenceNumber': 25, 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE is a small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for psoriatic arthritis and rheumatoid arthritis and has 4 investigational indications. This drug has a black box warning from the FDA.', 'Markup': [{'Start': 0, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}, {'ReferenceNumber': 29, 'Name': 'See Also', 'Value': {'StringWithMarkup': [{'String': 'See also: Tofacitinib (has active moiety).', 'Markup': [{'Start': 0, 'Length': 8, 'URL': '#section=Other-Relationships'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 10, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Computed Descriptors', 'Description': 'Structural descriptors generated or computed for the structures of this compound, including the IUPAC name, InChI/InChIKey, and canonical/isomeric SMILES.', 'Section': [{'TOCHeading': 'IUPAC Name', 'Description': 'Chemical name of this compound, computed from its structure based on the International Union of Pure and Applied Chemistry (IUPAC) nomenclature standards.', 'URL': 'https://iupac.org/what-we-do/nomenclature/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Lexichem TK 2.7.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile', 'Markup': [{'Start': 47, 'Length': 1, 'Type': 'Italics'}, {'Start': 50, 'Length': 1, 'Type': 'Italics'}, {'Start': 73, 'Length': 1, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'InChI', 'Description': 'The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard.', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1'}]}}]}, {'TOCHeading': 'InChIKey', 'Description': 'An InChIKey is a 27-character hash code derived from an InChI.  The International Chemical Identifier (InChI) is a computed, non-proprietary identifier for a chemical structure.  The InChI is an International Union of Pure and Applied Chemistry (IUPAC) standard. ', 'URL': 'https://iupac.org/who-we-are/divisions/division-details/inchi/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by InChI 1.07.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}]}}]}, {'TOCHeading': 'SMILES', 'Description': 'The Simplified Molecular Input Line Entry System (SMILES) is a widely-used line notation for chemical structures. The SMILES in this section includes both sterochemical and isotopic information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=SMILES', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by OEChem 2.3.0 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O'}]}}]}]}, {'TOCHeading': 'Molecular Formula', 'Description': 'A chemical formula is a way of expressing information about the proportions of atoms that constitute a particular chemical compound, using a single line of chemical element symbols and numbers. PubChem uses the Hill system, whereby the number of carbon atoms in a molecule is indicated first, the number of hydrogen atoms second, and then the number of all other chemical elements in alphabetical order. When the formula contains no carbon, all the elements, including hydrogen, are listed alphabetically. Sources other than PubChem may include a variant of the formula that is more structural or natural to chemists, for example, H2SO4 for sulfuric acid, rather than the Hill version H2O4S.', 'URL': 'https://pubs.acs.org/doi/abs/10.1021/ja02046a005', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'C22H28N6O8'}]}}]}, {'TOCHeading': 'Other Identifiers', 'Description': 'Other identifiers assigned to this chemical.', 'Section': [{'TOCHeading': 'CAS', 'Description': 'A CAS Registry Number (also called CAS RN or CAS Number) is a proprietary registry number assigned by the Chemical Abstracts Service (CAS) division of the American Chemical Society (ACS).  It is a numeric identifier that can contain up to 10 digits, divided by hyphens into three parts.', 'URL': 'https://www.cas.org/support/documentation/chemical-substances/faqs', 'Information': [{'ReferenceNumber': 1, 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 4, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 11, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 14, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}, {'ReferenceNumber': 15, 'Value': {'StringWithMarkup': [{'String': '540737-29-9'}]}}]}, {'TOCHeading': 'European Community (EC) Number', 'Description': 'The European Community (EC) number is a seven-digit identifier assigned by the European Chemicals Agency (ECHA) to substances for regulatory purposes within the European Union. EC numbers are sometimes referred to as EINECS, ELINCS, or NLP numbers, because the EC Inventory comprises three individual inventories (EINECS, ELINCS, and the NLP list).', 'URL': 'https://echa.europa.eu/information-on-chemicals/ec-inventory', 'Information': [{'ReferenceNumber': 14, 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'Value': {'StringWithMarkup': [{'String': '638-826-4'}]}}]}, {'TOCHeading': 'UNII', 'Description': 'UNique Ingredient Identifier (UNII) code for this chemical.  It is a non-proprietary registry number assigned by the U.S. Food and Drug Administration (FDA).', 'URL': 'https://www.fda.gov/industry/fda-data-standards-advisory-board/fdas-global-substance-registration-system', 'Information': [{'ReferenceNumber': 15, 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'Value': {'StringWithMarkup': [{'String': 'O1FF4DIV0D'}]}}]}, {'TOCHeading': 'ChEBI ID', 'Description': ""Identifier from database and ontology of molecular entities focused on 'small' chemical compounds used by the Chemical Entities of Biological Interest (ChEBI)"", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 2, 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'Value': {'StringWithMarkup': [{'String': 'CHEBI:71197'}]}}]}, {'TOCHeading': 'ChEMBL ID', 'Description': 'ChEMBL compound identifier', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 3, 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'Value': {'StringWithMarkup': [{'String': 'CHEMBL2103743'}]}}]}, {'TOCHeading': 'DSSTox Substance ID', 'Description': 'Substance identifier used in the Distributed Structure-Searchable Toxicity (DSSTox) Database.', 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 11, 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'Value': {'StringWithMarkup': [{'String': 'DTXSID80202404'}]}}]}, {'TOCHeading': 'KEGG ID', 'Description': 'KEGG compound/drug identifier', 'URL': 'https://www.kegg.jp/', 'Information': [{'ReferenceNumber': 21, 'URL': 'https://www.kegg.jp/entry/D09783', 'Value': {'StringWithMarkup': [{'String': 'D09783'}]}}]}, {'TOCHeading': 'NCI Thesaurus Code', 'Description': 'Stable, unique code for biomedical concept', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 23, 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'Value': {'StringWithMarkup': [{'String': 'C95801'}]}}]}, {'TOCHeading': 'RXCUI', 'Description': 'RxNorm concept unique identifier (RXCUI)', 'URL': 'https://www.nlm.nih.gov/research/umls/rxnorm/index.html', 'Information': [{'ReferenceNumber': 24, 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'Value': {'StringWithMarkup': [{'String': '1358492'}]}}]}, {'TOCHeading': 'Wikidata', 'Description': 'Wikidata entity identifier for the given compound.', 'URL': 'https://www.wikidata.org/w/index.php?title=Special:WhatLinksHere/Property:P662', 'Information': [{'ReferenceNumber': 27, 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'Value': {'StringWithMarkup': [{'String': 'Q27139435'}]}}]}]}, {'TOCHeading': 'Synonyms', 'Description': 'Alternative names for this PubChem Compound record.  A compound can have many different names.  For example, acetone (CH3C(=O)CH3) is also known as propanone, propan-2-one, or dimethyl ketone.  The brand name of a product is commonly used to indicate the primary chemical ingredient(s) in the product (e.g., Tylenol, a common pain killer, is often used for acetaminophen, its active ingredient).  Another example of common synonyms is record identifiers used in different data collections, such as Chemical Abstract Service (CAS) registry numbers, FDA UNII (Unique Ingredient Identifiers), and many others.  All these various names and identifiers that designate this compound are organized under the Synonyms section.', 'Section': [{'TOCHeading': 'MeSH Entry Terms', 'Description': 'Medical Subject Heading (MeSH) names or identifiers matching this PubChem Compound record.  The matching between the MeSH and compound records is performed by name matching (i.e., identical common names), as described in Kim et al., J. Cheminform., 2016, 8, 32.', 'URL': 'http://doi.org/10.1186/s13321-016-0142-6', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 30, 'Value': {'StringWithMarkup': [{'String': 'CP 690,550'}, {'String': 'CP 690550'}, {'String': 'CP-690,550'}, {'String': 'CP-690550'}, {'String': 'CP690550'}, {'String': 'tasocitinib'}, {'String': 'tofacitinib'}, {'String': 'tofacitinib citrate'}, {'String': 'Xeljanz'}]}}]}, {'TOCHeading': 'Depositor-Supplied Synonyms', 'Description': 'Chemical names provided by individual data contributors. Synonyms of Substances corresponding to a PubChem Compound record are combined. Some contributed names may be considered erroneous and filtered out. The link on each synonym shows which depositors provided that particular synonym for this structure.', 'DisplayControls': {'ListType': 'Columns', 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}, {'String': '540737-29-9'}, {'String': 'Xeljanz'}, {'String': 'CP-690550 citrate'}, {'String': 'Xeljanz Xr'}, {'String': 'Tasocitinib monocitrate'}, {'String': 'UNII-O1FF4DIV0D'}, {'String': 'O1FF4DIV0D'}, {'String': 'CP-690550-10'}, {'String': 'CHEBI:71197'}, {'String': 'Tofacitinib monocitrate'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'DTXSID80202404'}, {'String': 'CP-690'}, {'String': '3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)'}, {'String': '3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate'}, {'String': 'XELJANZXR'}, {'String': 'DTXCID40124895'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-beta-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '3-((3r,4r)-4-methyl-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile monocitrate'}, {'String': 'Tasocitinib citrate'}, {'String': 'Tofacitinib (CP-690550) Citrate'}, {'String': 'Tofacitinib (citrate)'}, {'String': 'Tofacitinib citrate [USAN]'}, {'String': 'CP-690,550-10'}, {'String': '540737-29-9 (citrate)'}, {'String': '1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': '2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile'}, {'String': 'CP 690550 citrate'}, {'String': 'MFCD11616529'}, {'String': '3-{(3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl}-amino]-piperidin-1-yl)-3-oxo-propionitrile citrate salt'}, {'String': 'Xeljanz (TN)'}, {'String': 'Tasocitinib citric acid salt'}, {'String': 'MLS006010058'}, {'String': 'SCHEMBL1374185'}, {'String': 'CHEMBL2103743'}, {'String': 'Tofacitinib citrate (JAN/USAN)'}, {'String': 'EX-A204'}, {'String': 'TOFACITINIB CITRATE [JAN]'}, {'String': 'SYIKUFDOYJFGBQ-YLAFAASESA-N'}, {'String': 'Tofacitinib (citrate) (Standard)'}, {'String': 'HY-40354AR'}, {'String': 'TOFACITINIB MONOCITRATE [MI]'}, {'String': 'HB1427'}, {'String': 'HY-40354A'}, {'String': 's5001'}, {'String': 'TOFACITINIB CITRATE [WHO-DD]'}, {'String': 'AKOS022178222'}, {'String': 'Tofacitinib citrate, >=98% (HPLC)'}, {'String': 'CCG-269730'}, {'String': 'CS-0928'}, {'String': 'TOFACITINIB CITRATE [ORANGE BOOK]'}, {'String': 'AC-25004'}, {'String': 'AS-19392'}, {'String': 'BT163661'}, {'String': 'DA-78526'}, {'String': 'SMR004701220'}, {'String': 'CP 690550 citrate (Tofacitinib citrate)'}, {'String': 'Tofacitinib citrate (CP-690550 citrate)'}, {'String': 'CP 690550-10'}, {'String': 'D09783'}, {'String': 'EN300-7423761'}, {'String': 'Q27139435'}, {'String': 'Z2235801937'}, {'String': '(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 2-hydroxy-1,2,3-propanetricarboxylate'}, {'String': '1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1)'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YLAMINO)-BETA-OXO-,(3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE(1:1)'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile  monocitrate'}, {'String': '3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile mono citrate salt'}, {'String': '3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile Mono Citrate Salt'}]}}]}, {'TOCHeading': 'Removed Synonyms', 'Description': 'Potentially erroneous chemical names and identifiers provided by PubChem Substance records for the same chemical structure that were removed by name/structure consistency filtering.', 'DisplayControls': {'HideThisSection': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib'}, {'String': 'citro; tofacitinib'}, {'String': 'tofacitinib citric acid'}, {'String': 'Tofacitinib citrate (API)'}, {'String': 'CEP-18770(Delanzomib)'}, {'String': 'AMY4175'}, {'String': 'CP-690550'}, {'String': 'Tofacitinib citrate(CP690550)'}, {'String': 'C22H28N6O8'}, {'String': 'AOB87768'}, {'String': 'NP2603'}, {'String': 'CP-690550  - Tofacitinib citrate'}, {'String': 'ACN-037647'}, {'String': 'CID10174505'}, {'String': 'CP-690550 Citrate (Tofacitinib Citrate)'}, {'String': 'BC600313'}, {'String': 'CID 10174505'}, {'String': 'CP690550'}, {'String': 'SC-12808'}, {'String': 'Tofacitinib citrate, 99% - 10MG 10mg'}, {'String': 'AB0033779'}, {'String': 'C16-H20-N6-O.C6-H8-O7'}, {'String': 'CP 690550'}, {'String': 'A4135'}, {'String': 'CP-690,550'}, {'String': 'FT-0665216'}, {'String': 'ST24050181'}, {'String': 'X7518'}, {'String': 'Q-3287'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-?-oxo-1-piperidinepropanenitrile citrate'}, {'String': '(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI); CP 690500-10; CP 690550-10; Tasocitinib citrate; Tofacitinib citrate; Xeljanz'}, {'String': '1-PIPERIDINEPROPANENITRILE,4-METHYL-3- -BETA-OXO-, -,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE'}, {'String': '1092578-47-6'}]}}]}]}, {'TOCHeading': 'Create Date', 'Description': 'Date when this compound record was created. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2006-10-25']}}]}, {'TOCHeading': 'Modify Date', 'Description': 'Date when this compound record was last modified. For more information on various dates for PubChem records, visit the PubChem Record Dates help page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/record-dates', 'DisplayControls': {'HideThisSection': True, 'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'DateISO8601': ['2025-07-05']}}]}]}, {'TOCHeading': 'Chemical and Physical Properties', 'Description': 'Various chemical and physical properties that are experimentally determined for this compound.  See also the Safety and Hazard Properties section (if available), which has additional properties pertinent to chemical safety and hazards.', 'Section': [{'TOCHeading': 'Computed Properties', 'Description': 'Properties of this compound computed from its molecular formula and structure.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 3, 'ColumnHeadings': ['Property Name', 'Property Value', 'Reference'], 'ColumnContents': ['Name', 'Value', 'Reference']}}, 'Section': [{'TOCHeading': 'Molecular Weight', 'Description': 'Molecular weight or molecular mass refers to the mass of a molecule. It is calculated as the sum of the mass of each constituent atom multiplied by the number of atoms of that element in the molecular formula.  The molecular weight is also called the relative molar mass, because molecular weights are reported in daltons, which is defined relative to the mass of the isotope 12C (carbon 12).', 'URL': 'https://www.degruyter.com/document/doi/10.1515/pac-2017-1002/html?lang=en', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.5'}], 'Unit': 'g/mol'}}]}, {'TOCHeading': 'Hydrogen Bond Donor Count', 'Description': 'The number of hydrogen bond donors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [5]}}]}, {'TOCHeading': 'Hydrogen Bond Acceptor Count', 'Description': 'The number of hydrogen bond acceptors in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [12]}}]}, {'TOCHeading': 'Rotatable Bond Count', 'Description': 'A rotatable bond is defined as any single-order non-ring bond, where atoms on either side of the bond are in turn bound to nonterminal heavy (i.e., non-hydrogen) atoms. That is, where rotation around the bond axis changes the overall shape of the molecule, and generates conformers which can be distinguished by standard fast spectroscopic methods.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [8]}}]}, {'TOCHeading': 'Exact Mass', 'Description': 'The exact mass of an isotopic species is obtained by summing the masses of the individual isotopes of the molecule.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Monoisotopic Mass', 'Description': 'The monoisotopic mass is the sum of the masses of the atoms in a molecule using the unbound, ground-state, rest mass of the principal (most abundant) isotope for each element instead of the isotopic average mass.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem 2.2 (PubChem release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': '504.19686187'}], 'Unit': 'Da'}}]}, {'TOCHeading': 'Topological Polar Surface Area', 'Description': 'The topological polar surface area (TPSA) is an estimate of the polar surface area (in Angstroms^2) of a molecule, computed as the surface sum over polar atoms in the molecule.  The implementation follows the paper by Ertl et al. [J. Med. Chem. 2000, 43, 3714-3717]: only N and O are considered, 3D coordinates are not used, and there are various precomputed factors for different hybridizations, charges and participation in aromatic systems.', 'URL': 'https://pubmed.ncbi.nlm.nih.gov/11020286/', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [221], 'Unit': 'Å²'}}]}, {'TOCHeading': 'Heavy Atom Count', 'Description': 'The number of heavy atoms (i.e., non-hydrogen atoms) in this compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [36]}}]}, {'TOCHeading': 'Formal Charge', 'Description': 'Formal charge is the difference between the number of valence electrons of each atom and the number of electrons the atom is associated with. Formal charge assumes any shared electrons are equally shared between the two bonded atoms.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Complexity', 'Description': 'The complexity rating of a compound is a rough estimate of how complicated a structure is, seen from both the point of view of the elements contained and the displayed structural features including symmetry. This complexity rating is computed using the Bertz/Hendrickson/Ihlenfeldt formula.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/glossary#section=Complexity', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by Cactvs 3.4.8.18 (PubChem release 2025.04.14)'], 'Value': {'Number': [716]}}]}, {'TOCHeading': 'Isotope Atom Count', 'Description': 'Isotope atom count is the number of isotopes that are not most abundant for the corresponding chemical elements.  Isotopes are variants of a chemical element which differ in neutron number.  For example, among three isotopes of carbon (i.e., C-12, C-13, and C-14), the isotope atom count considers the C-13 and C-14 atoms, because C-12 is the most abundant isotope of carbon.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Atom Stereocenter Count', 'Description': 'An atom stereocenter, also known as a chiral center, is an atom that is attached to four different types of atoms (or groups of atoms) in the tetrahedral arrangement. It can have either (R)- or (S)- configurations.  Some compounds, such as racemic mixtures, have an undefined atom stereocenter, whose (R/S)-configuration is not specifically defined.  The ""defined atom stereocenter count"" is the number of atom stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Undefined Atom Stereocenter Count', 'Description': 'The number of atom stereocenters whose configurations are not specifically defined.  For the definition of atom stereocenters, see the ""defined atom stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Defined Bond Stereocenter Count', 'Description': 'A bond stereocenter is a non-rotatable bond around which two atoms can have different arrangement (as in cis- and trans-forms of butene around its double bond).  Some compounds have an undefined bond stereocenter, whose stereochemistry is not specifically defined.  The ""defined bond stereocenter count"" is the number of bond stereocenters whose configurations are specifically defined.  ', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Undefined Bond Stereocenter Count', 'Description': 'The number of bond stereocenters whose configurations are not specifically defined.  For the definition of bond stereocenters, see the ""defined bond stereocenter count"" above.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [0]}}]}, {'TOCHeading': 'Covalently-Bonded Unit Count', 'Description': 'A covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or a single atom without covalent bonds).  The ""covalently-bonded unit count"" property is the number of such units in this compound compound.', 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem'], 'Value': {'Number': [2]}}]}, {'TOCHeading': 'Compound Is Canonicalized', 'Description': ""Whether the compound has successfully passed PubChem's valence bond canonicalization procedure. Some large, complex, or highly symmetric structures may fail this process."", 'Information': [{'ReferenceNumber': 29, 'Reference': ['Computed by PubChem (release 2025.04.14)'], 'Value': {'StringWithMarkup': [{'String': 'Yes'}]}}]}]}, {'TOCHeading': 'Chemical Classes', 'Description': 'Chemical classes are groupings that relate chemicals by similar features. Chemicals can be classified by their structure (e.g., hydrocarbons), uses (e.g., pesticides), physical properties, radiological properties, or other factors.', 'Section': [{'TOCHeading': 'Drugs', 'Description': 'Chemicals are used as active ingredients in drug/pharmaceutical products, including human drugs, animal drugs, biologics, etc.', 'Section': [{'TOCHeading': 'Human Drugs', 'Description': 'Chemicals are used as active ingredients in human drug products.', 'Information': [{'ReferenceNumber': 8, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 9, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Prescription'}]}}, {'ReferenceNumber': 10, 'Value': {'StringWithMarkup': [{'String': 'Human drug -> Discontinued; Active ingredient (TOFACITINIB CITRATE)', 'Markup': [{'Start': 47, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/TOFACITINIB%20CITRATE', 'Type': 'PubChem Internal Link', 'Extra': 'CID-10174505'}]}]}}]}]}]}]}, {'TOCHeading': 'Related Records', 'Description': 'Records related to this compound.  This includes PubChem compound and substance records, as well as records in NCBI resources (e.g., PubMed, Gene, Protein Structure, and Taxonomy) and other databases external to NCBI.', 'Section': [{'TOCHeading': 'Related Compounds with Annotation', 'Description': 'Compound records that are closely related to this record AND that have biomedical annotations.  In essence, they are a subset of the compounds included in the ""Related Compounds"" section below this section.  The ""Related Compounds"" include the parent, components, mixtures, and salt forms of this compound record as well as the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Follow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see the neighbor discontinuation help page for details), but these live search links provide equivalent functionality to the table that was previously shown here.', 'Markup': [{'Start': 22, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity&sort=annothitcnt'}, {'Start': 45, 'Length': 19, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d&sort=annothitcnt'}, {'Start': 144, 'Length': 38, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/neighbor-discontinuation'}]}]}}]}, {'TOCHeading': 'Component Compounds', 'Description': 'Component parts of the compound when it consists of multiple covalently-bonded units.  In PubChem, a covalently-bonded unit is a group of atoms connected by covalent bonds, ignoring other bond types (or single atom without covalent bonds).', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'CID 9926791 (Tofacitinib)', 'Markup': [{'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}, {'Start': 0, 'Length': 25, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}]}, {'String': 'CID 311 (Citric Acid)', 'Markup': [{'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=311', 'Type': 'Icon'}, {'Start': 0, 'Length': 21, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/311'}]}]}}]}, {'TOCHeading': 'Related Compounds', 'Description': 'Compound records closely related to this record.  It includes compounds which are the parent, components, mixtures, and salt forms of this compound record.  It also includes the ""similar compounds"" and ""similar conformers"", which are structurally similar to this record in terms of 2-D and 3-D chemical structure similarity measures, respectively, as explained in Kim et al., J. Cheminform. 2016, 8, 62.', 'URL': 'https://doi.org/10.1186/s13321-016-0163-1', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Connectivity Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_connectivity&list_return=redirect', 'Value': {'Number': [8]}}, {'ReferenceNumber': 29, 'Name': 'Same Stereo Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_stereo&list_return=redirect', 'Value': {'Number': [4]}}, {'ReferenceNumber': 29, 'Name': 'Same Isotope Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=same_isotopes&list_return=redirect', 'Value': {'Number': [5]}}, {'ReferenceNumber': 29, 'Name': 'Mixtures, Components, and Neutralized Forms Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/cids/JSON?cids_type=component&list_return=redirect', 'Value': {'Number': [2]}}, {'ReferenceNumber': 29, 'Name': 'Similar Compounds (2D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}, {'ReferenceNumber': 29, 'Name': 'Similar Conformers (3D)', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/#query=CID10174505%20structure&tab=similarity_3d', 'Value': {'StringWithMarkup': [{'String': 'View in PubChem Search'}]}}]}, {'TOCHeading': 'Substances', 'Description': 'Substance records associated with this compound.  In PubChem, the term ""substance"" refers to depositor-provided data for a chemical..', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/substances', 'Section': [{'TOCHeading': 'PubChem Reference Collection SID', 'Description': 'Substances from the special PubChem Reference Collection associated with this compound.', 'DisplayControls': {'MoveToTop': True}, 'Information': [{'ReferenceNumber': 29, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/483926425', 'Value': {'Number': [483926425]}}]}, {'TOCHeading': 'Related Substances', 'Description': 'Substance records related to this compound (e.g., the standardized chemical structures of these substances are the same as this compound or correspond to a mixture containing this compound as a component).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'Same Count', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/sids/JSON?sids_type=standardized&list_return=redirect', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Substances by Category', 'Description': 'Substances associated with this compound, grouped by the category of the data sources who submitted the substances to PubChem (e.g., government organizations, chemical vendors, research and development, curation efforts, NIH initiatives, etc.).', 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Chemical Vendors'}, {'String': 'Curation Efforts'}, {'String': 'Governmental Organizations'}, {'String': 'Journal Publishers'}, {'String': 'Legacy Depositors'}, {'String': 'NIH Initiatives'}, {'String': 'Research and Development'}, {'String': 'Subscription Services'}]}}]}]}, {'TOCHeading': 'Other Relationships', 'Description': 'Other types of related records, such as alternative forms, monomers or polymers, components of important mixtures, etc. In this table, the relationship is in parentheses, and the implied grammar is ""the compound summarized on this page ... has this relationship to ... this item in the table.""', 'DisplayControls': {'ListType': 'Columns'}, 'Information': [{'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib (has active moiety)', 'Markup': [{'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/compound/9926791'}, {'Start': 0, 'Length': 11, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/image/imgsrv.fcgi?t=s&cid=9926791', 'Type': 'Icon'}]}]}}]}, {'TOCHeading': 'Entrez Crosslinks', 'Description': 'Cross-references to associated records in other Entrez databases such as PubMed, Gene, Protein, etc.', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 29, 'Name': 'PubMed Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [1]}}, {'ReferenceNumber': 29, 'Name': 'Gene Count', 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_gene&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Number': [4]}}]}]}, {'TOCHeading': 'Chemical Vendors', 'Description': ""A list of chemical vendors that sell this compound. Note that the order of chemical vendors on the list is randomized, and that PubChem do not endorse any of the vendors. Each vendor may have multiple products containing the same chemical, but different in various aspects, such as amount and purity.  For each product, the external identifier used to locate the product on the vendor's website is provided under the Purchasable Chemical column, and clicking this identifier directs you to the vendor's website.  The information on the product provided by the vendor to PubChem can be accessed at the Summary page of the corresponding PubChem Substance ID (SID).  "", 'Information': [{'ReferenceNumber': 29, 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Drug and Medication Information', 'Description': 'This section provides drug and medication information for this compound, including drug indications, labeling, clinical trials, idiosyncrasies, tolerance, reported fatal doses, etc.', 'Section': [{'TOCHeading': 'Drug Indication', 'Description': 'A drug indication refers to any valid reason (e.g., signs/symptoms or diseases/disorders) to use a certain drug.  Many indications are label indications, approved by a regulatory agency (e.g., the U.S. Food and Drug Administration or European Medical Agency), meaning that the manufacturer is allowed to market the drug for the approved indications.  However, some indications are not approved, and therefore, they are called off-label indications.  This section may include both label indications and off-label indications.', 'DisplayControls': {'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'collection=opentargetsdrugindication&devel=1'}}]}, {'TOCHeading': 'FDA Medication Guides', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.', 'URL': 'https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 5, 'ColumnsFromNamedLists': {'Name': ['Drug', 'Active Ingredient', 'Form;Route', 'Company', 'Date'], 'UseNamesAsColumnHeadings': True}}, 'ShowAtMost': 3}, 'Information': [{'ReferenceNumber': 16, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}, {'String': 'XELJANZ', 'Markup': [{'Start': 0, 'Length': 7, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 16, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}, {'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 16, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'SOLUTION;ORAL'}, {'String': 'TABLET;ORAL'}]}}, {'ReferenceNumber': 16, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}, {'String': 'PF PRISM CV'}]}}, {'ReferenceNumber': 16, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}, {'String': '02/21/2025'}]}}, {'ReferenceNumber': 17, 'Name': 'Drug', 'Value': {'StringWithMarkup': [{'String': 'XELJANZ XR', 'Markup': [{'Start': 0, 'Length': 10, 'URL': 'https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/203214s038,208246s025,213082s010lbl.pdf#page=66'}]}]}}, {'ReferenceNumber': 17, 'Name': 'Active Ingredient', 'Value': {'StringWithMarkup': [{'String': 'TOFACITINIB CITRATE'}]}}, {'ReferenceNumber': 17, 'Name': 'Form;Route', 'Value': {'StringWithMarkup': [{'String': 'TABLET, EXTENDED RELEASE;ORAL'}]}}, {'ReferenceNumber': 17, 'Name': 'Company', 'Value': {'StringWithMarkup': [{'String': 'PFIZER'}]}}, {'ReferenceNumber': 17, 'Name': 'Date', 'Value': {'StringWithMarkup': [{'String': '02/21/2025'}]}}]}, {'TOCHeading': 'FDA Approved Drugs', 'Description': 'Drugs@FDA includes information about approved drugs and biological products for human use in the United States.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/about-drugsfda', 'Information': [{'ReferenceNumber': 7, 'Value': {'ExternalTableName': ""collection=fdadrug&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA Orange Book', 'Description': 'The Orange Book identifies drug products approved on the basis of safety and effectiveness by the U.S. Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act and and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorangebook&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'FDA National Drug Code Directory', 'Description': 'The National Drug Code (NDC) is a unique product identifier in three-segment number used in the United States for human drugs (the Drug Listing Act of 1972).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'Information': [{'ReferenceNumber': 22, 'Value': {'ExternalTableName': ""collection=fdandc&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Drug Labels', 'Description': 'This section provides the drug labeling information for drug products associated with this compound. This information is from The National Library of Medicine (NLM)\'s DailyMed, which provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., ""in use"" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products such as medical gases, devices, cosmetics, dietary supplements, and medical foods.', 'URL': 'https://dailymed.nlm.nih.gov/dailymed/', 'Information': [{'ReferenceNumber': 6, 'Name': 'Drug and label', 'Value': {'ExternalTableName': ""collection=dailymed&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}, {'ReferenceNumber': 6, 'Name': 'Active ingredient and drug', 'Value': {'ExternalTableName': ""collection=dailymed_i&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Clinical Trials', 'Description': 'Clinical trials are research studies performed in people to evaluate a medical, surgical, or behavioral intervention. They are the primary way that researchers find out if a new treatment (e.g., a drug or diet) or medical device (e.g., a pacemaker) is safe and effective in people.  This section provides information on clinical trials for this chemical.', 'Section': [{'TOCHeading': 'ClinicalTrials.gov', 'Description': 'Brief clinical trials summary from ClinicalTrials.gov at the U.S. National Library of Medicine.', 'URL': 'http://clinicaltrials.gov/', 'Information': [{'ReferenceNumber': 5, 'Name': 'ClinicalTrials.gov', 'Value': {'ExternalTableName': 'clinicaltrials', 'ExternalTableNumRows': 8}}]}, {'TOCHeading': 'EU Clinical Trials Register', 'Description': 'Brief clinical trials summary from the EU Clinical Trials Register.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'Information': [{'ReferenceNumber': 12, 'Name': 'EU Clinical Trials Register', 'Value': {'ExternalTableName': 'clinicaltrials_eu', 'ExternalTableNumRows': 56}}]}]}, {'TOCHeading': 'Japan PMDA Drugs', 'Description': 'Drug information from Japan Pharmaceuticals and Medical Devices Agency (PMDA).', 'URL': 'https://www.pmda.go.jp/english/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 19, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 19, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Initial Approval'}]}}, {'ReferenceNumber': 19, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'March 2013'}]}}, {'ReferenceNumber': 19, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000153609.pdf'}]}]}}, {'ReferenceNumber': 20, 'Name': 'Brand Name', 'Value': {'StringWithMarkup': [{'String': 'Xeljanz'}]}}, {'ReferenceNumber': 20, 'Name': 'Non-proprietary Name', 'Value': {'StringWithMarkup': [{'String': 'Tofacitinib citrate'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Note', 'Value': {'StringWithMarkup': [{'String': 'Partial Change Approval'}]}}, {'ReferenceNumber': 20, 'Name': 'Approval Date', 'Value': {'StringWithMarkup': [{'String': 'May 2018'}]}}, {'ReferenceNumber': 20, 'Name': 'Review Document', 'Value': {'StringWithMarkup': [{'String': 'PDF', 'Markup': [{'Start': 0, 'Length': 3, 'URL': 'https://www.pmda.go.jp/files/000237584.pdf'}]}]}}]}]}, {'TOCHeading': 'Pharmacology and Biochemistry', 'Description': 'Pharmacology and biochemistry information related to this compound, including the pharmacodynamics, pharmacokinetics, metabolism, mechanism of action, biological half-life, biochemical reactions, and many others.', 'Section': [{'TOCHeading': 'MeSH Pharmacological Classification', 'Description': 'Pharmacological action classes from the Medical Subject Headings (MeSH) thesaurus.', 'URL': 'https://meshb.nlm.nih.gov/record/ui?ui=D020228', 'Information': [{'ReferenceNumber': 50, 'Name': 'Janus Kinase Inhibitors', 'Value': {'StringWithMarkup': [{'String': 'Agents that inhibit JANUS KINASES. (See all compounds classified as Janus Kinase Inhibitors.)', 'Markup': [{'Start': 40, 'Length': 51, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?Db=pccompound&DbFrom=mesh&Cmd=Link&LinkName=mesh_pccompound&IdsFromResult=2023419'}]}]}}]}]}, {'TOCHeading': 'Use and Manufacturing', 'Description': 'This section provides information on the use and manufacturing information for this chemical, such as uses, consumption patterns, manufacturing methods, and U.S. imports/exports/production.', 'Section': [{'TOCHeading': 'Uses', 'Description': 'Major uses of this chemical, including both consumer uses and industrial uses.', 'Section': [{'TOCHeading': 'Use Classification', 'Description': 'This section contains use classification/category information for this compound from various sources.', 'Information': [{'ReferenceNumber': 18, 'Value': {'StringWithMarkup': [{'String': 'Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients'}]}}]}]}]}, {'TOCHeading': 'Safety and Hazards', 'Description': 'Information on safety and hazards for this compound, including safety/hazards properties, reactivity, incompatibilities, management techniques, first aid treatments, and more.  For toxicity and related information, please see the Toxicity section.', 'Section': [{'TOCHeading': 'Hazards Identification', 'Description': 'This section identifies the hazards of the chemical presented on the safety data sheet (SDS) and the appropriate warning information associated with those hazards.  The information in this section includes, but are not limited to, the hazard classification of the chemical, signal word, pictograms, hazard statements and precautionary statements.', 'URL': 'https://www.osha.gov/sites/default/files/publications/OSHA3514.pdf', 'Section': [{'TOCHeading': 'GHS Classification', 'Description': 'GHS (Globally Harmonized System of Classification and Labelling of Chemicals) is a United Nations system to identify hazardous chemicals and to inform users about these hazards. GHS has been adopted by many countries around the world and is now also used as the basis for international and national transport regulations for dangerous goods. The GHS hazard statements, class categories, pictograms, signal words, and the precautionary statements can be found on the PubChem GHS page.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'ThisSection', 'NumberOfColumns': 2, 'ColumnContents': ['Name', 'Value']}, 'ShowAtMost': 1}, 'Information': [{'ReferenceNumber': 13, 'Name': 'Pictogram(s)', 'Value': {'StringWithMarkup': [{'String': '          ', 'Markup': [{'Start': 0, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS07.svg', 'Type': 'Icon', 'Extra': 'Irritant'}, {'Start': 1, 'Length': 1, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/images/ghs/GHS08.svg', 'Type': 'Icon', 'Extra': 'Health Hazard'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Signal', 'Value': {'StringWithMarkup': [{'String': 'Danger', 'Markup': [{'Start': 0, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'GHS Hazard Statements', 'Value': {'StringWithMarkup': [{'String': 'H302 (97%): Harmful if swallowed [Warning Acute toxicity, oral]', 'Markup': [{'Start': 34, 'Length': 7, 'Type': 'Color', 'Extra': 'GHSWarning'}]}, {'String': 'H360 (90.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]', 'Markup': [{'Start': 56, 'Length': 6, 'Type': 'Color', 'Extra': 'GHSDanger'}]}]}}, {'ReferenceNumber': 13, 'Name': 'Precautionary Statement Codes', 'Value': {'StringWithMarkup': [{'String': 'P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501', 'Markup': [{'Start': 0, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P203'}, {'Start': 6, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P264'}, {'Start': 12, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P270'}, {'Start': 18, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P280'}, {'Start': 24, 'Length': 9, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P301+P317'}, {'Start': 35, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P318'}, {'Start': 41, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P330'}, {'Start': 47, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P405'}, {'Start': 57, 'Length': 4, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/#P501'}]}]}}, {'ReferenceNumber': 13, 'Name': 'ECHA C&L Notifications Summary', 'Value': {'StringWithMarkup': [{'String': 'Aggregated GHS information provided per 33 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.', 'Markup': [{'Start': 0, 'Length': 176, 'Type': 'Italics'}]}, {'String': 'Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit  ECHA C&L website.', 'Markup': [{'Start': 327, 'Length': 20, 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285'}, {'Start': 0, 'Length': 348, 'Type': 'Italics'}]}]}}]}, {'TOCHeading': 'Hazard Classes and Categories', 'Description': 'The Hazard Classes and Categories are aligned with GHS (Globally Harmonized System of Classification and Labelling of Chemicals) hazard statement codes.  The percentage data in the parenthesis from ECHA indicates that the hazard classes and categories information are consolidated from multiple companies.  Also, see the detailed explanation from the above GHS classification section.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/ghs/', 'DisplayControls': {'ShowAtMost': 2}, 'Information': [{'ReferenceNumber': 13, 'Value': {'StringWithMarkup': [{'String': 'Acute Tox. 4 (97%)'}, {'String': 'Repr. 1B (90.9%)'}]}}]}]}]}, {'TOCHeading': 'Associated Disorders and Diseases', 'Description': 'Disorders and diseases associated with the compound.  The contexts of the associations listed in this section vary. For example, a compound may cause its associated diseases (e.g., carcinogens and cancers) or have a therapeutic effect in treatment of the diseases (e.g., antihistamines and allergies), or be used as a marker/indicator for the diseases (e.g., glucose and diabetes).', 'DisplayControls': {'CreateTable': {'FromInformationIn': 'Subsections', 'NumberOfColumns': 2, 'ColumnHeadings': ['Disease', 'References'], 'ColumnContents': ['Name', 'Value']}}, 'Information': [{'ReferenceNumber': 25, 'Value': {'ExternalTableName': 'consolidateddiseaseassociation'}}]}, {'TOCHeading': 'Literature', 'Description': 'Scientific articles associated with this compound.  Some chemical-literature associations in this section are provided by data contributors or derived from MeSH annotations, as explained in Kim et al., J. Cheminform. 2016, 8, 32.  This section also provides the lists of chemicals, genes/proteins, and diseases, that are co-mentioned in scientific articles, as described in Zaslavsky et al., Front. Res. Metr. Anal., 2021, 6, 689059.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Section': [{'TOCHeading': 'Consolidated References', 'Description': 'The consolidated references include literature data from all sources including Springer Nature, Thieme Chemistry, Wiley, Nature journals, depositor provided citations, and NLM curated PubMed citations.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/literature', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'literature'}}]}, {'TOCHeading': 'NLM Curated PubMed Citations', 'Description': 'The NLM Curated PubMed Citations section links to all PubMed records that are tagged with the same MeSH term that has been associated with a particular compound.', 'URL': 'https://jcheminf.biomedcentral.com/articles/10.1186/s13321-016-0142-6', 'Information': [{'ReferenceNumber': 49, 'URL': 'https://www.ncbi.nlm.nih.gov/sites/entrez?LinkName=pccompound_pubmed_mesh&db=pccompound&cmd=Link&from_uid=10174505', 'Value': {'Boolean': [True]}}]}, {'TOCHeading': 'Thieme References', 'Description': 'Literature references related to scientific contents from Thieme Chemistry journals and books. The Thieme Chemistry content within this section is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'Information': [{'ReferenceNumber': 26, 'Value': {'ExternalTableName': 'collection=thiemechemistry&query_type=sid&query=376755820'}}]}, {'TOCHeading': 'Wiley References', 'Description': 'Literature references related to scientific contents from Wiley journals and books.', 'Information': [{'ReferenceNumber': 28, 'Value': {'ExternalTableName': 'collection=wiley&query_type=sid&query=386269757'}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Literature', 'Description': 'Chemical co-occurrences in literature highlight chemicals mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalNeighbor'}, {'String': 'Chemical'}, {'String': 'ChemicalName_1'}, {'String': 'ChemicalName_2'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Literature', 'Description': 'Chemical-gene co-occurrences in the literature highlight chemical-gene pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two.  Note that a co-occurring gene entity is organism non-specific and could refer to a gene, protein, or enzyme.  Also note that this content is not human curated.  It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalGeneSymbolNeighbor'}, {'String': 'Gene/Protein/Enzyme'}, {'String': 'ChemicalName'}, {'String': 'GeneSymbolName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Literature', 'Description': 'Chemical-disease co-occurrences in literature highlight chemical-disease pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'URL': 'https://doi.org/10.3389/frma.2021.689059', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalDiseaseNeighbor'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'DiseaseName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Literature', 'Description': 'Chemical-organism co-occurrences in literature highlight chemical-organism pairs mentioned together in scientific articles. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of publications and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'ChemicalOrganismNeighbor'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'OrganismName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Patents', 'Description': 'Patent applications/documents that mention this compound.', 'DisplayControls': {'ListType': 'Columns'}, 'Section': [{'TOCHeading': 'Depositor-Supplied Patent Identifiers', 'Description': 'Patent identifiers provided by data depositors, along with information on those patents.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'patent'}}, {'ReferenceNumber': 29, 'Value': {'StringWithMarkup': [{'String': 'Link to all deposited patent identifiers', 'Markup': [{'Start': 0, 'Length': 40, 'URL': 'https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/10174505/xrefs/PatentID/TXT'}]}]}}]}, {'TOCHeading': 'FDA Orange Book Patents', 'Description': 'Patents listed for this chemical in the Orange Book published by U.S. Food and Drug Administration (FDA). The Orange Book identifies FDA-approved drug products and related patent and exclusivity information.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'Information': [{'ReferenceNumber': 18, 'Value': {'ExternalTableName': ""collection=fdaorgpt&query_type=synonym&query='^TOFACITINIB CITRATE$'""}}]}, {'TOCHeading': 'Chemical Co-Occurrences in Patents', 'Description': 'Chemical co-occurrences in patents highlight chemicals mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalChemical'}, {'String': 'Chemical'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'SUMMARY_URL.cid'}, {'String': 'CID'}, {'String': 'CID'}]}}]}, {'TOCHeading': 'Chemical-Disease Co-Occurrences in Patents', 'Description': 'Disease co-occurrences in patents highlight chemicals and diseases mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalDisease'}, {'String': 'Disease'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://meshb.nlm.nih.gov/record/ui?ui='}, {'String': 'CID'}, {'String': 'MeSH'}]}}]}, {'TOCHeading': 'Chemical-Gene Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and genes mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalGene'}, {'String': 'Gene'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/gene/SYMBOL:'}, {'String': 'CID'}, {'String': 'GeneSymbol'}]}}]}, {'TOCHeading': 'Chemical-Organism Co-Occurrences in Patents', 'Description': 'Gene co-occurrences in patents highlight chemicals and organisms mentioned together in patent documents. This may suggest that an important relationship exists between the two. Please note that this content is not human curated. It is generated by text-mining algorithms that can be fooled such that a co-occurrence may be happenstance or a casual mention. The lists are ordered by relevancy as indicated by count of patents and other statistics, with the most relevant mentions appearing at the top.', 'Information': [{'ReferenceNumber': 29, 'Name': 'Co-Occurrence Panel', 'Value': {'StringWithMarkup': [{'String': 'PatentChemicalOrganism'}, {'String': 'Organism'}, {'String': 'ChemicalName'}, {'String': 'NeighborName'}, {'String': 'https://pubchem.ncbi.nlm.nih.gov/taxonomy/'}, {'String': 'CID'}, {'String': 'TaxonomyID'}]}}]}]}, {'TOCHeading': 'Biological Test Results', 'Description': 'A PubChem substance or compound summary page displays biological test results from the PubChem BioAssay database, if/as available, for the chemical structure currently displayed. You can embed biological test results displays within your own web pages, for a PubChem Compound or Substance of interest, by using the BioActivity Widget.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/docs/widgets', 'Section': [{'TOCHeading': 'BioAssay Results', 'Description': 'Bioactivity data for this compound, reported in PubChem BioAssay records.', 'Information': [{'ReferenceNumber': 29, 'Value': {'ExternalTableName': 'bioactivity'}}]}]}, {'TOCHeading': 'Classification', 'Description': 'A set of concepts and categories in a subject area or domain that shows their properties and the relations between them.', 'Section': [{'TOCHeading': 'MeSH Tree', 'Description': 'The Medical Subject Headings (MeSH) tree for this entity.  MeSH is a controlled and hierarchically-organized vocabulary produced by the National Library of Medicine.', 'URL': 'https://www.nlm.nih.gov/mesh', 'Information': [{'ReferenceNumber': 31, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=1', 'Value': {'Number': [1]}}]}, {'TOCHeading': 'NCI Thesaurus Tree', 'Description': 'NCI Thesaurus (NCIt) hierarchy', 'URL': 'https://ncithesaurus.nci.nih.gov', 'Information': [{'ReferenceNumber': 44, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=112', 'Value': {'Number': [112]}}]}, {'TOCHeading': 'ChEBI Ontology', 'Description': ""ChEBI Ontology tree.  ChEBI is an acronym for Chemical Entities of Biological Interest, which is a freely available dictionary of molecular entities focused on 'small' chemical compounds. ChEBI incorporates an ontological classification, whereby the relationships between molecular entities or classes of entities and their parents and/or children are specified."", 'URL': 'https://www.ebi.ac.uk/chebi/', 'Information': [{'ReferenceNumber': 32, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=2', 'Value': {'Number': [2]}}]}, {'TOCHeading': 'KEGG: Drug', 'Description': 'Classification/ontology tree for therapeutic categories of drugs in Japan, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08301', 'Information': [{'ReferenceNumber': 33, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=14', 'Value': {'Number': [14]}}]}, {'TOCHeading': 'KEGG: USP', 'Description': 'US Pharmacopeia (USP) drug classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08302', 'Information': [{'ReferenceNumber': 34, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=15', 'Value': {'Number': [15]}}]}, {'TOCHeading': 'KEGG: ATC', 'Description': 'Anatomical Therapeutic Chemical (ATC) classification tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08303', 'Information': [{'ReferenceNumber': 35, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=16', 'Value': {'Number': [16]}}]}, {'TOCHeading': 'KEGG: Target-based Classification of Drugs', 'Description': 'Target-based classification tree of drugs, from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08310', 'Information': [{'ReferenceNumber': 36, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=22', 'Value': {'Number': [22]}}]}, {'TOCHeading': 'KEGG: Drug Groups', 'Description': 'KEGG : Drug Groups tree', 'Information': [{'ReferenceNumber': 41, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=96', 'Value': {'Number': [96]}}]}, {'TOCHeading': 'KEGG: Drug Classes', 'Description': 'Drug classes tree from the Kyoto Encyclopedia of Genes and Genomes (KEGG).', 'URL': 'https://www.genome.jp/kegg-bin/get_htext?htext=br08332', 'Information': [{'ReferenceNumber': 46, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=118', 'Value': {'Number': [118]}}]}, {'TOCHeading': 'ChemIDplus', 'Description': 'Classification of this compound, provided by ChemIDplus, which is a free web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases.  ChemIDplus groups chemicals based on the source locators (i.e., what information resources have data for a given chemical).', 'URL': 'https://chem.nlm.nih.gov/chemidplus/', 'Information': [{'ReferenceNumber': 39, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=84', 'Value': {'Number': [84]}}]}, {'TOCHeading': 'ChEMBL Target Tree', 'Description': 'Classification of this entity in the context of targets, provided by ChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/', 'Information': [{'ReferenceNumber': 40, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=87', 'Value': {'Number': [87]}}]}, {'TOCHeading': 'UN GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labelling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, and health and safety information on hazardous chemical substances and mixtures."", 'URL': 'https://unece.org/about-ghs', 'Information': [{'ReferenceNumber': 38, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=83', 'Value': {'Number': [83]}}]}, {'TOCHeading': 'EPA DSSTox Classification', 'Description': ""Classification from the U.S. Environmental Protection Agency's Distributed Structure-Searchable Toxicity (DSSTox) database. DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology. A distinguishing feature of this effort is the accurate mapping of bioassay and physicochemical property data associated with chemical substances to their corresponding chemical structures. "", 'URL': 'https://www.epa.gov/chemical-research/distributed-structure-searchable-toxicity-dsstox-database', 'Information': [{'ReferenceNumber': 42, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=105', 'Value': {'Number': [105]}}]}, {'TOCHeading': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is based on the FDA drug type and pharm classes data from the National Drug Code (NDC) Directory.', 'Information': [{'ReferenceNumber': 45, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=116', 'Value': {'Number': [116]}}]}, {'TOCHeading': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign compounds to structural classes, currently mapped to >1.7 million per- and polyfluoroalkyl substances (PFAS) extracted from the datasets explained in Barnabas et al (2022) DOI: 10.1039/D2DD00019A', 'URL': 'https://github.com/MolGenie/ontology/', 'Information': [{'ReferenceNumber': 47, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=134', 'Value': {'Number': [134]}}]}, {'TOCHeading': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.', 'Information': [{'ReferenceNumber': 48, 'Name': 'HID', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/classification/#hid=135', 'Value': {'Number': [135]}}]}]}], 'Reference': [{'ReferenceNumber': 1, 'SourceName': 'CAS Common Chemistry', 'SourceID': '540737-29-9', 'Name': 'Tofacitinib citrate', 'Description': 'CAS Common Chemistry is an open community resource for accessing chemical information. Nearly 500,000 chemical substances from CAS REGISTRY cover areas of community interest, including common and frequently regulated chemicals, and those relevant to high school and undergraduate chemistry classes. This chemical information, curated by our expert scientists, is provided in alignment with our mission as a division of the American Chemical Society.', 'URL': 'https://commonchemistry.cas.org/detail?cas_rn=540737-29-9', 'LicenseNote': 'The data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc/4.0/', 'ANID': 12841017}, {'ReferenceNumber': 4, 'SourceName': 'ChemIDplus', 'SourceID': '0540737299', 'Name': 'Tofacitinib citrate [USAN]', 'Description': 'ChemIDplus is a free, web search system that provides access to the structure and nomenclature authority files used for the identification of chemical substances cited in National Library of Medicine (NLM) databases, including the TOXNET system.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0540737299', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True, 'ANID': 1137661}, {'ReferenceNumber': 11, 'SourceName': 'EPA DSSTox', 'SourceID': 'DTXSID80202404', 'Name': 'Tofacitinib citrate', 'Description': 'DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.', 'URL': 'https://comptox.epa.gov/dashboard/DTXSID80202404', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources', 'ANID': 1256973}, {'ReferenceNumber': 14, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '638-826-4', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile', 'Description': ""The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness."", 'URL': 'https://echa.europa.eu/substance-information/-/substanceinfo/100.166.451', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 15121079}, {'ReferenceNumber': 15, 'SourceName': 'FDA Global Substance Registration System (GSRS)', 'SourceID': 'O1FF4DIV0D', 'Name': 'Tofacitinib citrate', 'Description': 'The FDA Global Substance Registration System (GSRS) enables the efficient and accurate exchange of information on what substances are in regulated products. Instead of relying on names, which vary across regulatory domains, countries, and regions, the GSRS knowledge base makes it possible for substances to be defined by standardized, scientific descriptions.', 'URL': 'https://gsrs.ncats.nih.gov/ginas/app/beta/substances/O1FF4DIV0D', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 5827374}, {'ReferenceNumber': 2, 'SourceName': 'ChEBI', 'SourceID': 'CHEBI:OBO:10174505', 'Name': 'Tofacitinib citrate', 'Description': 'Chemical Entities of Biological Interest (ChEBI) is a database and ontology of molecular entities focused on \'small\' chemical compounds, that is part of the Open Biomedical Ontologies effort. The term ""molecular entity"" refers to any constitutionally or isotopically distinct atom, molecule, ion, ion pair, radical, radical ion, complex, conformer, etc., identifiable as a separately distinguishable entity.', 'URL': 'https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:71197', 'ANID': 2438742}, {'ReferenceNumber': 23, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'C95801::Compound', 'Description': 'NCI Thesaurus (NCIt), from the U.S. National Cancer Institute, provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C95801', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse', 'ANID': 19450627}, {'ReferenceNumber': 25, 'SourceName': 'Open Targets', 'SourceID': 'Compound::CHEMBL2103743', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets.', 'URL': 'https://platform.opentargets.org/drug/CHEMBL2103743', 'LicenseNote': 'Datasets generated by the Open Targets Platform are freely available for download.', 'LicenseURL': 'https://platform-docs.opentargets.org/licence', 'ANID': 45237079}, {'ReferenceNumber': 3, 'SourceName': 'ChEMBL', 'SourceID': 'Compound::CHEMBL2103743', 'Description': 'ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug-like properties. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.', 'URL': 'https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2103743', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html', 'ANID': 32458663}, {'ReferenceNumber': 5, 'SourceName': 'ClinicalTrials.gov', 'SourceID': 'cid10174505', 'Description': 'ClinicalTrials.gov is an NIH registry and results database of publicly and privately supported clinical studies of human participants conducted around the world.', 'URL': 'https://clinicaltrials.gov/', 'LicenseNote': 'The ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.', 'LicenseURL': 'https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use', 'ANID': 8469261}, {'ReferenceNumber': 6, 'SourceName': 'DailyMed', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The U.S. National Library of Medicine's DailyMed provides trustworthy information about marketed drugs. DailyMed is the official provider of FDA label information (package inserts)."", 'URL': 'https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TOFACITINIB+CITRATE', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'ANID': 30969489}, {'ReferenceNumber': 7, 'SourceName': 'Drugs@FDA', 'SourceID': '65e3a9640c98b2a62e25da465bf27db6', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38968356}, {'ReferenceNumber': 8, 'SourceName': 'Drugs@FDA', 'SourceID': '91a4b6f22fd3e0eb99d193e3250db37b', 'Name': 'XELJANZ', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38973752}, {'ReferenceNumber': 9, 'SourceName': 'Drugs@FDA', 'SourceID': '0db3870d4aaa0c78f4bbac3dbfb8ab49', 'Name': 'XELJANZ XR', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38978315}, {'ReferenceNumber': 10, 'SourceName': 'Drugs@FDA', 'SourceID': '17e547e9102d0f62a452eaeb90cfaee7', 'Name': 'TOFACITINIB CITRATE', 'Description': 'Drugs@FDA includes most of the drug products approved for human use since 1939. This includes prescription, generic, over-the-counter and therapeutic biological products. The majority of patient information, labels, approval letters and reviews are available for drug products approved since 1998.', 'URL': 'https://www.accessdata.fda.gov/scripts/cder/daf/', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 38979432}, {'ReferenceNumber': 12, 'SourceName': 'EU Clinical Trials Register', 'SourceID': 'cid10174505', 'Description': 'The EU Clinical Trials Register contains information on interventional clinical trials on medicines conducted in the European Union (EU), or the European Economic Area (EEA) which started after 1 May 2004.', 'URL': 'https://www.clinicaltrialsregister.eu/', 'ANID': 6482641}, {'ReferenceNumber': 13, 'SourceName': 'European Chemicals Agency (ECHA)', 'SourceID': '171285', 'Name': '2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile (EC: 638-826-4)', 'Description': 'The information provided here is aggregated from the ""Notified classification and labelling"" from ECHA\'s C&L Inventory. Read more: https://echa.europa.eu/information-on-chemicals/cl-inventory-database', 'URL': 'https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/171285', 'LicenseNote': 'Use of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: ""Source: European Chemicals Agency, http://echa.europa.eu/"". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.', 'LicenseURL': 'https://echa.europa.eu/web/guest/legal-notice', 'ANID': 1908109}, {'ReferenceNumber': 16, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ', 'Name': 'XELJANZ', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228897}, {'ReferenceNumber': 17, 'SourceName': 'FDA Medication Guides', 'SourceID': 'XELJANZ XR', 'Name': 'XELJANZ XR', 'Description': 'FDA Medication Guides are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events. https://dps.fda.gov/medguide', 'URL': 'https://dps.fda.gov/medguide', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 45228898}, {'ReferenceNumber': 18, 'SourceName': 'FDA Orange Book', 'SourceID': '0da72ea9c4041d0c7d8fda95597fe4b9', 'Name': 'TOFACITINIB CITRATE', 'Description': 'The publication, Approved Drug Products with Therapeutic Equivalence Evaluations (the List, commonly known as the Orange Book), identifies drug products approved on the basis of safety and effectiveness by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act (the Act).', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 35238202}, {'ReferenceNumber': 19, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2316230497', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413640}, {'ReferenceNumber': 20, 'SourceName': 'Japan Pharmaceuticals and Medical Devices Agency (PMDA)', 'SourceID': '2672473321', 'Name': 'Tofacitinib citrate', 'Description': 'The Japan Pharmaceuticals and Medical Devices Agency (PMDA) is the Japanese regulatory agency, working together with the Ministry of Health, Labour and Welfare, that protects the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.', 'URL': 'https://www.pmda.go.jp/english/review-services/reviews/approved-information/drugs/0001.html', 'ANID': 39413641}, {'ReferenceNumber': 21, 'SourceName': 'KEGG', 'SourceID': 'D09783', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'https://www.kegg.jp/entry/D09783', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html', 'ANID': 31108837}, {'ReferenceNumber': 22, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'ef6063d1c5af5f9f88d17fd81a91f5e9', 'Name': 'TOFACITINIB CITRATE', 'Description': ""The National Drug Code (NDC) is a unique, three-segment number that serves as FDA's identifier for drugs. The NDC Directory contains information on active and certified finished and unfinished drugs submitted to FDA."", 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking', 'ANID': 31082893}, {'ReferenceNumber': 24, 'SourceName': 'NLM RxNorm Terminology', 'SourceID': '1358492', 'Name': 'tofacitinib citrate', 'Description': 'RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software.', 'URL': 'https://rxnav.nlm.nih.gov/id/rxnorm/1358492', 'LicenseNote': 'The RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.', 'LicenseURL': 'https://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html', 'ANID': 15098179}, {'ReferenceNumber': 26, 'SourceName': 'Thieme Chemistry', 'SourceID': '376755820', 'Description': 'Thieme Chemistry is part of the privately owned Thieme Group and publishes highly evaluated information about synthetic and general chemistry for professional chemists and advanced students since 1909. \n \nOur portfolio includes the journals SYNFACTS, SYNLETT, SYNTHESIS and SynOpen, the synthetic methodology reference work Science of Synthesis, the German chemical encyclopedia ROEMPP, and monographs in electronic and printed format. The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license (https://creativecommons.org/licenses/by-nc-nd/4.0/), unless otherwise stated.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/376755820', 'LicenseNote': 'The Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.', 'LicenseURL': 'https://creativecommons.org/licenses/by-nc-nd/4.0/', 'ANID': 48717829}, {'ReferenceNumber': 27, 'SourceName': 'Wikidata', 'SourceID': 'Compound::Q27139435', 'Name': 'tofacitinib citrate', 'Description': 'Wikidata is a CCZero crowdsourced and curated database, linked to Wikipedia, with a strong machine readable architecture.', 'URL': 'https://www.wikidata.org/wiki/Q27139435', 'LicenseNote': 'CCZero', 'LicenseURL': 'https://creativecommons.org/publicdomain/zero/1.0/', 'ANID': 44237777}, {'ReferenceNumber': 28, 'SourceName': 'Wiley', 'SourceID': '386269757', 'Description': 'Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/substance/386269757', 'ANID': 49039699}, {'ReferenceNumber': 29, 'SourceName': 'PubChem', 'SourceID': 'PubChem', 'Description': 'Data deposited in or computed by PubChem', 'URL': 'https://pubchem.ncbi.nlm.nih.gov'}, {'ReferenceNumber': 30, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '67479163', 'Name': 'tofacitinib', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/67479163', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 31, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'DescTree', 'Name': 'MeSH Tree', 'Description': 'MeSH (Medical Subject Headings) is the NLM controlled vocabulary thesaurus used for indexing articles for PubMed.', 'URL': 'http://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 32, 'SourceName': 'ChEBI', 'SourceID': 'OBO', 'Name': 'ChEBI Ontology', 'Description': 'The ChEBI Ontology is a structured classification of the entities contained within ChEBI.', 'URL': 'http://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology'}, {'ReferenceNumber': 33, 'SourceName': 'KEGG', 'SourceID': 'br08301', 'Name': 'Therapeutic category of drugs in Japan', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08301.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 34, 'SourceName': 'KEGG', 'SourceID': 'br08302', 'Name': 'USP drug classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08302.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 35, 'SourceName': 'KEGG', 'SourceID': 'br08303', 'Name': 'Anatomical Therapeutic Chemical (ATC) classification', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08303.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 36, 'SourceName': 'KEGG', 'SourceID': 'br08310', 'Name': 'Target-based classification of drugs', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08310.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 38, 'SourceName': 'GHS Classification (UNECE)', 'SourceID': 'UN_GHS_tree', 'Name': 'GHS Classification', 'Description': ""The United Nations' Globally Harmonized System of Classification and Labeling of Chemicals (GHS) provides a harmonized basis for globally uniform physical, environmental, health and safety information on hazardous chemical substances and mixtures."", 'URL': 'http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html'}, {'ReferenceNumber': 39, 'SourceName': 'ChemIDplus', 'SourceID': 'ChemIDplus_tree', 'Name': 'ChemIDplus Chemical Information Classification', 'Description': 'ChemIDplus is a TOXNET (TOXicology data NETwork) databases that contain chemicals and drugs related information.', 'URL': 'https://pubchem.ncbi.nlm.nih.gov/source/chemidplus', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html', 'IsToxnet': True}, {'ReferenceNumber': 40, 'SourceName': 'ChEMBL', 'SourceID': 'Target Tree', 'Name': 'ChEMBL Protein Target Tree', 'Description': 'The ChEMBL Protein Target Tree is a structured classification of the protein target entities contained with the ChEMBL resource release version 35\nChEMBL.', 'URL': 'https://www.ebi.ac.uk/chembl/g/#browse/targets', 'LicenseNote': ""Access to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/)."", 'LicenseURL': 'http://www.ebi.ac.uk/Information/termsofuse.html'}, {'ReferenceNumber': 41, 'SourceName': 'KEGG', 'SourceID': 'br08330', 'Name': 'Drug Groups', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08330.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 42, 'SourceName': 'EPA DSSTox', 'SourceID': 'dsstoxlist_tree', 'Name': 'CompTox Chemicals Dashboard Chemical Lists', 'Description': 'This classification lists the chemical categories from the EPA CompTox Chemicals Dashboard.', 'URL': 'https://comptox.epa.gov/dashboard/chemical-lists/', 'LicenseURL': 'https://www.epa.gov/privacy/privacy-act-laws-policies-and-resources'}, {'ReferenceNumber': 44, 'SourceName': 'NCI Thesaurus (NCIt)', 'SourceID': 'NCIt', 'Name': 'NCI Thesaurus', 'Description': 'The NCI Thesaurus (NCIt) provides reference terminology for many NCI and other systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.', 'URL': 'https://ncit.nci.nih.gov', 'LicenseNote': 'Unless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.', 'LicenseURL': 'https://www.cancer.gov/policies/copyright-reuse'}, {'ReferenceNumber': 45, 'SourceName': 'National Drug Code (NDC) Directory', 'SourceID': 'fdandc_tree', 'Name': 'FDA Drug Type and Pharmacologic Classification', 'Description': 'The FDA Drug Type and Pharmacologic Classification is created based on the FDA drug types and pharm classes data from the National Drug Code (NDC) Directory.', 'URL': 'https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory', 'LicenseNote': 'Unless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.', 'LicenseURL': 'https://www.fda.gov/about-fda/about-website/website-policies#linking'}, {'ReferenceNumber': 46, 'SourceName': 'KEGG', 'SourceID': 'br08332', 'Name': 'Drug Classes', 'Description': 'KEGG is an encyclopedia of genes and genomes. Assigning functional meanings to genes and genomes both at the molecular and higher levels is the primary objective of the KEGG database project.', 'URL': 'http://www.genome.jp/kegg-bin/get_htext?br08332.keg', 'LicenseNote': 'Academic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license', 'LicenseURL': 'https://www.kegg.jp/kegg/legal.html'}, {'ReferenceNumber': 47, 'SourceName': 'MolGenie', 'SourceID': 'mol_classes', 'Name': 'MolGenie Organic Chemistry Ontology', 'Description': 'An organic chemistry ontology developed by MolGenie and OntoChem to assign chemical entities to structural classes, split into three main subsections: calculated properties, compounds and substructural concepts. The ontology contains chemistry structural classes with a focus on elements and small organic compounds, but not inorganic, polymer, biopolymer, metal complexes, metal organic frameworks (MOFs) and other chemistry entities. The ontology has been mapped to several collections of chemicals, including (a) Chemicals of Biological Interest (ChEBI), (b) the ChEMBL database of bioactive molecules, (c) the LOTUS natural product collection, (d) per- and polyfluoroalkyl substances (PFAS) extracted from Barnabas et al (2022) DOI: 10.1039/D2DD00019A (e) PubChemLite and (f) the ZeroPM Global Chemical Inventory.', 'URL': 'https://github.com/MolGenie/ontology/', 'LicenseNote': 'CC-BY 4.0', 'LicenseURL': 'https://creativecommons.org/licenses/by/4.0/'}, {'ReferenceNumber': 48, 'SourceName': 'PubChem', 'SourceID': 'regtree', 'Name': 'Chemicals in PubChem from Regulatory Sources', 'Description': 'PubChem chemicals with regulatory data sources provides list of chemicals with annotation specific to regulatory data sources.'}, {'ReferenceNumber': 49, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': 'PubMed from MeSH', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.nlm.nih.gov/mesh/meshhome.html', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}, {'ReferenceNumber': 50, 'SourceName': 'Medical Subject Headings (MeSH)', 'SourceID': '2023419', 'Name': 'Janus Kinase Inhibitors', 'Description': ""MeSH (Medical Subject Headings) is the U.S. National Library of Medicine's controlled vocabulary thesaurus used for indexing articles for PubMed."", 'URL': 'https://www.ncbi.nlm.nih.gov/mesh/2023419', 'LicenseNote': 'Works produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.', 'LicenseURL': 'https://www.nlm.nih.gov/copyright.html'}]}}",,,,,,,,,,,,[8],[12],[5],[36],[221]
